
<html lang="en"     class="pb-page"  data-request-id="5c899bc3-30cc-4b7b-a9c9-d79a6e002f3c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2000.43.issue-7;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm990482t"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Tyrosine Kinase Inhibitors. 17. Irreversible Inhibitors of the Epidermal Growth Factor Receptor:  4-(Phenylamino)quinazoline- and 4-(Phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides Bearing Additional Solubilizing Functions" /></meta><meta name="dc.Creator" content="Jeff B.  Smaill,†" /></meta><meta name="dc.Creator" content="Gordon W.  Rewcastle,†" /></meta><meta name="dc.Creator" content="Joseph A.  Loo,‡" /></meta><meta name="dc.Creator" content="Kenneth D.  Greis,§" /></meta><meta name="dc.Creator" content="O. Helen  Chan,‡" /></meta><meta name="dc.Creator" content="Eric L.  Reyner,‡" /></meta><meta name="dc.Creator" content="Elke  Lipka,‡" /></meta><meta name="dc.Creator" content="H. D. Hollis  Showalter,‡" /></meta><meta name="dc.Creator" content="Patrick W.  Vincent,‡" /></meta><meta name="dc.Creator" content="William L.  Elliott,‡ and" /></meta><meta name="dc.Creator" content="William A.  Denny*,†" /></meta><meta name="dc.Description" content="4-Anilinoquinazoline- and 4-anilinopyrido[3,2-d]pyrimidine-6-acrylamides substituted with solubilizing 7-alkylamine or 7-alkoxyamine side chains were prepared by reaction of the corresponding 6-ami..." /></meta><meta name="Description" content="4-Anilinoquinazoline- and 4-anilinopyrido[3,2-d]pyrimidine-6-acrylamides substituted with solubilizing 7-alkylamine or 7-alkoxyamine side chains were prepared by reaction of the corresponding 6-ami..." /></meta><meta name="dc.Publisher" content=" American Chemical Society " /></meta><meta name="dc.Date" scheme="WTN8601" content="March 14, 2000" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm990482t" /></meta><meta name="dc.Identifier" scheme="crossover-key" content="JMCMAr-43-7-1380" /></meta><meta name="dc.Identifier" scheme="pii" content="S0022-2623(99)00482-3" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2000 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm990482t" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm990482t" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm990482t" /></link>
        
    
    

<title>Tyrosine Kinase Inhibitors. 17. Irreversible Inhibitors of the Epidermal Growth Factor Receptor:  4-(Phenylamino)quinazoline- and 4-(Phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides Bearing Additional Solubilizing Functions | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm990482t" /></meta><meta property="og:title" content="Tyrosine Kinase Inhibitors. 17. Irreversible Inhibitors of the Epidermal Growth Factor Receptor:  4-(Phenylamino)quinazoline- and 4-(Phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides Bearing Additional Solubilizing Functions" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482tn00001.jpeg" /></meta><meta property="og:description" content=" 4-Anilinoquinazoline- and 4-anilinopyrido[3,2-d]pyrimidine-6-acrylamides substituted with solubilizing 7-alkylamine or 7-alkoxyamine side chains were prepared by reaction of the corresponding 6-amines with acrylic acid or acrylic acid anhydrides. In the pyrido[3,2-d]pyrimidine series, the intermediate 6-amino-7-alkylamines were prepared from 7-bromo-6-fluoropyrido[3,2-d]pyrimidine via Stille coupling with the appropriate stannane under palladium(0) catalysis. This proved a versatile method for the introduction of cationic solubilizing side chains. The compounds were evaluated for their inhibition of phosphorylation of the isolated EGFR enzyme and for inhibition of EGF-stimulated autophosphorylation of EGFR in A431 cells and of heregulin-stimulated autophosphorylation of erbB2 in MDA-MB 453 cells. Quinazoline analogues with 7-alkoxyamine solubilizing groups were potent irreversible inhibitors of the isolated EGFR enzyme, with IC50[app] values from 2 to 4 nM, and potently inhibited both EGFR and erbB2 autophosphorylation in cells. 7-Alkylamino- and 7-alkoxyaminopyrido[3,2-d]pyrimidines were also irreversible inhibitors with equal or superior potency against the isolated enzyme but were less effective in the cellular autophosphorylation assays. Both quinazoline- and pyrido[3,2-d]pyrimidine-6-acrylamides bound at the ATP site alkylating cysteine 773, as shown by electrospray ionization mass spectrometry, and had similar rates of absorptive and secretory transport in Caco-2 cells. A comparison of two 7-propoxymorpholide analogues showed that the pyrido[3,2-d]pyrimidine-6-acrylamide had greater amide instability and higher acrylamide reactivity, being converted to glutathione adducts in cells more rapidly than the corresponding quinazoline. This difference may contribute to the observed lower cellular potency of the pyrido[3,2-d]pyrimidine-6-acrylamides. Selected compounds showed high in vivo activity against A431 xenografts on oral dosing, with the quinazolines being superior to the pyrido[3,2-d]pyrimidines. Overall, the quinazolines proved superior to previous analogues in terms of aqueous solubility, potency, and in vivo antitumor activity, and one example (CI 1033) has been selected for clinical evaluation.  " /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm990482t"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm990482t">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm990482t&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm990482t&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm990482t&amp;href=/doi/10.1021/jm990482t" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2000</span><span class="cit-fg-volume">, 43</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 1380-1397</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/43/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm9911579" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm990483l" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/jm000250q"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Tyrosine Kinase Inhibitors. 17. Irreversible Inhibitors of the Epidermal Growth Factor Receptor:  4-(Phenylamino)quinazoline- and 4-(Phenylamino)pyrido[3,2-<i>d</i>]pyrimidine-6-acrylamides Bearing Additional Solubilizing Functions</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeff+B.++Smaill">Jeff B. Smaill</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gordon+W.++Rewcastle">Gordon W. Rewcastle</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+A.++Loo">Joseph A. Loo</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenneth+D.++Greis">Kenneth D. Greis</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=O.+Helen++Chan">O. Helen Chan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric+L.++Reyner">Eric L. Reyner</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elke++Lipka">Elke Lipka</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=H.+D.+Hollis++Showalter">H. D. Hollis Showalter</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick+W.++Vincent">Patrick W. Vincent</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+L.++Elliott">William L. Elliott</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+A.++Denny">William A. Denny</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland, New Zealand, and Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047 </span></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="JMCMAr" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm990482t&amp;href=/doi/10.1021%2Fjm990482t" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2000</span></span><span class="cit-volume">, 43</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 1380–1397</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 14, 2000</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 September 1999</li><li><span class="item_label"><b>Published</b> online</span>14 March 2000</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 6 April 2000</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm990482t" title="DOI URL">https://doi.org/10.1021/jm990482t</a></div><div class="article_header-article-copyright"><strong>Copyright © 2000 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1380%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJeff%2BB.%2BSmaill%252C%2BGordon%2BW.%2BRewcastle%252C%2BJoseph%2BA.%2BLoo%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D43%26issueNum%3D7%26contentID%3Djm990482t%26title%3DTyrosine%2BKinase%2BInhibitors.%2B17.%2BIrreversible%2BInhibitors%2Bof%2Bthe%2BEpidermal%2BGrowth%2BFactor%2BReceptor%253A%25E2%2580%2589%2B4-%2528Phenylamino%2529quinazoline-%2Band%2B4-%2528Phenylamino%2529pyrido%255B3%252C2-d%255Dpyrimidine-6-acrylamides%2BBearing%2BAdditional%2BSolubilizing%2BFunctions%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1397%26publicationDate%3DApril%2B2000">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm990482t"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3495</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">204</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm990482t" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Tyrosine Kinase Inhibitors. 17. Irreversible Inhibitors of the Epidermal Growth Factor Receptor:  4-(Phenylamino)quinazoline- and 4-(Phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides Bearing Additional Solubilizing Functions&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jeff&quot;,&quot;last_name&quot;:&quot;B. Smaill&quot;},{&quot;first_name&quot;:&quot;Gordon&quot;,&quot;last_name&quot;:&quot;W. Rewcastle&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;A. Loo&quot;},{&quot;first_name&quot;:&quot;Kenneth&quot;,&quot;last_name&quot;:&quot;D. Greis&quot;},{&quot;first_name&quot;:&quot;O.&quot;,&quot;last_name&quot;:&quot;Helen Chan&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;L. Reyner&quot;},{&quot;first_name&quot;:&quot;Elke&quot;,&quot;last_name&quot;:&quot;Lipka&quot;},{&quot;first_name&quot;:&quot;H.&quot;,&quot;last_name&quot;:&quot;D. Hollis Showalter&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;W. Vincent&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;L. Elliott&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;A. Denny&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2000&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;43&quot;,&quot;pages&quot;:&quot;1380-1397&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm990482t&quot;},&quot;abstract&quot;:&quot;4-Anilinoquinazoline- and 4-anilinopyrido[3,2-d]pyrimidine-6-acrylamides substituted with solubilizing 7-alkylamine or 7-alkoxyamine side chains were prepared by reaction of the corresponding 6-amines with acrylic acid or acrylic acid anhydrides. In the pyrido[3,2-d]pyrimidine series, the intermediate 6-amino-7-alkylamines were prepared from 7-bromo-6-fluoropyrido[3,2-d]pyrimidine via Stille coupling with the appropriate stannane under palladium(0) catalysis. This proved a versatile method for the introduction of cationic solubilizing side chains. The compounds were evaluated for their inhibition of phosphorylation of the isolated EGFR enzyme and for inhibition of EGF-stimulated autophosphorylation of EGFR in A431 cells and of heregulin-stimulated autophosphorylation of erbB2 in MDA-MB 453 cells. Quinazoline analogues with 7-alkoxyamine solubilizing groups were potent irreversible inhibitors of the isolated EGFR enzyme, with IC50[app] values from 2 to 4 nM, and potently inhibited both EGFR and erbB2 autophosp&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm990482t&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm990482t" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm990482t&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm990482t" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm990482t&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm990482t" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm990482t&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm990482t&amp;href=/doi/10.1021/jm990482t" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm990482t" /></input><a href="/doi/pdf/10.1021/jm990482t" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (286 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm990482t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm990482t%26sid%3Dliteratum%253Aachs%26pmid%3D10753475%26genre%3Darticle%26aulast%3DSmaill%26date%3D2000%26atitle%3DTyrosine%2BKinase%2BInhibitors.%2B17.%2BIrreversible%2BInhibitors%2Bof%2Bthe%2BEpidermal%2BGrowth%2BFactor%2BReceptor%253A%25E2%2580%2589%2B4-%2528Phenylamino%2529quinazoline-%2Band%2B4-%2528Phenylamino%2529pyrido%255B3%252C2-d%255Dpyrimidine-6-acrylamides%2BBearing%2BAdditional%2BSolubilizing%2BFunctions%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D43%26issue%3D7%26spage%3D1380%26epage%3D1397%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291917" title="Pyrimidine">Pyrimidine</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/43/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/medium/jm990482tn00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482tn00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm990482t&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">4-Anilinoquinazoline- and 4-anilinopyrido[3,2-<i>d</i>]pyrimidine-6-acrylamides substituted with solubilizing 7-alkylamine or 7-alkoxyamine side chains were prepared by reaction of the corresponding 6-amines with acrylic acid or acrylic acid anhydrides. In the pyrido[3,2-<i>d</i>]pyrimidine series, the intermediate 6-amino-7-alkylamines were prepared from 7-bromo-6-fluoropyrido[3,2-<i>d</i>]pyrimidine via Stille coupling with the appropriate stannane under palladium(0) catalysis. This proved a versatile method for the introduction of cationic solubilizing side chains. The compounds were evaluated for their inhibition of phosphorylation of the isolated EGFR enzyme and for inhibition of EGF-stimulated autophosphorylation of EGFR in A431 cells and of heregulin-stimulated autophosphorylation of <i>erb</i>B2 in MDA-MB 453 cells. Quinazoline analogues with 7-alkoxyamine solubilizing groups were potent irreversible inhibitors of the isolated EGFR enzyme, with IC<sub>50[app]</sub> values from 2 to 4 nM, and potently inhibited both EGFR and <i>erb</i>B2 autophosphorylation in cells. 7-Alkylamino- and 7-alkoxyaminopyrido[3,2-<i>d</i>]pyrimidines were also irreversible inhibitors with equal or superior potency against the isolated enzyme but were less effective in the cellular autophosphorylation assays. Both quinazoline- and pyrido[3,2-<i>d</i>]pyrimidine-6-acrylamides bound at the ATP site alkylating cysteine 773, as shown by electrospray ionization mass spectrometry, and had similar rates of absorptive and secretory transport in Caco-2 cells. A comparison of two 7-propoxymorpholide analogues showed that the pyrido[3,2-<i>d</i>]pyrimidine-6-acrylamide had greater amide instability and higher acrylamide reactivity, being converted to glutathione adducts in cells more rapidly than the corresponding quinazoline. This difference may contribute to the observed lower cellular potency of the pyrido[3,2-<i>d</i>]pyrimidine-6-acrylamides. Selected compounds showed high in vivo activity against A431 xenografts on oral dosing, with the quinazolines being superior to the pyrido[3,2-<i>d</i>]pyrimidines. Overall, the quinazolines proved superior to previous analogues in terms of aqueous solubility, potency, and in vivo antitumor activity, and one example (CI 1033) has been selected for clinical evaluation. </p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec fnGroup"><div class="fnGroupItem" id="jm990482tAF2"><span><h4><span class="NLM_fn-symbol">†</span></h4></span><span><p class="last">  The University of Auckland.</p></span></div><div class="fnGroupItem" id="jm990482tAF3"><span><h4><span class="NLM_fn-symbol">‡</span></h4></span><span><p class="last">  Parke-Davis Pharmaceutical Research.</p></span></div><div class="fnGroupItem" id="jm990482tAF4"><span><h4><span class="NLM_fn-symbol">§</span></h4></span><span><p class="last">  Current address:  Procter & Gamble Pharmaceuticals, 8700 Mason-Montgomery Rd., Mason, OH 45040.</p></span></div><div class="fnGroupItem" id="jm990482tAF1"><span><h4><span class="NLM_fn-symbol">*</span></h4></span><span><p class="last">  To whom correspondence should be addressed. Tel:  64 9 3737 599, ext. 6144. Fax:  64 9 3737 502. E-mail:  <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="c0a2eea4a5aeaeb980a1b5a3abaca1aea4eea1a3eeaebaee">[email protected]</a></p></span></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20813" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20813" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Overexpression of the epidermal growth factor receptor (EGFR) tyrosine kinase is associated with poor prognosis in a significant proportion of human tumors.<sup><a onclick="showRef(event, 'jm990482tb00001 jm990482tb00002'); return false;" href="javascript:void(0);" class="ref jm990482tb00001 jm990482tb00002">1,2</a></sup> Compounds that inhibit EGFR autophosphorylation and concomitantly EGF-stimulated signal transduction are potentially a new class of anticancer drugs.<sup><a onclick="showRef(event, 'jm990482tb00003 jm990482tb00004 jm990482tb00005'); return false;" href="javascript:void(0);" class="ref jm990482tb00003 jm990482tb00004 jm990482tb00005">3-5</a></sup> The most potent and selective EGFR inhibitors reported to date are the 4-anilinoquinazolines and related 4-anilinopyrido[<i>d</i>]pyrimidines.<sup><a onclick="showRef(event, 'jm990482tb00006 jm990482tb00007 jm990482tb00008 jm990482tb00009 jm990482tb00010'); return false;" href="javascript:void(0);" class="ref jm990482tb00006 jm990482tb00007 jm990482tb00008 jm990482tb00009 jm990482tb00010">6-10</a></sup> These compounds bind reversibly at the ATP binding domain of EGFR, and two examples (<b>1</b>, <b>2</b>) are reported to be in clinical trial.<sup><a onclick="showRef(event, 'jm990482tb00011 jm990482tb00012'); return false;" href="javascript:void(0);" class="ref jm990482tb00011 jm990482tb00012">11,12</a></sup><a data-tab="pane-pcw-Figures" href="#jm990482tf1" id="" class=" internalNav"></a><div id="_i4"><figure id="jm990482tf1" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/medium/jm990482tf1.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482tf1.jpeg" id="_i5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482tf1.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm990482t&amp;id=jm990482tf1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">In a further development of this class, we have recently reported<sup><a onclick="showRef(event, 'jm990482tb00013 jm990482tb00014'); return false;" href="javascript:void(0);" class="ref jm990482tb00013 jm990482tb00014">13,14</a></sup> that acrylamide-substituted 4-anilinoquinazolines and 4-anilinopyrido[<i>d</i>]pyrimidines (e.g. <b>3</b>, <b>4</b>) are potent, selective, and irreversible inhibitors of the <i>erb</i>B family of receptor tyrosine kinases. These compounds also bind in the ATP domain of the EGFR but then alkylate the enzyme at cysteine 773, irreversibly shutting down EGFR autophosphorylation.<sup>13</sup> They show superior in vivo activity in animal tumor models in comparison with related reversible inhibitors, <a name="jm004300701381" id="jm004300701381"></a> particularly by oral dosing regimens.<sup>14</sup> Structure−activity and molecular modeling studies have shown that positioning of the acrylamide at the 6-position is optimal for rapid irreversible inhibition (appropriate positioning of the Michael acceptor with respect to the cysteine SH).<sup>13</sup> Apart from this requirement, wide variation in the drug structure is tolerated, with 6-acrylamide-substituted 4-anilinoquinazolines, 4-anilinopyrido[3,4-<i>d</i>]pyrimidines, and 4-anilino[3,2-<i>d</i>]pyrimidines all being potent, selective, irreversible inhibitors of EGFR autophosphorylation.<sup>13,14</sup></div><div class="NLM_p last">As part of further investigations of structure−activity relationships in this new series of irreversible EGFR inhibitors, we now report the synthesis and biological activity of a series of quinazoline-6-acrylamides (compounds <b>5</b>−<b>19</b>) and pyrido[3,2-<i>d</i>]pyrimidine-6-acrylamides (compounds <b>20</b>−<b>27</b>) substituted with solubilizing cationic side chains at positions separate from the Michael acceptor. We show that the 7-substituted compounds are superior in terms of aqueous solubility, potency, and in vivo antitumor activity to previous analogues. One example (<b>18</b>, PD 183805) has been selected for clinical evaluation (as the dihydrochloride salt, CI 1033).<sup><a onclick="showRef(event, 'jm990482tb00015'); return false;" href="javascript:void(0);" class="ref jm990482tb00015">15</a></sup></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23847" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23847" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The acrylamides (<b>5</b>−<b>11</b>, <b>13</b>, <b>14</b>, <b>16</b>, <b>18</b>, <b>19</b>, <b>21</b>−<b>27</b>) of Table 1 were obtained by direct coupling of their precursor amines (<b>37</b>, <b>38</b>, <b>47a</b><b>−</b><b>e</b>, <b>48a</b>,<b>b</b>, <b>49b</b>, <b>50b</b>,<b>f</b>, <b>61</b>, <b>63</b>, <b>72a</b><b>−</b><b>c</b>, <b>75</b>, <b>72d,</b> respectively) with acrylic acid. In general 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI·HCl) was employed as the coupling reagent. However acylation of amine <b>50f</b> was achieved using the mixed anhydride from acrylic acid and isobutyl chloroformate. EDCI-promoted acylation of the 6-aminopyrido[3,2-<i>d</i>]pyrimidine nucleus was exceedingly slow due to low nucleophilicity of the amines, and therefore the reactive mixed anhydride formed from acrylic acid and 2,4,6-trichlorobenzoyl chloride was employed. </div><div class="NLM_p">The 6-aminoquinazolines <b>37</b> and <b>38</b> required first the synthesis of anilines <b>30</b> and <b>33</b> (Scheme 1<a data-tab="pane-pcw-Figures" href="#jm990482th00001" id="" class=" internalNav"></a>). 2-Bromo-4-nitrobenzyl bromide (<b>28</b>)<sup><a onclick="showRef(event, 'jm990482tb00016'); return false;" href="javascript:void(0);" class="ref jm990482tb00016">16</a></sup> was reacted with dimethylamine to give benzylamine <b>29</b>, which was subsequently reduced with iron dust to aniline <b>30</b>. Alkylation of 2-bromo-4-nitrophenol (<b>31</b>) with 2-dimethylaminoethyl chloride hydrochloride gave nitrobenzene <b>32</b>, which was reduced to aniline <b>33</b> by iron dust in low yield, whereas hydrogenation over Pt−C gave aniline <b>33</b> in acceptable yield (56%). Reaction of anilines <b>30</b> and <b>33</b> with 4-chloro-6-nitroquinazoline (<b>34</b>)<sup><a onclick="showRef(event, 'jm990482tb00017'); return false;" href="javascript:void(0);" class="ref jm990482tb00017">17</a></sup> gave the 6-nitroquinazolines <b>35</b> and <b>36,</b> respectively, which underwent subsequent iron dust reduction to give the desired 6-aminoquinazolines <b>37</b> and <b>38</b>. <div id="_i7"><figure id="jm990482th00001" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/medium/jm990482th00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482th00001.jpeg" id="_i8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 1 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) MeOH/Me<sub>2</sub>NH/20 °C/1 h; (ii) Cl(CH<sub>2</sub>)<sub>2</sub>NMe·HCl/K<sub>2</sub>CO<sub>3</sub>/DMF/100 °C/4 h; (iii) Fe/AcOH/EtOH/H<sub>2</sub>O/reflux/20 min or H<sub>2</sub>/Pt-C (for <b>32</b>); (iv) <i>i</i>-PrOH/CH<sub>2</sub>Cl<sub>2</sub>/Et<sub>3</sub>N/reflux/3 h; (v) CH<sub>2</sub><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCO<sub>2</sub>H/EDCI·HCl/pyridine/DMA/20 °C/2 h.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482th00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm990482t&amp;id=jm990482th00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">The 6-amino-7-alkoxyquinazolines (<b>47a</b><b>−</b><b>d</b>, <b>48a</b>,<b>b</b>, <b>49b</b>, <b>50b</b>,<b>f</b>) and the 6-amino-7-thioalkoxyquinazoline (<b>47e</b>) were each obtained from their 7-fluoro-6-nitroquinazoline precursors (<b>39</b><b>−</b><b>42</b>) by displacement of the activated fluorine with the sodium (or potassium) alkoxide (or sodium thioalkoxide) of the requisite amine side chain (Scheme 2<a data-tab="pane-pcw-Figures" href="#jm990482th00002" id="" class=" internalNav"></a>). The sodium alkoxide was generated by reaction of the alcohol with either sodium metal or sodium hydride in THF, the latter giving a more efficient conversion and therefore better control of the number of equivalents of alkoxide employed. At least 2 equiv of alkoxide are required, with the first equivalent deprotonating the 4-anilino proton to give a characteristic dark red/purple anion in solution. However, when excess alkoxide was used in the reaction of <b>39</b> to give <b>43c</b> the only product isolated was the amine <b>47c</b> (in low yield), a result of alkoxide displacement and subsequent in situ nitro group reduction. Iron dust reduction of the 6-nitroquinazolines <b>43a</b>,<b>b</b>,<b>d</b>,<b>e</b>, <b>45b,</b> and <b>46b</b> gave the 6-aminoquinazolines <b>47a</b>,<b>b</b>,<b>d</b>,<b>e</b>, <b>49b</b>, and <b>50b,</b> respectively in excellent yield, while catalytic hydrogenation of the 6-nitroquinazolines<b> 44a</b>,<b>b</b>,<b>f</b> gave the required 6-aminoquinazolines <b>48a</b>,<b>b</b> and <b>50f,</b> respectively, also in excellent yield. <div id="_i9"><figure id="jm990482th00002" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/medium/jm990482th00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482th00002.jpeg" id="_i10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 2 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) RO<sup>-</sup>Na<sup>+</sup>/THF/reflux/18−24 h or RS<sup>-</sup>Na<sup>+</sup>/DMSO/65 °C (for <b>39</b>−<b>43e</b>) or RO<sup>-</sup>K<sup>+</sup>/DMSO/25 °C (for <b>42</b>−<b>46f</b>); (ii) Fe/AcOH/EtOH/H<sub>2</sub>O/reflux/20 min or H<sub>2</sub>/Pd−C/MeOH:EtOAc (2:1) (for X = 3‘-Me) or H<sub>2</sub>/Raney Ni/THF (for <b>46f</b>); (iii) CH<sub>2</sub><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCO<sub>2</sub>H/EDCI·HCl/pyridine or Et<sub>3</sub>N/DMA or DMF/2 h or (for <b>50f</b>) CH<sub>2</sub><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCO<sub>2</sub>H/<i>i-</i>BuOCOCl/Et<sub>3</sub>N/THF.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482th00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm990482t&amp;id=jm990482th00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">The 6-aminopyrido[3,2-<i>d</i>]pyrimidines <b>61</b> and <b>63</b> were both obtained from the key intermediate 7-bromo-6-<a name="jm004300701382" id="jm004300701382"></a> fluoropyrido[3,2-<i>d</i>]pyrimidine (<b>57</b>) (Scheme 3<a data-tab="pane-pcw-Figures" href="#jm990482th00003" id="" class=" internalNav"></a>). This intermediate is synthesized in good overall yield from chloropyridine <b>51</b>.<sup>9</sup> Initial reaction with ammonia introduces the amino functionality at the 2-position of pyridine <b>52</b>, which was required for the activation and directing of subsequent bromination at the adjacent 3-position, to give the bromopyridine <b>53</b>. Iron dust reduction of <b>53</b> gave diamine <b>54</b> which was converted to the pyrido[3,2-<i>d</i>]pyrimidone <b>55</b> in refluxing triethyl orthoformate. At this stage the 6-amino group of <b>55</b> is essentially “protected” by diazotization to fluorine, to give the 6-bromo-7-fluoropyrido[3,2-<i>d</i>]pyrimidone (<b>56</b>) (at a later stage this activated fluorine is readily displaced by ammonia to regenerate the required amine functionality at this position). Chlorination of the pyrimidone <b>56</b> in POCl<sub>3</sub> and displacement with 3-chloro-4-fluoroaniline gave the required intermediate 7-bromo-6-fluoropyrido[3,2-<i>d</i>]pyrimidine (<b>57</b>). <div id="_i11"><figure id="jm990482th00003" data-index="4" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/medium/jm990482th00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482th00003.jpeg" id="_i12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 3 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) NH<sub>4</sub>OH/EtOH/100 °C/20 h (pressure vessel); (ii) Br<sub>2</sub>/AcOH/HOAc/20 °C/90 min; (iii) Fe/AcOH/EtOH/H<sub>2</sub>O/reflux/10 min; (iv) (EtO)<sub>3</sub>CH/reflux/3 h; (v) HBF<sub>4</sub>/NaNO<sub>2</sub>/−20 °C/18 h; (vi) POCl<sub>3</sub>/reflux/110 min, then 3-chloro-4-fluoroaniline/<i>i-</i>PrOH/60 °C/30 min; (vii) AIBN/(Bu)<sub>3</sub>SnH/90 °C/16 h; (viii) (Ph<sub>3</sub>P)<sub>4</sub>Pd/DMF/100 °C/ 75 min; (ix) NH<sub>3</sub>(g)/<i>i-</i>PrOH/100 °C/24 h (pressure vessel); (x) CH<sub>2</sub><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCO<sub>2</sub>H/2,4,6-triClPhCOCl/Et<sub>3</sub>N/THF/0 °C/15 min, then <b>61</b>/DMAP/THF/0 °C/15 min to rt/2 h; (xi) PtO<sub>2</sub>/H<sub>2</sub>/THF/MeOH/20 °C/18 h; (xii) HOBT/Et<sub>3</sub>N/CH<sub>2</sub><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCO<sub>2</sub>H/EDCI·HCl/DMA/THF/20 °C/6 weeks. </p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482th00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm990482t&amp;id=jm990482th00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Model studies showed that Stille coupling of <b>57</b> with tetravinyltin and allyltributylstannane gave the respective 7-vinyl and 7-allyl derivatives of <b>57</b> in good yield (data not shown), with the expected complete selectivity for bromine over chlorine and fluorine. Therefore it was decided to introduce the required alkylmorpholine side chain via Stille coupling of the morpholinostannane <b>59</b>. Stannane <b>59</b> was synthesized in good yield from 3-butyn-1-ol by mesylation and displacement with morpholine to give butyne (<b>58</b>) which underwent AIBN-initiated radical hydrostannylation with tributyltin hydride to give predominantly the <i>E</i>-stannane <b>59</b> which could be further purified by chromatography. Stille coupling of stannane <b>59</b> with the 7-bromopyrido[3,2-<i>d</i>]pyrimidine (<b>57</b>) under palladium(0) catalysis gave the morpholinylbutenylpyrido[3,2-<i>d</i>]pyrimidine <b>60</b> in high yield (72%). This Stille coupling approach to the introduction of cationic solubilizing side chains in medicinal chemistry is novel to our knowledge and may prove to be a versatile method for analogue generation in the future, particularly lending itself to combinatorial methods. Direct displacement of the fluorine in pyridopyrimidine <b>60</b> by ammonia gave the required amine <b>61</b>, while hydrogenation of <b>60</b> over PtO<sub>2</sub> to give fluoro derivative <b>62</b> and then ammonia treatment gave amine <b>63</b>. </div><div class="NLM_p">Synthesis of the 6-amino-7-alkoxypyrido[3,2-<i>d</i>]pyrimidines (<b>72a</b><b>−</b><b>d</b>) and the 6-methylamine (<b>75</b>) required first the synthesis of the key intermediate 7-methoxy-6-(methylthio)pyrido[3,2-<i>d</i>]pyrimidine (<b>70a</b>) (Scheme 4<a data-tab="pane-pcw-Figures" href="#jm990482th00004" id="" class=" internalNav"></a>). This pivotal intermediate was obtained in four steps from 2-bromo-5-methoxy-6-(methylthio)-3-nitropyridine<sup><a onclick="showRef(event, 'jm990482tb00018'); return false;" href="javascript:void(0);" class="ref jm990482tb00018">18</a></sup> (<b>64</b>) in good overall yield. Initially direct displacement of the activated bromine with cyanide anion to give the nitrile <b>65</b> was followed by hydrolysis of the cyano moiety to give the carboxamide <b>66</b> which was reduced with iron dust to amine <b>67</b> and subsequently reacted with triethyl orthoformate to give pyrimidone <b>68</b>. However low yields for the acid hydrolysis of nitrile <b>65</b> could not be overcome, so an alternate route was used. This involved iron dust reduction of <b>65 </b>and then direct cyclization<sup><a onclick="showRef(event, 'jm990482tb00019'); return false;" href="javascript:void(0);" class="ref jm990482tb00019">19</a></sup> of the resulting aminopyridonitrile <b>69</b> in 88% formic acid containing a small amount of concentrated H<sub>2</sub>SO<sub>4</sub> and gave the pyrimidone <b>68</b> in excellent yield. Chlorination in POCl<sub>3</sub> and reaction with 3-chloro-4-fluoroaniline gave the required intermediate <b>70a</b>. Oxidation of the methylthio derivative <b>70a</b> by <i>m-</i>CPBA to the methyl sulfoxide <b>71a</b>, followed by reaction with ammonia, gave the 6-amino-7-methoxypyrido[3,2-<i>d</i>]pyrimidine (<b>72a</b>). <div id="_i13"><figure id="jm990482th00004" data-index="5" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/medium/jm990482th00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482th00004.jpeg" id="_i14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 4 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) CuCN/NMP; (ii) 90% H<sub>2</sub>SO<sub>4</sub>; (iii) H<sub>2</sub>/Pd−C; (iv) (EtO)<sub>3</sub>CH/reflux/8 h; (v) Fe/AcOH/EtOH/H<sub>2</sub>O/reflux/20 min; (vi) HCO<sub>2</sub>H/H<sub>2</sub>SO<sub>4</sub>/reflux/16 h; (vii) POCl<sub>3</sub>, then ArNH<sub>2</sub>; (viii) <i>m</i>-CPBA/CH<sub>2</sub>Cl<sub>2</sub>/20 °C/ 1 h; (ix) NH<sub>3</sub>(g)/<i>i-</i>PrOH/100 °C/20 h (pressure vessel); (x) CH<sub>2</sub><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCO<sub>2</sub>H/Et<sub>3</sub>N, then 2,4,6-triClPhCOCl, then <b>72a</b>/DMAP/THF/0 °C/15 min to rt/2 h.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482th00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm990482t&amp;id=jm990482th00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p last">Selective cleavage of the methyl ether of <b>70a</b> in the presence of the methylthio moiety was achieved with pyridine hydrochloride to give the phenol <b>73</b> (Scheme 5<a data-tab="pane-pcw-Figures" href="#jm990482th00005" id="" class=" internalNav"></a>), which was then alkylated with either 3-bromopropanol or 2-bromoethylmethyl ether to give the alkoxy derivatives <b>74</b> and <b>70b,</b> respectively. Mesylation of <b>74</b> and reaction with morpholine or 4-methylpiperazine <a name="jm004300701383" id="jm004300701383"></a> provided the morpholinopropyloxy and 4-methylpiperazinylpropyloxy derivatives <b>70c</b>,<b>d,</b> respectively. Oxidation of the 7-alkoxy-6-methylthiopyrido[3,2-<i>d</i>]pyrimidine (<b>70b</b>) with <i>m</i>-CPBA gave the methylsulfinyl compound <b>71b</b>, while sodium periodate oxidation of methylthio derivatives <b>70c</b>,<b>d</b> gave their respective methylsulfinyl derivatives <b>71c</b>,<b>d</b>. Tertiary amine <i>N</i>-oxide formation was prevented during the latter oxidation of amines <b>70c</b>,<b>d</b> by performing the reaction in 1 N HCl. Reaction of <b>71b</b><b>−</b><b>d</b> with ammonia provided the 6-amino derivatives <b>72b</b><b>−</b><b>d</b>, while reaction of methyl sulfoxide <b>71c</b> with methylamine provided the 6-methylamino derivative <b>75</b><div id="_i15"><figure id="jm990482th00005" data-index="6" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/medium/jm990482th00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482th00005.jpeg" id="_i16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 5 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) Pyridine·HCl/200−210 °C/8 min; (ii) Br(CH<sub>2</sub>)<sub>3</sub>OH or Br(CH<sub>2</sub>)<sub>2</sub>OMe/K<sub>2</sub>CO<sub>3</sub>/THF/DMF/reflux/1−2 h; (iii) Et<sub>3</sub>N/MsCl/THF/DMF/0 °C/1 h, then morpholine or 4-Me-piperazine/reflux/4−5 days; (v) <i>m</i>-CPBA/CH<sub>2</sub>Cl<sub>2</sub>/rt/1 h or NaIO<sub>4</sub>/1 N HCl/4 °C (for <b>70c</b>,<b>d</b>); (vi) NH<sub>3</sub>(g)/<i>i-</i>PrOH/100 °C/20 h (pressure vessel); (vii) CH<sub>2</sub><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCO<sub>2</sub>H/Et<sub>3</sub>N, then 2,4,6-triClPhCOCl, then <b>72b</b><b>−</b><b>d</b>/DMAP/THF/0 °C/15 min to rt/2 h; (viii) MeNH<sub>2</sub>/water/DMSO/110 °C/18 h (pressure vessel).</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482th00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm990482t&amp;id=jm990482th00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34046" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34046" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The structures and physicochemical properties of the acrylamides studied are listed in Table 1, together with their potencies (IC<sub>50[app]</sub> in nM) for inhibition of phosphorylation of a random glutamic acid/tyrosine copolymer substrate by isolated EGFR enzyme, inhibition of EGF-stimulated autophosphorylation of EGFR in A431 cells, and (for some examples) inhibition of heregulin-stimulated autophosphorylation of erbB2 in MDA-MB 453 cells.<sup>10</sup> The type of inhibition of the isolated EGFR enzyme is also listed. Irreversible inhibition is defined<sup>14</sup> as 80% or greater inhibition after a 10-min exposure to drug followed by drug washout and restimulation by EGF 8 h later. Drugs that produced 20−80% inhibition were designated as partially irreversible (although in reality they can almost certainly fully inactivate the enzyme via alkylation given enough time). Those that produced less than 20 inhibition were classified as reversible. For compounds capable of rapid and complete alkylation of the enzyme, the IC<sub>50</sub> values derive essentially from titrating the enzyme activity in a stoichiometric manner and for this reason are designated as apparent IC<sub>50</sub>s (IC<sub>50[app]</sub>).<sup>14</sup> The concentration of EGFR in the isolated enzyme assays is calculated at 1.18 nM and was held as constant as possible (<10% variation). The IC<sub>50[app]</sub> values are an average of at least two separate determinations.<a class="ref showTableEvent internalNav" data-ID="jm990482tt00001" href="#jm990482tt00001"></a><div class="NLM_table-wrap" id="jm990482tt00001"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 1.  Kinase Inhibition by Soluble 4-(Phenylamino)quinazoline- and 4-(Phenylamino)pyrido[3,2-<i>d</i>]pyrimidine-6-acrylamides<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/medium/jm990482tu00001a.gif" alt="" id="_i18" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="3">EGFR</td><td class="colsep2 rowsep2"><i>erb</i>B2</td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">no.</td><td class="colsep2 rowsep2">Fm</td><td class="colsep2 rowsep2">R</td><td class="colsep2 rowsep2">X</td><td class="colsep2 rowsep2">Y</td><td class="colsep2 rowsep2">mp (°C)</td><td class="colsep2 rowsep2">enz<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">auto<i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">type<i><sup>c</sup></i><sup></sup></td><td class="colsep2 rowsep2"> auto<i><sup>d</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>3</b></td><td class="colsep2 rowsep2">A </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H</td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">ref 14 </td><td class="colsep2 rowsep2">0.70 </td><td class="colsep2 rowsep2">2.7 </td><td class="colsep2 rowsep2">irrev </td><td class="colsep2 rowsep2">5.7 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>5</b></td><td class="colsep2 rowsep2">A </td><td class="colsep2 rowsep2">CH<sub>2</sub>NMe<sub>2</sub></td><td class="colsep2 rowsep2">H</td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">206 </td><td class="colsep2 rowsep2">45 </td><td class="colsep2 rowsep2">416 </td><td class="colsep2 rowsep2">rev </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>6</b></td><td class="colsep2 rowsep2">A </td><td class="colsep2 rowsep2">OCH<sub>2</sub>CH<sub>2</sub>NMe<sub>2</sub></td><td class="colsep2 rowsep2">H</td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">181−184.5 </td><td class="colsep2 rowsep2">27 </td><td class="colsep2 rowsep2">7693 </td><td class="colsep2 rowsep2">rev </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7</b></td><td class="colsep2 rowsep2">B </td><td class="colsep2 rowsep2">O(CH<sub>2</sub>)<sub>3</sub>4-Mepip </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Br </td><td class="colsep2 rowsep2">105−107 </td><td class="colsep2 rowsep2">1.7 </td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">irrev </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8</b></td><td class="colsep2 rowsep2">B </td><td class="colsep2 rowsep2">O(CH<sub>2</sub>)<sub>3</sub>morph </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Br </td><td class="colsep2 rowsep2">170−172 </td><td class="colsep2 rowsep2">3.6 </td><td class="colsep2 rowsep2">5.3 </td><td class="colsep2 rowsep2">irrev </td><td class="colsep2 rowsep2">6.4 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>9</b></td><td class="colsep2 rowsep2">B </td><td class="colsep2 rowsep2">O(CH<sub>2</sub>)<sub>4</sub>NMe<sub>2</sub></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Br </td><td class="colsep2 rowsep2">112−115 </td><td class="colsep2 rowsep2">3.9 </td><td class="colsep2 rowsep2">7.9 </td><td class="colsep2 rowsep2">irrev </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>10</b></td><td class="colsep2 rowsep2">B </td><td class="colsep2 rowsep2">O(CH<sub>2</sub>)<sub>3</sub>imidazoyl </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Br </td><td class="colsep2 rowsep2">235−237 </td><td class="colsep2 rowsep2">3.0 </td><td class="colsep2 rowsep2">21 </td><td class="colsep2 rowsep2">irrev </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>11</b></td><td class="colsep2 rowsep2">B </td><td class="colsep2 rowsep2">S(CH<sub>2</sub>)<sub>3</sub>NEt<sub>2</sub></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Br </td><td class="colsep2 rowsep2">77−79 </td><td class="colsep2 rowsep2">0.78 </td><td class="colsep2 rowsep2">196 </td><td class="colsep2 rowsep2">partial </td><td class="colsep2 rowsep2">400 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>12</b></td><td class="colsep2 rowsep2">B </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">CH<sub>3</sub></td><td class="colsep2 rowsep2">ref 14 </td><td class="colsep2 rowsep2">0.42 </td><td class="colsep2 rowsep2">4.7 </td><td class="colsep2 rowsep2">irrev </td><td class="colsep2 rowsep2">22 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>13</b></td><td class="colsep2 rowsep2">B </td><td class="colsep2 rowsep2">O(CH<sub>2</sub>)<sub>3</sub>4-Mepip </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">CH<sub>3</sub></td><td class="colsep2 rowsep2">60−66 </td><td class="colsep2 rowsep2">2.0 </td><td class="colsep2 rowsep2">18 </td><td class="colsep2 rowsep2">irrev </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>14</b></td><td class="colsep2 rowsep2">B </td><td class="colsep2 rowsep2">O(CH<sub>2</sub>)<sub>3</sub>morph </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">CH<sub>3</sub></td><td class="colsep2 rowsep2">69−72 </td><td class="colsep2 rowsep2">1.5 </td><td class="colsep2 rowsep2">27 </td><td class="colsep2 rowsep2">irrev </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>15</b></td><td class="colsep2 rowsep2">B </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Br </td><td class="colsep2 rowsep2">ref 14 </td><td class="colsep2 rowsep2">0.69 </td><td class="colsep2 rowsep2">2.7 </td><td class="colsep2 rowsep2">irrev </td><td class="colsep2 rowsep2">7.3 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>16</b></td><td class="colsep2 rowsep2">B </td><td class="colsep2 rowsep2">O(CH<sub>2</sub>)<sub>3</sub>morph </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Br </td><td class="colsep2 rowsep2">171−173 </td><td class="colsep2 rowsep2">1.8 </td><td class="colsep2 rowsep2">4.7 </td><td class="colsep2 rowsep2">irrev </td><td class="colsep2 rowsep2">8.2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>17</b></td><td class="colsep2 rowsep2">B </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">ref 14 </td><td class="colsep2 rowsep2">0.75 </td><td class="colsep2 rowsep2">3.1 </td><td class="colsep2 rowsep2">irrev </td><td class="colsep2 rowsep2">4.3 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>18</b></td><td class="colsep2 rowsep2">B </td><td class="colsep2 rowsep2">O(CH<sub>2</sub>)<sub>3</sub>morph </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">188−190 </td><td class="colsep2 rowsep2">1.5 </td><td class="colsep2 rowsep2">7.4 </td><td class="colsep2 rowsep2">irrev </td><td class="colsep2 rowsep2">9.0 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>19</b></td><td class="colsep2 rowsep2">B </td><td class="colsep2 rowsep2">[O(CH<sub>2</sub>)<sub>2</sub>]<sub>2</sub>(CH<sub>2</sub>)<sub>2</sub>OH </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">131−132 </td><td class="colsep2 rowsep2">1.7 </td><td class="colsep2 rowsep2">ND </td><td class="colsep2 rowsep2">ND </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>20</b></td><td class="colsep2 rowsep2">C </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">ref 14 </td><td class="colsep2 rowsep2">0.75 </td><td class="colsep2 rowsep2">18 </td><td class="colsep2 rowsep2">irrev </td><td class="colsep2 rowsep2">12 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>21</b></td><td class="colsep2 rowsep2">C </td><td class="colsep2 rowsep2">CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH(CH<sub>2</sub>)<sub>2</sub>morph </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">190−193 </td><td class="colsep2 rowsep2">0.16 </td><td class="colsep2 rowsep2">119 </td><td class="colsep2 rowsep2">irrev </td><td class="colsep2 rowsep2">12 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>22</b></td><td class="colsep2 rowsep2">C </td><td class="colsep2 rowsep2">(CH<sub>2</sub>)<sub>4</sub>morph </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">180−182 </td><td class="colsep2 rowsep2">2.7 </td><td class="colsep2 rowsep2">5100 </td><td class="colsep2 rowsep2">irrev </td><td class="colsep2 rowsep2">>5000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>23</b></td><td class="colsep2 rowsep2">C </td><td class="colsep2 rowsep2">OMe </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">226−228 </td><td class="colsep2 rowsep2">0.95 </td><td class="colsep2 rowsep2">291 </td><td class="colsep2 rowsep2">partial </td><td class="colsep2 rowsep2">125 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>24</b></td><td class="colsep2 rowsep2">C </td><td class="colsep2 rowsep2">O(CH<sub>2</sub>)<sub>2</sub>OMe </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">205−206 </td><td class="colsep2 rowsep2">0.97 </td><td class="colsep2 rowsep2">377 </td><td class="colsep2 rowsep2">partial </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25</b></td><td class="colsep2 rowsep2">C </td><td class="colsep2 rowsep2">O(CH<sub>2</sub>)<sub>3</sub>morph </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">185−186 </td><td class="colsep2 rowsep2">1.5 </td><td class="colsep2 rowsep2">434 </td><td class="colsep2 rowsep2">irrev </td><td class="colsep2 rowsep2">189 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>26</b></td><td class="colsep2 rowsep2">C </td><td class="colsep2 rowsep2">O(CH<sub>2</sub>)<sub>3</sub>morph </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">176−178 </td><td class="colsep2 rowsep2">20 </td><td class="colsep2 rowsep2">88 </td><td class="colsep2 rowsep2">partial </td><td class="colsep2 rowsep2">>200 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>27</b></td><td class="colsep2 rowsep2">C </td><td class="colsep2 rowsep2">O(CH<sub>2</sub>)<sub>3</sub>4-Mepip </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">166−168 </td><td class="colsep2 rowsep2">6.6 </td><td class="colsep2 rowsep2">264 </td><td class="colsep2 rowsep2">partial </td><td class="colsep2 rowsep2">182</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Concentration (IC<sub>50[app]</sub> in nM) to inhibit by 50% the phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography). Values are the averages from at least two independent dose−response curves; variation was generally ±15%.<i><sup>b</sup></i><sup></sup> Concentration (IC<sub>50</sub> in nM) to inhibit by 50% the phosphorylation of EGFR in A431 cells (detected by immunoblotting).<i><sup>c</sup></i><sup></sup> Irreversible inhibition is defined as >80% inhibition of formation of phosphorylated EGFR in A431 cells 8 h after washing cells free of the inhibitor.<i><sup>d</sup></i><sup></sup> IC<sub>50</sub> values (nM) for inhibition of autophosphorylation of <i>erb</i>B2 (in MDA-MB 453 cells) in culture. Values are the average of at least two experiments.</p></div></div></div><div class="NLM_p"><b>Cationic </b><b>Side Chain</b><b>s at the 4</b>‘<b>-Position of the Aniline.</b> We have previously reported<sup>14</sup> that in the 6-acrylamido-4-anilinoquinazoline series there is some bulk tolerance at the 4‘-position of the aniline ring, with both phenyloxy and benzyloxy analogues retaining potent (IC<sub>50</sub>s 4.8 and 4.2 nM, respectively) and fully irreversible inhibition of cellular autophosphorylation. Substitution at this position with relatively sterically nondemanding cationic side chains was therefore evaluated in a search for more soluble irreversible inhibitors. A 3‘-bromo substituent, known to enhance the EGFR binding of reversible inhibitors,<sup>7</sup> was also added. Both the 3‘-bromo-4‘-(<i>N,N</i>-dimethylaminomethyl) and 3‘-bromo-4‘-(<i>N,N</i>-dimethylaminoethoxy) analogues (<b>5</b> and <b>6</b>) showed improved aqueous solubility but were not irreversible inhibitors. They also showed a large reduction in potency in both the isolated enzyme (32−54-fold) and cellular (155−2850-fold) assays, compared to the unsubstituted quinazoline (<b>3</b>). There thus appears to be no tolerance at the 4‘-position of the aniline ring for cationic side chains, with such substitutions resulting in a loss of binding affinity in the ATP binding domain of EGFR and a subsequent loss of delivery of the acrylamide moiety to the key cysteine of the active site. </div><div class="NLM_p"><b>Cationic </b><b>Side Chain</b><b>s at the 7-Position of the Quinazoline.</b> Both molecular modeling<sup><a onclick="showRef(event, 'jm990482tb00020'); return false;" href="javascript:void(0);" class="ref jm990482tb00020">20</a></sup> and structure−activity relationship studies<sup><a onclick="showRef(event, 'jm990482tb00021'); return false;" href="javascript:void(0);" class="ref jm990482tb00021">21</a></sup> in the quinazoline and pyrido[<i>d</i>]pyrimidine series of reversible EGFR inhibitors have shown that there is tolerance for substitution at the 7-position with soluble cationic side chains. Compounds <b>7</b>−<b>19</b> explore the concept of substituting the optimal 6-acrylamide series of 4-anilinoquinazolines at the available 7-position with a series of solubilizing cationic side chains. Compounds <b>7</b>−<b>11</b>, with a fixed 3‘-Br substituent, employ a range of side chains of varying p<i>K</i><sub>a</sub>, found to be acceptable in previous studies of related reversible analogues,<sup>21</sup> where they provided solubilities of >40 mM. The <i>N</i>-methylpiperazinylpropoxy (<b>7</b>), morpholinylpropoxy (<b>8</b>), and <i>N,N</i>-dimethylaminobutoxy (<b>9</b>) showed comparable activity (IC<sub>50[app]</sub>s 2−4 nM) in both the isolated enzyme and cellular autophosphorylation assays, with the 1-imidazolylpropoxy (<b>10</b>) being about 3−6-fold less potent in the autophosphorylation assay. All were irreversible inhibitors. In contrast, the S(CH<sub>2</sub>)<sub>3</sub>NEt<sub>2</sub> analogue <b>11</b> was only partially irreversible and much less effective in the autophosphorylation assay. </div><div class="NLM_p">The <i>N</i>-methylpiperazinylpropoxy and morpholinylpropoxy side chains were also employed in the 3‘-Me series (compounds <b>13</b> and <b>14</b>), since the parent compound (<b>12</b>) had been shown previously<sup>14</sup> to be a potent irreversible inhibitor. Both compounds retained their <a name="jm004300701384" id="jm004300701384"></a> ability to irreversibly inhibit EGFR, and while they were as potent as the 3‘-Br derivatives in the isolated enzyme assay, they were somewhat less potent at inhibiting cellular autophosphorylation (IC<sub>50</sub>s 18 and 27 nM, respectively). </div><div class="NLM_p">Two 4‘-F analogues with the morpholinylpropoxy solubilizing group (<b>16</b> and <b>18</b>) were also studied (using respectively 3‘-Br and 3‘-Cl binding enhancers), since work by others<sup><a onclick="showRef(event, 'jm990482tb00022'); return false;" href="javascript:void(0);" class="ref jm990482tb00022">22</a></sup> with reversible dianilinophthalimide EGFR inhibitors has shown that a <i>p-</i>F substituent provides longer in vivo half-lives, possibly by blocking metabolism. Both of these compounds had similar potencies to their nonsolubilized analogues (<b>15</b> and <b>17,</b> respectively) and also compared favorably to the corresponding nonfluorinated analogue <b>8</b>, suggesting that better metabolic stability can be provided without compromising inhibitory potency. Compound <b>19</b>, which explored the use of a neutral oxygenated solubilizing function, showed reasonably potent enzyme inhibitory properties but no distinct solubility advantage and was therefore not studied further. </div><div class="NLM_p">The quinazolines <b>8</b>, <b>16,</b> and <b>18,</b> bearing cationic side chains, show excellent potency for inhibition of <i>erb</i>B2 autophosphorylation in MDA-MB 453 cells (IC<sub>50</sub>s 6.4, 8.2, and 9.0 nM, respectively). We have previously reported<sup>13</sup> an acrylamide-bearing quinazoline capable of covalently modifying both EGFR and <i>erb</i>B2, both of which have the key cysteine 773 at the entrance of their ATP binding domain. It therefore seems likely that the excellent activity shown by quinazolines <b>8</b>, <b>16,</b> and <b>18</b> against <i>erb</i>B2 is due also to irreversible inhibition of this enzyme. These compounds therefore represent a novel class of potent, soluble, irreversible inhibitors of the larger EGFR family of tyrosine kinases. </div><div class="NLM_p"><b>Cationic </b><b>Side Chain</b><b>s at the 7-Position of the Pyrido[3,2-</b><b><i>d</i></b><b>]pyrimidine.</b> Because the pyrido[3,2-<i>d</i>]pyrimidines are also potent reversible inhibitors of EGFR,<sup>9</sup> it was of interest to see whether 6-acrylamide analogues of this additional series were also irreversible inhibitors. The pyrido[3,2-<i>d</i>]pyrimidine <b>20</b> was therefore prepared<sup>14</sup> and shown to be an irreversible inhibitor, with similar potency against the isolated enzyme to the corresponding quinazoline (<b>17)</b> (IC<sub>50[app]</sub>s both 0.75 nM), but with slightly lower potency in the autophosphorylation assay (IC<sub>50</sub>s 18 and 3.1 nM, respectively). The pyrido[3,2-<i>d</i>]pyrimidine chromophore also provided an opportunity to introduce solubilizing side chains at the 7-position while retaining the optimally positioned 6-acrylamide,<sup>13,14</sup> and a small series of analogues of <b>20</b> with solubilizing 7-substituents were prepared. The “carbon-linked” morpholinylbutyl derivative (<b>22</b>) showed good activity against the isolated enzyme (IC<sub>50[app]</sub> 2.8 nM) but a large loss of potency in the cellular autophosphorylation assays against EGFR and <i>erb</i>B2 (IC<sub>50</sub>s 5100 <a name="jm004300701385" id="jm004300701385"></a> and >5000 nM, respectively). However, the corresponding unsaturated derivative (<b>21</b>) was the most potent inhibitor of the isolated EGFR enzyme in the series, with an IC<sub>50[app]</sub> of 0.16 nM, possibly suggesting an advantage in terms of potency when the 7-side chain is conformationally restrained close to the chromophore ring system. Derivative <b>21</b> was less active in the EGFR autophosphorylation assay in A431 cells (although not to the same extent as derivative <b>22</b>), with an IC<sub>50</sub> of 119 nM, although it had high potency (IC<sub>50</sub> 12 nM) in the cellular <i>erb</i>B2 autophosphorylation assay (in MDA-MB 453 cells), showing the largest differential toward <i>erb</i>B2 of all the compounds evaluated. The general loss of potency for the “carbon-linked” solubilized pyrido[3,2-<i>d</i>]pyrimidines in the cellular assays, except for the <i>erb</i>B2 potency of compound <b>21</b>, suggests these compounds may suffer from metabolism, transport, permeability, or stability problems in a cell-line-specific manner. </div><div class="NLM_p">One possibility was that the “carbon-linked” soluble side chains were undergoing cellular metabolism at the benzylic position. This was consistent with the saturated derivative (<b>22</b>) being less potent than the unsaturated derivative (<b>21</b>). Therefore a series of “oxygen-linked” direct pyrido[3,2-<i>d</i>]pyrimidine analogues of quinazoline <b>18</b> were prepared. However, while these (<b>23</b>−<b>27</b>) were generally also potent inhibitors of the isolated EGFR enzyme, they were much less effective than the quinazolines in inhibiting EGFR and <i>erb</i>B2 autophosphorylation in cells and were generally classed as only partially irreversible in the 8-h washout assay. </div><div class="NLM_p"><b>Comparisons of Quinazoline and Pyrido[3,2-</b><b><i>d</i></b><b>]pyrimidine Analogues</b>. The reasons for the loss of cellular activity of the pyrido[3,2-<i>d</i>]pyrimidines compared with the corresponding quinazolines were sought in a number of comparative studies. The binding stoichiometry and the site(s) of interaction between EGF receptor tyrosine kinase and the morpholinylbutylpyrido[3,2-<i>d</i>]pyrimidine <b>22</b> was determined through the use of electrospray ionization mass spectrometry (ESI-MS),<sup><a onclick="showRef(event, 'jm990482tb00023'); return false;" href="javascript:void(0);" class="ref jm990482tb00023">23</a></sup> along with that of the quinazoline <b>18</b> as a positive control.<sup>13</sup> The molecular weight of the EGF receptor complexed with the compounds, as measured by ESI-MS, was approximately 485 Da higher than the apo-protein; the mass difference is consistent with a covalent 1:1 protein:drug complex.<sup>13</sup> A small amount (10−20% relative abundance) of 1:2 protein:drug complex was also observed. Trypsin digestion of the drug-bound protein and analyses by LC-ESI tandem mass spectrometry (MS/MS) identified cysteine 773 as the predominant site of interaction for both compounds, suggesting that a change in the target site was not the reason for the different activities. </div><div class="NLM_p">The absorptive and secretory transport of the quinazoline <b>18</b> and the pyrido[3,2-<i>d</i>]pyrimidine <b>25</b> were compared in Caco-2 cells<sup><a onclick="showRef(event, 'jm990482tb00024'); return false;" href="javascript:void(0);" class="ref jm990482tb00024">24</a></sup> (Table 2<a class="ref showTableEvent internalNav" data-ID="jm990482tt00002" href="#jm990482tt00002"></a>). Activity of P-gp in the Caco-2 cells was confirmed by substantially greater basolateral-to-apical (B→A) versus apical-to-basolateral (A→B) permeability of [<sup>3</sup>H]vinblastine, a known substrate of P-gp<sup><a onclick="showRef(event, 'jm990482tb00025 jm990482tb00026'); return false;" href="javascript:void(0);" class="ref jm990482tb00025 jm990482tb00026">25,26</a></sup> (Table 2). Compounds <b>18</b> and <b>25</b> both showed high permeability in Caco-2 cells (greater than the experimentally determined permeability of [<sup>3</sup>H]metoprolol, which is 90−95% absorbed in humans). The B→A/A→B ratios of 1.2 and 1.36 for <b>18</b> and <b>25</b>, respectively, suggest that efflux is not a concern with either of these compounds. The effect of <b>18</b> and <b>25</b> on inhibition of the secretory transport of vinblastine was also carried out in comparison with the known inhibitor cyclosporin A (Figure 1<a data-tab="pane-pcw-Figures" href="#jm990482tf00001" id="" class=" internalNav"></a>). Even though none of the inhibitory results were significantly different from the control, both compounds are likely inhibitors of P-gp, as evidenced by their similar effect on vinblastine efflux as compared with cyclosporin A.<sup><a onclick="showRef(event, 'jm990482tb00027 jm990482tb00028'); return false;" href="javascript:void(0);" class="ref jm990482tb00027 jm990482tb00028">27,28</a></sup><div id="_i19"><figure id="jm990482tf00001" data-index="7" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/medium/jm990482tf00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482tf00001.jpeg" id="_i20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 Inhibition of the secretory transport of vinblastine in Caco-2 cells by compounds <b>18</b> and <b>25</b>, in comparison to the known inhibitor cyclosporin A (mean ± SD, <i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482tf00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm990482t&amp;id=jm990482tf00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div class="NLM_table-wrap" id="jm990482tt00002"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 2.  Absorptive and Secretory Transport of <b>18</b> and <b>25</b> in Caco-2 Cells in Comparison to Metoprolol (90−95% absorbed) and Vinblastine (P-gp substrate)</p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="2">permeability × 10<sup>6</sup> (cm/s)<i><sup>a</sup></i><sup></sup></td></tr></tbody></table><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">compd</td><td class="colsep2 rowsep2">absorption</td><td class="colsep2 rowsep2">secretion</td><td class="colsep2 rowsep2">permeability limited?</td><td class="colsep2 rowsep2">efflux limited? </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>18</b></td><td class="colsep2 rowsep2">49.3 ± 8.92 </td><td class="colsep2 rowsep2">59.1 ± 4.81 </td><td class="colsep2 rowsep2">no </td><td class="colsep2 rowsep2">no </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25</b></td><td class="colsep2 rowsep2">59.6 ± 7.38 </td><td class="colsep2 rowsep2">81.2 ± 4.80 </td><td class="colsep2 rowsep2">no </td><td class="colsep2 rowsep2">no </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">metoprolol </td><td class="colsep2 rowsep2">21.4 ± 3.26 </td><td class="colsep2 rowsep2">38.2 ± 7.47 </td><td class="colsep2 rowsep2">no </td><td class="colsep2 rowsep2">no </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">vinblastine </td><td class="colsep2 rowsep2">1.54 ± 1.91 </td><td class="colsep2 rowsep2">12.5 ± 4.47 </td><td class="colsep2 rowsep2">yes </td><td class="colsep2 rowsep2">yes</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Data are reported as means ± SD from <i>n </i>= 3. Values for [<sup>14</sup>C]mannitol (leakage marker) ranged from 0.74 to 0.761 × 10<sup>-6</sup> cm/s for A→B studies and from 1.13 to 1.99 × 10<sup>-6</sup> cm/s for B→A studies.</p></div></div></div><div class="NLM_p">The structural similarity and above similar biochemical properties of <b>25</b> compared with <b>18</b> (which showed potent inhibition of autophosphorylation) make the poor cellular activity of the former difficult to understand. The Caco-2 studies show that <b>25</b> has cellular permeability and efflux characteristics similar to those of <b>18</b>. </div><div class="NLM_p">Another possibility for the poor cellular activity of the pyrido[3,2-<i>d</i>]pyrimidines (e.g., <b>25</b> versus <b>18</b>) was lower stability of the acrylamide moiety in the former. Accelerated cleavage of the acrylamide group of <b>25</b>, either by cellular amidases or a hydrolytic mechanism to give the 6-amino derivative <b>72c,</b> may lower its activity (<b>72c</b> has low potency in autophosphorylation assays, with an IC<sub>50</sub> for inhibition of heregulin-stimulated <i>erb</i>B2 autophosphorylation in MDA-MB 453 cells of 430 nM). This was explored by comparative stability studies of <b>25</b> and <b>18</b>. Solutions of these compounds in phosphate buffers <a name="jm004300701386" id="jm004300701386"></a> at pH 2.6, 6.67, and 10.75 were kept at 37 °C and monitored by HPLC for 24 h for formation of the corresponding 6-amine hydrolysis products (<b>72c</b> and <b>50b,</b> respectively). The quinazoline <b>18</b> was stable at all pH levels. In contrast, while the pyrido[3,2-<i>d</i>]pyrimidine <b>25</b> was stable at pH 2.6 and 6.67, it was quite unstable at pH 10.75, hydrolyzing to the corresponding amine <b>72c</b> with a half-life of about 2.5 h. Further support for this hypothesis was provided by the <i>N</i>-methylacrylamide <b>26</b> (the direct analogue of <b>25</b>). While <b>26</b> showed reduced potency in the isolated enzyme assay (IC<sub>50[app]</sub> 20 nM) and only partially irreversible inhibition (consistent with a reduced binding affinity in the ATP binding domain due to <i>N</i>-methylation), it showed improved cellular potency against EGFR autophosphorylation (IC<sub>50</sub> 88 nM compared to <b>25</b> with IC<sub>50</sub> 434 nM). This is consistent with higher metabolic stability. Finally, mass spectral studies of the metabolism of the two compounds in A431 cells in culture showed that <b>25</b> was converted much more rapidly than <b>18</b> to the corrresponding glutathione adducts. This higher apparent reactivity of the acrylamide in the pyrido[3,2-<i>d</i>]pyrimidine analogue may also contribute to the lower effectiveness of this compound in cells. </div><div class="NLM_p last"><b>In Vivo Activity.</b> The quinazolines <b>8</b> and <b>18</b> and the pyrido[3,2-<i>d</i>]pyrimidine <b>25</b> were evaluated against A431 xenografts in mice, and the results are given in Table 3<a class="ref showTableEvent internalNav" data-ID="jm990482tt00003" href="#jm990482tt00003"></a>. Both <b>8</b> and <b>18</b> showed impressive activity when dosed orally for 14 days, but the derivative <b>18</b> was much more potent (optimal dose 5 mg/kg/day) compared to the other analogues. The pyrido[3,2-<i>d</i>]pyrimidine <b>25</b> was only minimally effective, indicating a very low dose potency for this compared to both the other derivatives tested even though it was equally soluble. The essentially equivalent antitumor activity for <b>18</b> at the two dose levels shown in Table 3 suggests that this compound might have a good therapeutic index. Weight loss, as an indicator of compound-induced toxicity, was minimal in the experimental animals, being less than 10% at tolerated dose levels. <div class="NLM_table-wrap" id="jm990482tt00003"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 3.  In Vivo Antitumor Activities of Selected Soluble 4-Anilinoquinazoline- and 4-Anilinopyrido[3,2-<i>d</i>]pyrimidine-6- acrylamides in A431 Xenografts</p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">no.</td><td class="colsep2 rowsep2">dose<i><sup>a</sup></i><sup></sup> (mg/kg)</td><td class="colsep2 rowsep2">schedule<i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">weight change (g)</td><td class="colsep2 rowsep2">T/C (%) last  therapy day<i><sup>c</sup></i><sup></sup></td><td class="colsep2 rowsep2">T−C<i><sup>d</sup></i><sup></sup> (days) </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8</b></td><td class="colsep2 rowsep2">10 </td><td class="colsep2 rowsep2">ip, b.i.d., days 13−26 </td><td class="colsep2 rowsep2">+ </td><td class="colsep2 rowsep2">18 </td><td class="colsep2 rowsep2">21.5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">60 </td><td class="colsep2 rowsep2">po, days 10−24 </td><td class="colsep2 rowsep2">−1.6 </td><td class="colsep2 rowsep2">0 </td><td class="colsep2 rowsep2">29.8 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>18</b></td><td class="colsep2 rowsep2">18 </td><td class="colsep2 rowsep2">po, days 10−24 </td><td class="colsep2 rowsep2">−1.0 </td><td class="colsep2 rowsep2">0 </td><td class="colsep2 rowsep2">41.3 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">5<i><sup>e</sup></i><sup></sup></td><td class="colsep2 rowsep2">po, days 10−24 </td><td class="colsep2 rowsep2">−0.4 </td><td class="colsep2 rowsep2">4 </td><td class="colsep2 rowsep2">53.2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25</b></td><td class="colsep2 rowsep2">20<i><sup>e</sup></i><sup></sup></td><td class="colsep2 rowsep2">po, days 15−19, 22−26, 29−33 </td><td class="colsep2 rowsep2">−0.5 </td><td class="colsep2 rowsep2">69 </td><td class="colsep2 rowsep2">9.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Maximum tolerated dose (not exceeding LD<sub>10</sub>).<i><sup>b</sup></i><sup></sup> Compounds were administered in solution as the isethionate salts (<b>8</b> and <b>18</b>) or as a solution in lactate buffer (<b>25</b>), either intraperitoneally or orally on the indicated schedules. (Tumors were implanted sc into the right axilla of mice on day 0.) <i><sup>c</sup></i><sup></sup> Ratio of median treated tumor mass/median control tumor mass × 100.<i><sup>d</sup></i><sup></sup> The difference in days for treated (T) and control (C) tumors to reach 750 mg.<i><sup>e</sup></i><sup></sup> Not a maximum tolerated dose.</p></div></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75636" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75636" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">New and feasible synthetic routes to 4-anilinopyrido[3,2-<i>d</i>]pyrimidine-6-acrylamides bearing solubilizing 7-alkylamino and 7-alkoxyamino side chains have been developed. Stille coupling of stannanes with the 7-bromopyrido[3,2-<i>d</i>]pyrimidine (<b>57</b>) under palladium(0) catalysis was a facile way of introducing the 7-alkylamino side chains and could be more broadly used in medicinal chemistry. The solubilizing side chains do not alter the previously determined binding mode of these compounds to the EGFR enzyme:  binding at the ATP site and alkylating cysteine 773. They were potent and irreversible inhibitors of the isolated enzyme, and the quinazolines were also potent inhibitors of both EGFR and <i>erb</i>B2 autophosphorylation in cells, although the corresponding pyrido[3,2-<i>d</i>]pyrimidines (both 7-alkylamine and 7-alkoxyamine substituted) were less effective in the cellular assays. The reason for this is most likely due to differences in the chemistry of the acrylamide side chain, which in the pyrido[3,2-<i>d</i>]pyrimidines was less stable to both chemical hydrolysis at high pH to the amine (this may be a marker for more rapid hydrolysis by amidases) and cellular metabolism to the gluthathione conjugate. </div><div class="NLM_p last">The quinazoline propoxymorpholide <b>18</b> showed superior in vivo antitumor activity to previous nonsolubilized analogues, giving growth delays in A431 xenografts exceeding 50 days following oral administration. This compound (as the dihydrochloride salt, CI 1033) has been selected for clinical evaluation.<sup>15</sup></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82841" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82841" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Analyses were performed by the Microchemical Laboratory, University of Otago, Dunedin, NZ, or by Parke-Davis Pharmaceutical Research Analytical Department. Melting points were determined using an Electrothermal model 9200 or Gallenkamp digital melting point apparatus and are as read. NMR spectra were measured on Bruker DRX-400 or Varian Unity 400-MHz spectrometers and referenced to Me<sub>4</sub>Si. Mass spectra were recorded on either a Varian VG 7070 spectrometer at nominal 5000 resolution or a Finnigan MAT 900Q spectrometer. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[</b><b><i>N</i></b><b>-[3-Bromo-4-(dimethylaminomethyl)phenyl]amino]quinazolin-6-yl]acrylamide</b> (<b>5). </b><b>Example of the Method of Scheme 1. </b>To a solution of 2-bromo-4-nitrobenzyl bromide<sup>16</sup> (<b>28</b>) (7.00 g, 23.7 mmol) in MeOH (100 mL) was added excess dimethylamine (15 mL, 40% solution in water). After 1 h at room temperature the reaction mixture was concentrated under reduced pressure, diluted with water and extracted with EtOAc. The combined organic extracts were then extracted with 1 N HCl which was then basified with concentrated NH<sub>4</sub>OH and extracted with EtOAc. The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure before being chromatographed on silica gel eluting with EtOAc to give 2-bromo-4-nitro-<i>N,N</i>-dimethylbenzylamine (<b>29</b>) as an oil (5.0 g, 62%):  <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 8.40 (d, <i>J</i> = 2.4 Hz, 1 H, H-3), 8.24 (dd, <i>J</i> = 8.5, 2.5 Hz, 1 H, H-5), 7.75 (d, <i>J</i> = 8.5 Hz, 1 H, H-6), 3.56 (s, 2 H, ArCH<sub>2</sub>N), 2.24 (s, 6 H, N(CH<sub>3</sub>)<sub>2</sub>). HRMS (EI) Calculated for C<sub>9</sub>H<sub>11</sub><sup>79</sup>BrN<sub>2</sub>O<sub>2</sub>:  258.0004. Found:  258.0003. </div><div class="NLM_p">Iron powder (4.00 mol equiv, 5.46 g; freshly washed with 1 N HCl followed by distilled water) was added in portions to a refluxing solution of <b>29</b> (6.00 g, 24.5 mmol) in EtOH/H<sub>2</sub>O (2:1, 180 mL) containing glacial AcOH (6.0 mL). The resulting suspension was heated at reflux with vigorous stirring for 20 min, then cooled, basified with concentrated NH<sub>4</sub>OH and filtered through a pad of Celite. The Celite was washed with EtOH, and the combined filtrate was concentrated under reduced pressure, diluted with water and extracted with EtOAc. The combined organic extracts were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, concentrated under reduced pressure, and chromatographed on grade III alumina, eluting with EtOAc/hexane (1:2), to give 4-amino-2-bromo-<i>N,N</i>-dimethylbenzylamine (<b>30</b>) (5.03 g, 96%), which was used directly:  <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 7.01 (d, <i>J</i> = 8.2 Hz, 1 H, H-6), 6.77 (d, <i>J</i> = 2.2 Hz, 1 H, H-3), 6.51 (dd, <i>J</i> = 8.2, 2.2 Hz, 1 H, H-5), 5.26 (s, 2 H, NH<sub>2</sub>), 3.26 (s, 2 H, ArCH<sub>2</sub>N), 2.12 (s, 6 H, N(CH<sub>3</sub>)<sub>2</sub>). </div><div class="NLM_p"><a name="jm004300701387" id="jm004300701387"></a>To a solution of 2-bromo-4-nitrophenol (<b>31</b>) (2.50 g, 12.3 mmol) in DMF (30 mL) were added 2-dimethylaminoethyl chloride hydrochloride (2.65 g, 18.4 mmol) and K<sub>2</sub>CO<sub>3</sub> (5.08 g, 36.8 mmol). The resulting suspension was heated at 100 °C with stirring for 2 h before further 2-dimethylaminoethyl chloride hydrochloride (1.0 g) was added. After a further 2 h the DMF was removed under reduced pressure, the residue was diluted with NH<sub>4</sub>OH and extracted with EtOAc. The combined organic extracts were then dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure before being chromatographed on grade III alumina, eluting with EtOAc/hexane (1:2), to give 2-bromo-1-[2-(dimethylamino)ethoxy]-4-nitrobenzene (<b>32</b>) (0.96 g, 27%) as a glassy solid:  <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 8.42 (d, <i>J</i> = 2.7 Hz, 1 H, H-3), 8.26 (dd, <i>J</i> = 9.2, 2.7 Hz, 1 H, H-5), 7.36 (d, <i>J</i> = 9.2 Hz, 1 H, H-6), 4.30 (t, <i>J</i> = 5.6 Hz, 2 H, OC<i>H</i><sub>2</sub>CH<sub>2</sub>N), 2.72 (t, <i>J</i> = 5.6 Hz, 2 H, OCH<sub>2</sub>C<i>H</i><sub>2</sub>N), 2.25 (s, 6 H, N(CH<sub>3</sub>)<sub>2</sub>). HRMS (EI) Calculated for C<sub>10</sub>H<sub>13</sub><sup>79</sup>BrN<sub>2</sub>O<sub>3</sub>:  288.01095. Found:  288.01097. </div><div class="NLM_p">A solution of <b>32</b> (0.96 g, 3.39 mmol) in EtOAc/MeOH (60 mL, 5:1) was hydrogenated at 60 psi over Pt−C for 25 min before being filtered through Celite, concentrated and chromatographed on grade III alumina, eluting with EtOAc/hexane (1:1), to give 4-amino-2-bromo-1-[2-(dimethylamino)ethoxy]benzene (<b>33</b>) (0.49 g, 56%), which was used directly:  <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 6.84 (d, <i>J</i> = 8.7 Hz, 1 H, H-6), 6.79 (d, <i>J</i> = 2.6 Hz, 1 H, H-3), 6.51 (dd, <i>J</i> = 8.7, 2.6 Hz, 1 H, H-5), 4.87 (s, 2 H, NH<sub>2</sub>), 3.93 (t, <i>J</i> = 6.0 Hz, 2 H, OC<i>H</i><sub>2</sub>CH<sub>2</sub>N), 2.59 (t, <i>J</i> = 6.0 Hz, 2 H, OCH<sub>2</sub>C<i>H</i><sub>2</sub>N), 2.23 (s, 6 H, N(CH<sub>3</sub>)<sub>2</sub>). </div><div class="NLM_p">A suspension of 6-nitroquinazolone (3.50 g, 18.5 mmol) in neat SOCl<sub>2</sub> (30 mL) containing 2 drops of DMF was refluxed for 3 h until it became clear. The excess SOCl<sub>2</sub> was removed under reduced pressure, and dry benzene was added and then evaporated under reduced pressure to remove all traces of SOCl<sub>2</sub>. The resulting crude 4-chloro-6-nitroquinazoline<sup>17</sup> (<b>34</b>) was dissolved in dry CH<sub>2</sub>Cl<sub>2</sub> (50 mL) and washed twice with saturated Na<sub>2</sub>CO<sub>3</sub>, and this solution was then added to a solution of 4-amino-2-bromo-<i>N,N</i>-dimethylbenzylamine (<b>30</b>) (20.3 mmol, 4.64 g) in <i>i</i>-PrOH (60 mL) containing Et<sub>3</sub>N (excess, 7.0 mL). The resulting reaction mixture was heated at reflux for 3 h and then concentrated under reduced pressure, diluted with water and extracted with EtOAc. The combined organic extracts were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, concentrated under reduced pressure and chromatographed on silica gel eluting with CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (1:1) to MeOH/CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (2:9:9) to give 4-[<i>N</i>-[3-bromo-4-(dimethylaminomethyl)phenyl]amino]-6-nitroquinazoline (<b>35</b>) (0.62 g, 8%):  mp (CH<sub>2</sub>Cl<sub>2</sub>) 198−200 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.47 (br s, 1 H, NH), 9.66 (d, <i>J</i> = 2.5 Hz, 1 H, H-5), 8.77 (s, 1 H, H-2), 8.57 (dd, <i>J</i> = 9.2, 2.5 Hz, 1 H, H-7), 8.21 (d, <i>J</i> = 2.0 Hz, 1 H, H-2‘), 7.95 (d, <i>J</i> = 9.2 Hz, 1 H, H-8), 7.91 (dd, <i>J</i> = 8.5, 2.0 Hz, 1 H, H-6‘), 7.49 (d, <i>J</i> = 8.5 Hz, 1 H, H-5‘), 3.46 (s, 2 H, C<i>H</i><sub>2</sub>N(CH<sub>3</sub>)<sub>2</sub>), 2.22 (s, 6 H, N(CH<sub>3</sub>)<sub>2</sub>). Anal. (C<sub>17</sub>H<sub>16</sub>BrN<sub>5</sub>O<sub>2</sub>·1.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p">Iron dust reduction of <b>35</b> (0.52 g, 1.29 mmol) in EtOH/H<sub>2</sub>O (2:1, 50 mL) containing glacial AcOH (0.7 mL) as described above gave, after chromatography on grade III alumina, eluting with EtOAc to MeOH/EtOAc (5:95), 6-amino-4-[<i>N</i>-[3-bromo-4-(dimethylaminomethyl)phenyl]amino]quinazoline (<b>37</b>) (0.32 g, 67%):  mp (trihydrochloride salt from MeOH/Et<sub>2</sub>O) 296 °C dec; <sup>1</sup>H NMR [trihydrochloride salt, (CD<sub>3</sub>)<sub>2</sub>SO] δ 11.37 (s, 1 H, NH), 11.17 (br s, 1 H, NH), 8.81 (s, 1 H, H-2), 8.25 (d, <i>J</i> = 2.0 Hz, 1 H, H-2‘ or H-5), 8.02 (d, <i>J</i> = 8.4 Hz, 1 H, H-5‘), 7.96 (dd, <i>J</i> = 8.4, 2.0 Hz, 1 H, H-6‘), 7.87 (d, <i>J</i> = 9.0 Hz, 1 H, H-8), 7.78 (d, <i>J</i> = 2.1 Hz, 1 H, H-2‘ or H-5), 7.53 (dd, <i>J</i> = 9.0, 2.2 Hz, 1 H, H-7), 5.46 (br s, 4 H, NH), 4.47 (d, <i>J</i> = 5.3 Hz, 2 H, C<i>H</i><sub>2</sub>N<sup>+</sup>H(CH<sub>3</sub>)<sub>2</sub>), 2.79 (d, <i>J</i> = 4.6 Hz, 6 H, N<sup>+</sup>H(C<i>H</i><sub>3</sub>)<sub>2</sub>). Anal. (C<sub>17</sub>H<sub>18</sub>BrN<sub>5</sub>·3HCl·1.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p">1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI·HCl) (2 mol equiv, 1.31 mmol, 250 mg) was added to a stirred solution of <b>37</b> (243 mg, 0.65 mmol), acrylic acid (4 mol equiv, 2.61 mmol, 179 μL), and pyridine (excess, 1.0 mL) in DMA (15 mL) under N<sub>2</sub>. After 2 h at room temperature, the reaction mixture was concentrated under reduced pressure before being diluted with saturated NaHCO<sub>3</sub>, the resulting suspension was then extracted with EtOAc. The combined organic extracts were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated under reduced pressure before being chromatographed on silica gel eluting with EtOAc/CH<sub>2</sub>Cl<sub>2</sub> (1:1) to MeOH/CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (3:7:10), to give <b>5</b> (115 mg, 41%):  mp (CH<sub>2</sub>Cl<sub>2</sub>) 206 °C dec; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.52 (s, 1 H, CONH), 9.91 (s, 1 H, NH), 8.82 (d, <i>J</i> = 2.1 Hz, 1 H, H-5), 8.58 (s, 1 H, H-2), 8.20 (d, <i>J</i> = 2.1 Hz, 1 H, H-2‘), 7.90 (dd, <i>J</i> = 8.9, 2.1 Hz, 1 H, H-7), 7.87 (dd, <i>J</i> = 8.4, 2.1 Hz, 1 H, H-6‘), 7.80 (d, <i>J</i> = 8.9 Hz, 1 H, H-8), 7.44 (d, <i>J</i> = 8.4 Hz, 1 H, H-5‘), 6.54 (dd, <i>J</i> = 17.0, 10.1 Hz, 1 H, C<i>H</i><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH<sub>2</sub>), 6.35 (dd, <i>J</i> = 17.0, 1.9 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 5.84 (dd, <i>J</i> = 10.1, 1.9 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 3.46 (s, 2 H, C<i>H</i><sub>2</sub>N(CH<sub>3</sub>)<sub>2</sub>), 2.22 (s, 6 H, N(CH<sub>3</sub>)<sub>2</sub>). Anal. (C<sub>20</sub>H<sub>20</sub>BrN<sub>5</sub>O·H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[</b><b><i>N</i></b><b>-[3-Bromo-4-[2-(dimethylamino)ethoxy]phenyl]amino]quinazolin-6-yl]acrylamide </b><b>(6).</b> Reaction of 4-chloro-6-nitroquinazoline<sup>17</sup> (<b>34</b>) with 4-amino-2-bromo-1-[2-(dimethylamino)ethoxy]benzene (<b>33</b>) gave crude <b>36</b>, which was reduced with iron dust to crude <b>38</b>. EDCI·HCl-promoted acylation of this as described above gave <b>6</b>: mp (CH<sub>2</sub>Cl<sub>2</sub>/hexane) 181−184.5 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.50 (s, 1 H, CONH), 9.81 (s, 1 H, NH), 8.80 (br s, 1 H, H-5), 8.52 (s, 1 H, H-2), 8.09 (d, <i>J</i> = 2.6 Hz, 1 H, H-2‘), 7.88 (dd, <i>J</i> = 1.9, 9.0 Hz, 1 H, H-7), 7.78 (partially obscured d, <i>J</i> = 9.0 Hz, 1 H, H-8), 7.76 (partially obscured dd, <i>J</i> = 9.0, 2.6 Hz, 1 H, H-6‘), 7.17 (d, <i>J</i> = 9.0 Hz, 1 H, H-5‘), 6.53 (dd, <i>J</i> = 16.9, 10.1 Hz, 1 H, C<i>H</i><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH<sub>2</sub>), 6.35 (dd, <i>J</i> = 16.9, 1.8 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 5.84 (dd, <i>J</i> = 10.1, 1.8 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 4.14 (t, <i>J</i> = 5.7 Hz, 2 H, OC<i>H</i><sub>2</sub>CH<sub>2</sub>N), 2.69 (t, <i>J</i> = 5.7 Hz, 2 H, OCH<sub>2</sub>C<i>H</i><sub>2</sub>N), 2.27 (s, 6 H, N(CH<sub>3</sub>)<sub>2</sub>). Anal. (C<sub>21</sub>H<sub>22</sub>BrN<sub>5</sub>O<sub>2</sub>·0.25H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[</b><b><i>N</i></b><b>-(3-Bromophenyl)amino]-7-[3-(4-methyl-1-piperazinyl)propoxy]quinazolin-6-yl]acr</b><b>ylamide</b><b>(7). Example of the Method of Scheme 2</b>. Sodium metal (0.30 g, 13.2 mmol) was added to a solution of 3-(4-methyl-1-piperazinyl)-1-propanol (1.39 g, 8.81 mmol) in THF (40 mL) under N<sub>2</sub>, and the resulting suspension was stirred at 20 °C for 2 h and then cannulated into a solution of 4-[(3-bromophenyl)amino]-7-fluoro-6-nitroquinazoline<sup><a onclick="showRef(event, 'jm990482tb00029'); return false;" href="javascript:void(0);" class="ref jm990482tb00029">29</a></sup> (<b>39</b>) (0.80 g, 2.20 mmol) in THF (30 mL) under N<sub>2</sub>. The reaction mixture was refluxed for 18 h before the solvent was partially removed under reduced pressure and the residue was diluted with water and extracted with EtOAc. The combined organic extracts were dried (Na<sub>2</sub>SO<sub>4</sub>), concentrated under reduced pressure and chromatographed on silica gel, eluting with MeOH/CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (1:9:10) to MeOH/CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (2:3:5) to give 4-[<i>N</i>-(3-bromophenyl)amino]-7-[3-(4-methyl-1-piperazinyl)propoxy]-6-nitroquinazoline (<b>43a</b>) (0.36 g, 33%):  mp (trihydrochloride salt) (MeOH/Et<sub>2</sub>O) 233 °C dec; <sup>1</sup>H NMR [free base, (CD<sub>3</sub>)<sub>2</sub>SO] δ 10.12 (s, 1 H, NH), 9.24 (s, 1 H, H-5), 8.69 (s, 1 H, H-2), 8.19 (br s, 1 H, H-2‘), 7.88 (br d, <i>J</i> = 7.8 Hz, 1 H, H-6‘), 7.47 (s, 1 H, H-8), 7.38 (t, <i>J</i> = 7.8 Hz, 1 H, H-5‘), 7.34 (ddd, <i>J</i> = 7.8, 1.3, 1.3 Hz, 1 H, H-4‘), 4.33 (t, <i>J</i> = 6.1 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>O), 2.45 (t, <i>J</i> = 7.0 Hz, 2 H, NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 2.42−2.29 (br s, 8 H, piperazinyl methylene), 2.15 (s, 3 H, CH<sub>3</sub>N), 1.92 (quintet, <i>J</i> = 6.7 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>). Anal. (C<sub>22</sub>H<sub>25</sub>BrN<sub>6</sub>O<sub>3</sub>·3HCl·H<sub>2</sub>O) C, H, N, Cl. </div><div class="NLM_p">Reduction of <b>43a</b> (0.31 g, 0.62 mmol) with Fe powder in EtOH/H<sub>2</sub>O (2:1, 50 mL) containing glacial AcOH (1.0 mL) as above, followed by chromatography of the product on grade III alumina, eluting with MeOH/EtOAc (5:95), gave 6-amino-4-[<i>N</i>-(3-bromophenyl)amino]-7-[3-(4-methyl-1-piperazinyl)propoxy]quinazoline (<b>47a</b>) (238 mg, 82%):  mp (CH<sub>2</sub>Cl<sub>2</sub>) 171−172 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.36 (s, 1 H, NH), 8.38 (s, 1 H, H-2), 8.22 (t, <i>J</i> = 1.9 Hz, 1 H, H-2‘), 7.86 (ddd, <i>J</i> = 8.2, 1.9, 0.8 Hz, 1 H, H-6‘), 7.40 (s, 1 H, H-8), 7.30 (t, <i>J</i> = 8.0 Hz, 1 H, H-5‘), 7.20 (ddd, <i>J</i> = 8.3, 1.9, 1.0 Hz, 1 H, H-4‘), 7.09 (s, 1 H, H-5), 5.34 (s, 2 H, NH<sub>2</sub>), 4.19 (t, <i>J</i> = 6.2 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>O), 2.49 (obscured t, <i>J </i>∼ 7 Hz, 2 H, NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 2.43−2.29 (br s, 8 H, piperazinyl methylene), 2.16 (s, 3 H, CH<sub>3</sub>N), 1.97 (quintet, <i>J</i> = 6.8 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>). Anal. (C<sub>22</sub>H<sub>27</sub>BrN<sub>6</sub>O·1.25H<sub>2</sub>O) C, H, N. </div><div class="NLM_p">A stirred solution of <b>47a</b> (223 mg, 0.47 mmol), acrylic acid (6 mol equiv, 2.84 mmol, 195 μL) and Et<sub>3</sub>N (excess, 1.0 mL) in DMA (20 mL) under N<sub>2</sub> was treated with EDCI·HCl (3 mol <a name="jm004300701388" id="jm004300701388"></a> equiv, 1.42 mmol, 273 mg). Standard workup, followed by chromatography on grade III alumina, eluting with EtOAc/hexane (1:1) to MeOH/EtOAc (2:98), gave <b>7</b> (145 mg, 58%):  mp (CH<sub>2</sub>Cl<sub>2</sub>/Et<sub>2</sub>O/hexane) 105−107 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.78 (s, 1 H, CONH), 9.61 (s, 1 H, NH), 8.89 (s, 1 H, H-5), 8.56 (s, 1 H, H-2), 8.17 (t, <i>J</i> = 1.9 Hz, 1 H, H-2‘), 7.87 (br d, <i>J</i> = 8.3 Hz, 1 H, H-6‘), 7.34 (t, <i>J</i> = 8.3 Hz, 1 H, H-5‘), 7.28 (s, 1 H, H-8), 7.27 (obscured ddd, <i>J </i>∼ 8, ∼ 1, ∼ 1 Hz, 1 H, H-4‘), 6.72 (dd, <i>J</i> = 17.0, 10.3 Hz, 1 H, C<i>H</i><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH<sub>2</sub>), 6.32 (dd, <i>J</i> = 17.0, 1.9 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 5.83 (dd, <i>J</i> = 10.3, 1.9 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 4.26 (t, <i>J</i> = 6.3 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>O), 2.47 (t, <i>J</i> = 7.1 Hz, 2 H, NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 2.42−2.27 (br s, 8 H, piperazinyl methylene), 2.15 (s, 3 H, CH<sub>3</sub>N), 1.98 (quintet, <i>J</i> = 6.7 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>). Anal. (C<sub>25</sub>H<sub>29</sub>BrN<sub>6</sub>O<sub>2</sub>·0.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[</b><b><i>N</i></b><b>-(3-Bromophenyl)amino]-7-[3-(4-morpholinyl)propoxy]quinazolin-6-yl]acrylamide </b><b>(8).</b> Sodium metal (0.63 g, 27.6 mmol) was added to a solution of 3-(4-morpholinyl)-1-propanol (3.20 g, 22.0 mmol) in THF (60 mL) under N<sub>2</sub>. The resulting suspension was stirred at 20 °C for 2 h and then cannulated into a solution of <b>39</b><sup>29</sup> (2.0 g, 5.51 mmol) in THF (50 mL) under N<sub>2</sub>. Identical reaction procedure and workup as above gave, after chromatography on silica gel eluting with CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (1:1) to MeOH/CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (2:3:5), 4-[<i>N</i>-(3-bromophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-nitroquinazoline (<b>43b</b>) (1.75 g, 65%):  mp (MeOH) 216−220 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.12 (s, 1 H, NH), 9.24 (s, 1 H, H-5), 8.69 (s, 1 H, H-2), 8.19 (t, <i>J</i> = 1.8 Hz, 1 H, H-2‘), 7.88 (ddd, <i>J</i> = 8.0, 1.4, 1.4 Hz, 1 H, H-6‘), 7.49 (s, 1 H, H-8), 7.38 (t, <i>J</i> = 8.0 Hz, 1 H, H-5‘), 7.34 (ddd, <i>J</i> = 8.0, 1.4, 1.4 Hz, 1 H, H-4‘), 4.35 (t, <i>J</i> = 6.2 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>O), 3.58 (t, <i>J</i> = 4.6 Hz, 4 H, morpholino methylene), 2.45 (t, <i>J</i> = 7.0 Hz, 2 H, NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 2.37 (m, 4 H, morpholino methylene), 1.94 (quintet, <i>J</i> = 6.6 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>); <sup>13</sup>C NMR δ 157.76, 157.26, 153.76, 153.21, 140.32, 138.86, 130.37, 126.38, 124.26, 121.70, 121.13, 120.72, 110.11, 107.88, 67.87, 66.13 (×2), 54.42, 53.28 (×2), 25.30. Anal. (C<sub>21</sub>H<sub>22</sub>BrN<sub>5</sub>O<sub>4</sub>·0.75H<sub>2</sub>O) C, H, N. </div><div class="NLM_p">Reduction of <b>43b</b> (1.50 g, 3.07 mmol) with Fe powder in EtOH/H<sub>2</sub>O (2:1, 80 mL) containing glacial AcOH (2.0 mL) as above, followed by chromatography of the product on grade III alumina eluting with CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (1:1) to MeOH/EtOAc (2:98), gave 6-amino-4-[<i>N</i>-(3-bromophenyl)amino]-7-[3-(4-morpholinyl)propoxy]quinazoline (<b>47b</b>) (1.08 g, 77%):  mp (EtOAc/hexane) 158−160 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.37 (s, 1 H, NH), 8.40 (s, 1 H, H-2), 8.24 (t, <i>J</i> = 1.9 Hz, 1 H, H-2‘), 7.86 (ddd, <i>J</i> = 8.2, 1.9, 0.9 Hz, 1 H, H-6‘), 7.42 (s, 1 H, H-8), 7.30 (t, <i>J</i> = 8.2 Hz, 1 H, H-5‘), 7.21 (ddd, <i>J</i> = 8.2, 1.9, 0.9 Hz, 1 H, H-4‘), 7.09 (s, 1 H, H-5), 5.36 (s, 2 H, NH<sub>2</sub>), 4.20 (t, <i>J</i> = 6.2 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>O), 3.59 (t, <i>J</i> = 4.6 Hz, 4 H, morpholino methylene), 2.50 (t, <i>J</i> = 7.3 Hz, 2 H, NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 2.39 (m, 4 H, morpholino methylene), 1.99 (quintet, <i>J</i> = 6.7 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>); <sup>13</sup>C NMR δ 154.88, 151.94, 150.19, 144.84, 141.94, 138.50, 130.16, 124.66, 123.02, 121.09, 119.65, 110.42, 106.37, 100.81, 66.45, 66.14 (×2), 54.77, 53.29 (×2), 25.50. Anal. (C<sub>21</sub>H<sub>24</sub>BrN<sub>5</sub>O<sub>2</sub>·0.25H<sub>2</sub>O) C, H, N. </div><div class="NLM_p">A stirred solution of <b>47b</b> (0.50 g, 1.09 mmol), acrylic acid (6 mol equiv, 6.54 mmol, 449 μL), and Et<sub>3</sub>N (excess, 2.0 mL) in DMF (20 mL) under N<sub>2</sub> was treated with EDCI·HCl (3 mol equiv, 3.27 mmol, 627 mg). The standard procedure above was followed to give, after chromatography on grade III alumina eluting with EtOAc/hexane (9:1) to MeOH/EtOAc (2:98), <b>8</b> (329 mg, 59%):  mp (EtOAc/Et<sub>2</sub>O/hexane) 170−172 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.78 (s, 1 H, CONH), 9.62 (s, 1 H, NH), 8.89 (s, 1 H, H-5), 8.56 (s, 1 H, H-2), 8.18 (t, <i>J</i> = 1.9 Hz, 1 H, H-2‘), 7.88 (br d, <i>J</i> = 8.2 Hz, 1 H, H-6‘), 7.34 (t, <i>J</i> = 8.1 Hz, 1 H, H-5‘), 7.30 (s, 1 H, H-8), 7.27 (ddd, <i>J</i> = 7.9, 1.4, 0.8 Hz, 1 H, H-4‘), 6.72 (dd, <i>J</i> = 17.0, 10.2 Hz, 1 H, C<i>H</i><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH<sub>2</sub>), 6.33 (dd, <i>J</i> = 17.0, 1.9 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 5.83 (dd, <i>J</i> = 10.2, 1.9 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 4.27 (t, <i>J</i> = 6.3 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>O), 3.58 (t, <i>J</i> = 4.6 Hz, 4 H, morpholino methylene), 2.48 (t, <i>J</i> = 7.1 Hz, 2 H, NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 2.38 (m, 4 H, morpholino methylene), 1.99 (quintet, <i>J</i> = 6.7 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>); <sup>13</sup>C NMR δ 163.49, 156.68, 154.96, 153.92, 149.19, 141.20, 131.58, 130.19, 127.16, 126.95, 125.52, 123.97, 121.03, 120.52, 116.78, 108.80, 107.28, 66.96, 66.14 (×2), 54.54, 53.28 (×2), 25.31. Anal. (C<sub>24</sub>H<sub>26</sub>BrN<sub>5</sub>O<sub>3</sub>·0.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[</b><b><i>N</i></b><b>-(3-Bromophenyl)amino]-7-[4-(</b><b><i>N</i></b><b>,</b><b><i>N</i></b><b>-dimethylamino)butoxy]quinazolin-6-yl]acrylam</b><b>ide (9).</b> To a suspension of hexane-washed sodium hydride (11.0 mmol, 440 mg of a 60% dispersion in mineral oil) in THF (20 mL) was cannulated a solution of 4-(<i>N</i>,<i>N</i>-dimethylamino)-1-butanol (8.80 mmol, 1.03 g) in THF (30 mL). The resulting suspension was stirred at 20 °C under N<sub>2</sub> for 2 h and then cannulated into a solution of <b>39</b> (0.80 g, 2.20 mmol) in THF (30 mL) under N<sub>2</sub>. The dark red solution was heated at reflux overnight, then worked up as above. Chromatography of the crude product on grade III alumina eluting with EtOAc to MeOH/EtOAc (5:95), gave 6-amino-4-[<i>N</i>-(3-bromophenyl)amino]-7-[4-(<i>N</i>,<i>N</i>-dimethylamino)butoxy]quinazoline (<b>47c</b>) (310 mg, 33%):  mp (CH<sub>2</sub>Cl<sub>2</sub>/hexane) 155−156 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.36 (s, 1 H, NH), 8.39 (s, 1 H, H-2), 8.23 (t, <i>J</i> = 1.9 Hz, 1 H, H-2‘), 7.86 (br d, <i>J</i> = 8.0 Hz, 1 H, H-6‘), 7.41 (s, 1 H, H-8), 7.30 (t, <i>J</i> = 8.1 Hz, 1 H, H-5‘), 7.20 (ddd, <i>J</i> = 8.2, 1.9, 0.8 Hz, 1 H, H-4‘), 7.09 (s, 1 H, H-5), 5.32 (s, 2 H, NH<sub>2</sub>), 4.17 (t, <i>J</i> = 6.2 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>O), 2.47 (t, <i>J</i> = 7.3 Hz, 2 H, NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 2.15 (s, 6 H, N(CH<sub>3</sub>)<sub>2</sub>), 1.84 (quintet, <i>J</i> = 6.4 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 1.62 (quintet, <i>J</i> = 6.9 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>). Anal. (C<sub>20</sub>H<sub>24</sub>BrN<sub>5</sub>O·0.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p">A solution of <b>47c</b> (276 mg, 0.64 mmol), acrylic acid (6 mol equiv, 3.85 mmol, 264 μL), and Et<sub>3</sub>N (excess, 1.0 mL) in DMA (10 mL) under N<sub>2</sub> was treated with EDCI·HCl (3 mol equiv, 1.92 mmol, 369 mg). The standard procedure above, followed by chromatography of the product on grade III alumina eluting with EtOAc/hexane (1:1) to MeOH/EtOAc (3:97), gave <b>9 </b>(98 mg, 32%):  mp (CH<sub>2</sub>Cl<sub>2</sub>/Et<sub>2</sub>O) 112−115 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.77 (s, 1 H, CONH), 9.62 (s, 1 H, NH), 8.88 (s, 1 H, H-5), 8.56 (s, 1 H, H-2), 8.17 (t, <i>J</i> = 1.9 Hz, 1 H, H-2‘), 7.87 (ddd, <i>J</i> = 8.2, 1.9, 1.0 Hz, 1 H, H-6‘), 7.34 (t, <i>J</i> = 8.2 Hz, 1 H, H-5‘), 7.29 (s, 1 H, H-8), 7.27 (ddd, <i>J</i> = 8.2, 1.9, 1.0 Hz, 1 H, H-4‘), 6.71 (dd, <i>J</i> = 17.1, 10.2 Hz, 1 H, C<i>H</i><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH<sub>2</sub>), 6.32 (dd, <i>J</i> = 17.1, 1.9 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 5.82 (dd, <i>J</i> = 10.2, 1.9 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 4.24 (t, <i>J</i> = 6.6 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>O), 2.27 (t, <i>J</i> = 7.2 Hz, 2 H, NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 2.12 (s, 6 H, N(CH<sub>3</sub>)<sub>2</sub>), 1.85 (quintet, <i>J</i> = 6.9 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>), 1.60 (quintet, <i>J</i> = 7.4 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>). Anal. (C<sub>23</sub>H<sub>26</sub>BrN<sub>5</sub>O<sub>2</sub>·1.25H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[</b><b><i>N</i></b><b>-(3-Bromophenyl)amino]-7-[3-(1</b><b><i>H</i></b><b>-imidazol-1-yl)propoxy]quinazolin-6-yl]acrylami</b><b>de (10). </b>To a suspension of hexane-washed sodium hydride (5.50 mmol, 220 mg of a 60% dispersion in mineral oil) in THF (20 mL) was cannulated a solution of 3-(1<i>H</i>-imidazol-1-yl)-1-propanol (4.84 mmol, 0.61 g) in THF (30 mL). The resulting suspension was stirred at 20 °C under N<sub>2</sub> for 2 h during which time the required sodium alkoxide partially precipitated from solution. Solid <b>39</b> (0.80 g, 2.20 mmol) was then added, and the resulting dark red solution was heated at reflux for 24 h, then worked up as above. Chromatography of the product on silica gel, eluting with CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (1:1) to MeOH/CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (3:7:10), gave 4-[<i>N</i>-(3-bromophenyl)amino]-7-[3-(1<i>H</i>-imidazol-1-yl)propoxy]-6-nitroquinazoline (<b>43d</b>) (524 mg, 51%):  mp (CH<sub>2</sub>Cl<sub>2</sub>/hexane) 212−215 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.16 (s, 1 H, NH), 9.30 (s, 1 H, H-5), 8.70 (s, 1 H, H-2), 8.19 (t, <i>J</i> = 1.6 Hz, 1 H, H-2‘), 7.88 (ddd, <i>J</i> = 7.8, 1.5, 1.6 Hz, 1 H, H-6‘), 7.63 (s, 1 H, imidazolyl methine), 7.48 (s, 1 H, H-8), 7.39 (t, <i>J</i> = 7.9 Hz, 1 H, H-5‘), 7.35 (ddd, <i>J</i> = 8.0, 1.6, 1.6 Hz, 1 H, H-4‘), 7.21 (s, 1 H, imidazolyl methine), 6.90 (s, 1 H, imidazolyl methine), 4.22 (t, <i>J</i> = 6.0 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>), 4.18 (t, <i>J</i> = 6.8 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>), 2.26 (quintet, <i>J</i> = 6.4 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>). Anal. (C<sub>20</sub>H<sub>17</sub>BrN<sub>6</sub>O<sub>3</sub>) C, H, N. </div><div class="NLM_p">Reduction of <b>43d</b> (0.51 g, 1.08 mmol) with Fe (0.24 g, 4 mol equiv) in refluxing EtOH/H<sub>2</sub>O (2:1, 60 mL) containing glacial AcOH (0.7 mL) as above, followed by chromatography on grade III alumina eluting with MeOH/EtOAc (5:95), gave 6-amino-4-[<i>N</i>-(3-bromophenyl)amino]-7-[3-(1<i>H</i>-imidazol-1-yl)propoxy]quinazoline (<b>47d</b>) (389 mg, 82%):  mp (CH<sub>2</sub>Cl<sub>2</sub>/Et<sub>2</sub>O) 178−180 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.37 (s, 1 H, NH), 8.38 (s, 1 H, H-2), 8.22 (t, <i>J</i> = 1.8 Hz, 1 H, H-2‘), 7.86 (br d, <i>J</i> = 8.1 Hz, 1 H, H-6‘), 7.66 (s, 1 H, imidazolyl methine), 7.40 (s, 1 H, H-8), 7.30 <a name="jm004300701389" id="jm004300701389"></a> (t, <i>J</i> = 8.1 Hz, 1 H, H-5‘), 7.23 (s, 1 H, imidazolyl methine), 7.21 (br d, <i>J</i> = 7.7 Hz, 1 H, H-4‘), 7.06 (s, 1 H, H-5), 6.90 (s, 1 H, imidazolyl methine), 5.45 (s, 2 H, NH<sub>2</sub>), 4.28 (t, <i>J</i> = 7.1 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>), 4.10 (t, <i>J</i> = 5.8 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>), 2.27 (quintet, <i>J</i> = 6.5 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>). Anal. (C<sub>20</sub>H<sub>19</sub>BrN<sub>6</sub>O·0.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p">A stirred solution of <b>47d</b> (383 mg, 0.87 mmol), acrylic acid (6 mol equiv, 5.23 mmol, 359 μL), and pyridine (excess, 1.0 mL) in DMA (20 mL) under N<sub>2</sub> was treated with EDCI·HCl (5 mol equiv, 4.36 mmol, 838 mg). The standard procedure above, followed by chromatography on grade III alumina eluting with EtOAc/hexane (1:1) to MeOH/EtOAc (5:95), gave <b>10</b> (9 mg, 2%):  mp (CH<sub>2</sub>Cl<sub>2</sub>/Et<sub>2</sub>O/hexane) 235−237 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.79 (s, 1 H, CONH), 9.60 (s, 1 H, NH), 8.88 (s, 1 H, H-5), 8.55 (s, 1 H, H-2), 8.18 (t, <i>J</i> = 1.9 Hz, 1 H, H-2‘), 7.87 (ddd, <i>J</i> = 8.1, 1.9, 1.0 Hz, 1 H, H-6‘), 7.64 (s, 1 H, imidazolyl methine), 7.34 (t, <i>J</i> = 8.1 Hz, 1 H, H-5‘), 7.28 (partially obscured ddd,<i> J </i>∼ 8, 1.2, 1.2 Hz, 1 H, H-4‘), 7.27 (s, 1 H, H-5), 7.21 (t, <i>J</i> = 1.3 Hz, 1 H, imidazolyl methine), 6.89 (br s, 1 H, imidazolyl methine), 6.73 (dd, <i>J</i> = 17.0, 10.2 Hz, 1 H, C<i>H</i><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH<sub>2</sub>), 6.34 (dd, <i>J</i> = 17.0, 1.8 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 5.85 (dd, <i>J</i> = 10.2, 1.8 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 4.22 (t, <i>J</i> = 6.9 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>), 4.14 (t, <i>J</i> = 6.0 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>), 2.27 (quintet, <i>J</i> = 6.4 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>). Anal. (C<sub>23</sub>H<sub>21</sub>BrN<sub>6</sub>O<sub>2</sub>·0.75H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[</b><b><i>N</i></b><b>-(3-Bromophenyl)amino]-7-[3-(</b><b><i>N</i></b><b>,</b><b><i>N</i></b><b>-diethylamino)propylthio]quinazolin-6-yl]acryla</b><b>mide (11).</b> 3-(<i>N</i>,<i>N</i>-Diethylamino)propanethiol hydrochloride (422 mg, 2.20 mmol) was added to a slurry of hexane-washed NaH (60% oil suspension, 320 mg, 8.00 mmol) in DMSO (2 mL) stirred under N<sub>2</sub> at 25 °C. After 20 min, a solution of <b>39</b> (726 mg, 2.0 mmol) in DMSO (3 mL) was added, and the dark mixture was heated to 65 °C for 30 min, then poured onto ice-cold saturated NaHCO<sub>3</sub> solution. The precipitate was collected by filtration, rinsed with water, and dried to give 4-[<i>N</i>-(3-bromophenyl)amino]-7-[3-(<i>N</i>,<i>N</i>-diethylamino)propylthio]-6-nitroquinazoline (<b>43e</b>) (940 mg, 100%) as a brown solid, that was used directly; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.28 (s, 1 H, H-5), 8.34 (s, 1 H, H-2), 7.87 (s, 1 H, H-2‘), 7.52 (d, <i>J</i> = 7.6 Hz, H-6‘), 7.41 (s, 1 H, H-8), 7.21 (t, 1 H, <i>J</i> = 8.0 Hz, H-5‘), 7.12 (d, 1 H, <i>J</i> = 8.1 Hz, H-4‘), 3.05 (t, 1 H, <i>J</i> = 7.2 Hz, SCH<sub>2</sub>), 2.47 (t, 2 H, <i>J</i> = 7 Hz, NCH<sub>2</sub>), 2.40 (q, 4 H, <i>J</i> = 7.1 Hz, NCH<sub>2</sub>), 1.72 (quintet, 2 H, <i>J</i> = 7.1 Hz, CH<sub>2</sub>), 0.90 (t, 6 H, <i>J</i> = 7.2 Hz, Me). </div><div class="NLM_p">Iron powder (446 mg, 8.0 mmol) was added to a vigorously stirred mixture of <b>43e</b> (940 mg, 2.00 mmol) in refluxing EtOH/water/AcOH (8:4:0.5 mL). After 30 min the reaction mixture was allowed to cool to room temperature, and was then neutralized with concentrated aqueous ammonia, filtered through a pad of Celite, and the residue rinsed with EtOH. The combined filtrates were concentrated to small volume and extracted with EtOAc. The volatiles were removed rigorously under reduced pressure to give 6-amino-4-[<i>N</i>-(3-bromophenyl)amino]-7-[3-(<i>N</i>,<i>N</i>-diethylamino)propylthio]quinazoline (<b>47e</b>) (604 mg, 66%) as a brown solid, that was used directly:  <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.48 (s, 1 H, NH), 8.34 (s, 1 H, H-2), 8.16 (s, 1 H, H-2‘), 7.81 (d, <i>J</i> = 7.1 Hz, H-6‘), 7.51 (s, 1 H, H-5), 7.41 (s, 1 H, H-8), 7.26 (t, 1 H, <i>J</i> = 8.0 Hz, H-5‘), 7.18 (d, 1 H, <i>J</i> = 7.8 Hz, H-4‘), 5.42 (br s, 2 H, NH<sub>2</sub>), 3.03 (t, 1 H, <i>J</i> = 6.8 Hz, SCH<sub>2</sub>), 2.44 (t, 2 H, <i>J</i> = 7 Hz, NCH<sub>2</sub>), 2.39 (q, 4 H, <i>J</i> = 7.1 Hz, NCH<sub>2</sub>), 1.68 (quintet, 2 H, <i>J</i> = 6.6 Hz, CH<sub>2</sub>), 0.89 (t, 6 H, <i>J</i> = 6.8 Hz, CH<sub>3</sub>). </div><div class="NLM_p">A stirred solution of <b>47e</b> (604 mg, 1.30 mmol) and acrylic acid (0.19 mL, 2.8 mmol) and pyridine (0.22 mL, 2.7 mmol) in DMF (5 mL) was treated with EDCI·HCl (540 mg, 2.8 mmol) under N<sub>2</sub> at 0 °C, and reaction mixture was then stirred at 25 °C for 3 h before being quenched by the addition of water. The mixture was extracted with EtOAc, and the combined extracts were washed with water, saturated brine, dried (MgSO<sub>4</sub>) and evaporated under reduced pressure. The residue was flash chromatographed on silica gel, eluting with 2−20% MeOH in CH<sub>2</sub>Cl<sub>2</sub>, and the appropriate fractions were triturated with Me<sub>2</sub>CO to give <b>11 </b>(116 mg, 17%) as a light brown glass:  mp 77−79 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.88 (s, 1 H, NH), 9.78 (s, 1 H, NH), 8.57 (s, 1 H, H-5), 8.45 (s, 1 H, H-2), 8.16 (t, 1 H, <i>J</i> = 1.9 Hz, H-2‘), 7.85 (d, <i>J</i> = 8.8 Hz, H-6‘), 7.56 (s, 1 H, H-8), 7.27 (t, 1 H, <i>J</i> = 7.9 Hz, H-5‘), 7.21 (d, 1 H, <i>J</i> = 8.3 Hz, H-4‘), 6.54 (dd, 1 H, <i>J</i> = 17.5, 10.5 Hz, C<i>H</i><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH<sub>2</sub>), 6.25 (dd, 1 H, <i>J</i> = 1.7, 17.0 Hz, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 5.77 (d, 1 H, <i>J</i> = 10.3 Hz, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 3.07 (t, 1 H, <i>J</i> = 7.2 Hz, SCH<sub>2</sub>), 2.47 (t, 2 H, <i>J</i> = 6.8 Hz, NCH<sub>2</sub>), 2.41 (q, 4 H, <i>J</i> = 7.1 Hz, NCH<sub>2</sub>), 1.72 (quintet, 2 H, <i>J</i> = 6.9 Hz, CH<sub>2</sub>), 0.91(t, 6 H, <i>J</i> = 7.1 Hz, CH<sub>3</sub>); MS (APCI) 516 (95, <sup>81</sup>BrMH<sup>+</sup>), 514 (100, <sup>79</sup>BrMH<sup>+</sup>). Anal. (C<sub>24</sub>H<sub>28</sub>N<sub>5</sub>OBr·H<sub>2</sub>O·0.5CH<sub>2</sub>Cl<sub>2</sub>) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[</b><b><i>N</i></b><b>-(3-Methylphenyl)amino]-7-[3-(4-methyl-1-piperazinyl)propoxy]quinazolin-6-yl]acr</b><b>ylamide (13).</b> A solution of 4-chloro-7-fluoro-6-nitroquinazoline (prepared as described<sup>29</sup> from 7-fluoro-6-nitroquinazolone) was dissolved in dry CH<sub>2</sub>Cl<sub>2</sub> (50 mL) and added to a stirred solution of 3-methylaniline in <i>i-</i>PrOH (30 mL). The reaction mixture was stirred at 20 °C for 30 min and then diluted with hexane (200 mL). The resulting precipitate was collected, washed with hexane and dissolved in MeOH/H<sub>2</sub>O (4:1, 150 mL) with gentle warming. The solution was treated with excess Et<sub>3</sub>N and diluted with water (400 mL), and the precipitate was filtered, washed with water and dried under reduced pressure to give 7-fluoro-4-[<i>N</i>-(3-methylphenyl)amino]-6-nitroquinazoline (<b>40</b>) (3.01 g, 88%):  mp (CH<sub>2</sub>Cl<sub>2</sub>/hexane) 191−192 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.38 (s, 1 H, NH), 9.62 (d, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub><i>=</i> 8.1 Hz, 1 H, H-5), 8.67 (s, 1 H, H-2), 7.80 (d, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub><i>=</i> 12.6 Hz, 1 H, H-8), 7.63 (br d, <i>J</i> = 8.2 Hz, 1 H, H-6‘), 7.60 (br s, 1 H, H-2‘), 7.31 (t, <i>J</i> = 7.8 Hz, 1 H, H-5‘), 7.03 (br d, <i>J</i> = 7.5 Hz, 1 H, H-4‘), 2.35 (s, 3 H, ArCH<sub>3</sub>). Anal. (C<sub>15</sub>H<sub>11</sub>FN<sub>4</sub>O<sub>2</sub>) C, H, N. </div><div class="NLM_p">Sodium metal (0.23 g, 10.1 mmol) was added to a solution of 3-(4-methyl-1-piperazinyl)-1-propanol (1.06 g, 6.71 mmol) in THF (15 mL) under N<sub>2</sub>. The resulting suspension was stirred at 20 °C for 2 h and then cannulated into a solution of <b>40</b> (0.50 g, 1.68 mmol) in THF (20 mL) under N<sub>2</sub>. Standard workup followed by chromatography of the product on alumina, eluting with EtOAc/hexane (1:1) to EtOAc (2:3:5), gave 4-[<i>N</i>-(3-methylphenyl)amino]-7-[3-(4-methyl-1-piperazinyl)propoxy]-6-nitroquinazoline (<b>44a</b>) (0.67 g, 91%):  mp (Et<sub>2</sub>O/hexane) 155−156 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.00 (s, 1 H, NH), 9.26 (s, 1 H, H-5), 8.61 (s, 1 H, H-2), 7.64 (br d, <i>J</i> = 8.4 Hz, 1 H, H-6‘), 7.62 (br s, 1 H, H-2‘), 7.43 (s, 1 H, H-8), 7.29 (t, <i>J</i> = 7.8 Hz, 1 H, H-5‘), 6.99 (br d, <i>J</i> = 7.4 Hz, 1 H, H-4‘), 4.32 (t, <i>J</i> = 6.0 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>O), 2.44 (t, <i>J</i> = 7.0 Hz, 2 H, NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 2.39−2.28 (br s, 8 H, piperazinyl methylene), 2.34 (s, 3 H, CH<sub>3</sub>Ar), 2.14 (s, 3 H, CH<sub>3</sub>N), 1.92 (quintet, <i>J</i> = 6.6 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>). Anal. (C<sub>23</sub>H<sub>28</sub>N<sub>6</sub>O<sub>3</sub>) C, H, N. </div><div class="NLM_p">A solution of <b>44a</b> (0.61 g, 1.40 mmol) in MeOH/EtOAc (2:1, 50 mL) was hydrogenated (60 psi) over Pd−C for 5 h and then filtered through Celite. The filtrate was concentrated under reduced pressure and chromatographed on grade III alumina, eluting with MeOH/EtOAc (5:95) to give 6-amino-4-[<i>N</i>-(3-methylphenyl)amino]-7-[3-(4-methyl-1-piperazinyl)propoxy]quinazoline (<b>48a</b>) (361 mg), which appeared unstable (rapid discoloration) and was used without further characterization. A stirred solution of <b>48a</b> (0.36 g, 0.89 mmol), acrylic acid (6 mol equiv, 5.53 mmol, 366 μL), and Et<sub>3</sub>N (excess, 2.0 mL) in DMF (20 mL) under N<sub>2</sub> was treated with EDCI·HCl (3 mol equiv, 2.66 mmol, 511 mg). Standard workup followed by chromatography on grade III alumina, eluting with EtOAc to MeOH/EtOAc (2:98), gave <b>13</b> (65 mg, 16%):  mp (Et<sub>2</sub>O/hexane) 60−66 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.60 (s, 1 H, exchangeable), 9.59 (s, 1 H, exchangeable), 8.86 (s, 1 H, H-5), 8.48 (s, 1 H, H-2), 7.62 (partially obscured br d, <i>J</i> = 8.0 Hz, 1 H, H-6‘), 7.62 (br s, 1 H, H-2‘), 7.25 (partially obscured t, <i>J</i> = 8.1 Hz, 1 H, H-5‘), 7.25 (s, 1 H, H-8), 6.92 (br d, <i>J</i> = 7.5 Hz, 1 H, H-4‘), 6.70 (dd, <i>J</i> = 17.0, 10.2 Hz, 1 H, C<i>H</i><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH<sub>2</sub>), 6.31 (dd, <i>J</i> = 17.0, 1.8 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 5.83 (dd, <i>J</i> = 10.2, 1.8 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 4.24 (t, <i>J</i> = 6.3 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>O), 2.47 (t, <i>J</i> = 7.1 Hz, 2 H, NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 2.41−2.28 (br s, 8 H, piperazinyl methylene), 2.33 (s, 3 H, CH<sub>3</sub>Ar), 2.15 (s, 3 H, CH<sub>3</sub>N), 1.97 (quintet, <i>J</i> = 6.8 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>). EI HRMS (M<sup>+</sup>) C<sub>26</sub>H<sub>32</sub>N<sub>6</sub>O<sub>2</sub>:  Requires 460.2587. Found:  460.2576. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[</b><b><i>N</i></b><b>-(3-Methylphenyl)amino]-7-[3-(4-morpholinyl)propoxy]quinazolin-6-yl]acrylamide </b><b>(14).</b> Sodium metal (0.27 g, 11.8 mmol) was added to a solution of 3-(4-<a name="jm004300701390" id="jm004300701390"></a> morpholinyl)-1-propanol (1.22 g, 8.40 mmol) in THF (40 mL) under N<sub>2</sub>. The resulting suspension was stirred at 20 °C for 2 h and then cannulated into a solution of <b>40</b> (0.70 g, 2.35 mmol) in THF (30 mL) under N<sub>2</sub>. Reaction and workup as above, followed by chromatography on silica gel, eluting with MeOH/CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (5:45:50) to MeOH/CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (3:7:10), gave 4-[<i>N</i>-(3-methylphenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-nitroquinazoline (<b>44b</b>) (0.87 g, 88%):  mp (CH<sub>2</sub>Cl<sub>2</sub>/hexane) 169−170 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.00 (s, 1 H, NH), 9.26 (s, 1 H, H-5), 8.62 (s, 1 H, H-2), 7.64 (br d, <i>J</i> = 8.1 Hz, 1 H, H-6‘), 7.62 (br s, 1 H, H-2‘), 7.45 (s, 1 H, H-8), 7.29 (t, <i>J</i> = 7.8 Hz, 1 H, H-5‘), 6.99 (br d, <i>J</i> = 7.5 Hz, 1 H, H-4‘), 4.34 (t, <i>J</i> = 6.1 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>O), 3.58 (t, <i>J</i> = 4.6 Hz, 4 H, morpholino methylene), 2.46 (t, <i>J</i> = 7.0 Hz, 2 H, NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 2.38 (br s, 4 H, morpholino methylene), 2.35 (s, 3 H, CH<sub>3</sub>Ar), 1.94 (quintet, <i>J</i> = 6.6 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>). Anal. (C<sub>22</sub>H<sub>25</sub>N<sub>5</sub>O<sub>4</sub>) C, H, N. </div><div class="NLM_p">A solution of <b>44b </b>(0.71 g, 1.68 mmol) in MeOH/EtOAc (2:1, 60 mL) was hydrogenated (60 psi) over Pd−C for 6 h and then filtered through Celite and worked up as above to to give 6-amino-4-[<i>N</i>-(3-methylphenyl)amino]-7-[3-(4-morpholinyl)propoxy]quinazoline (<b>48b</b>), which was used without further characterization. A stirred solution of <b>48b</b> (0.7 g, 1.8 mmol), acrylic acid (6 mol equiv, 10.8 mmol, 776 μL), and Et<sub>3</sub>N (excess, 4.0 mL) in DMF (20 mL) under N<sub>2</sub> was treated with EDCI·HCl (3 mol equiv, 5.38 mmol, 1.03 g). Standard workup and chromatography on silica gel, eluting with CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (1:1) to MeOH/CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (3:7:10), gave <b>14</b> (175 mg, 22%):  mp (EtOAc/Et<sub>2</sub>O) 69−72 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.60 (s, 1 H, exchangeable), 9.59 (s, 1 H, exchangeable), 8.86 (s, 1 H, H-5), 8.48 (s, 1 H, H-2), 7.62 (partially obscured br d, <i>J</i> = 8.0 Hz, 1 H, H-6‘), 7.61 (br s, 1 H, H-2‘), 7.26 (s, 1 H, H-8), 7.25 (t, <i>J</i> = 7.8 Hz, 1 H, H-5‘), 6.92 (br d, <i>J</i> = 7.4 Hz, 1 H, H-4‘), 6.70 (dd, <i>J</i> = 16.9, 10.2 Hz, 1 H, C<i>H</i><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH<sub>2</sub>), 6.32 (dd, <i>J</i> = 16.9, 1.9 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 5.82 (dd, <i>J</i> = 10.2, 1.9 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 4.26 (t, <i>J</i> = 6.3 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>O), 3.58 (t, <i>J</i> = 4.6 Hz, 4 H, morpholino methylene), 2.48 (t, <i>J</i> = 7.1 Hz, 2 H, NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 2.38 (m, 4 H, morpholino methylene), 2.33 (s, 3H, CH<sub>3</sub>Ar), 1.99 (quintet, <i>J</i> = 6.7 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>). Anal. (C<sub>25</sub>H<sub>29</sub>N<sub>5</sub>O<sub>3</sub>·0.25H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[</b><b><i>N</i></b><b>-(3-Bromo-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]quinazolin-6-yl]acr</b><b>ylamide (16). </b>Reaction of 4-chloro-7-fluoro-6-nitroquinazoline<sup>29</sup> with 3-bromo-4-fluoroaniline, using the procedure previously described for 3-bromoaniline,<sup>29</sup> gave 4-[<i>N</i>-(3-bromo-4-fluorophenyl)amino]-7-fluoro-6-nitroquinazoline (<b>41</b>) (89%):  mp (<i>i</i>-PrOH) 238−240 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.51 (s, 1 H, NH), 9.59 (d, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 8.0 Hz, 1 H, H-5), 8.74 (s, 1 H, H-2), 8.24 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 6.0 Hz, <i>J</i> = 2.2 Hz, 1 H, H-2'), 7.87 (m, 1H, H-6'), 7.86 (d, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 12.5 Hz, 1 H, H-8), 7.46 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 8.8 Hz, <i>J</i> = 8.8 Hz, H-5'). Anal. (C<sub>14</sub>H<sub>7</sub>BrF<sub>2</sub>N<sub>4</sub>O<sub>2</sub>) C, H, N. </div><div class="NLM_p">Treatment of <b>41</b> with the sodium salt of 3-(4-morpholinyl)-1-propanol, as described above, gave 4-[<i>N</i>-(3-bromo-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-nitroquinazoline (<b>45b</b>) (39%):  mp (MeOH) 186−188 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.14 (s, 1 H, NH), 9.21 (s, 1 H, H-5), 8.67 (d, <i>J</i> = 1.8 Hz, 1 H, H-2), 8.26 (td, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub><i> =</i> 6.0 Hz, <i>J</i> = 1.8, 1.8 Hz, 1 H, H-2‘), 7.89−7.83 (m, 1H, H-6‘), 7.48 (s, 1 H, H-8), 7.44 (t, <i>J</i> = 8.8 Hz, 1 H, H-5‘), 4.35 (t, <i>J</i> = 6.1 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>O), 3.58 (t, <i>J</i> = 4.5 Hz, 4 H, morpholino methylene), 2.45 (t, <i>J</i> = 6.6 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>N), 2.38 (m, 4 H, morpholino methylene), 1.95 (quintet, <i>J</i> = 6.6 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>). Anal. (C<sub>21</sub>H<sub>21</sub>BrFN<sub>5</sub>O<sub>4</sub>) C, H, N. </div><div class="NLM_p">Iron dust reduction of <b>45b</b> gave 6-amino-4-[<i>N</i>-(3-bromo-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]quinazoline (<b>49b</b>) (91%):  mp (<i>i</i>-Pr<sub>2</sub>O/CH<sub>2</sub>Cl<sub>2</sub>) 149−150 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.37 (s, 1 H, NH), 8.37 (s, 1 H, H-2), 8.29 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub><i> =</i> 6.3 Hz, <i>J</i> = 2.5 Hz, 1 H, H-2‘), 7.88−7.84 (m, 1 H, H-6‘), 7.38 (s, 1 H, H-8), 7.36 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub><i> =</i> 8.8 Hz, <i>J</i> = 8.8 Hz, 1 H, H-5‘), 7.08 (s, 1 H, H-5), 5.34 (s, 2 H, NH<sub>2</sub>), 4.20 (t, <i>J</i> = 6.2 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>O), 3.59 (t, <i>J</i> = 4.5 Hz, 4 H, morpholino methylene), 2.50 (t, <i>J</i> = 7.3 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>N), 2.40 (m, 4 H, morpholino methylene), 1.99 (quintet, <i>J</i> = 6.7 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>). Anal. (C<sub>21</sub>H<sub>23</sub>BrFN<sub>5</sub>O<sub>2</sub>) C, H, N. </div><div class="NLM_p">Treatment of <b>49b</b> with acrylic acid and EDCI·HCl in DMA, as described above, gave <b>16</b> (49%):  mp (MeOH) 171−173 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.80 (s, 1 H, CONH), 9.62 (s, 1 H, NH), 8.87 (s, 1 H, H-5), 8.54 (s, 1 H, H-2), 8.23 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub><i> =</i> 5.1 Hz, <i>J</i> = 2.6 Hz, 1 H, H-2‘), 7.88−7.84 (m, 1 H, H-6‘), 7.40 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 8.8 Hz, <i>J</i> = 8.8 Hz, 1 H, H-5‘), 7.29 (s, 1 H, H-8), 6.72 (dd, <i>J</i> = 17.0, 10.2 Hz, 1 H, C<i>H</i><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH<sub>2</sub>), 6.32 (dd, <i>J</i> = 17.0, 1.9 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 5.83 (dd, <i>J</i> = 10.2, 1.9 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 4.27 (t, <i>J</i> = 6.3 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>O), 3.59 (t, <i>J</i> = 4.3 Hz, 4 H, morpholino methylene), 2.49 (t, <i>J</i> = 7.3 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>N), 2.39 (m, 4 H, morpholino methylene), 2.00 (quintet, <i>J</i> = 6.7 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>). Anal. (C<sub>24</sub>H<sub>25</sub>BrFN<sub>5</sub>O<sub>3</sub>·H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[</b><b><i>N</i></b><b>-(3-Chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]quinazolin-6-yl]acr</b><b>ylamide (18). </b>Reaction of 4-chloro-7-fluoro-6-nitroquinazoline<sup>29</sup> with 3-chloro-4-fluoroaniline, as above, gave 4-[<i>N</i>-(3-chloro-4-fluorophenyl)amino]-7-fluoro-6-nitroquinazoline (<b>42</b>) (72%):  mp (<i>i</i>-PrOH) 239−240 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.43 (s, 1 H, NH), 9.53 (d, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 8.0 Hz, 1 H, H-5), 8.70 (s, 1 H, H-2), 8.11 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 6.7 Hz, <i>J</i> = 2.4 Hz, 1 H, H-2'), 7.80 (d, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 12.4 Hz, 1 H, H-8), 7.78 (m, 1H, H-6'), 7.46 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 9.1 Hz, <i>J</i> = 9.1 Hz, H-5'). Anal. (C<sub>14</sub>H<sub>7</sub>ClF<sub>2</sub>N<sub>4</sub>O<sub>2</sub>) C, H, N. </div><div class="NLM_p">Treatment of <b>42</b> with the sodium salt of 3-(4-morpholinyl)-1-propanol, as described above, gave 4-[<i>N</i>-(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-nitroquinazoline (<b>46b</b>) (58%):  mp (MeOH) 194−195 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.16 (s, 1 H, NH), 9.22 (s, 1 H, H-5), 8.68 (d, <i>J</i> = 1.8 Hz, 1 H, H-2), 8.17 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub><i> =</i> 6.8 Hz, <i>J</i> = 2.5 Hz, 1 H, H-2‘), 7.82−7.78 (m, 1H, H-6‘), 7.49 (s, 1 H, H-8), 7.47 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 8.9 Hz, <i>J</i> = 8.9 Hz, 1 H, H-5‘), 4.35 (t, <i>J</i> = 6.1 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>O), 3.57 (t, <i>J</i> = 4.5 Hz, 4 H, morpholino methylene), 2.46 (t, <i>J</i> = 7.0 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>N), 2.37 (m, 4 H, morpholino methylene), 1.94 (quintet, <i>J</i> = 6.7 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>). Anal. (C<sub>21</sub>H<sub>21</sub>ClFN<sub>5</sub>O<sub>4</sub>) C, H, N. </div><div class="NLM_p">Iron dust reduction of <b>46b </b>gave 6-amino-4-[<i>N</i>-(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]quinazoline (<b>50b</b>) (78%):  mp (<i>i</i>-Pr<sub>2</sub>O/CH<sub>2</sub>Cl<sub>2</sub>) 166−167 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.38 (s, 1 H, NH), 8.37 (s, 1 H, H-2), 8.19 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub><i> =</i> 6.9 Hz, <i>J</i> = 2.7 Hz, 1 H, H-2‘), 7.83−7.79 (m, 1 H, H-6‘), 7.39 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 9.1 Hz, <i>J</i> = 9.1 Hz, 1 H, H-5‘), 7.38 (s, 1 H, H-8), 7.08 (s, 1 H, H-5), 5.36 (s, 2 H, NH<sub>2</sub>), 4.20 (t, <i>J</i> = 6.2 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>O), 3.59 (t, <i>J</i> = 4.6 Hz, 4 H, morpholino methylene), 2.51 (t, <i>J</i> = 7.4 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>N), 2.40 (m, 4 H, morpholino methylene), 1.99 (quintet, <i>J</i> = 6.7 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>). Anal. (C<sub>21</sub>H<sub>23</sub>ClFN<sub>5</sub>O<sub>2</sub>) C, H, N. </div><div class="NLM_p">Treatment of <b>50b</b> with acrylic acid and EDCI·HCl in DMA, as described above, gave <b>18</b> (38%):  mp (MeOH) 188−190 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.80 (s, 1 H, CONH), 9.62 (s, 1 H, NH), 8.87 (s, 1 H, H-5), 8.54 (s, 1 H, H-2), 8.14 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub><i> =</i> 6.8 Hz, <i>J</i> = 2.6 Hz, 1 H, H-2‘), 7.83−7.79 (m, 1 H, H-6‘), 7.43 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 9.2 Hz, <i>J</i> = 9.2 Hz, 1 H, H-5‘), 7.30 (s, 1 H, H-8), 6.72 (dd, <i>J</i> = 17.1, 10.2 Hz, 1 H, C<i>H</i><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH<sub>2</sub>), 6.32 (dd, <i>J</i> = 17.1, 1.9 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 5.83 (dd, <i>J</i> = 10.2, 1.9 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 4.27 (t, <i>J</i> = 6.3 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>O), 3.58 (t, <i>J</i> = 4.6 Hz, 4 H, morpholino methylene), 2.48 (t, <i>J</i> = 7.1 Hz, 2 H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>N), 2.38 (m, 4 H, morpholino methylene), 2.00 (quintet, <i>J</i> = 6.7 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>). Anal. (C<sub>24</sub>H<sub>25</sub>ClFN<sub>5</sub>O<sub>3</sub>·H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[</b><b><i>N</i></b><b>-(3-Chloro-4-fluorophenyl)amino]-7-(3,6,9-trioxadecanoxy)quinazolin-6-yl]acrylami</b><b>de (19).</b> A mixture of <b>42</b> (673 mg, 2.00 mmol), triethylene glycol monomethyl ether (493 mg, 3.00 mmol) and potassium trimethylsilanolate (770 mg, 6.0 mmol) in DMSO (25 mL) was stirred together under N<sub>2</sub> for 5 h on a 25 °C water bath. The deep crimson mixture was poured onto stirred ice−water (40 mL), and the reddish precipitate was collected by Buchner filtration, rinsed with dilute Na<sub>2</sub>CO<sub>3</sub> solution and water (2 × 10 mL), and was dried in a vacuum oven at 60 °C over P<sub>2</sub>O<sub>5</sub> to give 4-[<i>N</i>-(3-chloro-4-fluorophenyl)amino]-6-nitro-7-(3,6,9-trioxadecanoxy)quinazoline (<b>46f</b>) (696 mg, 72%), which was used directly:  <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.16 (br s, 1 H, NH), 9.19 (s, 1 H, H-5), 8.66 (s, 1 H, H-2), 8.15 (dd, 1 H, <i>J</i> = 2.3, 6.8 Hz, H-2‘), 7.81−7.78 (m, 1 H, H-6‘), 7.50 (s, 1 H, H-8), 7.46 (t, 1 H, <i>J</i> = 9.1 Hz, H-5‘), <a name="jm004300701391" id="jm004300701391"></a> 4.43 (t, 2 H, <i>J</i> = 4.2 Hz, ArOCH<sub>2</sub>), 3.82 (t, 2 H, <i>J</i> = 4.2 Hz, ArOCH<sub>2</sub>C<i>H</i><sub>2</sub>), 3.62, 3.53, 3.51, 3.41 (dds, 2 H, 2 H, 2 H, 2 H,<i> J</i> ∼ 4, 6 Hz, OCH<sub>2</sub>s), 3.22 (s, 3 H, CH<sub>3</sub>). </div><div class="NLM_p">A solution of <b>46f</b> (684 mg, 1.42 mmol) in THF (50 mL) was hydrogenated over Raney nickel (0.5 g) at 50.7 psi for 22 h. The mixture was filtered through Celite, and the solution was stripped rigorously to dryness to give 6-amino-4-[<i>N</i>-(3-chloro-4-fluorophenyl)amino]-7-(3,6,9-trioxadecanoxy)quinazoline (<b>50f</b>) (654 mg, 95% corrected), contaminated with 17 mol % THF and 9 mol % BHT stabilizer, as a gray-green waxy solid that was used directly:  <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.44 (br s, 1 H, NH), 8.41 (s, 1 H, H-2), 8.23 (dd, 1 H, <i>J</i> = 2.6, 6.7 Hz, H-2‘), 7.84 (ddd, 1 H, <i>J</i> = 2.6, 4.1, 9.1 Hz, H-6‘), 7.44 (s, 1 H, H-5), 7.43 (t, 1 H, <i>J</i> = 9.2 Hz, H-5‘), 7.16 (s, 1 H, H-8), 5.36 (br s, 2 H, NH<sub>2</sub>), 4.33 (t, 2 H, <i>J</i> = 4.5 Hz, ArOCH<sub>2</sub>), 3.91 (t, 2 H, <i>J</i> = 4.5 Hz, ArOCH<sub>2</sub>C<i>H</i><sub>2</sub>), 3.68, 3.60 (dds, 2 H, 2 H, <i>J</i> = 3.6, 6.4 Hz, OCH<sub>2</sub>s), 3.56, 3.46 (dds, 2 H, 2 H, <i>J</i> = 3.7, 5.7 Hz, OCH<sub>2</sub>s), 3.27 (s, 3 H, CH<sub>3</sub>). </div><div class="NLM_p">Solid <b>50f</b> was added in one portion to a solution of the anhydride made by adding isobutyl chloroformate (65 mL, 0.5 mmol) dropwise to a stirred solution of acrylic acid (42 mg, 0.58 mmol) and Et<sub>3</sub>N (101 mg, 1.0 mmol) in THF (2.5 mL) at 0 °C under N<sub>2</sub>, and keeping for 10 min. After a further 20 min at 0 °C, the reaction mixture was applied directly to preparative TLC plates (silica, two 20 × 20 × 0.2 cm) and eluted once with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (19:1). The major band (<i>R</i><i><sub>f</sub></i> 0.28) was extracted with MeOH/CH<sub>2</sub>Cl<sub>2</sub>, and the solvent was removed under reduced pressure to give <b>19</b> (67 mg, 49%):  mp 131−132 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.83 (br s, 1 H, NH), 9.63 (br s, 1 H, NH), 8.91 (s, 1 H, H-5), 8.54 (s, 1 H, H-2), 8.14 (dd, 1 H, <i>J</i> = 2.7, 6.8 Hz, H-2‘), 7.80 (ddd, 1 H, <i>J</i> = 2.7, 4.4, 9.0 Hz, H-6‘), 7.43 (t, 1 H, <i>J</i> = 9.1 Hz, H-5‘), 7.34 (s, 1 H, H-8), 6.72 (dd, 1 H, <i>J</i> = 17.0, 10.4 Hz, C<i>H</i><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH<sub>2</sub>), 6.32 (dd, 1 H, <i>J</i> = 1.9, 17.1 Hz, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 5.83 (dd, 1 H, <i>J</i> = 1.9, 10.2 Hz, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 4.38 (t, 2 H, <i>J</i> = 4.5 Hz, Ar OCH<sub>2</sub>), 3.89 (t, 2 H, <i>J</i> = 4.5 Hz, ArOCH<sub>2</sub>C<i>H</i><sub>2</sub>), 3.64, 3.54 (dds, 2 H, 2 H, <i>J</i> = 5.4, 6.3 Hz, OCH<sub>2</sub>s), 3.50, 3.41 (dds, 2 H, 2 H, <i>J</i> = 4.9, 6.4 Hz, OCH<sub>2</sub>s), 3.21 (s, 3 H, OCH<sub>3</sub>); MS (APCI) 507 (57, <sup>37</sup>ClMH<sup>+</sup>), 505 (100, <sup>35</sup>ClMH<sup>+</sup>). Anal. (C<sub>24</sub>H<sub>26</sub>ClFN<sub>4</sub>O<sub>5</sub>·2H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[(1</b><b><i>E</i></b><b>)-4-(4-morpholinyl)-1-butenyl]pyrido[3,2-</b><b><i>d</i></b><b>]p</b><b>yrimidin-6-yl]-acrylamide (21).</b><b>Example of the Method of Scheme 3.</b> A solution of 6-chloro-3-nitropyridine-2-carboxamide (<b>51</b>)<sup>9</sup> (1.00 g, 4.96 mmol) in EtOH (60 mL) and concentrated ammonia (30 mL) was sealed and heated at 100 °C for 20 h. The mixture was then cooled, concentrated under reduced pressure, and chromatographed on silica gel. Eluants from EtOAc to MeOH/EtOAc (1:4) gave 6-amino-3-nitropyridine-2-carboxamide (<b>52</b>) (658 mg, 73%):  mp (EtOAc/MeOH) 219−226 °C dec; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 8.11 (d, <i>J</i> = 9.2 Hz, 1 H, H-4), 7.84 (s, 1 H, CONH<sub>2</sub>), 7.57 (s, 2 H, NH<sub>2</sub>), 7.52 (s, 1 H, CONH<sub>2</sub>), 6.50 (d, <i>J</i> = 9.2 Hz, 1 H, H-5). Anal. (C<sub>6</sub>H<sub>6</sub>N<sub>4</sub>O<sub>3</sub>) C, H, N. </div><div class="NLM_p">A suspension <b>52</b> (0.60 g, 3.29 mmol) in glacial AcOH (70 mL) was heated until homogeneous, then treated with solid KOAc (0.65 g, 6.59 mmol) and allowed to cool to 50 °C. Br<sub>2</sub> (0.34 mL, 6.59 mmol) was then added dropwise, and the reaction was allowed to cool and stirred at room temperature for 1.5 h. The resultant suspension was concentrated under reduced pressure, then diluted with water and basified with solid NaHCO<sub>3</sub>. The aqueous layer was extracted with EtOAc, and this extract was evaporated and the residue chromatographed on silica gel, eluting with EtOAc to MeOH/EtOAc (1:4), to give 6-amino-5-bromo-3-nitropyridine-2-carboxamide (<b>53</b>) (0.72 g, 84%):  mp (EtOAc) 250−252 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 8.47 (s, 1 H, H-4), 8.20−7.30 (br s, 2 H, NH<sub>2</sub>), 7.89 (s, 1 H, CONH<sub>2</sub>), 7.64 (s, 1 H, CONH<sub>2</sub>). Anal. (C<sub>6</sub>H<sub>5</sub>BrN<sub>4</sub>O<sub>3</sub>) C, H, N, Br. </div><div class="NLM_p">Iron dust reduction of <b>53</b> (14.44 g, 53.3 mmol) as described previously gave crude 5-bromo-3,6-diaminopyridine-2-carboxamide (<b>54</b>). This was not characterized further, but was suspended in triethyl orthoformate (300 mL) and heated at reflux for 3 h. The resulting suspension was concentrated under reduced pressure and diluted with hexane (200 mL). The resulting precipitate was collected, washed with hexane and dried, then dissolved in 1 N NaOH (600 mL) (heating) and the solution stirred at room temperature for 2 h. Acidification with saturated NH<sub>4</sub>Cl precipitated 6-amino-7-bromopyrido[3,2-<i>d</i>]pyrimidin-4(3<i>H</i>)-one (<b>55</b>) (8.3 g, 62%):  mp (AcOH) 300−306 °C dec; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 12.24 (br s, 1 H, NH), 8.12 (s, 1 H, aromatic), 7.88 (s, 1 H, aromatic), 6.91 (br s, 2 H, NH<sub>2</sub>). Anal. (C<sub>7</sub>H<sub>5</sub>BrN<sub>4</sub>O) C, H, N. </div><div class="NLM_p">A suspension of <b>55</b> (3.96 g, 16.4 mmol) in 50% HBF<sub>4</sub> (80 mL) was cooled to −10 °C, and NaNO<sub>2</sub> (2.27 g, 32.86 mmol) was added to this suspension in portions over 4 h. The resulting mixture was then kept at −20 °C for 18 h before being warmed to −10 °C and neutralized by the slow addition of solid Na<sub>2</sub>CO<sub>3</sub> (keeping the reaction temperature below −5 °C). The precipitate was filtered, washed with water and dried, then suspended in hot DMF and filtered through a pad of Celite which was washed with further hot DMF. The combined filtrates were evaporated to dryness under reduced pressure and chromatographed on silica gel. Gradient elution from MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:9) to MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:4) gave 7-bromo-6-fluoropyrido[3,2-<i>d</i>]pyrimidin-4(3<i>H</i>)-one (<b>56</b>) (2.15 g, 54%):  mp (MeOH/H<sub>2</sub>O) 301−305 °C dec; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 12.81 (br s, 1 H, NH), 8.69 (d, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 8.1 Hz, 1 H, H-8), 8.21 (s, 1 H, H-2). Anal. (C<sub>7</sub>H<sub>3</sub>BrFN<sub>3</sub>O) C, H, N, F. </div><div class="NLM_p">A suspension of <b>56</b> (70 mg, 0.29 mmol) in POCl<sub>3</sub> (15 mL) was heated at reflux for 20 min (when all material had dissolved), and then for a further 1.5 h. Excess POCl<sub>3</sub> was removed under reduced pressure, and the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub>, washed several times with saturated NaHCO<sub>3</sub> and brine and dried (Na<sub>2</sub>SO<sub>4</sub>). Evaporation under reduced pressure gave crude 7-bromo-4-chloro-6-fluoropyrido[3,2-<i>d</i>]pyrimidine, which was dissolved in <i>i-</i>PrOH (15 mL) and added to a solution of 3-chloro-4-fluoroaniline (84 mg, 0.57 mmol) in <i>i-</i>PrOH (20 mL) containing 1 drop of concentrated HCl. The resulting solution was heated under reflux for 5 min, and then at 60 °C for 30 min. The volume was then reduced to approximately 10 mL by evaporation under reduced pressure, and saturated aqueous NaHCO<sub>3</sub> was added. The resulting precipitate was collected by filtration, washed with water and dried under vacuum to give 7-bromo-4-[<i>N</i>-(3-chloro-4-fluorophenyl)amino]-6-fluoropyrido[3,2-<i>d</i>]pyrimidine (<b>57</b>) (96 mg, 90%):  mp (EtOAc) 249−251 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.37 (s, 1 H, NH), 8.84 (d, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub><i> =</i> 8.3 Hz, 1 H, H-8), 8.72 (d, <i>J</i> = 1.9 Hz, 1 H, H-2), 8.32 (m, 1 H, H-2‘), 7.98 (m, 1 H, H-6‘), 7.46 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub><i> =</i> 9.1 Hz, <i>J</i> = 9.1 Hz, 1 H, H-5‘). Anal. (C<sub>13</sub>H<sub>6</sub>BrClF<sub>2</sub>N<sub>4</sub>) C, H, N. </div><div class="NLM_p">A stirred solution of 3-butyn-1-ol (6.00 g, 85.6 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (200 mL) at 0 °C was treated with Et<sub>3</sub>N (256.8 mmol, 35.8 mL) followed by MsCl (111.3 mmol, 8.6 mL) dropwise. After stirring the reaction mixture for 30 min, morpholine (119.8 mmol, 10.5 mL) was added and the reaction mixture was allowed to warm to room temperature for 16 h. Further morpholine (10.5 mL) was then added, and the reaction was heated at reflux for 8 h. The solution was washed with saturated aqueous NaHCO<sub>3</sub> and brine, dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure. The resulting crude oil was filtered through a short column of silica gel, eluting with EtOAc/hexane (1:1), and the eluate, after the removal of solvent, was distilled to give 4-(3-butynyl)morpholine (<b>58</b>) (6.47 g, 54%) as a colorless oil; <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 3.72 (t, <i>J</i> = 4.7 Hz, 4 H, morpholino methylene), 2.59 (t, <i>J</i> = 7.8 Hz, 2 H, H-4), 2.49 (t, <i>J</i> = 4.7 Hz, 4 H, morpholino methylene), 2.38 (m, 2 H, H-3), 1.98 (s, 1H, H-1). </div><div class="NLM_p">To neat degassed <b>58</b> (3.64 g, 26.2 mmol) under N<sub>2</sub> was added AIBN (catalytic, 50 mg) followed by tributyltin hydride (26.2 mmol, 7.04 mL). The reaction mixture was heated to 90 °C with adequate venting (vigorous initial reaction) and kept at 90 °C for a further 16 h. The cooled mixture was diluted with hexane and chromatographed directly on silica gel, using gradient elution from hexane to EtOAc/hexane (2:3), to give 4-[(3<i>E</i>)-4-(tributylstannyl)-3-butenyl]morpholine (<b>59</b>) (7.76 g, 69%) as a colorless oil:  <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 5.94 (m, 2 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH), 3.71 (t, <i>J</i> = 4.6 Hz, 4 H, morpholino methylene), 2.46 (t, <i>J</i> = 4.6 Hz, 4 H, morpholino methylene), 2.42 (partially obscured, m, 2 H, NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH), 2.33 (m, 2 H, NCH<sub>2</sub>C<i>H</i><sub>2</sub>CH), <a name="jm004300701392" id="jm004300701392"></a> 1.48 (m, 6 H, Sn(CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>3</sub>)<sub>3</sub>), 1.30 (m, 6 H, Sn(CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>3</sub>)<sub>3</sub>), 0.89m (partially obscured t, <i>J</i> = 7.2 Hz, 9 H, Sn(CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>3</sub>)<sub>3</sub>), 0.87 (partially obscured m, 6 H, Sn(C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>3</sub>)<sub>3</sub>); <sup>13</sup>C NMR δ 146.6, 129.2, 67.0 (×2), 58.4, 53.7 (×2), 35.2, 29.1 (×3), 13.7 (×3), 9.4 (×3). </div><div class="NLM_p">The above stannane <b>59</b> (19.29 mmol, 8.30 g) was added to a degassed solution of <b>57</b> (4.78 g, 12.86 mmol) and catalytic tetrakistriphenylphosphinepalladium(0) (1.29 mmol, 1.49 g), in DMF (100 mL) under nitrogen. The reaction mixture was heated to 100 °C for 75 min (reaction complete by TLC), then diluted with water and extracted with EtOAc. The combined organic extracts were washed with water and dried (Na<sub>2</sub>SO<sub>4</sub>), then evaporated under reduced pressure. Chromatography on silica gel, eluting with EtOAc to MeOH/EtOAc (1:4), gave 4-[<i>N</i>-(3-chloro-4-fluorophenyl)amino]-6-fluoro-7-[(1<i>E</i>)-4-(4-morpholinyl)-1-butenyl]pyrido[3,2-<i>d</i>]pyrimidine (<b>60</b>) (3.98 g, 72%):  mp (Et<sub>2</sub>O/hexane) 189−190 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.21 (s, 1 H, NH), 8.70 (s, 1 H, H-2), 8.48 (d, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub><i> =</i> 9.2 Hz, 1 H, H-8), 8.35 (m, 1 H, H-2‘), 7.99 (m, 1 H, H-6‘), 7.45 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 9.1 Hz, <i>J</i> = 9.1 Hz, 1 H, H-5‘), 6.85 (m, 1 H, CH<sub>2</sub>C<i>H</i><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH), 6.66 (d, <i>J</i> = 16.0 Hz, 1 H, CH<sub>2</sub>CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i>), 3.59 (t, <i>J</i> = 4.5 Hz, 4 H, morpholino methylene), 2.50 (br s, 4 H, C<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH), 2.42 (t, <i>J</i> = 4.5 Hz, 4 H, morpholino methylene). Anal. (C<sub>21</sub>H<sub>20</sub>ClF<sub>2</sub>N<sub>5</sub>O) C, H, N. </div><div class="NLM_p">A suspension of <b>60</b> (325 mg, 0.753 mmol) in <i>i-</i>PrOH (60 mL) was saturated with NH<sub>3</sub>(g), then sealed in a pressure vessel and heated at 100 °C for 20 h. The resulting solution was cooled and evaporated to dryness under reduced pressure, then chromatographed on silica gel, eluting with MeOH/EtOAc (1:8), to give 6-amino-4-[<i>N</i>-(3-chloro-4-fluorophenyl)amino]-7-[(1<i>E</i>)-4-(4-morpholinyl)-1-butenyl]pyrido[3,2-<i>d</i>]pyrimidine (<b>61</b>) (316 mg, 98%):  mp (EtOAc) 157−158 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.36 (s, 1 H, NH), 8.44 (s, 1 H, H-2), 8.41 (m, 1 H, H-2‘), 7.88 (s, 1 H, H-8), 7.86 (m, 1 H, H-6‘), 7.43 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub><i> =</i> 9.1 Hz, <i>J</i> = 9.1 Hz, 1 H, H-5‘), 6.69 (partially obscured d, <i>J</i> = 15.5 Hz, 1 H, CH<sub>2</sub>CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i>), 6.67 (s, 2 H, NH<sub>2</sub>), 6.49 (dt, <i>J</i> = 15.5, 6.7 Hz, 1 H, CH<sub>2</sub>C<i>H</i><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH), 3.59 (t, <i>J</i> = 4.6 Hz, 4 H, morpholino methylene), 2.48−2.43 (m, 4 H, C<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH), 2.42 (br t, <i>J</i> = 4.6 Hz, 4 H, morpholino methylene). Anal. (C<sub>21</sub>H<sub>22</sub>ClFN<sub>6</sub>O) C, H, N. </div><div class="NLM_p">Acrylic acid (36.0 mmol, 2.54 mL) was added to a solution of Et<sub>3</sub>N (52.9 mmol, 7.44 mL) in dry THF (100 mL) at 0 °C under N<sub>2</sub>. This mixture was then treated dropwise with 2,4,6-trichlorobenzoyl chloride (31.7 mmol, 4.90 mL), and the resulting suspension was stirred for 15 min. A solution of <b>61</b> (907 mg, 2.11 mmol) and DMAP (0.42 mmol, 51 mg) in dry THF (60 mL) under N<sub>2</sub> was then added via cannula. The resulting mixture was stirred at 0 °C for a further 15 min before being warmed to room temperature. After 2 h (when TLC showed the reaction was complete), the mixture was diluted with water and extracted with EtOAc. The combined organic extracts were washed with water and dried (Na<sub>2</sub>SO<sub>4</sub>), then concentrated under reduced pressure and filtered through a plug of alumina in EtOAc to remove yellow polymeric baseline material. The crude residue was then stirred overnight in aqueous MeOH (10%, 80 mL) to hydrolyze any bisacyl material. The solvent was then partially removed under reduced pressure, and the residue was diluted with saturated NaHCO<sub>3</sub> and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic extracts were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>) and evaporated under reduced pressure. The residue was chromatographed on silica gel, eluting with EtOAc/DCM/MeOH (60:25:15), to give <b>21</b> (340 mg, 33%):  mp (EtOAc/MeOH/Et<sub>2</sub>O) 190−193 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.65 (s, 1 H, CONH), 10.00 (s, 1 H, NH), 8.69 (s, 1 H, H-2), 8.39 (m, 1 H, H-2‘), 8.37 (s, 1 H, H-8), 7.97 (m, 1 H, H-6‘), 7.45 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub><i> =</i> 9.1 Hz, <i>J</i> = 9.1 Hz, 1 H, H-5‘), 6.67 (dt, <i>J</i> = 15.9, 6.5 Hz, 1 H, CH<sub>2</sub>C<i>H</i><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH), 6.57 (dd, <i>J</i> = 17.1, 10.2 Hz, 1 H, COC<i>H</i><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH<sub>2</sub>), 6.52 (d, <i>J</i> = 15.9 Hz, 1 H, CH<sub>2</sub>CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i>), 6.34 (dd, <i>J</i> = 17.1, 1.7 Hz, 1 H, COCH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 5.86 (dd, <i>J</i> = 10.2, 1.7 Hz, 1 H, COCH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 3.58 (t, <i>J</i> = 4.6 Hz, 4 H, morpholino methylene), 2.44−2.37 (m, 8 H, C<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH, morpholino methylene). HRMS (FAB) M + 1 Required for C<sub>24</sub>H<sub>24</sub><sup>35</sup>ClFN<sub>6</sub>O<sub>2</sub>:  483.17114. Found:  483.17136. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[</b><b><i>N</i></b><b>-(3-Chloro-4-fluorophenyl)amino]-7-[4-(4-morpholinyl)butyl]pyrido[3,2-</b><b><i>d</i></b><b>]pyrimidi</b><b>n-6-yl]acrylamide (22).</b> A solution of <b>60</b> (3.60 g, 8.34 mmol) in THF/MeOH (2:1, 400 mL) was hydrogenated over PtO<sub>2</sub>·<i>x</i>H<sub>2</sub>O at 60 psi for 18 h before being filtered through Celite and concentrated under reduced pressure. Chromatography on a short column of alumina, eluting with MeOH/EtOAc (1:9), gave 4-[<i>N</i>-(3-chloro-4-fluorophenyl)amino]-6-fluoro-7-[4-(4-morpholinyl)butyl]pyrido[3,2-<i>d</i>]pyrimidine (<b>62</b>) (3.40 g, 94%):  mp (EtOAc) 147−148 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.21 (s, 1 H, NH), 8.70 (d, <i>J</i> = 1.6 Hz, 1 H, H-2), 8.36 (m, 1 H, H-2‘), 8.28 (d, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub><i> =</i> 9.1 Hz, 1 H, H-8), 7.99 (m, 1 H, H-6‘), 7.45 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub><i> =</i> 9.1 Hz, <i>J</i> = 9.1 Hz, 1 H, H-5‘), 3.55 (t, <i>J</i> = 4.6 Hz, 4 H, morpholino methylene), 2.84 (t, <i>J</i> = 7.5 Hz, 2 H, CH<sub>2</sub>Ar), 2.31 (m, 6 H, morpholino methylene, NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 1.71 (quintet, <i>J</i> = 7.5 Hz, 2 H, NCH<sub>2</sub>C<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>Ar), 1.50 (quintet, <i>J</i> = 7.5 Hz, 2 H, NCH<sub>2</sub>C<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>Ar). Anal. (C<sub>21</sub>H<sub>22</sub>ClF<sub>2</sub>N<sub>5</sub>O) C, H, N. </div><div class="NLM_p">A suspension of <b>62</b> (1.83 g, 4.22 mmol) in <i>i-</i>PrOH (240 mL) was treated with NH<sub>3</sub>(g) as above to give 6-amino-4-[<i>N</i>-(3-chloro-4-fluorophenyl)amino]-7-[4-(4-morpholinyl)butyl]pyrido[3,2-<i>d</i>]pyrimidine (<b>63</b>) (1.65 g, 91%):  mp (MeOH) 182−183 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.33 (s, 1 H, NH), 8.44 (s, 1 H, H-2), 8.41 (ddd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 6.9 Hz, <i>J</i> = 2.6, 2.6 Hz, 1 H, H-2‘), 7.85 (m, 1 H, H-6‘), 7.67 (s, 1 H, H-8), 7.43 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub><i> =</i> 9.1 Hz, <i>J</i> = 9.1 Hz, 1 H, H-5‘), 6.64 (s, 2 H, NH<sub>2</sub>), 3.57 (t, <i>J</i> = 4.6 Hz, 4 H, morpholino methylene), 2.64 (t, <i>J</i> = 7.4 Hz, 2 H, CH<sub>2</sub>Ar), 2.33 (m, 6 H, morpholino methylene, NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 1.64 (quintet, <i>J</i> = 7.4 Hz, 2 H, NCH<sub>2</sub>C<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>Ar), 1.53 (quintet, <i>J</i> = 7.4 Hz, 2 H, NCH<sub>2</sub>C<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>Ar). Anal. (C<sub>21</sub>H<sub>24</sub>ClFN<sub>6</sub>O) C, H, N. </div><div class="NLM_p">To a solution of <b>63</b> (1.65 g, 3.82 mmol) in DMA/THF (1:1, 100 mL) at 0 °C were added 1-hydroxybenzotriazole (3.82 mmol, 516 mg), triethylamine (57.3 mmol, 4.1 mL), acrylic acid (22.9 mmol, 1.58 mL) and EDCI·HCl (22.9 mmol, 4.40 g). The reaction mixture was stirred at 0 °C under N<sub>2</sub> for 30 min, then allowed to warm to room temperature. Additional acrylic acid (260 μL) and EDCI·HCl (730 mg) were added to the suspension twice weekly. After 6 weeks (despite considerable starting material remaining), the reaction mixture was diluted with water, basified with saturated aqueous NaHCO<sub>3</sub>, and extracted with EtOAc. The combined organic extracts were washed with brine and dried (Na<sub>2</sub>SO<sub>4</sub>), then evaporated under reduced pressure. Chromatography (2×) on silica gel, eluting with EtOAc/CH<sub>2</sub>Cl<sub>2</sub>/MeOH (7:2:1) gave a fraction (approximately 400 mg) enriched in the desired product. Reverse-phase preparative layer chromatography of this, eluting with MeOH/H<sub>2</sub>O/cNH<sub>3</sub> (93:5:2) (running each plate 3×) gave, at highest <i>R</i><i><sub>f</sub></i>, <b>22</b> (155 mg, 8%, 28% based on recovered starting material):  mp (EtOAc) 180−182 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.57 (s, 1 H, CONH), 10.00 (s, 1 H, NH), 8.69 (d, <i>J</i> = 1.6 Hz, 1 H, H-2), 8.37 (m, 1 H, H-2‘), 8.13 (s, 1 H, H-8), 7.96 (m, 1 H, H-6‘), 7.45 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub><i> =</i> 9.1 Hz, <i>J</i> = 9.1 Hz, 1 H, H-5‘), 6.56 (dd, <i>J</i> = 17.0, 10.2 Hz, 1 H, C<i>H</i><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH<sub>2</sub>), 6.33 (dd, <i>J</i> = 17.0, 1.8 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 5.85 (dd, <i>J</i> = 10.2, 1.8 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 3.54 (t, <i>J</i> = 4.6 Hz, 4 H, morpholino methylene), 2.78 (t, <i>J</i> = 7.5 Hz, 2 H, CH<sub>2</sub>Ar), 2.27 (m, 6 H, morpholino methylene, NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 1.66 (quintet, <i>J</i> = 7.5 Hz, 2 H, NCH<sub>2</sub>C<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>Ar), 1.44 (quintet, <i>J</i> = 7.5 Hz, 2 H, NCH<sub>2</sub>C<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>Ar). Anal. (C<sub>24</sub>H<sub>26</sub>ClFN<sub>6</sub>O<sub>2</sub>·0.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p">Starting material <b>63</b> (1.16 g combined weight from column and preparative layer chromatography, 70%) was also recovered:  <sup>1</sup>H NMR identical to an authentic sample. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[</b><b><i>N</i></b><b>-(3-Chloro-4-fluorophenyl)amino]-7-methoxypyrido[3,2-</b><b><i>d</i></b><b>]pyrimidin-6-yl]acrylamid</b><b>e (23).</b><b>Example of the Method of Scheme 4.</b> A solution of 2-bromo-5-methoxy-6-(methylthio)-3-nitropyridine<sup>18</sup> (<b>64</b>) (7.70 g, 27.6 mmol) in NMP (50 mL) was added to a solution of CuCN (4.94 g, 55.2 mmol) in NMP (200 mL) at 170 °C. The resultant mixture was heated at 170 °C for 10 min, then cooled and poured into ice water (2 L). The resulting precipitate was collected by filtration, washed with water, suspended in boiling EtOAc (400 mL) and filtered hot through a pad of Celite. The Celite was washed with EtOAc, and the combined filtrates were dried (Na<sub>2</sub>SO<sub>4</sub>) and evaporated to give 2-cyano-5-methoxy-6-(methylthio)-3-<a name="jm004300701393" id="jm004300701393"></a> nitropyridine (<b>65</b>) (5.90 g, 95%):  mp (EtOAc/hexane) 168−170 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 8.02 (s, 1 H, H-4), 4.10 (s, 3 H, OCH<sub>3</sub>), 2.58 (s, 3 H, SCH<sub>3</sub>). Anal. (C<sub>8</sub>H<sub>7</sub>N<sub>3</sub>O<sub>3</sub>S) C, H, N. </div><div class="NLM_p">A solution of <b>65</b> (5.19 g, 23.0 mmol) in 90% H<sub>2</sub>SO<sub>4</sub> (80 mL) was warmed at 50 °C for 1.5 h before being poured onto ice (1 L) and extracted with EtOAc. The combined organic extracts were washed with saturated aqueous NaHCO<sub>3</sub> and brine, then dried (Na<sub>2</sub>SO<sub>4</sub>). Evaporation gave a residue that was chromatographed on silica gel, eluting with EtOAc/hexane (1:1), to give 5-methoxy-6-(methylthio)-3-nitropyridine-2-carboxamide (<b>66</b>) (0.80 g, 14%):  mp (Et<sub>2</sub>O/hexane) 215−217 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 8.04 (s, 1 H, CONH<sub>2</sub>), 7.84 (partially obscured s, 1 H, CONH<sub>2</sub>), 7.83 (s, 1 H, H-4), 3.99 (s, 3 H, OCH<sub>3</sub>), 2.58 (s, 3 H, SCH<sub>3</sub>). Anal. (C<sub>8</sub>H<sub>9</sub>N<sub>3</sub>O<sub>4</sub>S) C, H, N. </div><div class="NLM_p">A solution of <b>66</b> (0.57 g, 2.34 mmol) in EtOAc/MeOH (1:1, 150 mL) was hydrogenated over Pd−C at 60 psi for 16 h, before fresh catalyst was added and the hydrogenation continued for a further 7 h. The solution was then filtered through Celite and evaporated to give crude 3-amino-5-methoxy-6-(methylthio)pyridine-2-carboxamide (<b>67</b>), which was suspended in neat triethyl orthoformate (30 mL) and heated under reflux for 8 h. The reaction mixture was concentrated under reduced pressure, hexane was added, and the resultant precipitate was collected, washed with hexane and dried to give 7-methoxy-6-(methylthio)pyrido[3,2-<i>d</i>]pyrimidin-4(3<i>H</i>)-one (<b>68</b>) (422 mg, 81%):  mp (MeOH) 279−281 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 12.44 (s, 1 H, NH), 8.08 (s, 1 H, H-2), 7.37 (s, 1 H, H-8), 4.00 (s, 3 H, OCH<sub>3</sub>), 2.55 (s, 3 H, SCH<sub>3</sub>). Anal. (C<sub>9</sub>H<sub>9</sub>N<sub>3</sub>O<sub>2</sub>S) C, H, N. </div><div class="NLM_p">Iron dust reduction of <b>65</b> (22.0 g, 97.7 mmol) as above gave crude 3-amino-2-cyano-5-methoxy-6-(methylthio)pyridine (<b>69</b>) which was filtered through a short column of silica gel, eluting with MeOH/EtOAc (1:9) to remove baseline impurities. The amine <b>69</b> was then added in portions over 1 h to a refluxing solution of 88% HCO<sub>2</sub>H (200 mL) and concentrated H<sub>2</sub>SO<sub>4</sub> (3.6 mL). The reaction was refluxed for 16 h, then cooled to room temperature and poured into ice water (2 L). The precipitate was filtered, washed with water, CH<sub>2</sub>Cl<sub>2</sub>/Et<sub>2</sub>O (1:1) and then Et<sub>2</sub>O and dried to give <b>68</b> (17.98 g, 82%):  <sup>1</sup>H NMR identical to an authentic sample. </div><div class="NLM_p">Activation of <b>68</b> (0.52 g, 2.33 mmol) in POCl<sub>3</sub> (20 mL) and subsequent reaction with 3-chloro-4-fluoroaniline (0.68 g, 4.66 mmol) as above gave, after chromatography on silica gel, eluting with EtOAc/CH<sub>2</sub>Cl<sub>2</sub> (1:1), 4-[<i>N</i>-(3-chloro-4-fluorophenyl)amino]-7-methoxy-6-(methylthio)pyrido[3,2-<i>d</i>]pyrimidine (<b>70a</b>) (0.63 g, 77%):  mp (CH<sub>2</sub>Cl<sub>2</sub>/Et<sub>2</sub>O) 234−236 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.54 (s, 1 H, NH), 8.59 (s, 1 H, H-2), 8.26 (m, 1 H, H-2‘), 7.93 (m, 1 H, H-6‘), 7.47 (m, 2 H, H-8, H-5‘), 4.05 (s, 3 H, OCH<sub>3</sub>), 2.75 (s, 3 H, SCH<sub>3</sub>). Anal. (C<sub>15</sub>H<sub>12</sub>ClFN<sub>4</sub>OS) C, H, N. </div><div class="NLM_p">A solution of <b>70a</b> (0.62 g, 1.77 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (350 mL) was treated with <i>m-</i>CPBA (1.94 mmol, 0.45 g of 75%) for 1 h at room temperature, then washed with saturated aqueous NaHCO<sub>3</sub> and brine, dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure<i>.</i> Addition of hexane to the concentrate gave a precipitate that was collected and washed with hexane to give 4-[<i>N</i>-(3-chloro-4-fluorophenyl)amino]-6-(methanesulfinyl)-7-methoxypyrido[3,2-<i>d</i>]pyrimidine (<b>71a</b>) (0.63 g, 97%):  mp (CH<sub>2</sub>Cl<sub>2</sub>/Et<sub>2</sub>O) 222−224 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.17 (s, 1 H, NH), 8.69 (s, 1 H, H-2), 8.28 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 6.8 Hz, <i>J</i> = 2.5 Hz, 1 H, H-2‘), 7.92 (m, 1 H, H-6‘), 7.83 (s, 1 H, H-8), 7.48 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 9.0 Hz, <i>J</i> = 9.0 Hz, 1 H, H-5‘), 4.09 (s, 3 H, OCH<sub>3</sub>), 3.06 (s, 3 H, S(O)CH<sub>3</sub>). Anal. (C<sub>15</sub>H<sub>12</sub>ClFN<sub>4</sub>O<sub>2</sub>S) C, H, N. </div><div class="NLM_p">A suspension of <b>71a</b> (0.63 g, 1.72 mmol) in <i>i-</i>PrOH (100 mL) was reacted with NH<sub>3</sub>(g) as above to give, after column chromatography on silica gel and elution with CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (1:1) to MeOH/ CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (2:48:50), 6-amino-4-[<i>N</i>-(3-chloro-4-fluorophenyl)amino]-7-methoxypyrido[3,2-<i>d</i>]pyrimidine (<b>72a</b>) (0.23 g, 42%):  mp (CH<sub>2</sub>Cl<sub>2</sub>/Et<sub>2</sub>O) 258−260 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.23 (s, 1 H, NH), 8.44 (s, 1 H, H-2), 8.39 (m, 1 H, H-2‘), 7.84 (m, 1 H, H-6‘), 7.41 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 9.1 Hz, <i>J</i> = 9.1 Hz, 1 H, H-5‘), 7.28 (s, 1 H, H-8), 6.68 (s, 2 H, NH<sub>2</sub>), 3.99 (s, 3 H, OCH<sub>3</sub>). Anal. (C<sub>14</sub>H<sub>11</sub>ClFN<sub>5</sub>O) C, H, N. </div><div class="NLM_p">A solution of <b>72a</b> (0.25 g, 0.782 mmol) in THF was reacted with the mixed anhydride of 2,4,6-trichlorobenzoyl chloride and acrylic acid as described above. Chromatography on silica gel, with gradient elution from CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (1:1) to MeOH/CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (1:4:5), gave <b>23</b> (123 mg, 42%):  mp (EtOAc/Et<sub>2</sub>O) 226−228 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.39 (s, 1 H, CONH), 9.69 (s, 1 H, NH), 8.65 (s, 1 H, H-2), 8.36 (m, 1 H, H-2‘), 7.89 (m, 1 H, H-6‘), 7.69 (s, 1 H, H-8), 7.45 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub><i> =</i> 9.0 Hz, <i>J</i> = 9.0 Hz, 1 H, H-5‘), 6.66 (dd, <i>J</i> = 17.1, 10.2 Hz, 1 H, C<i>H</i><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH<sub>2</sub>), 6.33 (dd, <i>J</i> = 17.1, 1.9 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 5.84 (dd, <i>J</i> = 10.2, 1.9 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 4.04 (s, 3 H, OCH<sub>3</sub>). Anal. (C<sub>17</sub>H<sub>13</sub>ClFN<sub>5</sub>O<sub>2</sub>) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[</b><b><i>N</i></b><b>-(3-Chloro-4-fluorophenyl)amino]-7-(2-meth-oxyethoxy)pyrido[3,2-</b><b><i>d</i></b><b>]pyrimidin-6-yl]</b><b>acrylamide (24)</b>. <b>Example of the Method of Scheme 5.</b> Anhydrous pyridine hydrochloride was prepared by adding concentrated HCl (37%, 148 mL) to a solution of pyridine (150 mL) in CH<sub>2</sub>Cl<sub>2</sub> (250 mL) at 0 °C, followed by concentration to dryness under reduced pressure. This was then heated to 200 °C under N<sub>2</sub>, and solid <b>70a</b> (10.5 g, 29.9 mmol) was then added. Once the solid had gone into solution (approximately 3 min) the reaction was heated at 200−210 °C for a further 5 min before being cooled to approximately 100 °C and diluted with water (500 mL). The resulting precipitate was collected by filtration and washed with water, then dissolved in DMSO (150 mL) (heating to 90 °C) and treated with activated charcoal for 10 min. The solution was filtered through Celite, the Celite was washed with DMSO (50 mL), and the combined filtrates were diluted with water (300 mL). The precipitate was collected, washed with water and Et<sub>2</sub>O and dried to give 4-[<i>N</i>-(3-chloro-4-fluorophenyl)amino]-7-hydroxy-6-(methylthio)pyrido[3,2-<i>d</i>]pyrimidine (<b>73</b>) (8.05 g, 80%):  mp (MeOH) 290−300 °C dec; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 11.82 (br s, 1 H, OH), 9.51 (s, 1 H, NH), 8.53 (s, 1 H, H-2), 8.26 (m, 1 H, H-2‘), 7.92 (m, 1 H, H-6‘), 7.46 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 9.1 Hz, <i>J</i> = 9.1 Hz, 1 H, H-5‘), 7.18 (s, 1 H, H-8), 2.72 (s, 3 H, SCH<sub>3</sub>). Anal. (C<sub>14</sub>H<sub>10</sub>ClFN<sub>4</sub>OS) C, H, N. </div><div class="NLM_p">A suspension of <b>73</b> (400 mg, 1.19 mmol) in DMF (15 mL) was heated briefly to 100 °C, and the resultant solution was cooled to 60 °C and treated successively with K<sub>2</sub>CO<sub>3</sub> (1.15 g, 8.32 mmol) and 2-bromoethyl methyl ether (558 μL, 5.94 mmol). The resulting mixture was heated at 60 °C for 2 h, then diluted with water and extracted with EtOAc. The combined organic extracts were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>) and evaporated, and the residue was chromatographed on silica gel, eluting with EtOAc/CH<sub>2</sub>Cl<sub>2</sub> (1:1) to EtOAc/CH<sub>2</sub>Cl<sub>2</sub>/MeOH (10:9:1), to give 4-[<i>N</i>-(3-chloro-4-fluorophenyl)amino]-7-(2-methoxyethoxy)-6-(methylthio)pyrido[3,2-<i>d</i>]pyrimidine (<b>70b</b>) (342 mg, 73%):  mp (MeOH/Et<sub>2</sub>O) 169−171 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.53 (s, 1 H, NH), 8.58 (s, 1 H, H-2), 8.27 (m, 1 H, H-2‘), 7.93 (m, 1 H, H-6‘), 7.49 (s, 1 H, H-8), 7.46 (partially obscured dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 9.1 Hz, <i>J</i> = 9.1 Hz, 1 H, H-5‘), 4.40 (t, <i>J</i> = 4.3 Hz, 2 H, C<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 3.76 (t, <i>J</i> = 4.3 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.37 (s, 3 H, OCH<sub>3</sub>), 2.74 (s, 3 H, SCH<sub>3</sub>). Anal. (C<sub>17</sub>H<sub>16</sub>ClFN<sub>4</sub>O<sub>2</sub>S) C, H, N. </div><div class="NLM_p">A solution of <b>70b</b> (242 mg, 0.613 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (70 mL) was oxidized with <i>m-</i>CPBA as above to give 4-[<i>N</i>-(3-chloro-4-fluorophenyl)amino]-6-(methanesulfinyl)-7-(2-methoxyethoxy)pyrido[3,2-<i>d</i>]pyrimidine (<b>71b</b>) (146 mg, 58%):  mp (MeOH/EtOAc) 237−240 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.50 (s, 1 H, NH), 8.70 (s, 1 H, H-2), 8.32 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 6.9 Hz, <i>J</i> = 2.7 Hz, 1 H, H-2‘), 7.95 (m, 1 H, H-6‘), 7.85 (s, 1 H, H-8), 7.48 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 9.1 Hz, <i>J</i> = 9.1 Hz, 1 H, H-5‘), 4.48 (m, 2 H, C<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 3.76 (t, <i>J</i> = 4.3 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.37 (s, 3 H, OCH<sub>3</sub>), 3.02 (s, 3 H, S(O)CH<sub>3</sub>). Anal. (C<sub>17</sub>H<sub>16</sub>ClFN<sub>4</sub>O<sub>3</sub>S·0.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p">A suspension of <b>71b</b> (0.30 g, 0.73 mmol) in <i>i-</i>PrOH (80 mL) was reacted with NH<sub>3</sub>(g) as above to give 6-amino-4-[<i>N</i>-(3-chloro-4-fluorophenyl)amino]-7-(2-methoxyethoxy)pyrido[3,2-<i>d</i>]pyrimidine (<b>72b</b>) (251 mg, 94%):  mp (EtOAc/Et<sub>2</sub>O) 195−197 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.24 (s, 1 H, NH), 8.44 (s, 1 H, H-2), 8.40 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 6.9 Hz, <i>J</i> = 2.7 Hz, 1 H, H-2‘), 7.85 (m, 1 H, H-6‘), 7.41 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 9.1 Hz, <i>J</i> = 9.1 Hz, 1 H, H-5‘), 7.31 (s, 1 H, H-8), 6.61 (br s, 2 H, NH<sub>2</sub>), 4.34 (m, 2 H, C<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 3.78 (m, 2 H, C<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 3.35 (s, 3 H, OCH<sub>3</sub>). Anal. (C<sub>16</sub>H<sub>15</sub>ClFN<sub>5</sub>O<sub>2</sub>) C, H, N. </div><div class="NLM_p"><a name="jm004300701394" id="jm004300701394"></a>A solution of <b>72b</b> (0.24 g, 0.66 mmol) in THF (35 mL) was reacted with the mixed anhydride of 2,4,6-trichlorobenzoyl chloride/acrylic acid as described above. Chromatography on silica gel with gradient elution from CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (1:1) to MeOH/CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (1:4:5) gave <b>24</b> (87 mg, 32%):  mp (EtOAc/Et<sub>2</sub>O) 205−206 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.31 (s, 1 H, CONH), 9.72 (s, 1 H, NH), 8.64 (s, 1 H, H-2), 8.35 (m, 1 H, H-2‘), 7.91 (m, 1 H, H-6‘), 7.73 (s, 1 H, H-8), 7.45 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub><i> =</i> 9.1 Hz, <i>J</i> = 9.1 Hz, 1 H, H-5‘), 6.66 (dd, <i>J</i> = 17.0, 10.2 Hz, 1 H, C<i>H</i><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH<sub>2</sub>), 6.33 (dd, <i>J</i> = 17.0, 1.9 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 5.83 (dd, <i>J</i> = 10.2, 1.9 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 4.38 (m, 2 H, C<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 3.75 (m, 2 H, C<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 3.35 (s, 3 H, OCH<sub>3</sub>). Anal. (C<sub>19</sub>H<sub>17</sub>ClFN<sub>5</sub>O<sub>3</sub>) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[</b><b><i>N</i></b><b>-(3-Chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]pyrido[3,2-</b><b><i>d</i></b><b>]pyrim</b><b>idin-6-yl]-acrylamide (25).</b> A suspension of <b>73</b> (296 mg, 0.88 mmol) in THF/DMF (4:1, 25 mL) was treated successively with K<sub>2</sub>CO<sub>3</sub> (1.2 g, 8.80 mmol) and 3-bromopropan-1-ol (397 μL, 4.40 mmol). The reaction mixture was heated at reflux for 1.25 h, then diluted with water and extracted with EtOAc. The combined organic extracts were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>) and evaporated. The residue was dry-loaded on silica gel and chromatographed, eluting with EtOAc/CH<sub>2</sub>Cl<sub>2</sub> (1:1) to EtOAc/CH<sub>2</sub>Cl<sub>2</sub>/MeOH (10:9:1), to give 4-[<i>N</i>-(3-chloro-4-fluorophenyl)amino]-7-(3-hydroxypropoxy)-6-(methylthio)pyrido[3,2-<i>d</i>]pyrimidine (<b>74</b>) (215 mg, 62%):  mp (MeOH/CH<sub>2</sub>Cl<sub>2</sub>) 212−214 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.54 (s, 1 H, NH), 8.58 (s, 1 H, H-2), 8.27 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 6.8 Hz, <i>J </i>= 2.5 Hz, 1 H, H-2‘), 7.93 (m, 1 H, H-6‘), 7.47 (partially obscured dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 9.2 Hz, <i>J</i> = 9.2 Hz, 1 H, H-5‘), 7.46 (partially obscured s, 1 H, H-8), 4.63 (t, <i>J</i> = 5.1 Hz, 1 H, OH), 4.33 (t, <i>J</i> = 6.1 Hz, 2 H, CH<sub>2</sub>OAr), 3.63 (m, 2 H, C<i>H</i><sub>2</sub>OH), 2.74 (s, 3 H, SCH<sub>3</sub>) 1.95 (quintet, <i>J</i> = 6.2 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>OH). Anal. (C<sub>17</sub>H<sub>16</sub>ClFN<sub>4</sub>O<sub>2</sub>S·0.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p">A suspension of <b>74</b> (1.65 g, 4.18 mmol) in THF/DMF (3:1, 130 mL) was warmed to give a solution which was then cooled to 0 °C before Et<sub>3</sub>N (12.5 mmol, 1.75 mL) and MsCl (4.60 mmol, 0.355 mL) were added. After 1 h the reaction mixture was concentrated under reduced pressure at <30 °C, then diluted with saturated NaHCO<sub>3</sub> and extracted with EtOAc. The combined organic extracts were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure to give the crude mesylate. This was immediately dissolved in THF (100 mL), treated with excess morpholine (4.0 mL) and heated at 50 °C for 4 days. The mixture was then concentrated, diluted with ammonia and extracted with EtOAc. The combined organic extracts were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>) and evaporated. The crude product was slurried in EtOAc/hexane (1:2), filtered, and washed with Et<sub>2</sub>O to give 4-[<i>N</i>-(3-chloro-4-fluorophenyl)amino]-6-(methylthio)-7-[3-(4-morpholinyl)propoxy]pyrido[3,2-<i>d</i>]pyrimidine (<b>70c</b>) (1.46 g, 75%):  mp (EtOAc) 196−198 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.54 (s, 1 H, NH), 8.59 (d, <i>J</i> = 1.4 Hz, 1 H, H-2), 8.28 (m, 1 H, H-2‘), 7.93 (m, 1 H, H-6‘), 7.47 (m, 2 H, H-8, H-5‘), 4.32 (t, <i>J</i> = 6.1 Hz, 2 H, CH<sub>2</sub>OAr), 3.58 (t, <i>J</i> = 4.6 Hz, 4 H, morpholino methylene), 2.74 (s, 3 H, SCH<sub>3</sub>), 2.44 (partially obscured m, 2 H, NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>OAr), 2.39 (br m, 4 H, morpholino methylene), 1.97 (quintet, <i>J</i> = 6.1 Hz, 2 H, NCH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>OAr). Anal. (C<sub>21</sub>H<sub>23</sub>ClFN<sub>5</sub>O<sub>2</sub>S·H<sub>2</sub>O) C, H. N. </div><div class="NLM_p">A suspension of <b>70c</b> (168 mg, 0.362 mmol) in 1 N HCl (100 mL) was warmed to 40 °C to give a solution which was then cooled to 0 °C, treated with added NaIO<sub>4</sub> (0.398 mmol, 85 mg) and kept at 4 °C for 48 h. It was then warmed to 40 °C to dissolve precipitated starting material and cooled to 0 °C when additional NaIO<sub>4</sub> (40 mg) was added. After a further 24 h at 4 °C the reaction was basified by the addition of concentrated ammonia and extracted with EtOAc. The combined organic extracts were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>) and evaporated. Chromatography of the residue, eluting with MeOH/CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (3:6:10), gave 4-[<i>N</i>-(3-chloro-4-fluorophenyl)amino]-6-(methanesulfinyl)-7-[3-(4-morpholinyl)propoxy]-pyrido[3,2-<i>d</i>]pyrimidine (<b>71c</b>) (163 mg, 94%):  mp (MeOH/ CH<sub>2</sub>Cl<sub>2</sub>/hexane) 160−162 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.13 (s, 1 H, NH), 8.69 (d, <i>J</i> = 2.0 Hz, 1 H, H-2), 8.28 (ddd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 6.7 Hz, <i>J</i> = 6.7, 2.6 Hz, 1 H, H-2‘), 7.93 (m, 1 H, H-6‘), 7.83 (s, 1 H, H-8), 7.48 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 9.1 Hz, <i>J</i> = 9.1 Hz, 1 H, H-5‘), 4.38 (t, <i>J</i> = 6.3 Hz, 2 H, CH<sub>2</sub>OAr), 3.58 (t, <i>J</i> = 4.5 Hz, 4 H, morpholino methylene), 3.05 (s, 3 H, S(O)CH<sub>3</sub>), 2.48 (partially obscured t, <i>J</i> = 6.3 Hz, 2 H, NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>OAr), 2.39 (br s, 4 H, morpholino methylene), 1.98 (quintet, <i>J</i> = 6.3 Hz, 2 H, NCH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>OAr). Anal. (C<sub>21</sub>H<sub>23</sub>ClFN<sub>5</sub>O<sub>3</sub>S·H<sub>2</sub>O) C, H, N. </div><div class="NLM_p">A suspension of <b>71c</b> (153 mg, 0.319 mmol) in <i>i-</i>PrOH was reacted with NH<sub>3</sub>(g) as above to give, after chromatography on silica gel, eluting with MeOH/CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (3:6:10), 6-amino-4-[<i>N</i>-(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]pyrido[3,2-<i>d</i>]pyrimidine (<b>72c</b>) (125 mg, 91%):  mp (MeOH/CH<sub>2</sub>Cl<sub>2</sub>/hexane) 192−194 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.26 (s, 1 H, NH), 8.43 (s, 1 H, H-2), 8.40 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 6.9 Hz, <i>J</i> = 2.7 Hz, 1 H, H-2‘), 7.85 (m, 1 H, H-6‘), 7.42 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 9.1 Hz, <i>J</i> = 9.1 Hz, 1 H, H-5‘), 7.25 (s, 1 H, H-8), 6.68 (br s, 2 H, NH<sub>2</sub>), 4.23 (t, <i>J</i> = 6.2 Hz, 2 H, CH<sub>2</sub>OAr), 3.59 (t, <i>J</i> = 4.4 Hz, 4 H, morpholino methylene), 2.52 (partially obscured t, <i>J</i> = 6.2 Hz, 2 H, NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>OAr), 2.40 (br s, 4 H, morpholino methylene), 1.98 (quintet, <i>J</i> = 6.2 Hz, 2 H, NCH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>OAr). Anal. (C<sub>20</sub>H<sub>22</sub>ClFN<sub>6</sub>O<sub>2</sub>·0.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p">A solution of <b>72c</b> (0.39 g, 0.90 mmol) in THF (40 mL) was reacted with the mixed anhydride of 2,4,6-trichlorobenzoyl chloride and acrylic acid as described above. Chromatography on silica gel, eluting with MeOH/CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (3:6:10), gave <b>25</b> (138 mg, 31%):  mp (EtOAc/Et<sub>2</sub>O) 185−186 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.32 (s, 1 H, CONH), 9.76 (s, 1 H, NH), 8.64 (s, 1 H, H-2), 8.37 (m, 1 H, H-2‘), 7.92 (m, 1 H, H-6‘), 7.68 (s, 1 H, H-8), 7.44 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub><i> =</i> 9.1 Hz, <i>J</i> = 9.1 Hz, 1 H, H-5‘), 6.63 (dd, <i>J</i> = 17.2, 10.3 Hz, 1 H, C<i>H</i><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH<sub>2</sub>), 6.32 (dd, <i>J</i> = 17.2, 1.7 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 5.83 (dd, <i>J</i> = 10.3, 1.7 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 4.27 (t, <i>J</i> = 5.9 Hz, 2 H, CH<sub>2</sub>OAr), 3.57 (t, <i>J</i> = 4.6 Hz, 4 H, morpholino methylene), 2.45 (t, <i>J</i> = 5.9 Hz, 2 H, NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>OAr), 2.37 (br s, 4 H, morpholino methylene), 1.92 (quintet, <i>J</i> = 5.9 Hz, 2 H, NCH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>OAr). Anal. (C<sub>23</sub>H<sub>24</sub>ClFN<sub>6</sub>O<sub>3</sub>·0.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[</b><b><i>N</i></b><b>-(3-Chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]pyrido[3,2-</b><b><i>d</i></b><b>]pyrim</b><b>idin-6-yl]-</b><b><i>N</i></b><b>-methylacrylamide (26). </b>Excess aqueous methylamine (40%, 25 mL) was added to a solution of <b>71c</b> (0.50 g, 1.04 mmol) in DMSO (50 mL), and the mixture was heated in a sealed pressure vessel at 110 °C for 18 h, before being cooled, diluted with water and extracted with EtOAc. The combined organic extracts were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure. Chromatography of the concentrate on silica gel, eluting with CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (1:1) to MeOH/CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (2:3:5), gave 4-[<i>N</i>-(3-chloro-4-fluorophenyl)amino]-6-(methylamino)-7-[3-(4-morpholinyl)propoxy]pyrido[3,2-<i>d</i>]pyrimidine (<b>75</b>) (322 mg, 69%):  mp (CH<sub>2</sub>Cl<sub>2</sub>/Et<sub>2</sub>O) 174−176 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.58 (br s, 1 H, NHAr<sub>2</sub>), 8.55 (s, 1 H, H-2), 8.09 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 6.5 Hz, <i>J</i> = 2.7 Hz, 1 H, H-2‘), 7.68 (m, 1 H, H-6‘), 7.16 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 8.8 Hz, <i>J</i> = 8.8 Hz, 1 H, H-5‘), 7.12 (s, 1 H, H-8), 5.60 (q, <i>J</i> = 4.9 Hz, 1 H, N<i>H</i>CH<sub>3</sub>), 4.23 (t, <i>J</i> = 6.3 Hz, 2 H, CH<sub>2</sub>OAr), 3.74 (t, <i>J</i> = 4.6 Hz, 4 H, morpholino methylene), 3.18 (d, <i>J</i> = 4.9 Hz, 3 H, NHC<i>H</i><sub>3</sub>), 2.55 (t, <i>J</i> = 6.3 Hz, 2 H, NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>OAr), 2.49 (br s, 4 H, morpholino methylene), 2.08 (quintet, <i>J</i> = 6.3 Hz, 2 H, NCH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>OAr). Anal. (C<sub>21</sub>H<sub>24</sub>ClFN<sub>6</sub>O<sub>2</sub>) C, H, N. </div><div class="NLM_p">A solution of <b>75</b> (0.235 g, 0.526 mmol) in THF (40 mL) was reacted with the mixed anhydride of 2,4,6-trichlorobenzoyl chloride and acrylic acid as described above, except that the reaction was performed at 50 °C for 48 h, with additional mixed anhydride (7.5 mol equiv) in THF (20 mL) being added after 24 h. Workup as described previously (without aqueous MeOH treatment), followed by chromatography on silica gel and elution with MeOH/CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (3:6:10), gave <b>26</b> (164 mg, 62%):  mp (EtOAc/Et<sub>2</sub>O) 176−178 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.08 (s, 1 H, CONH), 8.67 (s, 1 H, H-2), 8.33 (m, 1 H, H-2‘), 7.99 (m, 1 H, H-6‘), 7.80 (s, 1 H, H-8), 7.45 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub><i> =</i> 9.1 Hz, <i>J</i> = 9.1 Hz, 1 H, H-5‘), 6.17 (dd, <i>J</i> = 16.6, 2.5 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 6.09 (dd, <i>J</i> = 10.0, 16.6 Hz, 1 H, C<i>H</i><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH<sub>2</sub>), 5.58 (dd, <i>J</i> = 10.0, 2.5 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 4.27 (t, <i>J</i> = 6.0 Hz, 2 H, CH<sub>2</sub>OAr), 3.57 (t, <i>J</i> = 4.5 Hz, 4 H, morpholino methylene), 3.31 (obscured s, 3 H, NCH<sub>3</sub>), 2.38 (partially obscured t, <i>J</i> = <a name="jm004300701395" id="jm004300701395"></a> 6.0 Hz, 2 H, NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>OAr), 2.34 (br s, 4 H, morpholino methylene), 1.89 (quintet, <i>J</i> = 6.0 Hz, 2 H, NCH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>OAr). Anal. (C<sub>24</sub>H<sub>26</sub>ClFN<sub>6</sub>O<sub>3</sub>) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[</b><b><i>N</i></b><b>-(3-Chloro-4-fluorophenyl)amino]-7-[3-(4-methyl-1-piperazinyl)propoxy]pyrido[3,2</b><b>-</b><b><i>d</i></b><b>]pyrimidin-6-yl]acrylamide (27).</b> Mesylation of <b>74</b> (2.69 g, 6.80 mmol) as described previously, followed by treatment of the crude mesylate with 4-methylpiperazine (3.77 mL) in THF (150 mL) at reflux for 5 days, with additional 4-methylpiperazine (5.0 mL) added after day 3, gave after workup as above, 4-[<i>N</i>-(3-chloro-4-fluorophenyl)amino]-7-[3-(4-methyl-1-piperazinyl)propoxy]-6-(methylthio)pyrido[3,2-<i>d</i>]pyrimidine (<b>70d</b>) (2.23 g, 69%):  mp (EtOAc/Et<sub>2</sub>O) 162−164 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.70 (br s, 1 H, NH), 8.68 (s, 1 H, H-2), 8.10 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 6.5 Hz, <i>J</i> = 2.8 Hz, 1 H, H-2‘), 7.67 (m, 1 H, H-6‘), 7.25 (s, 1 H, H-8), 7.19 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 8.8 Hz, <i>J</i> = 8.8 Hz, 1 H, H-5‘), 4.26 (t, <i>J</i> = 6.2 Hz, 2 H, CH<sub>2</sub>OAr), 2.67 (s, 3 H, SCH<sub>3</sub>), 2.61 (t, <i>J</i> = 6.2 Hz, 2 H, NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>OAr), 2.55−2.42 (br s, 8 H, piperazine methylenes), 2.30 (s, 3 H, NCH<sub>3</sub>), 2.10 (quintet, <i>J</i> = 6.2 Hz, 2 H, NCH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>OAr). Anal. (C<sub>22</sub>H<sub>26</sub>ClFN<sub>6</sub>OS) C, H, N. </div><div class="NLM_p">A solution of <b>70d</b> (2.13 g, 4.47 mmol) in 1 N HCl (300 mL) was reacted with NaIO<sub>4</sub> as described above to give 4-[<i>N</i>-(3-chloro-4-fluorophenyl)amino]-6-(methanesulfinyl)-7-[3-(4-methyl-1-piperazinyl)propoxy]pyrido[3,2-<i>d</i>]pyrimidine (<b>71d</b>) (2.02 g, 92%):  mp (CH<sub>2</sub>Cl<sub>2</sub>/Et<sub>2</sub>O) 169−171 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.19 (s, 1 H, NH), 8.70 (s, 1 H, H-2), 8.29 (m, 1 H, H-2‘), 7.93 (m, 1 H, H-6‘), 7.83 (s, 1 H, H-8), 7.49 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 9.0 Hz, <i>J</i> = 9.0 Hz, 1 H, H-5‘), 4.39 (t, <i>J</i> = 5.8 Hz, 2 H, CH<sub>2</sub>OAr), 3.06 (s, 3 H, S(O)CH<sub>3</sub>), 3.00 (br s, 6 H, NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>OAr, piperazine methylene(×2)), 2.70−2.55 (br s, 7 H, NCH<sub>3</sub>, piperazine methylene(×2)), 2.02 (br s, 2 H, NCH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>OAr). Anal. (C<sub>22</sub>H<sub>26</sub>ClFN<sub>6</sub>O<sub>2</sub>S) C, H, N. </div><div class="NLM_p">A suspension of <b>71d</b> (1.92 g, 3.89 mmol) in <i>i-</i>PrOH was reacted with NH<sub>3</sub>(g) as described previously to give, after chromatography on alumina, eluting with CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (1:1) to MeOH/CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (1:9:10), 6-amino-4-[<i>N</i>-(3-chloro-4-fluorophenyl)amino]-7-[3-(4-methyl-1-piperazinyl)propoxy]pyrido[3,2-<i>d</i>]pyrimidine (<b>72d</b>) (1.24 g, 71%):  mp (EtOAc/Et<sub>2</sub>O) 190−191 °C; <sup>1</sup>H NMR ((CD<sub>3</sub>)<sub>2</sub>SO, 400 MHz) δ 9.22 (s, 1 H, NH), 8.43 (d, <i>J</i> = 0.7 Hz, 1 H, H-2), 8.40 (m, 1 H, H-2‘), 7.84 (m, 1 H, H-6‘), 7.41 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub> = 9.1 Hz, <i>J</i> = 9.1 Hz, 1 H, H-5‘), 7.24 (s, 1 H, H-8), 6.65 (br s, 2 H, NH<sub>2</sub>), 4.22 (t, <i>J</i> = 6.1 Hz, 2 H, CH<sub>2</sub>OAr), 2.51 (partially obscured t, <i>J</i> = 6.1 Hz, 2 H, NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>OAr), 2.41−2.29 (br s, 8 H, piperazine methylenes), 2.14 (s, 3 H, NCH<sub>3</sub>), 1.96 (quintet, <i>J</i> = 6.1 Hz, 2 H, NCH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>OAr). Anal. (C<sub>21</sub>H<sub>25</sub>ClFN<sub>7</sub>O) C, H, N. </div><div class="NLM_p">A solution of <b>72d</b> (0.60 g, 1.35 mmol) in THF (80 mL) was reacted with the mixed anhydride of 2,4,6-trichlorobenzoyl chloride and acrylic acid as described above. Chromatography of the crude product on silica gel, eluting with MeOH/CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (1:1:2) containing 1% Et<sub>3</sub>N, gave <b>27</b> (223 mg, 33%):  mp (EtOAc/Et<sub>2</sub>O) 166−168 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.33 (s, 1 H, CONH), 9.79 (s, 1 H, NH), 8.64 (s, 1 H, H-2), 8.36 (dd, <i>J</i> = 6.7 Hz, <i>J</i> = 2.2 Hz, 1 H, H-2‘), 7.92 (m, 1 H, H-6‘), 7.67 (s, 1 H, H-8), 7.44 (dd, <i>J</i><sub>H</sub><sub>-</sub><sub>F</sub><i> =</i> 9.2 Hz, <i>J</i> = 9.2 Hz, 1 H, H-5‘), 6.63 (dd, <i>J</i> = 17.1, 10.3 Hz, 1 H, C<i>H</i><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH<sub>2</sub>), 6.32 (dd, <i>J</i> = 17.1, 2.5 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 5.84 (dd, <i>J</i> = 10.3, 2.5 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i><sub>2</sub>), 4.26 (t, <i>J</i> = 6.0 Hz, 2 H, CH<sub>2</sub>OAr), 2.44 (t, <i>J</i> = 6.0 Hz, 2 H, NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>OAr), 2.40−2.29 (br s, 8 H, piperazine methylenes), 2.16 (s, 3 H, NCH<sub>3</sub>), 1.91 (quintet, <i>J</i> = 6.0 Hz, 2 H, NCH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>OAr). Anal. (C<sub>24</sub>H<sub>27</sub>ClFN<sub>7</sub>O<sub>2</sub>·0.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>Aqueous Stability Study of 18 and 25. </b>Stock solutions of the compounds in DMSO were diluted into phosphate buffers at pH 2.6, 6.67, and 10.75. The solutions were kept at 37 °C, and HPLC traces were made at time zero and at other time points out to 24 h. The peak areas of the parent drug and the amine hydrolysis product were calculated as a percent of the <i>t </i>= 0 value. The HPLC conditions were:  column, Zorbax SB-C18, 4.6 mm × 25 cm; mobile phase, 0.45 M formate buffer (ammonium formate + formic acid, pH 3.45), 80% acetonitrile, 20% MilliQ water; gradient elution, beginning aqueous/organic phase ratio 1:9, altering over 25 min to 100:0 and kept at 100:0 for another 5 min. Flow rate was 1.0 mL/min, and detection was by UV at 254 nm. </div><div class="NLM_p"><b>Mass Spectrometry.</b> Solutions of compounds <b>18</b> and <b>25</b> in DMSO were added to a solution containing 25 μg of EGF receptor tyrosine kinase protein (in 20 mM Tris, 150 mM NaCl, 1 mM DTT, 1 mM EDTA) and small amounts of protease inhibitors aprotinin and leupeptin and diluted with 75 mM ammonium bicarbonate (pH 7.5). The reaction was quenched after 90 min upon addition of 5% (v/v) acetic acid, and the protein was purified and concentrated by centrifugal filtration (Microcon-10, 10-kDa cutoff filter, Amicon, Inc., Beverly, MA). The molecular weight of the protein−drug complex in a denaturing solution (80% CH<sub>3</sub>CN, pH 2.5) was determined by ESI-MS (MAT 900Q mass spectrometer, Finnigan MAT, Bremen, Germany) equipped with a low-flow micro-ESI source operating at 150 nL/min. A portion of drug-bound protein was reduced, alkylated, and digested with trypsin. Peptide sequence analysis was performed by LC−ESI-MS/MS with a quadrupole ion trap mass spectrometer (Finnigan LCQ, Finnigan Corp., San Jose, CA) interfaced with a Michrom BioResources Magic 2002 HPLC (Auburn, CA). Peptides were eluted from the 0.3- × 15-mm Vydac C18 column directly into the mass spectrometer with a linear gradient of CH<sub>3</sub>CN at 5 γμL/min as follows:  5% solvent B to 95% solvent B over 10 min (where A = 0.05% TFA/2% CH<sub>3</sub>CN and B = 0.045% TFA/90% CH<sub>3</sub>CN). </div><div class="NLM_p"><b>Cell Culture.</b> A431 human epidermoid carcinoma cells were obtained from the American Type Culture Collection, Rockville, MD, and maintained as monolayers in αMEM (Dulbecco's modified eagle medium)/F12, 50:50 (Gibco/BRL) containing 10% fetal bovine serum. For growth inhibition assays, dilutions of the designated compound in 10 mL were placed in 24-well Linbro plates (1.7 × 1.6 cm, flat bottom) followed by the addition of cells (2 × 10<sup>4</sup>) in 2 mL of media. The plates were incubated for 72 h at 37 °C in a humidified atmosphere containing 5% CO<sub>2</sub> in air. Cell growth was determined by cell count with a Coulter model AM electronic cell counter (Coulter Electronics, Inc., Hialeah, FL). </div><div class="NLM_p"><b>Tyrosine Kinase Assays.</b> EGFR tyrosine kinase was purified as described previously.<sup>21</sup> Enzyme assays for IC<sub>50[app]</sub> determinations were performed in 96-well filter plates (Millipore MADVN6550, Millipore, Bedford, MA). The total volume was 0.1 mL containing 20 mM Hepes, pH 7.4, 50 mM sodium vanadate, 40 mM magnesium chloride, 10 μM adenosine triphosphate (ATP) containing 0.5 mCi of [<sup>32</sup>P]ATP, 20 mg of polyglutamic acid/tyrosine (Sigma Chemical Co., St. Louis, MO), 10 ng of EGFR tyrosine kinase, and appropriate dilutions of inhibitor. All components except the ATP were added to the well and the plate was incubated with shaking for 10 min at 25 °C. The reaction was started by adding [<sup>32</sup>P]ATP, and the plate was incubated at 25 °C for 10 min. The reaction was terminated by addition of 0.1 mL of 20% trichloroacetic acid (TCA). The plate was kept at 4 °C for at least 15 min to allow the substrate to precipitate. The wells was then washed five times with 0.2 mL of 10% TCA and <sup>32</sup>P incorporation determined with a Wallac beta plate counter (Wallac, Inc., Gaithersburg, PA). </div><div class="NLM_p"><b>Irreversibility Test Protocol.</b> A431 human epidermoid carcinoma cells were grown in 6-well plates to about 80% confluency and then incubated in serum-free media for 18 h. Duplicate sets of cells were treated with 2 mM of designated compound to be tested as an irreversible inhibitor for 2 h. One set of cells was then stimulated with 100 ng/mL EGF for 5 min and extracts made as described under the Western blotting procedure. The other set of cells was washed free of the compound with warmed serum-free media, incubated for 2 h, washed again, incubated another 2 h, washed again, and then incubated a further 4 h. This set of cells was then stimulated with EGF and extracts were made similar to the first set of cells. </div><div class="NLM_p"><b>Western Blotting Procedure.</b> Extracts were made by lysing cells in 0.2 mL of boiling Laemlli buffer (2% sodium dodecyl sulfate, 5% β-mercaptoethanol, 10% glycerol, and 50 mM tris[hydroxymethyl]aminomethane (Tris), pH 6.8), and the lysates were heated to 100 °C for 5 min. Proteins in the lysate were separated by polyacrylamide gel electrophoresis and <a name="jm004300701396" id="jm004300701396"></a> electrophoretically transferred to nitrocellulose. The membrane was washed once in 10 mM Tris, pH 7.2, 150 mM NaCl, 0.01% azide (TNA), and blocked overnight in TNA containing 5% bovine serum albumin and 1% ovalbumin. The membrane was blotted for 2 h with antiphosphotyrosine antibody (UBI, 1 mg/mL in blocking buffer) and then washed twice in TNA, once in TNA containing 0.05% Tween-20 detergent and 0.05% nonidet P-40 detergent, and twice in TNA. The membranes were then incubated for 2 h in blocking buffer containing 0.1 mCi/mL [<sup>125</sup>I]protein A and then washed again as above. After the blots were dry, they were loaded into a film cassette and exposed to X-AR X-ray film (Eastman Kodak Co., Rochester, NY) for 1−7 days. Band intensities were determined with a Molecular Dynamics laser densitometer. </div><div class="NLM_p"><b>Caco-2 Cell Permeability.</b> The absorptive and secretory transport of compounds <b>18</b> and <b>25</b> were carried out in Caco-2 cells.<sup>24</sup> Apical-to-basolateral (A→B) and basolateral-to-apical (B→A) experiments were performed in side-by-side diffusion apparatus with 25 μM of drug. [<sup>14</sup>C]Mannitol was used to monitor cell integrity and [<sup>3</sup>H]metoprolol, which is 90−95% absorbed in human,<sup><a onclick="showRef(event, 'jm990482tb00030 jm990482tb00031'); return false;" href="javascript:void(0);" class="ref jm990482tb00030 jm990482tb00031">30,31</a></sup> was used as a reference compound. Cells were at passage 35 or 21, 23 or 25 days post-seeding, with an average TEER measurement of 430−508. The incubation solutions were prepared in Hank's balanced salt solution (HBSS) with 2% ethanol and 2% DMSO; pH was 6.5 and 7.4, respectively, in apical and basolateral compartments. Bidirectional transport experiments of [<sup>3</sup>H]vinblastine were performed simultaneously for confirmation of P-gp activity.<sup>25,26</sup> Drug concentrations were monitored using an LC−MS/MS method; reference compounds were measured using scintillation counting. </div><div class="NLM_p">The effect of <b>18</b> and <b>25</b> on P-glycoprotein transport was carried out using Caco-2 cells of passage 21, 21 days post-seeding with an average TEER measurement of 484. Apical-to-basolateral (A→B) and basolateral-to-apical (B→A) control experiments were performed in side-by-side diffusion apparatus with [<sup>3</sup>H]vinblastine in the donor compartment. The compounds (25 μM) were added to both apical and basolateral compartments in B→A experiments to examine its inhibitory effects on [<sup>3</sup>H]vinblastine efflux. Cyclosporin (10 μM) was also used as a positive control inhibitor,<sup>27,28</sup> and [<sup>14</sup>C]mannitol was used to monitor cell integrity. The incubation solutions were prepared in Hank's balanced salt solution (HBSS) buffer (pH 6.5 apical, pH 7.4 basolateral) with 2% EtOH and 2% DMSO as cosolvents. [<sup>14</sup>C]Mannitol permeability values indicated that the cell monolayers remained viable throughout these studies. </div><div class="NLM_p"><b>In Vivo Chemotherapy.</b> Immune-deficient mice were housed in microisolator cages within a barrier facility on a 12-h light/dark cycle and received food and water ad libitum. Animal housing was in accord with AAALAC guidelines. All experimental protocols involving animals were approved by the institutional animal care and use committee. The A431 epidermoid carcinoma was maintained by serial passage in nude mice (NCr <i>nu/nu</i>). Nude mice were also used as tumor host for anticancer agent evaluations against this tumor model. In each experiment, test mice weighing 18−22 g were randomized and implanted with tumor fragments in the region of the right axilla on day 0. Animals were treated with test compounds on the basis of average cage weight (6 mice/dose group) initiated when tumors reached approximately 100−150 mg in mass and continued for the period indicated in Table 3. Whenever possible test compounds were evaluated over a range of dose levels ranging from toxic to ineffective. </div><div class="NLM_p last">The doses reported in Table 3 are the maximum doses that could be administered without exceeding the LD<sub>10</sub>, unless otherwise indicated. This maximum tolerated dose (MTD) allows comparisons to be made among the tested compounds at an equitoxic dose level. Derivatives <b>8</b> and <b>18</b> were administered as solutions of the isethionate salt generated in situ by the addition of 1.5 equiv of aqueous isethionic acid followed by dilution to dosing volume with distilled water (final pH 4). Compound <b>25</b> was dissolved directly in 50 mM sodium lactate buffer, pH 4. Compound dosing solutions were prepared for 5 days at a time. Host body weight change data are reported as the maximum treatment-related weight loss in these studies. Calculations of tumor growth inhibition (% T/C) and tumor growth delay (T−C) were performed as described previously.<sup><a onclick="showRef(event, 'jm990482tb00032 jm990482tb00033 jm990482tb00034 jm990482tb00035'); return false;" href="javascript:void(0);" class="ref jm990482tb00032 jm990482tb00033 jm990482tb00034 jm990482tb00035">32-35</a></sup></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37065" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37065" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><ul></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeff B. Smaill</span> - <span class="hlFld-Affiliation affiliation">Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland, New Zealand, and Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gordon W. Rewcastle</span> - <span class="hlFld-Affiliation affiliation">Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland, New Zealand, and Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph A. Loo</span> - <span class="hlFld-Affiliation affiliation">Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland, New Zealand, and Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenneth D. Greis</span> - <span class="hlFld-Affiliation affiliation">Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland, New Zealand, and Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">O. Helen Chan</span> - <span class="hlFld-Affiliation affiliation">Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland, New Zealand, and Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric L. Reyner</span> - <span class="hlFld-Affiliation affiliation">Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland, New Zealand, and Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elke Lipka</span> - <span class="hlFld-Affiliation affiliation">Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland, New Zealand, and Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">H. D. Hollis Showalter</span> - <span class="hlFld-Affiliation affiliation">Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland, New Zealand, and Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick W. Vincent</span> - <span class="hlFld-Affiliation affiliation">Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland, New Zealand, and Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William L. Elliott</span> - <span class="hlFld-Affiliation affiliation">Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland, New Zealand, and Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William A. Denny</span> - <span class="hlFld-Affiliation affiliation">Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland, New Zealand, and Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047 </span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm990482t" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83207" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83207" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was partially supported by the Auckland Division of the Cancer Society of New Zealand. The authors thank Karin Tan for HPLC studies. </p></div><div class="refs-header-label"></div><p class="references-count">
            This article references 35 other publications.
        </p><ol id="references" class="useLabel"><li id="jm990482tb00001"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00001'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="jm990482tb00001_1"><span><span class="NLM_string-ref">Kersemaekers, A. M. F.; Fleuren, G. J.; Kenter, E. G.; Van den Broek, L. J. C. M.; Uljee, S. M.; Hermans, J.; Van de Vijver, M. J. Oncogene alterations in carcinomas of the uterine cervix:  Overexpression of the epidermal growth factor receptor is associated with poor prognosis. <i>  Clin. Cancer Res</i>. <b>1999</b>, <i>5</i>, 577−586.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=586&author=A.+M.+F.+Kersemaekers&author=G.+J.+Fleuren&author=E.+G.+Kenter&author=L.+J.+C.+M.+Van+den+Broek&author=S.+M.+Uljee&author=J.+Hermans&author=M.+J+Van+de+Vijver&title=Oncogene+alterations+in+carcinomas+of+the+uterine+cervix%3A%E2%80%89+Overexpression+of+the+epidermal+growth+factor+receptor+is+associated+with+poor+prognosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKersemaekers%26aufirst%3DA.%2BM.%2BF.%26atitle%3DOncogene%2520alterations%2520in%2520carcinomas%2520of%2520the%2520uterine%2520cervix%253A%25E2%2580%2589%2520Overexpression%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520is%2520associated%2520with%2520poor%2520prognosis%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1999%26volume%3D5%26spage%3D586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00002"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00002'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="jm990482tb00002_1"><span><span class="NLM_string-ref">Maurizi, M.; Almadori, G.; Ferrandina, G.; Distefano, M.; Romanini, M. E.; Cadoni, G.; Benedetti-Panici, P.; Paludetti, G.; Scambia, G.; Mancuso S. Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. <i>  Br. J. Cancer</i><b>1996</b>, <i>74</i>, 1253−1257.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1996&pages=1257&author=M.+Maurizi&author=G.+Almadori&author=G.+Ferrandina&author=M.+Distefano&author=M.+E.+Romanini&author=G.+Cadoni&author=P.+Benedetti-Panici&author=G.+Paludetti&author=G.+Scambia&author=S+Mancuso&title=Prognostic+significance+of+epidermal+growth+factor+receptor+in+laryngeal+squamous+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaurizi%26aufirst%3DM.%26atitle%3DPrognostic%2520significance%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520in%2520laryngeal%2520squamous%2520cell%2520carcinoma%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1996%26volume%3D74%26spage%3D1257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00003"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00003'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="jm990482tb00003_1"><span><span class="NLM_string-ref">Klohs, W. D.; Fry, D. W.; Kraker, A. J. Inhibitors of tyrosine kinase<i>. Curr. Opin. </i><i>Oncol.</i><b>1997</b>, <i>9</i>, 562−568.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1997&pages=568&author=W.+D.+Klohs&author=D.+W.+Fry&author=A.+J+Kraker&title=Inhibitors+of+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKlohs%26aufirst%3DW.%2BD.%26atitle%3DInhibitors%2520of%2520tyrosine%2520kinase%26jtitle%3DCurr.%2520Opin.%2520Oncol.%26date%3D1997%26volume%3D9%26spage%3D568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00004"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00004'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="jm990482tb00004_1"><span><span class="NLM_string-ref">Voldborg, B. R.; Damstrup, L.; Spang-Thomsen, M.; Poulsen, H. S. Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials. <i>  Ann. Oncol</i>. <b>1997</b>, <i>8</i>, 1197−1206.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=1206&author=B.+R.+Voldborg&author=L.+Damstrup&author=M.+Spang-Thomsen&author=H.+S+Poulsen&title=Epidermal+growth+factor+receptor+%28EGFR%29+and+EGFR+mutations%2C+function+and+possible+role+in+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVoldborg%26aufirst%3DB.%2BR.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%2520and%2520EGFR%2520mutations%252C%2520function%2520and%2520possible%2520role%2520in%2520clinical%2520trials%26jtitle%3DAnn.%2520Oncol.%26date%3D1997%26volume%3D8%26spage%3D1206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00005"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00005'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="jm990482tb00005_1"><span><span class="NLM_string-ref">Kelloff, G. J.; Fay, J. R.; Steele, V. E.; Lubet, R. A.; Boone, C. W.; Crowell, J. A.; Sigman, C. C. Epidermal growth factor receptor tyrosine kinase inhibitors as potential cancer chemopreventives. <i>  Cancer Epidemiol. Biomarkers </i><i>Prevention</i><b>1996</b>, <i>5</i>, 657−666.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1996&pages=666&author=G.+J.+Kelloff&author=J.+R.+Fay&author=V.+E.+Steele&author=R.+A.+Lubet&author=C.+W.+Boone&author=J.+A.+Crowell&author=C.+C+Sigman&title=Epidermal+growth+factor+receptor+tyrosine+kinase+inhibitors+as+potential+cancer+chemopreventives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKelloff%26aufirst%3DG.%2BJ.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitors%2520as%2520potential%2520cancer%2520chemopreventives%26jtitle%3DCancer%2520Epidemiol.%2520Biomarkers%2520Prevention%26date%3D1996%26volume%3D5%26spage%3D666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00006"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00006'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="jm990482tb00006_1"><span><span class="NLM_string-ref">Thompson, A. M.; Bridges, A. J.; Fry, D. W.; Kraker, A. J.; Denny, W. A. Tyrosine kinase inhibitors. 7. 7-Amino-4-(phenylamino)- and 7-amino-4-[(phenylmethyl)amino]pyrido[4,3-<i>d</i>]pyrimidines; a new class of inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor<i>. J. Med. Chem</i>. <b>1995</b>, <i>38</i>, 3780−3788.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=3788&author=A.+M.+Thompson&author=A.+J.+Bridges&author=D.+W.+Fry&author=A.+J.+Kraker&author=W.+A+Denny&title=Tyrosine+kinase+inhibitors.+7.+7-Amino-4-%28phenylamino%29-+and+7-amino-4-%5B%28phenylmethyl%29amino%5Dpyrido%5B4%2C3-d%5Dpyrimidines%3B+a+new+class+of+inhibitors+of+the+tyrosine+kinase+activity+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BM.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%25207.%25207-Amino-4-%2528phenylamino%2529-%2520and%25207-amino-4-%255B%2528phenylmethyl%2529amino%255Dpyrido%255B4%252C3-d%255Dpyrimidines%253B%2520a%2520new%2520class%2520of%2520inhibitors%2520of%2520the%2520tyrosine%2520kinase%2520activity%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D3788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00007"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00007'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="jm990482tb00007_1"><span><span class="NLM_string-ref">Bridges, A. J.; Zhou, H.; Cody, D. R.; Rewcastle, G. W.; McMichael, A.; Showalter, H. D. H.; Fry, D. W.; Kraker, A. J.; Denny, W. A. Tyrosine kinase inhibitors. 8. An unusually steep structure−activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor. <i>  J. Med. Chem</i>. <b>1996</b>, <i>39</i>, 267−276.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=276&author=A.+J.+Bridges&author=H.+Zhou&author=D.+R.+Cody&author=G.+W.+Rewcastle&author=A.+McMichael&author=H.+D.+H.+Showalter&author=D.+W.+Fry&author=A.+J.+Kraker&author=W.+A+Denny&title=Tyrosine+kinase+inhibitors.+8.+An+unusually+steep+structure%E2%88%92activity+relationship+for+analogues+of+4-%283-bromoanilino%29-6%2C7-dimethoxyquinazoline+%28PD+153035%29%2C+a+potent+inhibitor+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%25208.%2520An%2520unusually%2520steep%2520structure%25E2%2588%2592activity%2520relationship%2520for%2520analogues%2520of%25204-%25283-bromoanilino%2529-6%252C7-dimethoxyquinazoline%2520%2528PD%2520153035%2529%252C%2520a%2520potent%2520inhibitor%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00008"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00008'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="jm990482tb00008_1"><span><span class="NLM_string-ref">Wakeling, A. E.; Barker, A. J.; Davies, D. H.; Brown, D. S.; Green, L. R.; Cartlidge, S. A.; Woodburn, J. R. Specific inhibition of epidermal growth factor receptor tyrosine kinase by 4-anilinoquinazolines. <i>  Breast Cancer </i><i>Res. Treat</i>. <b>1996</b>, <i>38</i>, 67−73.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1996&pages=73&author=A.+E.+Wakeling&author=A.+J.+Barker&author=D.+H.+Davies&author=D.+S.+Brown&author=L.+R.+Green&author=S.+A.+Cartlidge&author=J.+R+Woodburn&title=Specific+inhibition+of+epidermal+growth+factor+receptor+tyrosine+kinase+by+4-anilinoquinazolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWakeling%26aufirst%3DA.%2BE.%26atitle%3DSpecific%2520inhibition%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520by%25204-anilinoquinazolines%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D1996%26volume%3D38%26spage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00009"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00009'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="jm990482tb00009_1"><span><span class="NLM_string-ref">Rewcastle, G. W.; Palmer, B. D.; Thompson, A. M.; Bridges, A. J.; Cody, D. R.; Zhou, H.; Fry, D. W.; McMichael, A.; Denny, W. A. Tyrosine Kinase Inhibitors. 10. Isomeric 4-[(3-bromophenyl)amino]pyrido[<i>d</i>]pyrimidines are potent ATP binding site inhibitors of the tyrosine kinase function of the epidermal growth factor receptor. <i>  J. Med. Chem</i>. <b>1996</b>, <i>39</i>, 1823−1835.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=1835&author=G.+W.+Rewcastle&author=B.+D.+Palmer&author=A.+M.+Thompson&author=A.+J.+Bridges&author=D.+R.+Cody&author=H.+Zhou&author=D.+W.+Fry&author=A.+McMichael&author=W.+A+Denny&title=Tyrosine+Kinase+Inhibitors.+10.+Isomeric+4-%5B%283-bromophenyl%29amino%5Dpyrido%5Bd%5Dpyrimidines+are+potent+ATP+binding+site+inhibitors+of+the+tyrosine+kinase+function+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26atitle%3DTyrosine%2520Kinase%2520Inhibitors.%252010.%2520Isomeric%25204-%255B%25283-bromophenyl%2529amino%255Dpyrido%255Bd%255Dpyrimidines%2520are%2520potent%2520ATP%2520binding%2520site%2520inhibitors%2520of%2520the%2520tyrosine%2520kinase%2520function%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D1835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00010"><div class="reference"><div class="NLM_citation" id="jm990482tb00010_1"><span><span class="NLM_string-ref">Fry, D. W.; Nelson, J. M.; Slintak, V.; Keller, P. R.; Rewcastle, G. W.; Denny, W. A.; Zhou, H.; Bridges, A. J. Biochemical and antiproliferative properties of 4-[ar(alkyl)amino]-pyridopyrimidines, a new chemical class of potent and specific epidermal growth factor receptor tyrosine kinase inhibitor. <i>  Biochem. Pharmacol</i>. <b>1997</b>, <i>54</i>, 877−887.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1997&pages=887&author=D.+W.+Fry&author=J.+M.+Nelson&author=V.+Slintak&author=P.+R.+Keller&author=G.+W.+Rewcastle&author=W.+A.+Denny&author=H.+Zhou&author=A.+J+Bridges&title=Biochemical+and+antiproliferative+properties+of+4-%5Bar%28alkyl%29amino%5D-pyridopyrimidines%2C+a+new+chemical+class+of+potent+and+specific+epidermal+growth+factor+receptor+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DBiochemical%2520and%2520antiproliferative%2520properties%2520of%25204-%255Bar%2528alkyl%2529amino%255D-pyridopyrimidines%252C%2520a%2520new%2520chemical%2520class%2520of%2520potent%2520and%2520specific%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1997%26volume%3D54%26spage%3D887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00011"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00011'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="jm990482tb00011_1"><span><span class="NLM_string-ref">Woodburn, J. R.; Barker, A. J.; Gibson, K. H.; Ashton, S. E.; Wakeling, A. E.; Curry, B, J.; Scarlett, L.; Henthorn, L. R. ZD 1839, an epidermal growth factor tyrosine kinase inhibitor selected for clinical trial development. <i>  Proc. Am. Assoc. Cancer Res</i>. <b>1997</b>, <i>38</i>, 633 (Abstract 4251).</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1997&pages=633&author=J.+R.+Woodburn&author=A.+J.+Barker&author=K.+H.+Gibson&author=S.+E.+Ashton&author=A.+E.+Wakeling&author=B%2C+J+Curry&author=L.+Scarlett&author=L.+R.+Henthorn&title=an+epidermal+growth+factor+tyrosine+kinase+inhibitor+selected+for+clinical+trial+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoodburn%26aufirst%3DJ.%2BR.%26atitle%3Dan%2520epidermal%2520growth%2520factor%2520tyrosine%2520kinase%2520inhibitor%2520selected%2520for%2520clinical%2520trial%2520development%26jtitle%3DProc.%2520Am.%2520Assoc.%2520Cancer%2520Res.%26date%3D1997%26volume%3D38%26spage%3D633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00012"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00012'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="jm990482tb00012_1"><span><span class="NLM_string-ref">Moyer, J. D.; Barbacci, E. G.; Iwata, K. K.; Arnold, L.; Boman, B.; Cunningham, A.; DiOrio, C.; Doti, J.; Morin, M. J.; Moyer, M. P.; Neveu, M.; Pollack, V. A.; Pustilnik, L. R.; Reynolds, M. M.; Sloane, D.; Theleman, A.; Miller, P. Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase. <i>  Cancer Res.</i><b>1997</b>, <i>57</i>, 4838−4848.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=4848&author=J.+D.+Moyer&author=E.+G.+Barbacci&author=K.+K.+Iwata&author=L.+Arnold&author=B.+Boman&author=A.+Cunningham&author=C.+DiOrio&author=J.+Doti&author=M.+J.+Morin&author=M.+P.+Moyer&author=M.+Neveu&author=V.+A.+Pollack&author=L.+R.+Pustilnik&author=M.+M.+Reynolds&author=D.+Sloane&author=A.+Theleman&author=P+Miller&title=Induction+of+apoptosis+and+cell+cycle+arrest+by+CP-358%2C774%2C+an+inhibitor+of+epidermal+growth+factor+receptor+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoyer%26aufirst%3DJ.%2BD.%26atitle%3DInduction%2520of%2520apoptosis%2520and%2520cell%2520cycle%2520arrest%2520by%2520CP-358%252C774%252C%2520an%2520inhibitor%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D4848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00013"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00013'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="jm990482tb00013_1"><span><span class="NLM_string-ref">Fry, D. W.; Bridges, A. J.; Denny, W. A.; Doherty. A.; Gries, K. D.; Hicks, J. L.; Hook, K. E.; Keller, P. R.; Leopold, W. R.; Loo, J. A.; McNamara, D, J.; Nelson, J. M.; Sherwood, V.; Smaill, J. B.; Trumpp-Kallmeyer, S.; Dobrusin, E. M. Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor. <i>  Proc. </i><i>Natl. Acad. Sci. U.S.A.</i><b>1998</b>, <i>95</i>, 12022−12027.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=12027&author=D.+W.+Fry&author=A.+J.+Bridges&author=W.+A.+Denny&author=A.+Doherty&author=K.+D.+Gries&author=J.+L.+Hicks&author=K.+E.+Hook&author=P.+R.+Keller&author=W.+R.+Leopold&author=J.+A.+Loo&author=D%2C+J+McNamara&author=J.+M.+Nelson&author=V.+Sherwood&author=J.+B.+Smaill&author=S.+Trumpp-Kallmeyer&author=E.+M+Dobrusin&title=Specific%2C+irreversible+inactivation+of+the+epidermal+growth+factor+receptor+and+erbB2%2C+by+a+new+class+of+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DSpecific%252C%2520irreversible%2520inactivation%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520and%2520erbB2%252C%2520by%2520a%2520new%2520class%2520of%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D12027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00014"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00014'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="jm990482tb00014_1"><span><span class="NLM_string-ref">Smaill, J. B.; Palmer, B. D.; Rewcastle, G. W.; Denny, W. A.; McNamara, D. J.; Dobrusin, E. M.; Bridges, A. J.; Zhou, H.; Showalter, H. D. H.; Winters, R. T.; Leopold, W. R.; Fry, D. W.; Nelson, J. M.; Slintak, V.; Elliot, W. L.; Roberts, B. J.; Vincent,  1397  P. W.; Patmore, S. J. Tyrosine kinase inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(phenylamino)pyrido[<i>d</i>]pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptor. <i>  J. Med. Chem</i>. <b>1999</b>, <i>42</i>, 1803−1815.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1815&author=J.+B.+Smaill&author=B.+D.+Palmer&author=G.+W.+Rewcastle&author=W.+A.+Denny&author=D.+J.+McNamara&author=E.+M.+Dobrusin&author=A.+J.+Bridges&author=H.+Zhou&author=H.+D.+H.+Showalter&author=R.+T.+Winters&author=W.+R.+Leopold&author=D.+W.+Fry&author=J.+M.+Nelson&author=V.+Slintak&author=W.+L.+Elliot&author=B.+J.+Roberts&author=P.+W.+Vincent&author=S.+J+Patmore&title=Tyrosine+kinase+inhibitors.+15.+4-%28Phenylamino%29quinazoline+and+4-%28phenylamino%29pyrido%5Bd%5Dpyrimidine+acrylamides+as+irreversible+inhibitors+of+the+ATP+binding+site+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252015.%25204-%2528Phenylamino%2529quinazoline%2520and%25204-%2528phenylamino%2529pyrido%255Bd%255Dpyrimidine%2520acrylamides%2520as%2520irreversible%2520inhibitors%2520of%2520the%2520ATP%2520binding%2520site%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00015"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00015'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="jm990482tb00015_1"><span><span class="NLM_string-ref">Sherwood, V.; Bridges, A. J.; Denny, W. A.; Rewcastle, G. W.; Smaill, J. B.; Fry, D. W. Selective inhibition of heregulin-dependent tyrosine phosphorylation and cellular signaling through erbB2, erbB3 and erbB4 by PD 158780 and a new irreversible inhibitor, PD 183805. <i>  Proc. Am. Assoc. </i><i>Cancer Res</i>. <b>1999</b>, <i>40</i>, 723 (Abstract 4778).</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&conference=Proc.+Am.+Assoc.+Cancer+Res.&author=V.+Sherwood&author=A.+J.+Bridges&author=W.+A.+Denny&author=G.+W.+Rewcastle&author=J.+B.+Smaill&author=D.+W.+Fry&title=Selective+inhibition+of+heregulin-dependent+tyrosine+phosphorylation+and+cellular+signaling+through+erbB2%2C+erbB3+and+erbB4+by+PD+158780+and+a+new+irreversible+inhibitor%2C+PD+183805"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dproceeding%26sid%3Dliteratum%253Aachs%26aulast%3DSherwood%26aufirst%3DV.%26atitle%3DSelective%2520inhibition%2520of%2520heregulin-dependent%2520tyrosine%2520phosphorylation%2520and%2520cellular%2520signaling%2520through%2520erbB2%252C%2520erbB3%2520and%2520erbB4%2520by%2520PD%2520158780%2520and%2520a%2520new%2520irreversible%2520inhibitor%252C%2520PD%2520183805%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00016"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00016'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="jm990482tb00016_1"><span><span class="NLM_string-ref">Gogolimska, B.; Gruda, I. Synthesis of bromonitrobenzyl bromides. <i>  Acta</i><i>Polon. Pharm</i>. <b>1963</b>, <i>20</i>, 345−346; <i>Chem. Abstr</i>. <b>1963</b>, <i>62</i>, 463.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1963&pages=346&author=B.+Gogolimska&author=I+Gruda&title=Synthesis+of+bromonitrobenzyl+bromides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGogolimska%26aufirst%3DB.%26atitle%3DSynthesis%2520of%2520bromonitrobenzyl%2520bromides%26jtitle%3DActa%2520Polon.%2520Pharm.%26date%3D1963%26volume%3D20%26spage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00017"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00017'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="jm990482tb00017_1"><span><span class="NLM_string-ref">Morley, J. S.; Simpson, J. C. E. The chemistry of simple heterocyclic systems. Part 1. Reactions of 6- and 7-nitro-4-hydroxyquinazoline and their derivatives. <i>  J. Chem. Soc.</i><b>1948</b>, 360−366.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=1948&pages=366&author=J.+S.+Morley&author=J.+C.+E+Simpson&title=The+chemistry+of+simple+heterocyclic+systems.+Part+1.+Reactions+of+6-+and+7-nitro-4-hydroxyquinazoline+and+their+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00017_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorley%26aufirst%3DJ.%2BS.%26atitle%3DThe%2520chemistry%2520of%2520simple%2520heterocyclic%2520systems.%2520Part%25201.%2520Reactions%2520of%25206-%2520and%25207-nitro-4-hydroxyquinazoline%2520and%2520their%2520derivatives%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1948%26volume%3D360%26spage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00018"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00018'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="jm990482tb00018_1"><span><span class="NLM_string-ref">Barraclough, P.; Black, J. W.; Cambridge, D.; Collard, D.; Firmin, D.; Gerskowitch, V. P.; Glen, R. C.; Giles, H.; Hill, A. P.; Hull, R. A. D.; Iyer, R.; King, W. R.; Kneen, C. O.; Lindon, J. C.; Nobbs, M. S.; Randall, P.; Shah, G. P.; Smith, S.; Vine, S. J.; Whiting, M. V.; Williams, J. M. Inotropic “A” ring substituted sulmazole and isomazole analogues. <i>  J. Med. </i><i>Chem</i>. <b>1990</b>, <i>33</i>, 2231−2239.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=2239&author=P.+Barraclough&author=J.+W.+Black&author=D.+Cambridge&author=D.+Collard&author=D.+Firmin&author=V.+P.+Gerskowitch&author=R.+C.+Glen&author=H.+Giles&author=A.+P.+Hill&author=R.+A.+D.+Hull&author=R.+Iyer&author=W.+R.+King&author=C.+O.+Kneen&author=J.+C.+Lindon&author=M.+S.+Nobbs&author=P.+Randall&author=G.+P.+Shah&author=S.+Smith&author=S.+J.+Vine&author=M.+V.+Whiting&author=J.+M.+Williams&author=+Inotropic&title=%E2%80%9CA%E2%80%9D+ring+substituted+sulmazole+and+isomazole+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00018_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarraclough%26aufirst%3DP.%26atitle%3D%25E2%2580%259CA%25E2%2580%259D%2520ring%2520substituted%2520sulmazole%2520and%2520isomazole%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D2239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00019"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00019'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="jm990482tb00019_1"><span><span class="NLM_string-ref">Roth, G. A.; Tai, J. J. A new synthesis of aryl substituted quinazolin-4(1<i>H</i>)-ones. <i>  J. Heterocycl. Chem</i>. <b>1996</b>, <i>33</i>, 2051−2053.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1996&pages=2053&author=G.+A.+Roth&author=J.+J+Tai&title=A+new+synthesis+of+aryl+substituted+quinazolin-4%281H%29-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00019_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DG.%2BA.%26atitle%3DA%2520new%2520synthesis%2520of%2520aryl%2520substituted%2520quinazolin-4%25281H%2529-ones%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1996%26volume%3D33%26spage%3D2053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00020"><div class="reference"><div class="NLM_citation" id="jm990482tb00020_1"><span><span class="NLM_string-ref">Palmer, B. D.; Trumpp-Kallmeyer, S.; Fry, D. W.; Nelson, J. M.; Showalter, H. D. H.; Denny, W. A. Tyrosine kinase inhibitors. 11. Soluble analogues of pyrrolo- and pyrazoloquinazolines as epidermal growth factor receptor inhibitors:  synthesis, biological evaluation, and modeling of the mode of binding. <i>  J. Med. Chem</i>. <b>1997</b>, <i>40</i>, 1519−1529.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=1529&author=B.+D.+Palmer&author=S.+Trumpp-Kallmeyer&author=D.+W.+Fry&author=J.+M.+Nelson&author=H.+D.+H.+Showalter&author=W.+A+Denny&title=Tyrosine+kinase+inhibitors.+11.+Soluble+analogues+of+pyrrolo-+and+pyrazoloquinazolines+as+epidermal+growth+factor+receptor+inhibitors%3A%E2%80%89+synthesis%2C+biological+evaluation%2C+and+modeling+of+the+mode+of+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00020_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DB.%2BD.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252011.%2520Soluble%2520analogues%2520of%2520pyrrolo-%2520and%2520pyrazoloquinazolines%2520as%2520epidermal%2520growth%2520factor%2520receptor%2520inhibitors%253A%25E2%2580%2589%2520synthesis%252C%2520biological%2520evaluation%252C%2520and%2520modeling%2520of%2520the%2520mode%2520of%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D1529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00021"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00021'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="jm990482tb00021_1"><span><span class="NLM_string-ref">Thompson, A. M.; Murray, D. K.; Elliott, W. L.; Fry, D. W.; Nelson, J. A.; Showalter, H. D. H.; Roberts, B. J.; Vincent, P. W.; Denny, W. A. Tyrosine kinase inhibitors. 13. Structure−activity relationships for soluble 7-substituted 4-[(3-bromophenyl)amino]-pyrido[4,3-<i>d</i>]pyrimidines designed as inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor. <i>  J. Med. Chem</i>. <b>1997</b>, <i>40</i>, 3915−3925.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=3925&author=A.+M.+Thompson&author=D.+K.+Murray&author=W.+L.+Elliott&author=D.+W.+Fry&author=J.+A.+Nelson&author=H.+D.+H.+Showalter&author=B.+J.+Roberts&author=P.+W.+Vincent&author=W.+A+Denny&title=Tyrosine+kinase+inhibitors.+13.+Structure%E2%88%92activity+relationships+for+soluble+7-substituted+4-%5B%283-bromophenyl%29amino%5D-pyrido%5B4%2C3-d%5Dpyrimidines+designed+as+inhibitors+of+the+tyrosine+kinase+activity+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00021_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BM.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252013.%2520Structure%25E2%2588%2592activity%2520relationships%2520for%2520soluble%25207-substituted%25204-%255B%25283-bromophenyl%2529amino%255D-pyrido%255B4%252C3-d%255Dpyrimidines%2520designed%2520as%2520inhibitors%2520of%2520the%2520tyrosine%2520kinase%2520activity%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D3925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00022"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00022'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="jm990482tb00022_1"><span><span class="NLM_string-ref">Trinks, U.; Buchdunger, E.; Furet, P.; Kump, W.; Mett, H.; Meyer, T.; Muller, M.; Regenass, U.; Rihs, G.; Lydon, N.; Traxler, P. Dianilinophthalimides:  potent and selective, ATP-competitive inhibitors of the EGF-receptor protein tyrosine kinase. <i>  J. Med. Chem</i>. <b>1994</b>, <i>37</i>, 1015−1027.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=1027&author=U.+Trinks&author=E.+Buchdunger&author=P.+Furet&author=W.+Kump&author=H.+Mett&author=T.+Meyer&author=M.+Muller&author=U.+Regenass&author=G.+Rihs&author=N.+Lydon&author=P.+Traxler&author=+Dianilinophthalimides&title=potent+and+selective%2C+ATP-competitive+inhibitors+of+the+EGF-receptor+protein+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00022_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrinks%26aufirst%3DU.%26atitle%3Dpotent%2520and%2520selective%252C%2520ATP-competitive%2520inhibitors%2520of%2520the%2520EGF-receptor%2520protein%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D1027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00023"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00023'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="jm990482tb00023_1"><span><span class="NLM_string-ref">Fenn, J. B.; Mann, M.; Meng, C. K.; Wong, S. F.; Whitehouse, C. M. Electrospray ionization for mass spectrometry of large biomolecules. <i>  Science</i><b>1989</b>, <i>246</i>, 64−71.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=246&publication_year=1989&pages=71&author=J.+B.+Fenn&author=M.+Mann&author=C.+K.+Meng&author=S.+F.+Wong&author=C.+M+Whitehouse&title=Electrospray+ionization+for+mass+spectrometry+of+large+biomolecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00023_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFenn%26aufirst%3DJ.%2BB.%26atitle%3DElectrospray%2520ionization%2520for%2520mass%2520spectrometry%2520of%2520large%2520biomolecules%26jtitle%3DScience%26date%3D1989%26volume%3D246%26spage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00024"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00024'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="jm990482tb00024_1"><span><span class="NLM_string-ref">Stewart, B. H.; Chan, O. H.; Lu, R. H.; Reyner, E. L.; Schmid, H. L.; Hamilton, H. W.; Steinbaugh, B. A.; Taylor, M. D. Comparison of intestinal permeabilities determined in multiple in vitro and in situ models:  relationship to absorption in humans. <i>  Pharm. Res.</i><b>1995</b>, <i>12</i>, 693−699.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1995&pages=699&author=B.+H.+Stewart&author=O.+H.+Chan&author=R.+H.+Lu&author=E.+L.+Reyner&author=H.+L.+Schmid&author=H.+W.+Hamilton&author=B.+A.+Steinbaugh&author=M.+D+Taylor&title=Comparison+of+intestinal+permeabilities+determined+in+multiple+in+vitro+and+in+situ+models%3A%E2%80%89+relationship+to+absorption+in+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00024_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStewart%26aufirst%3DB.%2BH.%26atitle%3DComparison%2520of%2520intestinal%2520permeabilities%2520determined%2520in%2520multiple%2520in%2520vitro%2520and%2520in%2520situ%2520models%253A%25E2%2580%2589%2520relationship%2520to%2520absorption%2520in%2520humans%26jtitle%3DPharm.%2520Res.%26date%3D1995%26volume%3D12%26spage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00025"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00025'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="jm990482tb00025_1"><span><span class="NLM_string-ref">Scala, S.; Akhmed, N.; Rao, U. S.; Paull, K.; Lan, L. B.; Dickstein, B.; Lee, J. S.; Elgemeie, G. H.; Stein, W. D.; Bates, S. E. P-Glycoprotein substrates and antagonists cluster into two distinct groups. <i>  Mol. Pharmacol</i>. <b>1997</b>, <i>51</i>, 1024−1033.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1997&pages=1033&author=S.+Scala&author=N.+Akhmed&author=U.+S.+Rao&author=K.+Paull&author=L.+B.+Lan&author=B.+Dickstein&author=J.+S.+Lee&author=G.+H.+Elgemeie&author=W.+D.+Stein&author=S.+E+Bates&title=P-Glycoprotein+substrates+and+antagonists+cluster+into+two+distinct+groups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00025_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScala%26aufirst%3DS.%26atitle%3DP-Glycoprotein%2520substrates%2520and%2520antagonists%2520cluster%2520into%2520two%2520distinct%2520groups%26jtitle%3DMol.%2520Pharmacol.%26date%3D1997%26volume%3D51%26spage%3D1033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00026"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00026'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="jm990482tb00026_1"><span><span class="NLM_string-ref">Horio, M.; Lovelace, E.; Pastan, I.; Gottesman, M. M. Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesicles. <i>  Biochim. Biophys. Acta</i><b>1991</b>, <i>1061</i>, 106−111.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1061&publication_year=1991&pages=111&author=M.+Horio&author=E.+Lovelace&author=I.+Pastan&author=M.+M+Gottesman&title=Agents+which+reverse+multidrug-resistance+are+inhibitors+of+%5B3H%5Dvinblastine+transport+by+isolated+vesicles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00026_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHorio%26aufirst%3DM.%26atitle%3DAgents%2520which%2520reverse%2520multidrug-resistance%2520are%2520inhibitors%2520of%2520%255B3H%255Dvinblastine%2520transport%2520by%2520isolated%2520vesicles%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1991%26volume%3D1061%26spage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00027"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00027'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="jm990482tb00027_1"><span><span class="NLM_string-ref">Zacherl, J.; Hamilton, G.; Thalhammer, T.; Riegler, M.; Cosentini, E. P.; Ellinger, A.; Bischof, G.; Schweitzer, M.; Teleky, B.; Koperna, T.; Wenzl, E. Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH. <i>  Cancer Chemother. </i><i>Pharmacol</i>. <b>1994</b>, <i>34</i>, 125−132.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1994&pages=132&author=J.+Zacherl&author=G.+Hamilton&author=T.+Thalhammer&author=M.+Riegler&author=E.+P.+Cosentini&author=A.+Ellinger&author=G.+Bischof&author=M.+Schweitzer&author=B.+Teleky&author=T.+Koperna&author=E+Wenzl&title=Inhibition+of+P-glycoprotein-mediated+vinblastine+transport+across+HCT-8+intestinal+carcinoma+monolayers+by+verapamil%2C+cyclosporine+A+and+SDZ+PSC+833+in+dependence+on+extracellular+pH"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00027_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZacherl%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520P-glycoprotein-mediated%2520vinblastine%2520transport%2520across%2520HCT-8%2520intestinal%2520carcinoma%2520monolayers%2520by%2520verapamil%252C%2520cyclosporine%2520A%2520and%2520SDZ%2520PSC%2520833%2520in%2520dependence%2520on%2520extracellular%2520pH%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1994%26volume%3D34%26spage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00028"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00028'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="jm990482tb00028_1"><span><span class="NLM_string-ref">Ford, J. M.; Hait, W. M. Pharmacology of drugs that alter multidrug resistance in cancer. <i>  Pharmacol. Rev</i>. <b>1990</b>, <i>42</i>, 155−199.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1990&pages=199&author=J.+M.+Ford&author=W.+M+Hait&title=Pharmacology+of+drugs+that+alter+multidrug+resistance+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00028_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFord%26aufirst%3DJ.%2BM.%26atitle%3DPharmacology%2520of%2520drugs%2520that%2520alter%2520multidrug%2520resistance%2520in%2520cancer%26jtitle%3DPharmacol.%2520Rev.%26date%3D1990%26volume%3D42%26spage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00029"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00029'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="jm990482tb00029_1"><span><span class="NLM_string-ref">Rewcastle, G. W.; Palmer, B. D.; Bridges, A. J.; Showalter, H. D. H.; Sun, L.; Nelson, J.; McMichael, A.; Kraker, A. J.; Fry, D. W.; Denny, W. A. Tyrosine kinase inhibitors. 9. Synthesis and evaluation of fused tricyclic quinazoline analogues as ATP site inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor. <i>  J. Med. Chem</i>. <b>1996</b>, <i>39</i>, 918−928.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=928&author=G.+W.+Rewcastle&author=B.+D.+Palmer&author=A.+J.+Bridges&author=H.+D.+H.+Showalter&author=L.+Sun&author=J.+Nelson&author=A.+McMichael&author=A.+J.+Kraker&author=D.+W.+Fry&author=W.+A+Denny&title=Tyrosine+kinase+inhibitors.+9.+Synthesis+and+evaluation+of+fused+tricyclic+quinazoline+analogues+as+ATP+site+inhibitors+of+the+tyrosine+kinase+activity+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00029_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%25209.%2520Synthesis%2520and%2520evaluation%2520of%2520fused%2520tricyclic%2520quinazoline%2520analogues%2520as%2520ATP%2520site%2520inhibitors%2520of%2520the%2520tyrosine%2520kinase%2520activity%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00030"><div class="reference"><div class="NLM_citation" id="jm990482tb00030_1"><span><span class="NLM_string-ref">Meier, J. Pharmacokinetic comparison of pindolol with other beta-adrenoceptor-blocking agents. <i>  Am. Heart J</i>. <b>1982</b>, <i>104</i>, 364−373.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=1982&pages=373&author=J+Meier&title=Pharmacokinetic+comparison+of+pindolol+with+other+beta-adrenoceptor-blocking+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00030_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeier%26aufirst%3DJ%26atitle%3DPharmacokinetic%2520comparison%2520of%2520pindolol%2520with%2520other%2520beta-adrenoceptor-blocking%2520agents%26jtitle%3DAm.%2520Heart%2520J.%26date%3D1982%26volume%3D104%26spage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00031"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00031'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="jm990482tb00031_1"><span><span class="NLM_string-ref">Fagerholm, U.; Johansson, M.; Lennernas, H. Comparison between permeability coefficients in rat and human jejunum. <i>  Pharm. Res</i>. <b>1996</b>, <i>13</i>, 1336−1342.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1996&pages=1342&author=U.+Fagerholm&author=M.+Johansson&author=H+Lennernas&title=Comparison+between+permeability+coefficients+in+rat+and+human+jejunum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00031_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFagerholm%26aufirst%3DU.%26atitle%3DComparison%2520between%2520permeability%2520coefficients%2520in%2520rat%2520and%2520human%2520jejunum%26jtitle%3DPharm.%2520Res.%26date%3D1996%26volume%3D13%26spage%3D1342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00032"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00032'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="jm990482tb00032_1"><span><span class="NLM_string-ref">Schabel, F. M., Jr.; Griswold, D. P., Jr.; Laster, W. R., Jr.; Corbett, T. H.; Lloyd, H. H. Quantitative evaluation of anticancer agent activity in experimental animals. <i>  Pharmacol. Ther</i>. <b>1977</b>, <i>1</i>, 411−435.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1977&pages=435&author=F.+M.+Schabel&author=+Jr&author=+Jr&author=+Jr&author=H.+H+Lloyd&title=Quantitative+evaluation+of+anticancer+agent+activity+in+experimental+animals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00032_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchabel%26aufirst%3DF.%2BM.%26atitle%3DQuantitative%2520evaluation%2520of%2520anticancer%2520agent%2520activity%2520in%2520experimental%2520animals%26jtitle%3DPharmacol.%2520Ther.%26date%3D1977%26volume%3D1%26spage%3D435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00033"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00033'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="jm990482tb00033_1"><span><span class="NLM_string-ref">Leopold, W. R.; Nelson, J. M.; Plowman, J.; Jackson, R. C. Anthrapyrazoles, a new class of intercalating agents with high-level, broad spectrum activity against murine tumors. <i>  Cancer Res</i>. <b>1985</b>, <i>45</i>, 5532−5539.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1985&pages=5539&author=W.+R.+Leopold&author=J.+M.+Nelson&author=J.+Plowman&author=R.+C+Jackson&title=Anthrapyrazoles%2C+a+new+class+of+intercalating+agents+with+high-level%2C+broad+spectrum+activity+against+murine+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00033_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeopold%26aufirst%3DW.%2BR.%26atitle%3DAnthrapyrazoles%252C%2520a%2520new%2520class%2520of%2520intercalating%2520agents%2520with%2520high-level%252C%2520broad%2520spectrum%2520activity%2520against%2520murine%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D1985%26volume%3D45%26spage%3D5539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00034"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00034'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="jm990482tb00034_1"><span><span class="NLM_string-ref">Elliott, W. L.; Howard, C. T.; Dykes, D. J.; Leopold, W. R. Sequence and schedule-dependent synergy of trimetrexate in combination with 5-fluorouracil in vitro and in mice. <i>  Cancer Res</i>. <b>1989</b>, <i>49</i>, 5586−5590.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1989&pages=5590&author=W.+L.+Elliott&author=C.+T.+Howard&author=D.+J.+Dykes&author=W.+R+Leopold&title=Sequence+and+schedule-dependent+synergy+of+trimetrexate+in+combination+with+5-fluorouracil+in+vitro+and+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00034_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DElliott%26aufirst%3DW.%2BL.%26atitle%3DSequence%2520and%2520schedule-dependent%2520synergy%2520of%2520trimetrexate%2520in%2520combination%2520with%25205-fluorouracil%2520in%2520vitro%2520and%2520in%2520mice%26jtitle%3DCancer%2520Res.%26date%3D1989%26volume%3D49%26spage%3D5590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm990482tb00035"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm990482tb00035'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="jm990482tb00035_1"><span><span class="NLM_string-ref">Elliott, W. L.; Roberts, B. J.; Howard, C. T.; Leopold, W. R. Chemotherapy with [SP-4-3-(<i>R</i>)]-[1,1-cyclobutanedicarboxylato(2-)](2-methyl-1,4-butanediamine-N,N‘)platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo. <i>  Cancer Res</i>. <b>1994</b>, <i>54</i>, 4412−4418.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1994&pages=4418&author=W.+L.+Elliott&author=B.+J.+Roberts&author=C.+T.+Howard&author=W.+R.+Leopold&author=+Chemotherapy&author=+N%E2%80%98&title=in+combination+with+standard+agents+against+murine+tumors+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00035_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DElliott%26aufirst%3DW.%2BL.%26atitle%3Din%2520combination%2520with%2520standard%2520agents%2520against%2520murine%2520tumors%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D1994%26volume%3D54%26spage%3D4418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'jm990482tb00001':['jm990482tb00001_1'],'jm990482tb00002':['jm990482tb00002_1'],'jm990482tb00003':['jm990482tb00003_1'],'jm990482tb00004':['jm990482tb00004_1'],'jm990482tb00005':['jm990482tb00005_1'],'jm990482tb00006':['jm990482tb00006_1'],'jm990482tb00007':['jm990482tb00007_1'],'jm990482tb00008':['jm990482tb00008_1'],'jm990482tb00009':['jm990482tb00009_1'],'jm990482tb00010':['jm990482tb00010_1'],'jm990482tb00011':['jm990482tb00011_1'],'jm990482tb00012':['jm990482tb00012_1'],'jm990482tb00013':['jm990482tb00013_1'],'jm990482tb00014':['jm990482tb00014_1'],'jm990482tb00015':['jm990482tb00015_1'],'jm990482tb00016':['jm990482tb00016_1'],'jm990482tb00017':['jm990482tb00017_1'],'jm990482tb00018':['jm990482tb00018_1'],'jm990482tb00019':['jm990482tb00019_1'],'jm990482tb00020':['jm990482tb00020_1'],'jm990482tb00021':['jm990482tb00021_1'],'jm990482tb00022':['jm990482tb00022_1'],'jm990482tb00023':['jm990482tb00023_1'],'jm990482tb00024':['jm990482tb00024_1'],'jm990482tb00025':['jm990482tb00025_1'],'jm990482tb00026':['jm990482tb00026_1'],'jm990482tb00027':['jm990482tb00027_1'],'jm990482tb00028':['jm990482tb00028_1'],'jm990482tb00029':['jm990482tb00029_1'],'jm990482tb00030':['jm990482tb00030_1'],'jm990482tb00031':['jm990482tb00031_1'],'jm990482tb00032':['jm990482tb00032_1'],'jm990482tb00033':['jm990482tb00033_1'],'jm990482tb00034':['jm990482tb00034_1'],'jm990482tb00035':['jm990482tb00035_1']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 204 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhisong Wang, Yan Gao, Lei He, Shuhao Sun, Tingting Xia, Lu Hu, Licheng Yao, Liangliang Wang, Dan Li, Hui Shi, <span class="NLM_string-name hlFld-ContribAuthor">Xuebin Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of Highly Potent Toll-like Receptor 7/8 Dual Agonists for Cancer Immunotherapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (11)
                                     , 7507-7532. <a href="https://doi.org/10.1021/acs.jmedchem.1c00179" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00179</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00179%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252BHighly%252BPotent%252BToll-like%252BReceptor%252B7%25252F8%252BDual%252BAgonists%252Bfor%252BCancer%252BImmunotherapy%26aulast%3DWang%26aufirst%3DZhisong%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D01022021%26date%3D28052021%26volume%3D64%26issue%3D11%26spage%3D7507%26epage%3D7532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Matthias Gehringer, <span class="NLM_string-name hlFld-ContribAuthor">Stefan A. Laufer</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (12)
                                     , 5673-5724. <a href="https://doi.org/10.1021/acs.jmedchem.8b01153" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01153</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01153%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEmerging%252Band%252BRe-Emerging%252BWarheads%252Bfor%252BTargeted%252BCovalent%252BInhibitors%25253A%252BApplications%252Bin%252BMedicinal%252BChemistry%252Band%252BChemical%252BBiology%26aulast%3DGehringer%26aufirst%3DMatthias%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D23072018%26date%3D25012019%26date%3D19122018%26volume%3D62%26issue%3D12%26spage%3D5673%26epage%3D5724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yongjia Hao, Jiankun Lyu, Rong Qu, Yi Tong, Deheng Sun, Fang Feng, Linjiang Tong, Tingyuan Yang, Zhenjiang Zhao, Lili Zhu, Jian Ding, Yufang Xu, Hua Xie, <span class="NLM_string-name hlFld-ContribAuthor">Honglin Li</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Pyrimido[4,5-d]pyrimidine-2,4(1H,3H)-diones as Potent and Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors against L858R/T790M Resistance Mutation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (13)
                                     , 5609-5622. <a href="https://doi.org/10.1021/acs.jmedchem.8b00346" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00346</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00346%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BPyrimido%25255B4%25252C5-d%25255Dpyrimidine-2%25252C4%2525281H%25252C3H%252529-diones%252Bas%252BPotent%252Band%252BSelective%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252B%252528EGFR%252529%252BInhibitors%252Bagainst%252BL858R%25252FT790M%252BResistance%252BMutation%26aulast%3DHao%26aufirst%3DYongjia%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D04032018%26date%3D25062018%26date%3D15062018%26volume%3D61%26issue%3D13%26spage%3D5609%26epage%3D5622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mostafa M.  Hamed</span>, <span class="hlFld-ContribAuthor ">Sarah S.  Darwish</span>, <span class="hlFld-ContribAuthor ">Jennifer  Herrmann</span>, <span class="hlFld-ContribAuthor ">Ashraf H.  Abadi</span>, and <span class="hlFld-ContribAuthor ">Matthias  Engel</span>  . </span><span class="cited-content_cbyCitation_article-title">First Bispecific Inhibitors of the Epidermal Growth Factor Receptor Kinase and the NF-κB Activity As Novel Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (7)
                                     , 2853-2868. <a href="https://doi.org/10.1021/acs.jmedchem.6b01774" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01774</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01774%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFirst%252BBispecific%252BInhibitors%252Bof%252Bthe%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BKinase%252Band%252Bthe%252BNF-%2525CE%2525BAB%252BActivity%252BAs%252BNovel%252BAnticancer%252BAgents%26aulast%3DHamed%26aufirst%3DMostafa%2BM.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D08122016%26date%3D28032017%26date%3D13042017%26date%3D14032017%26volume%3D60%26issue%3D7%26spage%3D2853%26epage%3D2868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atli  Thorarensen</span>, <span class="hlFld-ContribAuthor ">Martin E.  Dowty</span>, <span class="hlFld-ContribAuthor ">Mary Ellen  Banker</span>, <span class="hlFld-ContribAuthor ">Brian  Juba</span>, <span class="hlFld-ContribAuthor ">Jason  Jussif</span>, <span class="hlFld-ContribAuthor ">Tsung  Lin</span>, <span class="hlFld-ContribAuthor ">Fabien  Vincent</span>, <span class="hlFld-ContribAuthor ">Robert M.  Czerwinski</span>, <span class="hlFld-ContribAuthor ">Agustin  Casimiro-Garcia</span>, <span class="hlFld-ContribAuthor ">Ray  Unwalla</span>, <span class="hlFld-ContribAuthor ">John I.  Trujillo</span>, <span class="hlFld-ContribAuthor ">Sidney  Liang</span>, <span class="hlFld-ContribAuthor ">Paul  Balbo</span>, <span class="hlFld-ContribAuthor ">Ye  Che</span>, <span class="hlFld-ContribAuthor ">Adam M.  Gilbert</span>, <span class="hlFld-ContribAuthor ">Matthew F.  Brown</span>, <span class="hlFld-ContribAuthor ">Matthew  Hayward</span>, <span class="hlFld-ContribAuthor ">Justin  Montgomery</span>, <span class="hlFld-ContribAuthor ">Louis  Leung</span>, <span class="hlFld-ContribAuthor ">Xin  Yang</span>, <span class="hlFld-ContribAuthor ">Sarah  Soucy</span>, <span class="hlFld-ContribAuthor ">Martin  Hegen</span>, <span class="hlFld-ContribAuthor ">Jotham  Coe</span>, <span class="hlFld-ContribAuthor ">Jonathan  Langille</span>, <span class="hlFld-ContribAuthor ">Felix  Vajdos</span>, <span class="hlFld-ContribAuthor ">Jill  Chrencik</span>, and <span class="hlFld-ContribAuthor ">Jean-Baptiste  Telliez</span>  . </span><span class="cited-content_cbyCitation_article-title">Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in Humans. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (5)
                                     , 1971-1993. <a href="https://doi.org/10.1021/acs.jmedchem.6b01694" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01694</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01694%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Bof%252Ba%252BJanus%252BKinase%252B3%252B%252528JAK3%252529%252BSpecific%252BInhibitor%252B1-%252528%2525282S%25252C5R%252529-5-%252528%2525287H-Pyrrolo%25255B2%25252C3-d%25255Dpyrimidin-4-yl%252529amino%252529-2-methylpiperidin-1-yl%252529prop-2-en-1-one%252B%252528PF-06651600%252529%252BAllowing%252Bfor%252Bthe%252BInterrogation%252Bof%252BJAK3%252BSignaling%252Bin%252BHumans%26aulast%3DThorarensen%26aufirst%3DAtli%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D23112016%26date%3D16022017%26date%3D09032017%26date%3D31012017%26volume%3D60%26issue%3D5%26spage%3D1971%26epage%3D1993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeff B.  Smaill</span>, <span class="hlFld-ContribAuthor ">Andrea J.  Gonzales</span>, <span class="hlFld-ContribAuthor ">Julie A.  Spicer</span>, <span class="hlFld-ContribAuthor ">Helen  Lee</span>, <span class="hlFld-ContribAuthor ">Jessica E.  Reed</span>, <span class="hlFld-ContribAuthor ">Karen  Sexton</span>, <span class="hlFld-ContribAuthor ">Irene W.  Althaus</span>, <span class="hlFld-ContribAuthor ">Tong  Zhu</span>, <span class="hlFld-ContribAuthor ">Shannon L.  Black</span>, <span class="hlFld-ContribAuthor ">Adrian  Blaser</span>, <span class="hlFld-ContribAuthor ">William A.  Denny</span>, <span class="hlFld-ContribAuthor ">Paul A.  Ellis</span>, <span class="hlFld-ContribAuthor ">Stephen  Fakhoury</span>, <span class="hlFld-ContribAuthor ">Patricia J.  Harvey</span>, <span class="hlFld-ContribAuthor ">Ken  Hook</span>, <span class="hlFld-ContribAuthor ">Florence O. J.  McCarthy</span>, <span class="hlFld-ContribAuthor ">Brian D.  Palmer</span>, <span class="hlFld-ContribAuthor ">Freddy  Rivault</span>, <span class="hlFld-ContribAuthor ">Kevin  Schlosser</span>, <span class="hlFld-ContribAuthor ">Teresa  Ellis</span>, <span class="hlFld-ContribAuthor ">Andrew M.  Thompson</span>, <span class="hlFld-ContribAuthor ">Erin  Trachet</span>, <span class="hlFld-ContribAuthor ">R. Thomas  Winters</span>, <span class="hlFld-ContribAuthor ">Haile  Tecle</span>, and <span class="hlFld-ContribAuthor ">Alexander  Bridges</span>  . </span><span class="cited-content_cbyCitation_article-title">Tyrosine Kinase Inhibitors. 20. Optimization of Substituted Quinazoline and Pyrido[3,4-d]pyrimidine Derivatives as Orally Active, Irreversible Inhibitors of the Epidermal Growth Factor Receptor Family. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (17)
                                     , 8103-8124. <a href="https://doi.org/10.1021/acs.jmedchem.6b00883" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00883</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00883%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTyrosine%252BKinase%252BInhibitors.%252B20.%252BOptimization%252Bof%252BSubstituted%252BQuinazoline%252Band%252BPyrido%25255B3%25252C4-d%25255Dpyrimidine%252BDerivatives%252Bas%252BOrally%252BActive%25252C%252BIrreversible%252BInhibitors%252Bof%252Bthe%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BFamily%26aulast%3DSmaill%26aufirst%3DJeff%2BB.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D15062016%26date%3D22082016%26date%3D08092016%26date%3D04082016%26volume%3D59%26issue%3D17%26spage%3D8103%26epage%3D8124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gérald  Lelais</span>, <span class="hlFld-ContribAuthor ">Robert  Epple</span>, <span class="hlFld-ContribAuthor ">Thomas H.  Marsilje</span>, <span class="hlFld-ContribAuthor ">Yun O.  Long</span>, <span class="hlFld-ContribAuthor ">Matthew  McNeill</span>, <span class="hlFld-ContribAuthor ">Bei  Chen</span>, <span class="hlFld-ContribAuthor ">Wenshuo  Lu</span>, <span class="hlFld-ContribAuthor ">Jaganmohan  Anumolu</span>, <span class="hlFld-ContribAuthor ">Sangamesh  Badiger</span>, <span class="hlFld-ContribAuthor ">Badry  Bursulaya</span>, <span class="hlFld-ContribAuthor ">Michael  DiDonato</span>, <span class="hlFld-ContribAuthor ">Rina  Fong</span>, <span class="hlFld-ContribAuthor ">Jose  Juarez</span>, <span class="hlFld-ContribAuthor ">Jie  Li</span>, <span class="hlFld-ContribAuthor ">Mari  Manuia</span>, <span class="hlFld-ContribAuthor ">Daniel E.  Mason</span>, <span class="hlFld-ContribAuthor ">Perry  Gordon</span>, <span class="hlFld-ContribAuthor ">Todd  Groessl</span>, <span class="hlFld-ContribAuthor ">Kevin  Johnson</span>, <span class="hlFld-ContribAuthor ">Yong  Jia</span>, <span class="hlFld-ContribAuthor ">Shailaja  Kasibhatla</span>, <span class="hlFld-ContribAuthor ">Chun  Li</span>, <span class="hlFld-ContribAuthor ">John  Isbell</span>, <span class="hlFld-ContribAuthor ">Glen  Spraggon</span>, <span class="hlFld-ContribAuthor ">Steven  Bender</span>, and <span class="hlFld-ContribAuthor ">Pierre-Yves  Michellys</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of (R,E)-N-(7-Chloro-1-(1-[4-(dimethylamino)but-2-enoyl]azepan-3-yl)-1H-benzo[d]imidazol-2-yl)-2-methylisonicotinamide (EGF816), a Novel, Potent, and WT Sparing Covalent Inhibitor of Oncogenic (L858R, ex19del) and Resistant (T790M) EGFR Mutants for the Treatment of EGFR Mutant Non-Small-Cell Lung Cancers. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (14)
                                     , 6671-6689. <a href="https://doi.org/10.1021/acs.jmedchem.5b01985" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01985</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01985%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%252528R%25252CE%252529-N-%2525287-Chloro-1-%2525281-%25255B4-%252528dimethylamino%252529but-2-enoyl%25255Dazepan-3-yl%252529-1H-benzo%25255Bd%25255Dimidazol-2-yl%252529-2-methylisonicotinamide%252B%252528EGF816%252529%25252C%252Ba%252BNovel%25252C%252BPotent%25252C%252Band%252BWT%252BSparing%252BCovalent%252BInhibitor%252Bof%252BOncogenic%252B%252528L858R%25252C%252Bex19del%252529%252Band%252BResistant%252B%252528T790M%252529%252BEGFR%252BMutants%252Bfor%252Bthe%252BTreatment%252Bof%252BEGFR%252BMutant%252BNon-Small-Cell%252BLung%252BCancers%26aulast%3DLelais%26aufirst%3DG%25C3%25A9rald%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D22122015%26date%3D19072016%26date%3D28072016%26volume%3D59%26issue%3D14%26spage%3D6671%26epage%3D6689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Zhou</span>, <span class="hlFld-ContribAuthor ">Jiang  Wang</span>, <span class="hlFld-ContribAuthor ">Zhanni  Gu</span>, <span class="hlFld-ContribAuthor ">Shuni  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Zhu</span>, <span class="hlFld-ContribAuthor ">José Luis  Aceña</span>, <span class="hlFld-ContribAuthor ">Vadim A.  Soloshonok</span>, <span class="hlFld-ContribAuthor ">Kunisuke  Izawa</span>, and <span class="hlFld-ContribAuthor ">Hong  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (2)
                                     , 422-518. <a href="https://doi.org/10.1021/acs.chemrev.5b00392" title="DOI URL">https://doi.org/10.1021/acs.chemrev.5b00392</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.5b00392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.5b00392%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DNext%252BGeneration%252Bof%252BFluorine-Containing%252BPharmaceuticals%25252C%252BCompounds%252BCurrently%252Bin%252BPhase%252BII%2525E2%252580%252593III%252BClinical%252BTrials%252Bof%252BMajor%252BPharmaceutical%252BCompanies%25253A%252BNew%252BStructural%252BTrends%252Band%252BTherapeutic%252BAreas%26aulast%3DZhou%26aufirst%3DYu%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D06072015%26date%3D12012016%26date%3D27012016%26volume%3D116%26issue%3D2%26spage%3D422%26epage%3D518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor "> Jessica E.    Reed </span><span class="hlFld-ContribAuthor "> Jeff B.    Smaill </span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery of Dacomitinib, a Potent Irreversible EGFR Inhibitor. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 207-233. <a href="https://doi.org/10.1021/bk-2016-1239.ch008" title="DOI URL">https://doi.org/10.1021/bk-2016-1239.ch008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bk-2016-1239.ch008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbk-2016-1239.ch008%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDiscovery%252Bof%252BDacomitinib%25252C%252Ba%252BPotent%252BIrreversible%252BEGFR%252BInhibitor%26aulast%3DReed%26aufirst%3DJessica%2BE.%26date%3D2016%26date%3D2016%26spage%3D207%26epage%3D233%26atitle%3DComprehensive%252BAccounts%252Bof%252BPharmaceutical%252BResearch%252Band%252BDevelopment%25253A%252BFrom%252BDiscovery%252Bto%252BLate-Stage%252BProcess%252BDevelopment%252BVolume%252B1%26aulast%3DAbdel-Magid%26aufirst%3DAhmed%2BF.%26date%3D2016%26date%3D2016%26volume%3D1239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryan P.  Wurz</span>, <span class="hlFld-ContribAuthor ">Liping H.  Pettus</span>, <span class="hlFld-ContribAuthor ">Kate  Ashton</span>, <span class="hlFld-ContribAuthor ">James  Brown</span>, <span class="hlFld-ContribAuthor ">Jian Jeffrey  Chen</span>, <span class="hlFld-ContribAuthor ">Brad  Herberich</span>, <span class="hlFld-ContribAuthor ">Fang-Tsao  Hong</span>, <span class="hlFld-ContribAuthor ">Essa  Hu-Harrington</span>, <span class="hlFld-ContribAuthor ">Tom  Nguyen</span>, <span class="hlFld-ContribAuthor ">David J.  St. Jean, Jr.</span>, <span class="hlFld-ContribAuthor ">Seifu  Tadesse</span>, <span class="hlFld-ContribAuthor ">David  Bauer</span>, <span class="hlFld-ContribAuthor ">Michele  Kubryk</span>, <span class="hlFld-ContribAuthor ">Jinghui  Zhan</span>, <span class="hlFld-ContribAuthor ">Keegan  Cooke</span>, <span class="hlFld-ContribAuthor ">Petia  Mitchell</span>, <span class="hlFld-ContribAuthor ">Kristin L.  Andrews</span>, <span class="hlFld-ContribAuthor ">Faye  Hsieh</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Nataraj  Kalyanaraman</span>, <span class="hlFld-ContribAuthor ">Tian  Wu</span>, <span class="hlFld-ContribAuthor ">Darren L.  Reid</span>, <span class="hlFld-ContribAuthor ">Edward K.  Lobenhofer</span>, <span class="hlFld-ContribAuthor ">Dina A.  Andrews</span>, <span class="hlFld-ContribAuthor ">Nancy  Everds</span>, <span class="hlFld-ContribAuthor ">Roberto  Guzman</span>, <span class="hlFld-ContribAuthor ">Andrew T.  Parsons</span>, <span class="hlFld-ContribAuthor ">Simon J.  Hedley</span>, <span class="hlFld-ContribAuthor ">Jason  Tedrow</span>, <span class="hlFld-ContribAuthor ">Oliver R.  Thiel</span>, <span class="hlFld-ContribAuthor ">Matthew  Potter</span>, <span class="hlFld-ContribAuthor ">Robert  Radinsky</span>, <span class="hlFld-ContribAuthor ">Pedro J.  Beltran</span>, and <span class="hlFld-ContribAuthor ">Andrew S.  Tasker</span>  . </span><span class="cited-content_cbyCitation_article-title">Oxopyrido[2,3-d]pyrimidines as Covalent L858R/T790M Mutant Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>6 </em>
                                    (9)
                                     , 987-992. <a href="https://doi.org/10.1021/acsmedchemlett.5b00193" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00193</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00193%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DOxopyrido%25255B2%25252C3-d%25255Dpyrimidines%252Bas%252BCovalent%252BL858R%25252FT790M%252BMutant%252BSelective%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252B%252528EGFR%252529%252BInhibitors%26aulast%3DWurz%26aufirst%3DRyan%2BP.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D08052015%26date%3D27072015%26date%3D31072015%26date%3D10092015%26date%3D27072015%26volume%3D6%26issue%3D9%26spage%3D987%26epage%3D992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xitao  Li</span>, <span class="hlFld-ContribAuthor ">Yingying  Zuo</span>, <span class="hlFld-ContribAuthor ">Guanghui  Tang</span>, <span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Yiqing  Zhou</span>, <span class="hlFld-ContribAuthor ">Xueying  Wang</span>, <span class="hlFld-ContribAuthor ">Tianlin  Guo</span>, <span class="hlFld-ContribAuthor ">Mengying  Xia</span>, <span class="hlFld-ContribAuthor ">Ning  Ding</span>, and <span class="hlFld-ContribAuthor ">Zhengying  Pan</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Series of 2,5-Diaminopyrimidine Covalent Irreversible Inhibitors of Bruton’s Tyrosine Kinase with in Vivo Antitumor Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (12)
                                     , 5112-5128. <a href="https://doi.org/10.1021/jm4017762" title="DOI URL">https://doi.org/10.1021/jm4017762</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4017762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4017762%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BSeries%252Bof%252B2%25252C5-Diaminopyrimidine%252BCovalent%252BIrreversible%252BInhibitors%252Bof%252BBruton%2525E2%252580%252599s%252BTyrosine%252BKinase%252Bwith%252Bin%252BVivo%252BAntitumor%252BActivity%26aulast%3DLi%26aufirst%3DXitao%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D16112013%26date%3D10062014%26date%3D26062014%26volume%3D57%26issue%3D12%26spage%3D5112%26epage%3D5128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianwei  Wu</span>, <span class="hlFld-ContribAuthor ">Wenteng  Chen</span>, <span class="hlFld-ContribAuthor ">Guangxin  Xia</span>, <span class="hlFld-ContribAuthor ">Jing  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiaan  Shao</span>, <span class="hlFld-ContribAuthor ">Biqin  Tan</span>, <span class="hlFld-ContribAuthor ">Chunchun  Zhang</span>, <span class="hlFld-ContribAuthor ">Wanwan  Yu</span>, <span class="hlFld-ContribAuthor ">Qinjie  Weng</span>, <span class="hlFld-ContribAuthor ">Haiyan  Liu</span>, <span class="hlFld-ContribAuthor ">Miao  Hu</span>, <span class="hlFld-ContribAuthor ">Hailin  Deng</span>, <span class="hlFld-ContribAuthor ">Yu  Hao</span>, <span class="hlFld-ContribAuthor ">Jingkang  Shen</span>, and <span class="hlFld-ContribAuthor ">Yongping  Yu</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Novel Conformationally Constrained Inhibitors Targeting EGFR. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>4 </em>
                                    (10)
                                     , 974-978. <a href="https://doi.org/10.1021/ml4002437" title="DOI URL">https://doi.org/10.1021/ml4002437</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml4002437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml4002437%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BConformationally%252BConstrained%252BInhibitors%252BTargeting%252BEGFR%26aulast%3DWu%26aufirst%3DJianwei%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D27062013%26date%3D06082013%26date%3D09082013%26date%3D10102013%26date%3D06082013%26volume%3D4%26issue%3D10%26spage%3D974%26epage%3D978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">André  Koch</span>, <span class="hlFld-ContribAuthor ">Haridas B.  Rode</span>, <span class="hlFld-ContribAuthor ">André  Richters</span>, <span class="hlFld-ContribAuthor ">Daniel  Rauh</span>, and <span class="hlFld-ContribAuthor ">Silke  Hauf</span>  . </span><span class="cited-content_cbyCitation_article-title">A Chemical Genetic Approach for Covalent Inhibition of Analogue-Sensitive Aurora Kinase. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2012,</strong> <em>7 </em>
                                    (4)
                                     , 723-731. <a href="https://doi.org/10.1021/cb200465c" title="DOI URL">https://doi.org/10.1021/cb200465c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb200465c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb200465c%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DA%252BChemical%252BGenetic%252BApproach%252Bfor%252BCovalent%252BInhibition%252Bof%252BAnalogue-Sensitive%252BAurora%252BKinase%26aulast%3DKoch%26aufirst%3DAndr%25C3%25A9%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D12112011%26date%3D20012012%26date%3D01022012%26date%3D20042012%26date%3D20012012%26volume%3D7%26issue%3D4%26spage%3D723%26epage%3D731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaohua  Chang</span>, <span class="hlFld-ContribAuthor ">Lianwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Shilin  Xu</span>, <span class="hlFld-ContribAuthor ">Jinfeng  Luo</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Lu</span>, <span class="hlFld-ContribAuthor ">Zhang  Zhang</span>, <span class="hlFld-ContribAuthor ">Tianfeng  Xu</span>, <span class="hlFld-ContribAuthor ">Yingxue  Liu</span>, <span class="hlFld-ContribAuthor ">Zhengchao  Tu</span>, <span class="hlFld-ContribAuthor ">Yong  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaomei  Ren</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, <span class="hlFld-ContribAuthor ">Duanqing  Pei</span>, and <span class="hlFld-ContribAuthor ">Ke  Ding</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Novel Conformationally Constrained Inhibitors Targeting Epidermal Growth Factor Receptor Threonine790 → Methionine790 Mutant. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (6)
                                     , 2711-2723. <a href="https://doi.org/10.1021/jm201591k" title="DOI URL">https://doi.org/10.1021/jm201591k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201591k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201591k%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BConformationally%252BConstrained%252BInhibitors%252BTargeting%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BThreonine790%252B%2525E2%252586%252592%252BMethionine790%252BMutant%26aulast%3DChang%26aufirst%3DShaohua%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D25112011%26date%3D01032012%26date%3D22032012%26date%3D16022012%26volume%3D55%26issue%3D6%26spage%3D2711%26epage%3D2723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gwenaelle  Bouscary-Desforges</span>, <span class="hlFld-ContribAuthor ">Agnes  Bombrun</span>, <span class="hlFld-ContribAuthor ">John Kallikat  Augustine</span>, <span class="hlFld-ContribAuthor ">Gérald  Bernardinelli</span>, and <span class="hlFld-ContribAuthor ">Anna  Quattropani</span>  . </span><span class="cited-content_cbyCitation_article-title">Regioselective Synthesis of 2,8-Disubstituted 4-Aminopyrido[3,2-d]pyrimidine-6-carboxylic Acid Methyl Ester Compounds. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2012,</strong> <em>77 </em>
                                    (1)
                                     , 243-252. <a href="https://doi.org/10.1021/jo201834d" title="DOI URL">https://doi.org/10.1021/jo201834d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo201834d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo201834d%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRegioselective%252BSynthesis%252Bof%252B2%25252C8-Disubstituted%252B4-Aminopyrido%25255B3%25252C2-d%25255Dpyrimidine-6-carboxylic%252BAcid%252BMethyl%252BEster%252BCompounds%26aulast%3DBouscary-Desforges%26aufirst%3DGwenaelle%26date%3D2012%26date%3D2011%26date%3D2011%26date%3D06092011%26date%3D19122011%26date%3D06012012%26date%3D28112011%26volume%3D77%26issue%3D1%26spage%3D243%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rui  Zhang</span>, <span class="hlFld-ContribAuthor ">Dingyuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Yongjiu  Liang</span>, <span class="hlFld-ContribAuthor ">Guangyuan  Zhou</span>, and <span class="hlFld-ContribAuthor ">Dewen  Dong</span>  . </span><span class="cited-content_cbyCitation_article-title">Vilsmeier Reaction of 3-Aminopropenamides: One-Pot Synthesis of Pyrimidin-4(3H)-ones. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2011,</strong> <em>76 </em>
                                    (8)
                                     , 2880-2883. <a href="https://doi.org/10.1021/jo101949y" title="DOI URL">https://doi.org/10.1021/jo101949y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo101949y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo101949y%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DVilsmeier%252BReaction%252Bof%252B3-Aminopropenamides%25253A%252BOne-Pot%252BSynthesis%252Bof%252BPyrimidin-4%2525283H%252529-ones%26aulast%3DZhang%26aufirst%3DRui%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D02102010%26date%3D18032011%26date%3D15042011%26date%3D10032011%26volume%3D76%26issue%3D8%26spage%3D2880%26epage%3D2883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alan C.  Cheng</span>, <span class="hlFld-ContribAuthor ">John  Eksterowicz</span>, <span class="hlFld-ContribAuthor ">Stephanie  Geuns-Meyer</span> and <span class="hlFld-ContribAuthor ">Yaxiong  Sun</span>  . </span><span class="cited-content_cbyCitation_article-title">Analysis of Kinase Inhibitor Selectivity using a Thermodynamics-Based Partition Index. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (11)
                                     , 4502-4510. <a href="https://doi.org/10.1021/jm100301x" title="DOI URL">https://doi.org/10.1021/jm100301x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100301x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100301x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAnalysis%252Bof%252BKinase%252BInhibitor%252BSelectivity%252Busing%252Ba%252BThermodynamics-Based%252BPartition%252BIndex%26aulast%3DCheng%26aufirst%3DAlan%2BC.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D06032010%26date%3D11052010%26date%3D10062010%26volume%3D53%26issue%3D11%26spage%3D4502%26epage%3D4510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caterina  Carmi</span>, <span class="hlFld-ContribAuthor ">Andrea  Cavazzoni</span>, <span class="hlFld-ContribAuthor ">Stefano  Vezzosi</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Bordi</span>, <span class="hlFld-ContribAuthor ">Federica  Vacondio</span>, <span class="hlFld-ContribAuthor ">Claudia  Silva</span>, <span class="hlFld-ContribAuthor ">Silvia  Rivara</span>, <span class="hlFld-ContribAuthor ">Alessio  Lodola</span>, <span class="hlFld-ContribAuthor ">Roberta R.  Alfieri</span>, <span class="hlFld-ContribAuthor ">Silvia  La Monica</span>, <span class="hlFld-ContribAuthor ">Maricla  Galetti</span>, <span class="hlFld-ContribAuthor ">Andrea  Ardizzoni</span>, <span class="hlFld-ContribAuthor ">Pier Giorgio  Petronini</span> and <span class="hlFld-ContribAuthor ">Marco  Mor</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Irreversible Epidermal Growth Factor Receptor Inhibitors by Chemical Modulation of the Cysteine-Trap Portion. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (5)
                                     , 2038-2050. <a href="https://doi.org/10.1021/jm901558p" title="DOI URL">https://doi.org/10.1021/jm901558p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm901558p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm901558p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BIrreversible%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BInhibitors%252Bby%252BChemical%252BModulation%252Bof%252Bthe%252BCysteine-Trap%252BPortion%26aulast%3DCarmi%26aufirst%3DCaterina%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D21102009%26date%3D12022010%26date%3D11032010%26volume%3D53%26issue%3D5%26spage%3D2038%26epage%3D2050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Concettina  La Motta</span>, <span class="hlFld-ContribAuthor ">Stefania  Sartini</span>, <span class="hlFld-ContribAuthor ">Tiziano  Tuccinardi</span>, <span class="hlFld-ContribAuthor ">Erika  Nerini</span>, <span class="hlFld-ContribAuthor ">Federico  Da Settimo</span> and <span class="hlFld-ContribAuthor ">Adriano  Martinelli</span>. </span><span class="cited-content_cbyCitation_article-title">Computational Studies of Epidermal Growth Factor Receptor: Docking Reliability, Three-Dimensional Quantitative Structure−Activity Relationship Analysis, and Virtual Screening Studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (4)
                                     , 964-975. <a href="https://doi.org/10.1021/jm800829v" title="DOI URL">https://doi.org/10.1021/jm800829v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm800829v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm800829v%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DComputational%252BStudies%252Bof%252BEpidermal%252BGrowth%252BFactor%252BReceptor%25253A%252BDocking%252BReliability%25252C%252BThree-Dimensional%252BQuantitative%252BStructure%2525E2%252588%252592Activity%252BRelationship%252BAnalysis%25252C%252Band%252BVirtual%252BScreening%252BStudies%26aulast%3DLa%2BMotta%26aufirst%3DConcettina%26date%3D2009%26date%3D2009%26date%3D2008%26date%3D26%252002%25202009%26date%3D26%252001%25202009%26date%3D8%252007%25202008%26volume%3D52%26issue%3D4%26spage%3D964%26epage%3D975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rambabu  Gundla</span>, <span class="hlFld-ContribAuthor ">Roza  Kazemi</span>, <span class="hlFld-ContribAuthor ">Ramadevi  Sanam</span>, <span class="hlFld-ContribAuthor ">Ravikumar  Muttineni</span>, <span class="hlFld-ContribAuthor ">Jagarlapudi A. R. P.  Sarma</span>, <span class="hlFld-ContribAuthor ">Raveendra  Dayam</span> and <span class="hlFld-ContribAuthor ">Nouri  Neamati</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Small-Molecule Inhibitors of Human Epidermal Growth Factor Receptor-2: Combined Ligand and Target-Based Approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2008,</strong> <em>51 </em>
                                    (12)
                                     , 3367-3377. <a href="https://doi.org/10.1021/jm7013875" title="DOI URL">https://doi.org/10.1021/jm7013875</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm7013875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm7013875%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BSmall-Molecule%252BInhibitors%252Bof%252BHuman%252BEpidermal%252BGrowth%252BFactor%252BReceptor-2%25253A%252BCombined%252BLigand%252Band%252BTarget-Based%252BApproach%26aulast%3DGundla%26aufirst%3DRambabu%26date%3D2008%26date%3D2008%26date%3D2007%26date%3D26%252006%25202008%26date%3D24%252005%25202008%26date%3D05%252011%25202007%26volume%3D51%26issue%3D12%26spage%3D3367%26epage%3D3377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Grace Shiahuy  Chen,,   Shivaramayya  Kalchar,,   Chun-Wei  Kuo,,   Chih-Shiang  Chang,,   Cyril O.  Usifoh, and,   <span class="NLM_string-name hlFld-ContribAuthor">Ji-Wang  Chern</span>. </span><span class="cited-content_cbyCitation_article-title">Studies on Quinazolines. 11. Intramolecular Imidate-Amide Rearrangement of 2-Substituted 4-(ω-Chloroalkoxy)quinazoline Derivatives. 1,3 -O → N Shift of Chloroalkyl Groups via Cyclic 1,3-Azaoxonium Intermediates. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2003,</strong> <em>68 </em>
                                    (6)
                                     , 2502-2505. <a href="https://doi.org/10.1021/jo0263420" title="DOI URL">https://doi.org/10.1021/jo0263420</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo0263420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo0263420%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DStudies%252Bon%252BQuinazolines.%252B11.%252BIntramolecular%252BImidate-Amide%252BRearrangement%252Bof%252B2-Substituted%252B4-%252528%2525CF%252589-Chloroalkoxy%252529quinazoline%252BDerivatives.%252B1%25252C3%2525E2%252580%252589-O%252B%2525E2%252586%252592%252BN%252BShift%252Bof%252BChloroalkyl%252BGroups%252Bvia%252BCyclic%252B1%25252C3-Azaoxonium%252BIntermediates%26aulast%3DChen%26aufirst%3DGrace%2BShiahuy%26date%3D2003%26date%3D2003%26date%3D2002%26date%3D22%252008%25202002%2520Received%2520August%252022%252C%25202002%26volume%3D68%26issue%3D6%26spage%3D2502%26epage%3D2505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tao  Peng,,   Jianfeng  Pei, and,   <span class="NLM_string-name hlFld-ContribAuthor">Jiaju  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">3D-QSAR and Receptor Modeling of Tyrosine Kinase Inhibitors with Flexible Atom Receptor Model (FLARM). </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Computer Sciences</span><span> <strong>2003,</strong> <em>43 </em>
                                    (1)
                                     , 298-303. <a href="https://doi.org/10.1021/ci0256034" title="DOI URL">https://doi.org/10.1021/ci0256034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci0256034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci0256034%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Computer%2520Sciences%26atitle%3D3D-QSAR%252Band%252BReceptor%252BModeling%252Bof%252BTyrosine%252BKinase%252BInhibitors%252Bwith%252BFlexible%252BAtom%252BReceptor%252BModel%252B%252528FLARM%252529%26aulast%3DPeng%26aufirst%3DTao%26date%3D2003%26date%3D2002%26date%3D2002%26date%3D16%252009%25202002%2520Received%2520September%252016%252C%25202002%26volume%3D43%26issue%3D1%26spage%3D298%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Alexander J.  Bridges</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical Inhibitors of Protein Kinases. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2001,</strong> <em>101 </em>
                                    (8)
                                     , 2541-2572. <a href="https://doi.org/10.1021/cr000250y" title="DOI URL">https://doi.org/10.1021/cr000250y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr000250y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr000250y%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DChemical%252BInhibitors%252Bof%252BProtein%252BKinases%26aulast%3DBridges%26aufirst%3DAlexander%2BJ.%26date%3D2001%26date%3D2001%26date%3D2000%26date%3D30%252010%25202000%2520Received%2520October%252030%252C%25202000%26volume%3D101%26issue%3D8%26spage%3D2541%26epage%3D2572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Alka  Kurup,,   Rajni  Garg, and,   <span class="NLM_string-name hlFld-ContribAuthor">Corwin  Hansch</span>. </span><span class="cited-content_cbyCitation_article-title">Comparative QSAR Study of Tyrosine Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2001,</strong> <em>101 </em>
                                    (8)
                                     , 2573-2600. <a href="https://doi.org/10.1021/cr010154c" title="DOI URL">https://doi.org/10.1021/cr010154c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr010154c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr010154c%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DComparative%252BQSAR%252BStudy%252Bof%252BTyrosine%252BKinase%252BInhibitors%26aulast%3DKurup%26aufirst%3DAlka%26date%3D2001%26date%3D2001%26date%3D2001%26date%3D19%252004%25202001%2520Received%2520April%252019%252C%25202001%26volume%3D101%26issue%3D8%26spage%3D2573%26epage%3D2600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seyed-Omar  Zaraei</span>, <span class="hlFld-ContribAuthor ">Rawan M.  Sbenati</span>, <span class="hlFld-ContribAuthor ">Nour N.  Alach</span>, <span class="hlFld-ContribAuthor ">Hanan S.  Anbar</span>, <span class="hlFld-ContribAuthor ">Randa  El-Gamal</span>, <span class="hlFld-ContribAuthor ">Hamadeh  Tarazi</span>, <span class="hlFld-ContribAuthor ">Mahmoud K.  Shehata</span>, <span class="hlFld-ContribAuthor ">Mohammed S.  Abdel-Maksoud</span>, <span class="hlFld-ContribAuthor ">Chang-Hyun  Oh</span>, <span class="hlFld-ContribAuthor ">Mohammed I.  El-Gamal</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of first-in-class imidazothiazole-based potent and selective ErbB4 (HER4) kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>224 </em>, 113674. <a href="https://doi.org/10.1016/j.ejmech.2021.113674" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113674</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113674%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bfirst-in-class%252Bimidazothiazole-based%252Bpotent%252Band%252Bselective%252BErbB4%252B%252528HER4%252529%252Bkinase%252Binhibitors%26aulast%3DZaraei%26aufirst%3DSeyed-Omar%26date%3D2021%26volume%3D224%26spage%3D113674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaojuan  Qu</span>, <span class="hlFld-ContribAuthor ">Haixia  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaoling  Song</span>, <span class="hlFld-ContribAuthor ">Ning  Sun</span>, <span class="hlFld-ContribAuthor ">Hui  Zhong</span>, <span class="hlFld-ContribAuthor ">Xing  Qiu</span>, <span class="hlFld-ContribAuthor ">Xiaobao  Yang</span>, <span class="hlFld-ContribAuthor ">Biao  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Effective degradation of EGFRL858R+T790M mutant proteins by CRBN-based PROTACs through both proteosome and autophagy/lysosome degradation systems. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>218 </em>, 113328. <a href="https://doi.org/10.1016/j.ejmech.2021.113328" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113328</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113328%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEffective%252Bdegradation%252Bof%252BEGFRL858R%25252BT790M%252Bmutant%252Bproteins%252Bby%252BCRBN-based%252BPROTACs%252Bthrough%252Bboth%252Bproteosome%252Band%252Bautophagy%25252Flysosome%252Bdegradation%252Bsystems%26aulast%3DQu%26aufirst%3DXiaojuan%26date%3D2021%26volume%3D218%26spage%3D113328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Zhao</span>, <span class="hlFld-ContribAuthor ">Tingting  Fan</span>, <span class="hlFld-ContribAuthor ">Zhichao  Shi</span>, <span class="hlFld-ContribAuthor ">Chao  Ding</span>, <span class="hlFld-ContribAuthor ">Cunlong  Zhang</span>, <span class="hlFld-ContribAuthor ">Zigao  Yuan</span>, <span class="hlFld-ContribAuthor ">Qinsheng  Sun</span>, <span class="hlFld-ContribAuthor ">Chunyan  Tan</span>, <span class="hlFld-ContribAuthor ">Bizhu  Chu</span>, <span class="hlFld-ContribAuthor ">Yuyang  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of novel ErbB/HDAC multitargeted inhibitors with selectivity in EGFRT790M mutant cell lines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>213 </em>, 113173. <a href="https://doi.org/10.1016/j.ejmech.2021.113173" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113173</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113173%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bnovel%252BErbB%25252FHDAC%252Bmultitargeted%252Binhibitors%252Bwith%252Bselectivity%252Bin%252BEGFRT790M%252Bmutant%252Bcell%252Blines%26aulast%3DZhao%26aufirst%3DLei%26date%3D2021%26volume%3D213%26spage%3D113173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiqiang  Chen</span>, <span class="hlFld-ContribAuthor ">Mei  Liu</span>, <span class="hlFld-ContribAuthor ">Hui-Jing  Li</span>, <span class="hlFld-ContribAuthor ">Yan-Chao  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Switchable and efficient conversion of 2-amido-aryl oxazolines to quinazolin-4(3
              H
              )-ones and
              N
              -(2-chloroethyl)benzamides. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2021,</strong> <em>8 </em>
                                    (3)
                                     , 584-590. <a href="https://doi.org/10.1039/D0QO01368D" title="DOI URL">https://doi.org/10.1039/D0QO01368D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO01368D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO01368D%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DSwitchable%252Band%252Befficient%252Bconversion%252Bof%252B2-amido-aryl%252Boxazolines%252Bto%252Bquinazolin-4%2525283%252BH%252B%252529-ones%252Band%252BN%252B-%2525282-chloroethyl%252529benzamides%26aulast%3DChen%26aufirst%3DWeiqiang%26date%3D2021%26date%3D2021%26volume%3D8%26issue%3D3%26spage%3D584%26epage%3D590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Cao</span>, <span class="hlFld-ContribAuthor ">Michael L.  Martini</span>, <span class="hlFld-ContribAuthor ">Kwang-Su  Park</span>, <span class="hlFld-ContribAuthor ">H. Ümit  Kaniskan</span>, <span class="hlFld-ContribAuthor ">Jian  Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrimidines and Their Benzo Derivatives. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00041-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00041-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00041-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00041-X%26sid%3Dliteratum%253Aachs%26atitle%3DPyrimidines%252Band%252BTheir%252BBenzo%252BDerivatives%26aulast%3DCao%26aufirst%3DTao%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2021%26volume%3Dvol.%25206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Schröder</span>, <span class="hlFld-ContribAuthor ">Panagis  Filippakopoulos</span>, <span class="hlFld-ContribAuthor ">Martin P.  Schwalm</span>, <span class="hlFld-ContribAuthor ">Carla A.  Ferrer</span>, <span class="hlFld-ContribAuthor ">David H.  Drewry</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, <span class="hlFld-ContribAuthor ">Apirat  Chaikuad</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal Structure and Inhibitor Identifications Reveal Targeting Opportunity for the Atypical MAPK Kinase ERK3. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (21)
                                     , 7953. <a href="https://doi.org/10.3390/ijms21217953" title="DOI URL">https://doi.org/10.3390/ijms21217953</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21217953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21217953%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DCrystal%252BStructure%252Band%252BInhibitor%252BIdentifications%252BReveal%252BTargeting%252BOpportunity%252Bfor%252Bthe%252BAtypical%252BMAPK%252BKinase%252BERK3%26aulast%3DSchr%25C3%25B6der%26aufirst%3DMartin%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D21%26spage%3D7953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nourah A.  AL Zahrani</span>, <span class="hlFld-ContribAuthor ">Reda M.  El-Shishtawy</span>, <span class="hlFld-ContribAuthor ">Abdullah M.  Asiri</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments of gallic acid derivatives and their hybrids in medicinal chemistry: A review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>204 </em>, 112609. <a href="https://doi.org/10.1016/j.ejmech.2020.112609" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112609</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112609%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bdevelopments%252Bof%252Bgallic%252Bacid%252Bderivatives%252Band%252Btheir%252Bhybrids%252Bin%252Bmedicinal%252Bchemistry%25253A%252BA%252Breview%26aulast%3DAL%2BZahrani%26aufirst%3DNourah%2BA.%26date%3D2020%26volume%3D204%26spage%3D112609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Teresa  Żołek</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Trzeciak</span>, <span class="hlFld-ContribAuthor ">Dorota  Maciejewska</span>. </span><span class="cited-content_cbyCitation_article-title">Theoretical evaluation of EGFR kinase inhibition and toxicity of di-indol-3-yl disulphides with anti-cancer potency. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>13 </em>, 1-13. <a href="https://doi.org/10.1080/07391102.2020.1815576" title="DOI URL">https://doi.org/10.1080/07391102.2020.1815576</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1815576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1815576%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DTheoretical%252Bevaluation%252Bof%252BEGFR%252Bkinase%252Binhibition%252Band%252Btoxicity%252Bof%252Bdi-indol-3-yl%252Bdisulphides%252Bwith%252Banti-cancer%252Bpotency%26aulast%3D%25C5%25BBo%25C5%2582ek%26aufirst%3DTeresa%26date%3D2020%26date%3D2020%26volume%3D13%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Colin  Bournez</span>, <span class="hlFld-ContribAuthor ">Fabrice  Carles</span>, <span class="hlFld-ContribAuthor ">Gautier  Peyrat</span>, <span class="hlFld-ContribAuthor ">Samia  Aci-Sèche</span>, <span class="hlFld-ContribAuthor ">Stéphane  Bourg</span>, <span class="hlFld-ContribAuthor ">Christophe  Meyer</span>, <span class="hlFld-ContribAuthor ">Pascal  Bonnet</span>. </span><span class="cited-content_cbyCitation_article-title">Comparative Assessment of Protein Kinase Inhibitors in Public Databases and in PKIDB. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (14)
                                     , 3226. <a href="https://doi.org/10.3390/molecules25143226" title="DOI URL">https://doi.org/10.3390/molecules25143226</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25143226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25143226%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DComparative%252BAssessment%252Bof%252BProtein%252BKinase%252BInhibitors%252Bin%252BPublic%252BDatabases%252Band%252Bin%252BPKIDB%26aulast%3DBournez%26aufirst%3DColin%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D14%26spage%3D3226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lídia Moreira  Lima</span>, <span class="hlFld-ContribAuthor ">Maria Letícia  de Castro Barbosa</span>, <span class="hlFld-ContribAuthor ">Daniel Nascimento  do Amaral</span>, <span class="hlFld-ContribAuthor ">Eliezer J.  Barreiro</span>. </span><span class="cited-content_cbyCitation_article-title">Case Study on Receptor Tyrosine Kinases EGFR, VEGFR, and PDGFR. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 155-201. <a href="https://doi.org/10.1007/7355_2020_95" title="DOI URL">https://doi.org/10.1007/7355_2020_95</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2020_95&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2020_95%26sid%3Dliteratum%253Aachs%26atitle%3DCase%252BStudy%252Bon%252BReceptor%252BTyrosine%252BKinases%252BEGFR%25252C%252BVEGFR%25252C%252Band%252BPDGFR%26aulast%3DLima%26aufirst%3DL%25C3%25ADdia%2BMoreira%26date%3D2020%26date%3D2020%26spage%3D155%26epage%3D201%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DProteinkinase%252BInhibitors%26aulast%3DLaufer%26aufirst%3DStefan%26date%3D2021%26volume%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara  Ferluga</span>, <span class="hlFld-ContribAuthor ">Daniele  Baiz</span>, <span class="hlFld-ContribAuthor ">David A  Hilton</span>, <span class="hlFld-ContribAuthor ">Claire L  Adams</span>, <span class="hlFld-ContribAuthor ">Emanuela  Ercolano</span>, <span class="hlFld-ContribAuthor ">Jemma  Dunn</span>, <span class="hlFld-ContribAuthor ">Kayleigh  Bassiri</span>, <span class="hlFld-ContribAuthor ">Kathreena M  Kurian</span>, <span class="hlFld-ContribAuthor ">Clemens O  Hanemann</span>. </span><span class="cited-content_cbyCitation_article-title">Constitutive activation of the EGFR–STAT1 axis increases proliferation of meningioma tumor cells. </span><span class="cited-content_cbyCitation_journal-name">Neuro-Oncology Advances</span><span> <strong>2020,</strong> <em>2 </em>
                                    (1)
                                     <a href="https://doi.org/10.1093/noajnl/vdaa008" title="DOI URL">https://doi.org/10.1093/noajnl/vdaa008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/noajnl/vdaa008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnoajnl%2Fvdaa008%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuro-Oncology%2520Advances%26atitle%3DConstitutive%252Bactivation%252Bof%252Bthe%252BEGFR%2525E2%252580%252593STAT1%252Baxis%252Bincreases%252Bproliferation%252Bof%252Bmeningioma%252Btumor%252Bcells%26aulast%3DFerluga%26aufirst%3DSara%26date%3D2020%26date%3D2020%26volume%3D2%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N. A.  Seebacher</span>, <span class="hlFld-ContribAuthor ">A. E.  Stacy</span>, <span class="hlFld-ContribAuthor ">G. M.  Porter</span>, <span class="hlFld-ContribAuthor ">A. M.  Merlot</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical development of targeted and immune based anti-cancer therapies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Experimental & Clinical Cancer Research</span><span> <strong>2019,</strong> <em>38 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13046-019-1094-2" title="DOI URL">https://doi.org/10.1186/s13046-019-1094-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13046-019-1094-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13046-019-1094-2%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Experimental%2520%2526%2520Clinical%2520Cancer%2520Research%26atitle%3DClinical%252Bdevelopment%252Bof%252Btargeted%252Band%252Bimmune%252Bbased%252Banti-cancer%252Btherapies%26aulast%3DSeebacher%26aufirst%3DN.%2BA.%26date%3D2019%26date%3D2019%26volume%3D38%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Janakiraman  Subramanian</span>, <span class="hlFld-ContribAuthor ">Archana  Katta</span>, <span class="hlFld-ContribAuthor ">Ashiq  Masood</span>, <span class="hlFld-ContribAuthor ">Dashavantha Reddy  Vudem</span>, <span class="hlFld-ContribAuthor ">Rama Krishna  Kancha</span>. </span><span class="cited-content_cbyCitation_article-title">Emergence of
              ERBB2
              Mutation as a Biomarker and an Actionable Target in Solid Cancers. </span><span class="cited-content_cbyCitation_journal-name">The Oncologist</span><span> <strong>2019,</strong> <em>24 </em>
                                    (12)
                                     <a href="https://doi.org/10.1634/theoncologist.2018-0845" title="DOI URL">https://doi.org/10.1634/theoncologist.2018-0845</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1634/theoncologist.2018-0845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1634%2Ftheoncologist.2018-0845%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Oncologist%26atitle%3DEmergence%252Bof%252BERBB2%252BMutation%252Bas%252Ba%252BBiomarker%252Band%252Ban%252BActionable%252BTarget%252Bin%252BSolid%252BCancers%26aulast%3DSubramanian%26aufirst%3DJanakiraman%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amaia Eleonora  Maennling</span>, <span class="hlFld-ContribAuthor ">Mehmet Kemal  Tur</span>, <span class="hlFld-ContribAuthor ">Marcus  Niebert</span>, <span class="hlFld-ContribAuthor ">Torsten  Klockenbring</span>, <span class="hlFld-ContribAuthor ">Felix  Zeppernick</span>, <span class="hlFld-ContribAuthor ">Stefan  Gattenlöhner</span>, <span class="hlFld-ContribAuthor ">Ivo  Meinhold-Heerlein</span>, <span class="hlFld-ContribAuthor ">Ahmad Fawzi  Hussain</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Targeting Therapy against EGFR Family in Breast Cancer: Progress and Future Potentials. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (12)
                                     , 1826. <a href="https://doi.org/10.3390/cancers11121826" title="DOI URL">https://doi.org/10.3390/cancers11121826</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11121826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11121826%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DMolecular%252BTargeting%252BTherapy%252Bagainst%252BEGFR%252BFamily%252Bin%252BBreast%252BCancer%25253A%252BProgress%252Band%252BFuture%252BPotentials%26aulast%3DMaennling%26aufirst%3DAmaia%2BEleonora%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D12%26spage%3D1826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed H.  Hekal</span>, <span class="hlFld-ContribAuthor ">Fatma S. M.  Abu El-Azm</span>, <span class="hlFld-ContribAuthor ">Saad R.  Atta-Allah</span>. </span><span class="cited-content_cbyCitation_article-title">Ecofriendly and highly efficient microwave-induced synthesis of novel quinazolinone-undecyl hybrids with
              in vitro
              antitumor activity. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2019,</strong> <em>49 </em>
                                    (20)
                                     , 2630-2641. <a href="https://doi.org/10.1080/00397911.2019.1637001" title="DOI URL">https://doi.org/10.1080/00397911.2019.1637001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2019.1637001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2019.1637001%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DEcofriendly%252Band%252Bhighly%252Befficient%252Bmicrowave-induced%252Bsynthesis%252Bof%252Bnovel%252Bquinazolinone-undecyl%252Bhybrids%252Bwith%252Bin%252Bvitro%252Bantitumor%252Bactivity%26aulast%3DHekal%26aufirst%3DMohamed%2BH.%26date%3D2019%26date%3D2019%26volume%3D49%26issue%3D20%26spage%3D2630%26epage%3D2641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed A.  Sabry</span>, <span class="hlFld-ContribAuthor ">Heba A.  Ewida</span>, <span class="hlFld-ContribAuthor ">Ghada S.  Hassan</span>, <span class="hlFld-ContribAuthor ">Mariam A.  Ghaly</span>, <span class="hlFld-ContribAuthor ">Hussein I.  El-Subbagh</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, antitumor testing and molecular modeling study of some new 6-substituted amido, azo or thioureido-quinazolin-4(3H)-ones. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>88 </em>, 102923. <a href="https://doi.org/10.1016/j.bioorg.2019.102923" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.102923</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.102923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.102923%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%25252C%252Bantitumor%252Btesting%252Band%252Bmolecular%252Bmodeling%252Bstudy%252Bof%252Bsome%252Bnew%252B6-substituted%252Bamido%25252C%252Bazo%252Bor%252Bthioureido-quinazolin-4%2525283H%252529-ones%26aulast%3DSabry%26aufirst%3DMohamed%2BA.%26date%3D2019%26volume%3D88%26spage%3D102923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Debasis  Das</span>, <span class="hlFld-ContribAuthor ">Jian  Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advancements of 4-aminoquinazoline derivatives as kinase inhibitors and their applications in medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>170 </em>, 55-72. <a href="https://doi.org/10.1016/j.ejmech.2019.03.004" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.03.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.03.004%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvancements%252Bof%252B4-aminoquinazoline%252Bderivatives%252Bas%252Bkinase%252Binhibitors%252Band%252Btheir%252Bapplications%252Bin%252Bmedicinal%252Bchemistry%26aulast%3DDas%26aufirst%3DDebasis%26date%3D2019%26volume%3D170%26spage%3D55%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cuiping  Guo</span>, <span class="hlFld-ContribAuthor ">Yu  Chang</span>, <span class="hlFld-ContribAuthor ">Xin  Wang</span>, <span class="hlFld-ContribAuthor ">Chengqian  Zhang</span>, <span class="hlFld-ContribAuthor ">Piliang  Hao</span>, <span class="hlFld-ContribAuthor ">Ke  Ding</span>, <span class="hlFld-ContribAuthor ">Zhengqiu  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Minimalist linkers suitable for irreversible inhibitors in simultaneous proteome profiling, live-cell imaging and drug screening. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2019,</strong> <em>55 </em>
                                    (6)
                                     , 834-837. <a href="https://doi.org/10.1039/C8CC08685K" title="DOI URL">https://doi.org/10.1039/C8CC08685K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8CC08685K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8CC08685K%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DMinimalist%252Blinkers%252Bsuitable%252Bfor%252Birreversible%252Binhibitors%252Bin%252Bsimultaneous%252Bproteome%252Bprofiling%25252C%252Blive-cell%252Bimaging%252Band%252Bdrug%252Bscreening%26aulast%3DGuo%26aufirst%3DCuiping%26date%3D2019%26date%3D2019%26volume%3D55%26issue%3D6%26spage%3D834%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lixue  Chen</span>, <span class="hlFld-ContribAuthor ">Fuyun  Chi</span>, <span class="hlFld-ContribAuthor ">Tong  Wang</span>, <span class="hlFld-ContribAuthor ">Ning  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Kexin  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Shu</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>, <span class="hlFld-ContribAuthor ">Youjun  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">The synthesis of 4-arylamido-2-arylaminoprimidines as potent EGFR T790M/L858R inhibitors for NSCLC. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (23-24)
                                     , 6087-6095. <a href="https://doi.org/10.1016/j.bmc.2018.11.009" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.11.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.11.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bsynthesis%252Bof%252B4-arylamido-2-arylaminoprimidines%252Bas%252Bpotent%252BEGFR%252BT790M%25252FL858R%252Binhibitors%252Bfor%252BNSCLC%26aulast%3DChen%26aufirst%3DLixue%26date%3D2018%26volume%3D26%26issue%3D23-24%26spage%3D6087%26epage%3D6095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoyun  Lu</span>, <span class="hlFld-ContribAuthor ">Lei  Yu</span>, <span class="hlFld-ContribAuthor ">Zhang  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaomei  Ren</span>, <span class="hlFld-ContribAuthor ">Jeff B.  Smaill</span>, <span class="hlFld-ContribAuthor ">Ke  Ding</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting EGFR
              L858R/T790M
              and EGFR
              L858R/T790M/C797S
              resistance mutations in NSCLC: Current developments in medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2018,</strong> <em>38 </em>
                                    (5)
                                     , 1550-1581. <a href="https://doi.org/10.1002/med.21488" title="DOI URL">https://doi.org/10.1002/med.21488</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21488%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DTargeting%252BEGFR%252BL858R%25252FT790M%252Band%252BEGFR%252BL858R%25252FT790M%25252FC797S%252Bresistance%252Bmutations%252Bin%252BNSCLC%25253A%252BCurrent%252Bdevelopments%252Bin%252Bmedicinal%252Bchemistry%26aulast%3DLu%26aufirst%3DXiaoyun%26date%3D2018%26date%3D2018%26volume%3D38%26issue%3D5%26spage%3D1550%26epage%3D1581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zrinka  Rajić</span>, <span class="hlFld-ContribAuthor ">Maja  Beus</span>, <span class="hlFld-ContribAuthor ">Hana  Michnová</span>, <span class="hlFld-ContribAuthor ">Josipa  Vlainić</span>, <span class="hlFld-ContribAuthor ">Leentje  Persoons</span>, <span class="hlFld-ContribAuthor ">Ivan  Kosalec</span>, <span class="hlFld-ContribAuthor ">Josef  Jampílek</span>, <span class="hlFld-ContribAuthor ">Dominique  Schols</span>, <span class="hlFld-ContribAuthor ">Toma  Keser</span>, <span class="hlFld-ContribAuthor ">Branka  Zorc</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetric Primaquine and Halogenaniline Fumardiamides as Novel Biologically Active Michael Acceptors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (7)
                                     , 1724. <a href="https://doi.org/10.3390/molecules23071724" title="DOI URL">https://doi.org/10.3390/molecules23071724</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23071724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23071724%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DAsymmetric%252BPrimaquine%252Band%252BHalogenaniline%252BFumardiamides%252Bas%252BNovel%252BBiologically%252BActive%252BMichael%252BAcceptors%26aulast%3DRaji%25C4%2587%26aufirst%3DZrinka%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D7%26spage%3D1724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael J.  Waring</span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery of Osimertinib (TAGRISSO™): An Irreversible Inhibitor of Activating and T790M Resistant Forms of the Epidermal Growth Factor Receptor Tyrosine Kinase for the Treatment of Non-Small Cell Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 341-357. <a href="https://doi.org/10.1002/9783527808694.ch12" title="DOI URL">https://doi.org/10.1002/9783527808694.ch12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527808694.ch12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527808694.ch12%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDiscovery%252Bof%252BOsimertinib%252B%252528TAGRISSO%2525E2%252584%2525A2%252529%25253A%252BAn%252BIrreversible%252BInhibitor%252Bof%252BActivating%252Band%252BT790M%252BResistant%252BForms%252Bof%252Bthe%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BTyrosine%252BKinase%252Bfor%252Bthe%252BTreatment%252Bof%252BNon-Small%252BCell%252BLung%252BCancer%26aulast%3DWaring%26aufirst%3DMichael%2BJ.%26date%3D2018%26date%3D2018%26spage%3D341%26epage%3D357%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DSuccessful%252BDrug%252BDiscovery%26aulast%3DFischer%26aufirst%3DJ%25C3%25A1nos%26date%3D2018%26volume%3D378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Apirat  Chaikuad</span>, <span class="hlFld-ContribAuthor ">Pierre  Koch</span>, <span class="hlFld-ContribAuthor ">Stefan A.  Laufer</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>. </span><span class="cited-content_cbyCitation_article-title">Das Cysteinom der Proteinkinasen als Zielstruktur in der Arzneistoffentwicklung. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2018,</strong> <em>130 </em>
                                    (16)
                                     , 4456-4470. <a href="https://doi.org/10.1002/ange.201707875" title="DOI URL">https://doi.org/10.1002/ange.201707875</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201707875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201707875%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DDas%252BCysteinom%252Bder%252BProteinkinasen%252Bals%252BZielstruktur%252Bin%252Bder%252BArzneistoffentwicklung%26aulast%3DChaikuad%26aufirst%3DApirat%26date%3D2018%26date%3D2018%26volume%3D130%26issue%3D16%26spage%3D4456%26epage%3D4470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Apirat  Chaikuad</span>, <span class="hlFld-ContribAuthor ">Pierre  Koch</span>, <span class="hlFld-ContribAuthor ">Stefan A.  Laufer</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>. </span><span class="cited-content_cbyCitation_article-title">The Cysteinome of Protein Kinases as a Target in Drug Development. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2018,</strong> <em>57 </em>
                                    (16)
                                     , 4372-4385. <a href="https://doi.org/10.1002/anie.201707875" title="DOI URL">https://doi.org/10.1002/anie.201707875</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201707875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201707875%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DThe%252BCysteinome%252Bof%252BProtein%252BKinases%252Bas%252Ba%252BTarget%252Bin%252BDrug%252BDevelopment%26aulast%3DChaikuad%26aufirst%3DApirat%26date%3D2018%26date%3D2018%26volume%3D57%26issue%3D16%26spage%3D4372%26epage%3D4385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fusheng  Zhou</span>, <span class="hlFld-ContribAuthor ">Liang  Zhang</span>, <span class="hlFld-ContribAuthor ">Yunzhou  Jin</span>, <span class="hlFld-ContribAuthor ">Wei  Liu</span>, <span class="hlFld-ContribAuthor ">Pengfei  Cheng</span>, <span class="hlFld-ContribAuthor ">Xiangyu  He</span>, <span class="hlFld-ContribAuthor ">Jing  Xie</span>, <span class="hlFld-ContribAuthor ">Sida  Shen</span>, <span class="hlFld-ContribAuthor ">Jing  Lei</span>, <span class="hlFld-ContribAuthor ">Haixia  Ji</span>, <span class="hlFld-ContribAuthor ">Yi  Hu</span>, <span class="hlFld-ContribAuthor ">Yingtao  Liu</span>, <span class="hlFld-ContribAuthor ">Yumin  Cui</span>, <span class="hlFld-ContribAuthor ">Qiang  Lv</span>, <span class="hlFld-ContribAuthor ">Jiong  Lan</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N -aryl- N ′-pyrimidin-4-yl ureas as irreversible L858R/T790M mutant selective epidermal growth factor receptor inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (7)
                                     , 1257-1261. <a href="https://doi.org/10.1016/j.bmcl.2017.12.009" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.12.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.12.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BN%252B-aryl-%252BN%252B%2525E2%252580%2525B2-pyrimidin-4-yl%252Bureas%252Bas%252Birreversible%252BL858R%25252FT790M%252Bmutant%252Bselective%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor%252Binhibitors%26aulast%3DZhou%26aufirst%3DFusheng%26date%3D2018%26volume%3D28%26issue%3D7%26spage%3D1257%26epage%3D1261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samir Y.  Abbas</span>, <span class="hlFld-ContribAuthor ">Khairy A. M.  El-Bayouki</span>, <span class="hlFld-ContribAuthor ">Wahid M.  Basyouni</span>, <span class="hlFld-ContribAuthor ">Eslam A.  Mostafa</span>. </span><span class="cited-content_cbyCitation_article-title">New series of 4(3H)-quinazolinone derivatives: syntheses and evaluation of antitumor and antiviral activities. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2018,</strong> <em>27 </em>
                                    (2)
                                     , 571-582. <a href="https://doi.org/10.1007/s00044-017-2083-7" title="DOI URL">https://doi.org/10.1007/s00044-017-2083-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-017-2083-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-017-2083-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DNew%252Bseries%252Bof%252B4%2525283H%252529-quinazolinone%252Bderivatives%25253A%252Bsyntheses%252Band%252Bevaluation%252Bof%252Bantitumor%252Band%252Bantiviral%252Bactivities%26aulast%3DAbbas%26aufirst%3DSamir%2BY.%26date%3D2018%26date%3D2017%26volume%3D27%26issue%3D2%26spage%3D571%26epage%3D582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keuk Chan  Bang</span>, <span class="hlFld-ContribAuthor ">Tae Hun  Song</span>, <span class="hlFld-ContribAuthor ">Young Jin  Park</span>, <span class="hlFld-ContribAuthor ">Jong Soo  Lee</span>, <span class="hlFld-ContribAuthor ">Seungah  Jun</span>, <span class="hlFld-ContribAuthor ">Seung Hyun  Jung</span>, <span class="hlFld-ContribAuthor ">Young-Jin  Chun</span>, <span class="hlFld-ContribAuthor ">Ha Hyung  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 4-Anilinoquinazoline-Derivative Dual Kinase Inhibitors Targeting EGFR and VEGFR-2. </span><span class="cited-content_cbyCitation_journal-name">Bulletin of the Korean Chemical Society</span><span> <strong>2018,</strong> <em>39 </em>
                                    (1)
                                     , 123-125. <a href="https://doi.org/10.1002/bkcs.11348" title="DOI URL">https://doi.org/10.1002/bkcs.11348</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bkcs.11348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbkcs.11348%26sid%3Dliteratum%253Aachs%26jtitle%3DBulletin%2520of%2520the%2520Korean%2520Chemical%2520Society%26atitle%3DSynthesis%252Bof%252B4-Anilinoquinazoline-Derivative%252BDual%252BKinase%252BInhibitors%252BTargeting%252BEGFR%252Band%252BVEGFR-2%26aulast%3DBang%26aufirst%3DKeuk%2BChan%26date%3D2018%26date%3D2017%26volume%3D39%26issue%3D1%26spage%3D123%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian-Quan  Liu</span>, <span class="hlFld-ContribAuthor ">Fang  Dong</span>, <span class="hlFld-ContribAuthor ">Wen-Ting  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiang-Shan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient synthesis of quinazoline or pyrrolo[1,2-a]quinazolin-5(1H)-one derivatives in ionic liquids catalyzed by iodine. </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2017,</strong> <em>43 </em>
                                    (12)
                                     , 6787-6801. <a href="https://doi.org/10.1007/s11164-017-3020-6" title="DOI URL">https://doi.org/10.1007/s11164-017-3020-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-017-3020-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-017-3020-6%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DAn%252Befficient%252Bsynthesis%252Bof%252Bquinazoline%252Bor%252Bpyrrolo%25255B1%25252C2-a%25255Dquinazolin-5%2525281H%252529-one%252Bderivatives%252Bin%252Bionic%252Bliquids%252Bcatalyzed%252Bby%252Biodine%26aulast%3DLiu%26aufirst%3DJian-Quan%26date%3D2017%26date%3D2017%26volume%3D43%26issue%3D12%26spage%3D6787%26epage%3D6801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefanie  Taute</span>, <span class="hlFld-ContribAuthor ">Herbert J.  Pfister</span>, <span class="hlFld-ContribAuthor ">Gertrud  Steger</span>. </span><span class="cited-content_cbyCitation_article-title">Induction of Tyrosine Phosphorylation of UV-Activated EGFR by the Beta-Human Papillomavirus Type 8 E6 Leads to Papillomatosis. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Microbiology</span><span> <strong>2017,</strong> <em>8 </em><a href="https://doi.org/10.3389/fmicb.2017.02197" title="DOI URL">https://doi.org/10.3389/fmicb.2017.02197</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmicb.2017.02197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmicb.2017.02197%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Microbiology%26atitle%3DInduction%252Bof%252BTyrosine%252BPhosphorylation%252Bof%252BUV-Activated%252BEGFR%252Bby%252Bthe%252BBeta-Human%252BPapillomavirus%252BType%252B8%252BE6%252BLeads%252Bto%252BPapillomatosis%26aulast%3DTaute%26aufirst%3DStefanie%26date%3D2017%26date%3D2017%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Plano</span>, <span class="hlFld-ContribAuthor ">Verónica  Alcolea</span>, <span class="hlFld-ContribAuthor ">Carmen  Sanmartín</span>, <span class="hlFld-ContribAuthor ">Arun K.  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Methods of selecting combination therapy for colorectal cancer patients: a patent evaluation of US20160025730A1. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2017,</strong> <em>27 </em>
                                    (5)
                                     , 527-538. <a href="https://doi.org/10.1080/13543776.2017.1315103" title="DOI URL">https://doi.org/10.1080/13543776.2017.1315103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2017.1315103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2017.1315103%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DMethods%252Bof%252Bselecting%252Bcombination%252Btherapy%252Bfor%252Bcolorectal%252Bcancer%252Bpatients%25253A%252Ba%252Bpatent%252Bevaluation%252Bof%252BUS20160025730A1%26aulast%3DPlano%26aufirst%3DDaniel%26date%3D2017%26date%3D2017%26volume%3D27%26issue%3D5%26spage%3D527%26epage%3D538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chen  Hu</span>, <span class="hlFld-ContribAuthor ">Aoli  Wang</span>, <span class="hlFld-ContribAuthor ">Hong  Wu</span>, <span class="hlFld-ContribAuthor ">Ziping  Qi</span>, <span class="hlFld-ContribAuthor ">Xixiang  Li</span>, <span class="hlFld-ContribAuthor ">Xiao-E  Yan</span>, <span class="hlFld-ContribAuthor ">Cheng  Chen</span>, <span class="hlFld-ContribAuthor ">Kailin  Yu</span>, <span class="hlFld-ContribAuthor ">Fengming  Zou</span>, <span class="hlFld-ContribAuthor ">Wenchao  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Jiaxin  Wu</span>, <span class="hlFld-ContribAuthor ">Juan  Liu</span>, <span class="hlFld-ContribAuthor ">Beilei  Wang</span>, <span class="hlFld-ContribAuthor ">Li  Wang</span>, <span class="hlFld-ContribAuthor ">Tao  Ren</span>, <span class="hlFld-ContribAuthor ">Shanchun  Zhang</span>, <span class="hlFld-ContribAuthor ">Cai-Hong  Yun</span>, <span class="hlFld-ContribAuthor ">Jing  Liu</span>, <span class="hlFld-ContribAuthor ">Qingsong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and characterization of a novel irreversible EGFR mutants selective and potent kinase inhibitor CHMFL-EGFR-26 with a distinct binding mode. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (11)
                                     , 18359-18372. <a href="https://doi.org/10.18632/oncotarget.15443" title="DOI URL">https://doi.org/10.18632/oncotarget.15443</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.15443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.15443%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DDiscovery%252Band%252Bcharacterization%252Bof%252Ba%252Bnovel%252Birreversible%252BEGFR%252Bmutants%252Bselective%252Band%252Bpotent%252Bkinase%252Binhibitor%252BCHMFL-EGFR-26%252Bwith%252Ba%252Bdistinct%252Bbinding%252Bmode%26aulast%3DHu%26aufirst%3DChen%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D11%26spage%3D18359%26epage%3D18372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P. K.  Singh</span>, <span class="hlFld-ContribAuthor ">O.  Silakari</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular dynamics and pharmacophore modelling studies of different subtype (ALK and EGFR (T790M)) inhibitors in NSCLC. </span><span class="cited-content_cbyCitation_journal-name">SAR and QSAR in Environmental Research</span><span> <strong>2017,</strong> <em>28 </em>
                                    (3)
                                     , 221-233. <a href="https://doi.org/10.1080/1062936X.2017.1300189" title="DOI URL">https://doi.org/10.1080/1062936X.2017.1300189</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1062936X.2017.1300189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1062936X.2017.1300189%26sid%3Dliteratum%253Aachs%26jtitle%3DSAR%2520and%2520QSAR%2520in%2520Environmental%2520Research%26atitle%3DMolecular%252Bdynamics%252Band%252Bpharmacophore%252Bmodelling%252Bstudies%252Bof%252Bdifferent%252Bsubtype%252B%252528ALK%252Band%252BEGFR%252B%252528T790M%252529%252529%252Binhibitors%252Bin%252BNSCLC%26aulast%3DSingh%26aufirst%3DP.%2BK.%26date%3D2017%26date%3D2017%26volume%3D28%26issue%3D3%26spage%3D221%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M. Raymond V.  Finlay</span>, <span class="hlFld-ContribAuthor ">Richard A.  Ward</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecule Inhibitors of the Epidermal Growth Factor Receptor. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 39-39. <a href="https://doi.org/10.1007/7355_2016_26" title="DOI URL">https://doi.org/10.1007/7355_2016_26</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2016_26&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2016_26%26sid%3Dliteratum%253Aachs%26atitle%3DSmall%252BMolecule%252BInhibitors%252Bof%252Bthe%252BEpidermal%252BGrowth%252BFactor%252BReceptor%26aulast%3DFinlay%26aufirst%3DM.%2BRaymond%2BV.%26date%3D2017%26spage%3D39%26epage%3D39%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DCancer%252BII%26aulast%3DWaring%26aufirst%3DMichael%2BJ.%26date%3D2018%26volume%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.A.  Mortlock</span>, <span class="hlFld-ContribAuthor ">D.M.  Wilson</span>, <span class="hlFld-ContribAuthor ">J.G.  Kettle</span>, <span class="hlFld-ContribAuthor ">F.W.  Goldberg</span>, <span class="hlFld-ContribAuthor ">K.M.  Foote</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Kinase Inhibitors in Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 39-75. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12391-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12391-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12391-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12391-1%26sid%3Dliteratum%253Aachs%26atitle%3DSelective%252BKinase%252BInhibitors%252Bin%252BCancer%26aulast%3DMortlock%26aufirst%3DA.A.%26date%3D2017%26spage%3D39%26epage%3D75%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elena  Lenci</span>, <span class="hlFld-ContribAuthor ">Alessio  Rossi</span>, <span class="hlFld-ContribAuthor ">Gloria  Menchi</span>, <span class="hlFld-ContribAuthor ">Andrea  Trabocchi</span>. </span><span class="cited-content_cbyCitation_article-title">Short synthesis of polyfunctional sp
              3
              -rich threonine-derived morpholine scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2017,</strong> <em>15 </em>
                                    (45)
                                     , 9710-9717. <a href="https://doi.org/10.1039/C7OB02454A" title="DOI URL">https://doi.org/10.1039/C7OB02454A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7OB02454A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7OB02454A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DShort%252Bsynthesis%252Bof%252Bpolyfunctional%252Bsp%252B3%252B-rich%252Bthreonine-derived%252Bmorpholine%252Bscaffolds%26aulast%3DLenci%26aufirst%3DElena%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D45%26spage%3D9710%26epage%3D9717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dhrubajyoti  Gogoi</span>, <span class="hlFld-ContribAuthor ">Vishwa Jyoti  Baruah</span>, <span class="hlFld-ContribAuthor ">Amrita Kashyap  Chaliha</span>, <span class="hlFld-ContribAuthor ">Bibhuti Bhushan  Kakoti</span>, <span class="hlFld-ContribAuthor ">Diganta  Sarma</span>, <span class="hlFld-ContribAuthor ">Alak Kumar  Buragohain</span>. </span><span class="cited-content_cbyCitation_article-title">3D pharmacophore-based virtual screening, docking and density functional theory approach towards the discovery of novel human epidermal growth factor receptor-2 (HER2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Theoretical Biology</span><span> <strong>2016,</strong> <em>411 </em>, 68-80. <a href="https://doi.org/10.1016/j.jtbi.2016.09.016" title="DOI URL">https://doi.org/10.1016/j.jtbi.2016.09.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jtbi.2016.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jtbi.2016.09.016%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Theoretical%2520Biology%26atitle%3D3D%252Bpharmacophore-based%252Bvirtual%252Bscreening%25252C%252Bdocking%252Band%252Bdensity%252Bfunctional%252Btheory%252Bapproach%252Btowards%252Bthe%252Bdiscovery%252Bof%252Bnovel%252Bhuman%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor-2%252B%252528HER2%252529%252Binhibitors%26aulast%3DGogoi%26aufirst%3DDhrubajyoti%26date%3D2016%26volume%3D411%26spage%3D68%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shirish  Paranjpe</span>, <span class="hlFld-ContribAuthor ">William C.  Bowen</span>, <span class="hlFld-ContribAuthor ">Wendy M.  Mars</span>, <span class="hlFld-ContribAuthor ">Anne  Orr</span>, <span class="hlFld-ContribAuthor ">Meagan M.  Haynes</span>, <span class="hlFld-ContribAuthor ">Marie C.  DeFrances</span>, <span class="hlFld-ContribAuthor ">Silvia  Liu</span>, <span class="hlFld-ContribAuthor ">George C.  Tseng</span>, <span class="hlFld-ContribAuthor ">Anastasia  Tsagianni</span>, <span class="hlFld-ContribAuthor ">George K.  Michalopoulos</span>. </span><span class="cited-content_cbyCitation_article-title">Combined systemic elimination of MET and epidermal growth factor receptor signaling completely abolishes liver regeneration and leads to liver decompensation. </span><span class="cited-content_cbyCitation_journal-name">Hepatology</span><span> <strong>2016,</strong> <em>64 </em>
                                    (5)
                                     , 1711-1724. <a href="https://doi.org/10.1002/hep.28721" title="DOI URL">https://doi.org/10.1002/hep.28721</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/hep.28721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fhep.28721%26sid%3Dliteratum%253Aachs%26jtitle%3DHepatology%26atitle%3DCombined%252Bsystemic%252Belimination%252Bof%252BMET%252Band%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor%252Bsignaling%252Bcompletely%252Babolishes%252Bliver%252Bregeneration%252Band%252Bleads%252Bto%252Bliver%252Bdecompensation%26aulast%3DParanjpe%26aufirst%3DShirish%26date%3D2016%26date%3D2016%26volume%3D64%26issue%3D5%26spage%3D1711%26epage%3D1724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas A.  Baillie</span>. </span><span class="cited-content_cbyCitation_article-title">Zielgerichtete kovalente Inhibitoren für das Wirkstoffdesign. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2016,</strong> <em>128 </em>
                                    (43)
                                     , 13606-13619. <a href="https://doi.org/10.1002/ange.201601091" title="DOI URL">https://doi.org/10.1002/ange.201601091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201601091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201601091%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DZielgerichtete%252Bkovalente%252BInhibitoren%252Bf%2525C3%2525BCr%252Bdas%252BWirkstoffdesign%26aulast%3DBaillie%26aufirst%3DThomas%2BA.%26date%3D2016%26date%3D2016%26volume%3D128%26issue%3D43%26spage%3D13606%26epage%3D13619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas A.  Baillie</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Covalent Inhibitors for Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2016,</strong> <em>55 </em>
                                    (43)
                                     , 13408-13421. <a href="https://doi.org/10.1002/anie.201601091" title="DOI URL">https://doi.org/10.1002/anie.201601091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201601091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201601091%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DTargeted%252BCovalent%252BInhibitors%252Bfor%252BDrug%252BDesign%26aulast%3DBaillie%26aufirst%3DThomas%2BA.%26date%3D2016%26date%3D2016%26volume%3D55%26issue%3D43%26spage%3D13408%26epage%3D13421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monia  Hossam</span>, <span class="hlFld-ContribAuthor ">Deena S.  Lasheen</span>, <span class="hlFld-ContribAuthor ">Khaled A. M.  Abouzid</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent EGFR Inhibitors: Binding Mechanisms, Synthetic Approaches, and Clinical Profiles. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2016,</strong> <em>349 </em>
                                    (8)
                                     , 573-593. <a href="https://doi.org/10.1002/ardp.201600063" title="DOI URL">https://doi.org/10.1002/ardp.201600063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201600063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201600063%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DCovalent%252BEGFR%252BInhibitors%25253A%252BBinding%252BMechanisms%25252C%252BSynthetic%252BApproaches%25252C%252Band%252BClinical%252BProfiles%26aulast%3DHossam%26aufirst%3DMonia%26date%3D2016%26date%3D2016%26volume%3D349%26issue%3D8%26spage%3D573%26epage%3D593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pieter J.  Klein</span>, <span class="hlFld-ContribAuthor ">Marion  Chomet</span>, <span class="hlFld-ContribAuthor ">Athanasios  Metaxas</span>, <span class="hlFld-ContribAuthor ">Johannes A.M.  Christiaans</span>, <span class="hlFld-ContribAuthor ">Esther  Kooijman</span>, <span class="hlFld-ContribAuthor ">Robert C.  Schuit</span>, <span class="hlFld-ContribAuthor ">Adriaan A.  Lammertsma</span>, <span class="hlFld-ContribAuthor ">Bart N.M.  van Berckel</span>, <span class="hlFld-ContribAuthor ">Albert D.  Windhorst</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, radiolabeling and evaluation of novel amine guanidine derivatives as potential positron emission tomography tracers for the ion channel of the N-methyl-d-aspartate receptor. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>118 </em>, 143-160. <a href="https://doi.org/10.1016/j.ejmech.2016.04.022" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.04.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.04.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.04.022%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bradiolabeling%252Band%252Bevaluation%252Bof%252Bnovel%252Bamine%252Bguanidine%252Bderivatives%252Bas%252Bpotential%252Bpositron%252Bemission%252Btomography%252Btracers%252Bfor%252Bthe%252Bion%252Bchannel%252Bof%252Bthe%252BN-methyl-d-aspartate%252Breceptor%26aulast%3DKlein%26aufirst%3DPieter%2BJ.%26date%3D2016%26volume%3D118%26spage%3D143%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C.  Zambaldo</span>, <span class="hlFld-ContribAuthor ">J.-P.  Daguer</span>, <span class="hlFld-ContribAuthor ">J.  Saarbach</span>, <span class="hlFld-ContribAuthor ">S.  Barluenga</span>, <span class="hlFld-ContribAuthor ">N.  Winssinger</span>. </span><span class="cited-content_cbyCitation_article-title">Screening for covalent inhibitors using DNA-display of small molecule libraries functionalized with cysteine reactive moieties. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2016,</strong> <em>7 </em>
                                    (7)
                                     , 1340-1351. <a href="https://doi.org/10.1039/C6MD00242K" title="DOI URL">https://doi.org/10.1039/C6MD00242K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00242K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00242K%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DScreening%252Bfor%252Bcovalent%252Binhibitors%252Busing%252BDNA-display%252Bof%252Bsmall%252Bmolecule%252Blibraries%252Bfunctionalized%252Bwith%252Bcysteine%252Breactive%252Bmoieties%26aulast%3DZambaldo%26aufirst%3DC.%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D7%26spage%3D1340%26epage%3D1351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lumbini R.  Yadav</span>, <span class="hlFld-ContribAuthor ">Pankaj  Thapa</span>, <span class="hlFld-ContribAuthor ">Lipi  Das</span>, <span class="hlFld-ContribAuthor ">Ashok K.  Varma</span>. </span><span class="cited-content_cbyCitation_article-title">Structureomics in Systems-Based Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 33-51. <a href="https://doi.org/10.1007/978-81-322-2809-7_4" title="DOI URL">https://doi.org/10.1007/978-81-322-2809-7_4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-81-322-2809-7_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-81-322-2809-7_4%26sid%3Dliteratum%253Aachs%26atitle%3DStructureomics%252Bin%252BSystems-Based%252BDrug%252BDiscovery%26aulast%3DYadav%26aufirst%3DLumbini%2BR.%26date%3D2016%26date%3D2016%26spage%3D33%26epage%3D51%26pub%3DSpringer%2520India%26atitle%3DSystems%252BBiology%252BApplication%252Bin%252BSynthetic%252BBiology%26aulast%3DSingh%26aufirst%3DShailza%26date%3D2016%26volume%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sai-Jie  Zuo</span>, <span class="hlFld-ContribAuthor ">Sai  Zhang</span>, <span class="hlFld-ContribAuthor ">Shuai  Mao</span>, <span class="hlFld-ContribAuthor ">Xiao-Xiao  Xie</span>, <span class="hlFld-ContribAuthor ">Xue  Xiao</span>, <span class="hlFld-ContribAuthor ">Min-Hnag  Xin</span>, <span class="hlFld-ContribAuthor ">Wei  Xuan</span>, <span class="hlFld-ContribAuthor ">Yuan-Yuan  He</span>, <span class="hlFld-ContribAuthor ">Yong-Xiao  Cao</span>, <span class="hlFld-ContribAuthor ">San-Qi  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Combination of 4-anilinoquinazoline, arylurea and tertiary amine moiety to discover novel anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (2)
                                     , 179-190. <a href="https://doi.org/10.1016/j.bmc.2015.12.001" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.12.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.12.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DCombination%252Bof%252B4-anilinoquinazoline%25252C%252Barylurea%252Band%252Btertiary%252Bamine%252Bmoiety%252Bto%252Bdiscover%252Bnovel%252Banticancer%252Bagents%26aulast%3DZuo%26aufirst%3DSai-Jie%26date%3D2016%26volume%3D24%26issue%3D2%26spage%3D179%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yaning  Su</span>, <span class="hlFld-ContribAuthor ">Li  Li</span>, <span class="hlFld-ContribAuthor ">Haibin  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaochen  Wang</span>, <span class="hlFld-ContribAuthor ">Zhiyuan  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">All-in-One azides: empowered click reaction for in vivo labeling and imaging of biomolecules. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2016,</strong> <em>52 </em>
                                    (10)
                                     , 2185-2188. <a href="https://doi.org/10.1039/C5CC08466K" title="DOI URL">https://doi.org/10.1039/C5CC08466K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5CC08466K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5CC08466K%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DAll-in-One%252Bazides%25253A%252Bempowered%252Bclick%252Breaction%252Bfor%252Bin%252Bvivo%252Blabeling%252Band%252Bimaging%252Bof%252Bbiomolecules%26aulast%3DSu%26aufirst%3DYaning%26date%3D2016%26date%3D2016%26volume%3D52%26issue%3D10%26spage%3D2185%26epage%3D2188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuliana  Yosaatmadja</span>, <span class="hlFld-ContribAuthor ">Shevan  Silva</span>, <span class="hlFld-ContribAuthor ">James M.  Dickson</span>, <span class="hlFld-ContribAuthor ">Adam V.  Patterson</span>, <span class="hlFld-ContribAuthor ">Jeff B.  Smaill</span>, <span class="hlFld-ContribAuthor ">Jack U.  Flanagan</span>, <span class="hlFld-ContribAuthor ">Mark J.  McKeage</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Squire</span>. </span><span class="cited-content_cbyCitation_article-title">Binding mode of the breakthrough inhibitor AZD9291 to epidermal growth factor receptor revealed. </span><span class="cited-content_cbyCitation_journal-name">Journal of Structural Biology</span><span> <strong>2015,</strong> <em>192 </em>
                                    (3)
                                     , 539-544. <a href="https://doi.org/10.1016/j.jsb.2015.10.018" title="DOI URL">https://doi.org/10.1016/j.jsb.2015.10.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jsb.2015.10.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jsb.2015.10.018%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Structural%2520Biology%26atitle%3DBinding%252Bmode%252Bof%252Bthe%252Bbreakthrough%252Binhibitor%252BAZD9291%252Bto%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor%252Brevealed%26aulast%3DYosaatmadja%26aufirst%3DYuliana%26date%3D2015%26volume%3D192%26issue%3D3%26spage%3D539%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ikuo  Miyahisa</span>, <span class="hlFld-ContribAuthor ">Tomoya  Sameshima</span>, <span class="hlFld-ContribAuthor ">Mark S.  Hixon</span>. </span><span class="cited-content_cbyCitation_article-title">Rapid Determination of the Specificity Constant of Irreversible Inhibitors (
              k
              inact
              /
              K
              I
              ) by Means of an Endpoint Competition Assay. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2015,</strong> <em>127 </em>
                                    (47)
                                     , 14305-14308. <a href="https://doi.org/10.1002/ange.201505800" title="DOI URL">https://doi.org/10.1002/ange.201505800</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201505800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201505800%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DRapid%252BDetermination%252Bof%252Bthe%252BSpecificity%252BConstant%252Bof%252BIrreversible%252BInhibitors%252B%252528%252Bk%252Binact%252B%25252F%252BK%252BI%252B%252529%252Bby%252BMeans%252Bof%252Ban%252BEndpoint%252BCompetition%252BAssay%26aulast%3DMiyahisa%26aufirst%3DIkuo%26date%3D2015%26date%3D2015%26volume%3D127%26issue%3D47%26spage%3D14305%26epage%3D14308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ikuo  Miyahisa</span>, <span class="hlFld-ContribAuthor ">Tomoya  Sameshima</span>, <span class="hlFld-ContribAuthor ">Mark S.  Hixon</span>. </span><span class="cited-content_cbyCitation_article-title">Rapid Determination of the Specificity Constant of Irreversible Inhibitors (
              k
              inact
              /
              K
              I
              ) by Means of an Endpoint Competition Assay. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2015,</strong> <em>54 </em>
                                    (47)
                                     , 14099-14102. <a href="https://doi.org/10.1002/anie.201505800" title="DOI URL">https://doi.org/10.1002/anie.201505800</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201505800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201505800%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DRapid%252BDetermination%252Bof%252Bthe%252BSpecificity%252BConstant%252Bof%252BIrreversible%252BInhibitors%252B%252528%252Bk%252Binact%252B%25252F%252BK%252BI%252B%252529%252Bby%252BMeans%252Bof%252Ban%252BEndpoint%252BCompetition%252BAssay%26aulast%3DMiyahisa%26aufirst%3DIkuo%26date%3D2015%26date%3D2015%26volume%3D54%26issue%3D47%26spage%3D14099%26epage%3D14102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tom  Baladi</span>, <span class="hlFld-ContribAuthor ">Valentina  Abet</span>, <span class="hlFld-ContribAuthor ">Sandrine  Piguel</span>. </span><span class="cited-content_cbyCitation_article-title">State-of-the-art of small molecule inhibitors of the TAM family: The point of view of the chemist. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>105 </em>, 220-237. <a href="https://doi.org/10.1016/j.ejmech.2015.10.003" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.10.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.10.003%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DState-of-the-art%252Bof%252Bsmall%252Bmolecule%252Binhibitors%252Bof%252Bthe%252BTAM%252Bfamily%25253A%252BThe%252Bpoint%252Bof%252Bview%252Bof%252Bthe%252Bchemist%26aulast%3DBaladi%26aufirst%3DTom%26date%3D2015%26volume%3D105%26spage%3D220%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong  Wu</span>, <span class="hlFld-ContribAuthor ">Aoli  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Beilei  Wang</span>, <span class="hlFld-ContribAuthor ">Cheng  Chen</span>, <span class="hlFld-ContribAuthor ">Wenchao  Wang</span>, <span class="hlFld-ContribAuthor ">Chen  Hu</span>, <span class="hlFld-ContribAuthor ">Zi  Ye</span>, <span class="hlFld-ContribAuthor ">Zheng  Zhao</span>, <span class="hlFld-ContribAuthor ">Li  Wang</span>, <span class="hlFld-ContribAuthor ">Xixiang  Li</span>, <span class="hlFld-ContribAuthor ">Kailin  Yu</span>, <span class="hlFld-ContribAuthor ">Juan  Liu</span>, <span class="hlFld-ContribAuthor ">Jiaxin  Wu</span>, <span class="hlFld-ContribAuthor ">Xiao-E  Yan</span>, <span class="hlFld-ContribAuthor ">Peng  Zhao</span>, <span class="hlFld-ContribAuthor ">Jinhua  Wang</span>, <span class="hlFld-ContribAuthor ">Chu  Wang</span>, <span class="hlFld-ContribAuthor ">Ellen L.  Weisberg</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>, <span class="hlFld-ContribAuthor ">Cai-Hong  Yun</span>, <span class="hlFld-ContribAuthor ">Jing  Liu</span>, <span class="hlFld-ContribAuthor ">Liang  Chen</span>, <span class="hlFld-ContribAuthor ">Qingsong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Ibrutinib selectively and irreversibly targets EGFR (L858R, Del19) mutant but is moderately resistant to EGFR (T790M) mutant NSCLC Cells. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2015,</strong> <em>6 </em>
                                    (31)
                                     , 31313-31322. <a href="https://doi.org/10.18632/oncotarget.5182" title="DOI URL">https://doi.org/10.18632/oncotarget.5182</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.5182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.5182%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DIbrutinib%252Bselectively%252Band%252Birreversibly%252Btargets%252BEGFR%252B%252528L858R%25252C%252BDel19%252529%252Bmutant%252Bbut%252Bis%252Bmoderately%252Bresistant%252Bto%252BEGFR%252B%252528T790M%252529%252Bmutant%252BNSCLC%252BCells%26aulast%3DWu%26aufirst%3DHong%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D31%26spage%3D31313%26epage%3D31322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Long  Zhang</span>, <span class="hlFld-ContribAuthor ">Yingying  Yang</span>, <span class="hlFld-ContribAuthor ">Haojie  Zhou</span>, <span class="hlFld-ContribAuthor ">Qingmei  Zheng</span>, <span class="hlFld-ContribAuthor ">Yuhao  Li</span>, <span class="hlFld-ContribAuthor ">Shansong  Zheng</span>, <span class="hlFld-ContribAuthor ">Shuyong  Zhao</span>, <span class="hlFld-ContribAuthor ">Dong  Chen</span>, <span class="hlFld-ContribAuthor ">Chuanwen  Fan</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity study of quinazoline derivatives leading to the discovery of potent EGFR-T790M inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>102 </em>, 445-463. <a href="https://doi.org/10.1016/j.ejmech.2015.08.026" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.08.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.08.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.08.026%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-activity%252Bstudy%252Bof%252Bquinazoline%252Bderivatives%252Bleading%252Bto%252Bthe%252Bdiscovery%252Bof%252Bpotent%252BEGFR-T790M%252Binhibitors%26aulast%3DZhang%26aufirst%3DLong%26date%3D2015%26volume%3D102%26spage%3D445%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Juchum</span>, <span class="hlFld-ContribAuthor ">Marcel  Günther</span>, <span class="hlFld-ContribAuthor ">Stefan A.  Laufer</span>. </span><span class="cited-content_cbyCitation_article-title">Fighting cancer drug resistance: Opportunities and challenges for mutation-specific EGFR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Drug Resistance Updates</span><span> <strong>2015,</strong> <em>20 </em>, 12-28. <a href="https://doi.org/10.1016/j.drup.2015.05.002" title="DOI URL">https://doi.org/10.1016/j.drup.2015.05.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drup.2015.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drup.2015.05.002%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Resistance%2520Updates%26atitle%3DFighting%252Bcancer%252Bdrug%252Bresistance%25253A%252BOpportunities%252Band%252Bchallenges%252Bfor%252Bmutation-specific%252BEGFR%252Binhibitors%26aulast%3DJuchum%26aufirst%3DMichael%26date%3D2015%26volume%3D20%26spage%3D12%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Enzyme Inhibitor, Part I, Tyrosine Kinases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 117-160. <a href="https://doi.org/10.1002/9781118892572.ch8" title="DOI URL">https://doi.org/10.1002/9781118892572.ch8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118892572.ch8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118892572.ch8%26sid%3Dliteratum%253Aachs%26atitle%3DEnzyme%252BInhibitor%25252C%252BPart%252BI%25252C%252BTyrosine%252BKinases%26date%3D2015%26date%3D2015%26spage%3D117%26epage%3D160%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DAntineoplastic%252BDrugs%26aulast%3DLednicer%26aufirst%3DDaniel%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Moulay A.  Alaoui-Jamali</span>, <span class="hlFld-ContribAuthor ">GrÃ©goire B.  Morand</span>, <span class="hlFld-ContribAuthor ">Sabrina Daniela  da Silva</span>. </span><span class="cited-content_cbyCitation_article-title">ErbB polymorphisms: insights and implications for response to targeted cancer therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Genetics</span><span> <strong>2015,</strong> <em>6 </em><a href="https://doi.org/10.3389/fgene.2015.00017" title="DOI URL">https://doi.org/10.3389/fgene.2015.00017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fgene.2015.00017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffgene.2015.00017%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Genetics%26atitle%3DErbB%252Bpolymorphisms%25253A%252Binsights%252Band%252Bimplications%252Bfor%252Bresponse%252Bto%252Btargeted%252Bcancer%252Btherapeutics%26aulast%3DAlaoui-Jamali%26aufirst%3DMoulay%2BA.%26date%3D2015%26date%3D2015%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rishil J.  Kathawala</span>, <span class="hlFld-ContribAuthor ">Pranav  Gupta</span>, <span class="hlFld-ContribAuthor ">Charles R.  Ashby</span>, <span class="hlFld-ContribAuthor ">Zhe-Sheng  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade. </span><span class="cited-content_cbyCitation_journal-name">Drug Resistance Updates</span><span> <strong>2015,</strong> <em>18 </em>, 1-17. <a href="https://doi.org/10.1016/j.drup.2014.11.002" title="DOI URL">https://doi.org/10.1016/j.drup.2014.11.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drup.2014.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drup.2014.11.002%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Resistance%2520Updates%26atitle%3DThe%252Bmodulation%252Bof%252BABC%252Btransporter-mediated%252Bmultidrug%252Bresistance%252Bin%252Bcancer%25253A%252BA%252Breview%252Bof%252Bthe%252Bpast%252Bdecade%26aulast%3DKathawala%26aufirst%3DRishil%2BJ.%26date%3D2015%26volume%3D18%26spage%3D1%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katarina  Smiljanic</span>, <span class="hlFld-ContribAuthor ">Milan  Obradovic</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Jovanovic</span>, <span class="hlFld-ContribAuthor ">Jelena  Djordjevic</span>, <span class="hlFld-ContribAuthor ">Branislava  Dobutovic</span>, <span class="hlFld-ContribAuthor ">Danimir  Jevremovic</span>, <span class="hlFld-ContribAuthor ">Pierre  Marche</span>, <span class="hlFld-ContribAuthor ">Esma R.  Isenovic</span>. </span><span class="cited-content_cbyCitation_article-title">Thrombin stimulates VSMC proliferation through an EGFR-dependent pathway: involvement of MMP-2. </span><span class="cited-content_cbyCitation_journal-name">Molecular and Cellular Biochemistry</span><span> <strong>2014,</strong> <em>396 </em>
                                    (1-2)
                                     , 147-160. <a href="https://doi.org/10.1007/s11010-014-2151-y" title="DOI URL">https://doi.org/10.1007/s11010-014-2151-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11010-014-2151-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11010-014-2151-y%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520and%2520Cellular%2520Biochemistry%26atitle%3DThrombin%252Bstimulates%252BVSMC%252Bproliferation%252Bthrough%252Ban%252BEGFR-dependent%252Bpathway%25253A%252Binvolvement%252Bof%252BMMP-2%26aulast%3DSmiljanic%26aufirst%3DKatarina%26date%3D2014%26date%3D2014%26volume%3D396%26issue%3D1-2%26spage%3D147%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bryan R  Lanning</span>, <span class="hlFld-ContribAuthor ">Landon R  Whitby</span>, <span class="hlFld-ContribAuthor ">Melissa M  Dix</span>, <span class="hlFld-ContribAuthor ">John  Douhan</span>, <span class="hlFld-ContribAuthor ">Adam M  Gilbert</span>, <span class="hlFld-ContribAuthor ">Erik C  Hett</span>, <span class="hlFld-ContribAuthor ">Theodore O  Johnson</span>, <span class="hlFld-ContribAuthor ">Chris  Joslyn</span>, <span class="hlFld-ContribAuthor ">John C  Kath</span>, <span class="hlFld-ContribAuthor ">Sherry  Niessen</span>, <span class="hlFld-ContribAuthor ">Lee R  Roberts</span>, <span class="hlFld-ContribAuthor ">Mark E  Schnute</span>, <span class="hlFld-ContribAuthor ">Chu  Wang</span>, <span class="hlFld-ContribAuthor ">Jonathan J  Hulce</span>, <span class="hlFld-ContribAuthor ">Baoxian  Wei</span>, <span class="hlFld-ContribAuthor ">Laurence O  Whiteley</span>, <span class="hlFld-ContribAuthor ">Matthew M  Hayward</span>, <span class="hlFld-ContribAuthor ">Benjamin F  Cravatt</span>. </span><span class="cited-content_cbyCitation_article-title">A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Nature Chemical Biology</span><span> <strong>2014,</strong> <em>10 </em>
                                    (9)
                                     , 760-767. <a href="https://doi.org/10.1038/nchembio.1582" title="DOI URL">https://doi.org/10.1038/nchembio.1582</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nchembio.1582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnchembio.1582%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Chemical%2520Biology%26atitle%3DA%252Broad%252Bmap%252Bto%252Bevaluate%252Bthe%252Bproteome-wide%252Bselectivity%252Bof%252Bcovalent%252Bkinase%252Binhibitors%26aulast%3DLanning%26aufirst%3DBryan%2BR%26date%3D2014%26date%3D2014%26volume%3D10%26issue%3D9%26spage%3D760%26epage%3D767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edward L  Nelson</span>. </span><span class="cited-content_cbyCitation_article-title">HER2/neu: an increasingly important therapeutic target. Part 1: basic biology & therapeutic armamentarium. </span><span class="cited-content_cbyCitation_journal-name">Clinical Investigation</span><span> <strong>2014,</strong> <em>4 </em>
                                    (7)
                                     , 649-671. <a href="https://doi.org/10.4155/cli.14.57" title="DOI URL">https://doi.org/10.4155/cli.14.57</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/cli.14.57&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Fcli.14.57%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Investigation%26atitle%3DHER2%25252Fneu%25253A%252Ban%252Bincreasingly%252Bimportant%252Btherapeutic%252Btarget.%252BPart%252B1%25253A%252Bbasic%252Bbiology%252B%252526%252Btherapeutic%252Barmamentarium%26aulast%3DNelson%26aufirst%3DEdward%2BL%26date%3D2014%26volume%3D4%26issue%3D7%26spage%3D649%26epage%3D671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xun  Ji</span>, <span class="hlFld-ContribAuthor ">Ting  Peng</span>, <span class="hlFld-ContribAuthor ">Xu  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>, <span class="hlFld-ContribAuthor ">Wei  Yang</span>, <span class="hlFld-ContribAuthor ">Linjiang  Tong</span>, <span class="hlFld-ContribAuthor ">Rong  Qu</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, <span class="hlFld-ContribAuthor ">Hua  Xie</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel 6-alkenylamides substituted of 4-anilinothieno[2,3-d]pyrimidines as irreversible epidermal growth factor receptor inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (7)
                                     , 2366-2378. <a href="https://doi.org/10.1016/j.bmc.2014.01.035" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.01.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.01.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.01.035%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B6-alkenylamides%252Bsubstituted%252Bof%252B4-anilinothieno%25255B2%25252C3-d%25255Dpyrimidines%252Bas%252Birreversible%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor%252Binhibitors%26aulast%3DJi%26aufirst%3DXun%26date%3D2014%26volume%3D22%26issue%3D7%26spage%3D2366%26epage%3D2378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Si-Ning  Li</span>, <span class="hlFld-ContribAuthor ">Huan-Qiu  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Epidermal growth factor receptor inhibitors: a patent review (2010 – present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2014,</strong> <em>24 </em>
                                    (3)
                                     , 309-321. <a href="https://doi.org/10.1517/13543776.2014.871527" title="DOI URL">https://doi.org/10.1517/13543776.2014.871527</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2014.871527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2014.871527%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DEpidermal%252Bgrowth%252Bfactor%252Breceptor%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%252B%2525282010%252B%2525E2%252580%252593%252Bpresent%252529%26aulast%3DLi%26aufirst%3DSi-Ning%26date%3D2014%26date%3D2014%26volume%3D24%26issue%3D3%26spage%3D309%26epage%3D321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William A.  Denny</span>, <span class="hlFld-ContribAuthor ">Gordon W.  Rewcastle</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of the Phosphatidylinositol 3-Kinase Pathway. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 449-478. <a href="https://doi.org/10.1016/B978-0-12-396521-9.00015-2" title="DOI URL">https://doi.org/10.1016/B978-0-12-396521-9.00015-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-396521-9.00015-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-396521-9.00015-2%26sid%3Dliteratum%253Aachs%26atitle%3DInhibitors%252Bof%252Bthe%252BPhosphatidylinositol%252B3-Kinase%252BPathway%26aulast%3DDenny%26aufirst%3DWilliam%2BA.%26date%3D2014%26spage%3D449%26epage%3D478%26pub%3DElsevier%26atitle%3DCancer%252BDrug%252BDesign%252Band%252BDiscovery%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khadiga M.  Abu-Zied</span>, <span class="hlFld-ContribAuthor ">Tahia K.  Mohamed</span>, <span class="hlFld-ContribAuthor ">Omar K.  Al-Duiaj</span>, <span class="hlFld-ContribAuthor ">Magdi E.A.  Zaki</span>. </span><span class="cited-content_cbyCitation_article-title">A simple approach to fused pyrido[2,3-d]pyrimidines incorporating khellinone and trimethoxyphenyl moieties as new scaffolds for antibacterial and antifungal agents. </span><span class="cited-content_cbyCitation_journal-name">Heterocyclic Communications</span><span> <strong>2014,</strong> <em>20 </em>
                                    (2)
                                     <a href="https://doi.org/10.1515/hc-2013-0199" title="DOI URL">https://doi.org/10.1515/hc-2013-0199</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/hc-2013-0199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fhc-2013-0199%26sid%3Dliteratum%253Aachs%26jtitle%3DHeterocyclic%2520Communications%26atitle%3DA%252Bsimple%252Bapproach%252Bto%252Bfused%252Bpyrido%25255B2%25252C3-d%25255Dpyrimidines%252Bincorporating%252Bkhellinone%252Band%252Btrimethoxyphenyl%252Bmoieties%252Bas%252Bnew%252Bscaffolds%252Bfor%252Bantibacterial%252Band%252Bantifungal%252Bagents%26aulast%3DAbu-Zied%26aufirst%3DKhadiga%2BM.%26date%3D2014%26volume%3D20%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xu  Zhang</span>, <span class="hlFld-ContribAuthor ">Ting  Peng</span>, <span class="hlFld-ContribAuthor ">Xun  Ji</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>, <span class="hlFld-ContribAuthor ">Linjiang  Tong</span>, <span class="hlFld-ContribAuthor ">Zeng  Li</span>, <span class="hlFld-ContribAuthor ">Wei  Yang</span>, <span class="hlFld-ContribAuthor ">Yungen  Xu</span>, <span class="hlFld-ContribAuthor ">Mengyuan  Li</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Hua  Xie</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel 4-anilinoquinazolines with C-6 urea-linked side chains as inhibitors of the epidermal growth factor receptor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (24)
                                     , 7988-7998. <a href="https://doi.org/10.1016/j.bmc.2013.09.049" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.09.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.09.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.09.049%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B4-anilinoquinazolines%252Bwith%252BC-6%252Burea-linked%252Bside%252Bchains%252Bas%252Binhibitors%252Bof%252Bthe%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor%26aulast%3DZhang%26aufirst%3DXu%26date%3D2013%26volume%3D21%26issue%3D24%26spage%3D7988%26epage%3D7998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federica  Vacondio</span>, <span class="hlFld-ContribAuthor ">Caterina  Carmi</span>, <span class="hlFld-ContribAuthor ">Elena  Galvani</span>, <span class="hlFld-ContribAuthor ">Michele  Bassi</span>, <span class="hlFld-ContribAuthor ">Claudia  Silva</span>, <span class="hlFld-ContribAuthor ">Alessio  Lodola</span>, <span class="hlFld-ContribAuthor ">Silvia  Rivara</span>, <span class="hlFld-ContribAuthor ">Andrea  Cavazzoni</span>, <span class="hlFld-ContribAuthor ">Roberta R.  Alfieri</span>, <span class="hlFld-ContribAuthor ">Pier Giorgio  Petronini</span>, <span class="hlFld-ContribAuthor ">Marco  Mor</span>. </span><span class="cited-content_cbyCitation_article-title">Long-lasting inhibition of EGFR autophosphorylation in A549 tumor cells by intracellular accumulation of non-covalent inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (19)
                                     , 5290-5294. <a href="https://doi.org/10.1016/j.bmcl.2013.08.008" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.08.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.08.008%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DLong-lasting%252Binhibition%252Bof%252BEGFR%252Bautophosphorylation%252Bin%252BA549%252Btumor%252Bcells%252Bby%252Bintracellular%252Baccumulation%252Bof%252Bnon-covalent%252Binhibitors%26aulast%3DVacondio%26aufirst%3DFederica%26date%3D2013%26volume%3D23%26issue%3D19%26spage%3D5290%26epage%3D5294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jung Min  Nam</span>, <span class="hlFld-ContribAuthor ">Kyung-Hwa  Jeon</span>, <span class="hlFld-ContribAuthor ">Hanbyeol  Kwon</span>, <span class="hlFld-ContribAuthor ">Eunyoung  Lee</span>, <span class="hlFld-ContribAuthor ">Kyu-Yeon  Jun</span>, <span class="hlFld-ContribAuthor ">Yeung Bae  Jin</span>, <span class="hlFld-ContribAuthor ">Yun-Sil  Lee</span>, <span class="hlFld-ContribAuthor ">Younghwa  Na</span>, <span class="hlFld-ContribAuthor ">Youngjoo  Kwon</span>. </span><span class="cited-content_cbyCitation_article-title">Dithiiranylmethyloxy azaxanthone shows potent anti-tumor activity via suppression of HER2 expression and HER2-mediated signals in HER2-overexpressing breast cancer cells. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2013,</strong> <em>50 </em>
                                    (2)
                                     , 181-190. <a href="https://doi.org/10.1016/j.ejps.2013.06.014" title="DOI URL">https://doi.org/10.1016/j.ejps.2013.06.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2013.06.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2013.06.014%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DDithiiranylmethyloxy%252Bazaxanthone%252Bshows%252Bpotent%252Banti-tumor%252Bactivity%252Bvia%252Bsuppression%252Bof%252BHER2%252Bexpression%252Band%252BHER2-mediated%252Bsignals%252Bin%252BHER2-overexpressing%252Bbreast%252Bcancer%252Bcells%26aulast%3DNam%26aufirst%3DJung%2BMin%26date%3D2013%26volume%3D50%26issue%3D2%26spage%3D181%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lichen  Yang</span>, <span class="hlFld-ContribAuthor ">Ruimao  Hua</span>. </span><span class="cited-content_cbyCitation_article-title">Cycloaddition of 1,4-Diaryl-1,3-butadiynes with Nitriles: An Atom-economic One-pot Approach to Benzo[
              f
              ]quinazolines. </span><span class="cited-content_cbyCitation_journal-name">Chemistry Letters</span><span> <strong>2013,</strong> <em>42 </em>
                                    (7)
                                     , 769-771. <a href="https://doi.org/10.1246/cl.130206" title="DOI URL">https://doi.org/10.1246/cl.130206</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1246/cl.130206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1246%2Fcl.130206%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520Letters%26atitle%3DCycloaddition%252Bof%252B1%25252C4-Diaryl-1%25252C3-butadiynes%252Bwith%252BNitriles%25253A%252BAn%252BAtom-economic%252BOne-pot%252BApproach%252Bto%252BBenzo%25255B%252Bf%252B%25255Dquinazolines%26aulast%3DYang%26aufirst%3DLichen%26date%3D2013%26volume%3D42%26issue%3D7%26spage%3D769%26epage%3D771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guo-Wu  Rao</span>, <span class="hlFld-ContribAuthor ">Geng-Jie  Xu</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Xu-Liang  Jiang</span>, <span class="hlFld-ContribAuthor ">Hai-Bo  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Antitumor Evaluation and Docking Study of Novel 4-Anilinoquinazoline Derivatives as Potential Epidermal Growth Factor Receptor (EGFR) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2013,</strong> <em>8 </em>
                                    (6)
                                     , 928-933. <a href="https://doi.org/10.1002/cmdc.201300120" title="DOI URL">https://doi.org/10.1002/cmdc.201300120</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201300120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201300120%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSynthesis%25252C%252BAntitumor%252BEvaluation%252Band%252BDocking%252BStudy%252Bof%252BNovel%252B4-Anilinoquinazoline%252BDerivatives%252Bas%252BPotential%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252B%252528EGFR%252529%252BInhibitors%26aulast%3DRao%26aufirst%3DGuo-Wu%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D6%26spage%3D928%26epage%3D933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masahiko  Hirata</span>, <span class="hlFld-ContribAuthor ">Yasukazu  Kanai</span>, <span class="hlFld-ContribAuthor ">Sadahiro  Naka</span>, <span class="hlFld-ContribAuthor ">Mitsuyoshi  Yoshimoto</span>, <span class="hlFld-ContribAuthor ">Shinya  Kagawa</span>, <span class="hlFld-ContribAuthor ">Keiji  Matsumuro</span>, <span class="hlFld-ContribAuthor ">Hideyuki  Katsuma</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Yamaguchi</span>, <span class="hlFld-ContribAuthor ">Yasuhiro  Magata</span>, <span class="hlFld-ContribAuthor ">Yoshiro  Ohmomo</span>. </span><span class="cited-content_cbyCitation_article-title">A useful EGFR-TK ligand for tumor diagnosis with SPECT: development of radioiodinated 6-(3-morpholinopropoxy)-7-ethoxy-4-(3′-iodophenoxy)quinazoline. </span><span class="cited-content_cbyCitation_journal-name">Annals of Nuclear Medicine</span><span> <strong>2013,</strong> <em>27 </em>
                                    (5)
                                     , 431-443. <a href="https://doi.org/10.1007/s12149-013-0703-y" title="DOI URL">https://doi.org/10.1007/s12149-013-0703-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12149-013-0703-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12149-013-0703-y%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnals%2520of%2520Nuclear%2520Medicine%26atitle%3DA%252Buseful%252BEGFR-TK%252Bligand%252Bfor%252Btumor%252Bdiagnosis%252Bwith%252BSPECT%25253A%252Bdevelopment%252Bof%252Bradioiodinated%252B6-%2525283-morpholinopropoxy%252529-7-ethoxy-4-%2525283%2525E2%252580%2525B2-iodophenoxy%252529quinazoline%26aulast%3DHirata%26aufirst%3DMasahiko%26date%3D2013%26date%3D2013%26volume%3D27%26issue%3D5%26spage%3D431%26epage%3D443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Irreversible Enzyme Inactivators. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 345-382. <a href="https://doi.org/10.1002/9781118540398.ch9" title="DOI URL">https://doi.org/10.1002/9781118540398.ch9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118540398.ch9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118540398.ch9%26sid%3Dliteratum%253Aachs%26atitle%3DIrreversible%252BEnzyme%252BInactivators%26date%3D2013%26date%3D2013%26spage%3D345%26epage%3D382%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DEvaluation%252Bof%252BEnzyme%252BInhibitors%252Bin%252BDrug%252BDiscovery%26aulast%3DCopeland%26aufirst%3DRobert%2BA.%26date%3D2013%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin  Cai</span>, <span class="hlFld-ContribAuthor ">Min  Sun</span>, <span class="hlFld-ContribAuthor ">Xiaoqing  Wu</span>, <span class="hlFld-ContribAuthor ">Junqing  Chen</span>, <span class="hlFld-ContribAuthor ">Peng  Wang</span>, <span class="hlFld-ContribAuthor ">Xi  Zong</span>, <span class="hlFld-ContribAuthor ">Min  Ji</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of novel 4-benzothiazole amino quinazolines Dasatinib derivatives as potential anti-tumor agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>63 </em>, 702-712. <a href="https://doi.org/10.1016/j.ejmech.2013.03.013" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.03.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.03.013%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnovel%252B4-benzothiazole%252Bamino%252Bquinazolines%252BDasatinib%252Bderivatives%252Bas%252Bpotential%252Banti-tumor%252Bagents%26aulast%3DCai%26aufirst%3DJin%26date%3D2013%26volume%3D63%26spage%3D702%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samar  Mowafy</span>, <span class="hlFld-ContribAuthor ">Nahla A.  Farag</span>, <span class="hlFld-ContribAuthor ">Khaled A.M.  Abouzid</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and in vitro anti-proliferative activity of 4,6-quinazolinediamines as potent EGFR-TK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>61 </em>, 132-145. <a href="https://doi.org/10.1016/j.ejmech.2012.10.017" title="DOI URL">https://doi.org/10.1016/j.ejmech.2012.10.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2012.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2012.10.017%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bin%2525C2%2525A0vitro%252Banti-proliferative%252Bactivity%252Bof%252B4%25252C6-quinazolinediamines%252Bas%252Bpotent%252BEGFR-TK%252Binhibitors%26aulast%3DMowafy%26aufirst%3DSamar%26date%3D2013%26volume%3D61%26spage%3D132%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuchang  Ouyang</span>, <span class="hlFld-ContribAuthor ">Shuo  Zhou</span>, <span class="hlFld-ContribAuthor ">Chinh Tran To  Su</span>, <span class="hlFld-ContribAuthor ">Zemei  Ge</span>, <span class="hlFld-ContribAuthor ">Runtao  Li</span>, <span class="hlFld-ContribAuthor ">Chee Keong  Kwoh</span>. </span><span class="cited-content_cbyCitation_article-title">CovalentDock: Automated covalent docking with parameterized covalent linkage energy estimation and molecular geometry constraints. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computational Chemistry</span><span> <strong>2013,</strong> <em>34 </em>
                                    (4)
                                     , 326-336. <a href="https://doi.org/10.1002/jcc.23136" title="DOI URL">https://doi.org/10.1002/jcc.23136</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcc.23136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcc.23136%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computational%2520Chemistry%26atitle%3DCovalentDock%25253A%252BAutomated%252Bcovalent%252Bdocking%252Bwith%252Bparameterized%252Bcovalent%252Blinkage%252Benergy%252Bestimation%252Band%252Bmolecular%252Bgeometry%252Bconstraints%26aulast%3DOuyang%26aufirst%3DXuchang%26date%3D2013%26date%3D2012%26volume%3D34%26issue%3D4%26spage%3D326%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingsong  Liu</span>, <span class="hlFld-ContribAuthor ">Yogesh  Sabnis</span>, <span class="hlFld-ContribAuthor ">Zheng  Zhao</span>, <span class="hlFld-ContribAuthor ">Tinghu  Zhang</span>, <span class="hlFld-ContribAuthor ">Sara J.  Buhrlage</span>, <span class="hlFld-ContribAuthor ">Lyn H.  Jones</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>. </span><span class="cited-content_cbyCitation_article-title">Developing Irreversible Inhibitors of the Protein Kinase Cysteinome. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biology</span><span> <strong>2013,</strong> <em>20 </em>
                                    (2)
                                     , 146-159. <a href="https://doi.org/10.1016/j.chembiol.2012.12.006" title="DOI URL">https://doi.org/10.1016/j.chembiol.2012.12.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2012.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2012.12.006%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biology%26atitle%3DDeveloping%252BIrreversible%252BInhibitors%252Bof%252Bthe%252BProtein%252BKinase%252BCysteinome%26aulast%3DLiu%26aufirst%3DQingsong%26date%3D2013%26volume%3D20%26issue%3D2%26spage%3D146%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elena  Galvani</span>, <span class="hlFld-ContribAuthor ">Elisa  Giovannetti</span>, <span class="hlFld-ContribAuthor ">Francesca  Saccani</span>, <span class="hlFld-ContribAuthor ">Andrea  Cavazzoni</span>, <span class="hlFld-ContribAuthor ">Leticia G.  Leon</span>, <span class="hlFld-ContribAuthor ">Henk  Dekker</span>, <span class="hlFld-ContribAuthor ">Roberta  Alfieri</span>, <span class="hlFld-ContribAuthor ">Caterina  Carmi</span>, <span class="hlFld-ContribAuthor ">Marco  Mor</span>, <span class="hlFld-ContribAuthor ">Andrea  Ardizzoni</span>, <span class="hlFld-ContribAuthor ">Pier Giorgio  Petronini</span>, <span class="hlFld-ContribAuthor ">Godefridus J.  Peters</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Mechanisms Underlying the Antitumor Activity of 3-Aminopropanamide Irreversible Inhibitors of the Epidermal Growth Factor Receptor in Non–Small Cell Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Neoplasia</span><span> <strong>2013,</strong> <em>15 </em>
                                    (1)
                                     , 61-IN18. <a href="https://doi.org/10.1593/neo.121434" title="DOI URL">https://doi.org/10.1593/neo.121434</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1593/neo.121434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1593%2Fneo.121434%26sid%3Dliteratum%253Aachs%26jtitle%3DNeoplasia%26atitle%3DMolecular%252BMechanisms%252BUnderlying%252Bthe%252BAntitumor%252BActivity%252Bof%252B3-Aminopropanamide%252BIrreversible%252BInhibitors%252Bof%252Bthe%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252Bin%252BNon%2525E2%252580%252593Small%252BCell%252BLung%252BCancer%26aulast%3DGalvani%26aufirst%3DElena%26date%3D2013%26volume%3D15%26issue%3D1%26spage%3D61%26epage%3DIN18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ola  Åberg</span>, <span class="hlFld-ContribAuthor ">Bengt  Långström</span>. </span><span class="cited-content_cbyCitation_article-title">Combinatorial synthesis of labelled drugs and PET tracers: synthesis of a focused library of
              11
              C-
              carbonyl
              -labelled acrylamides as potential biomarkers of EGFR expression. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2012,</strong> <em>55 </em>
                                    (14)
                                     , 477-483. <a href="https://doi.org/10.1002/jlcr.2981" title="DOI URL">https://doi.org/10.1002/jlcr.2981</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.2981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.2981%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DCombinatorial%252Bsynthesis%252Bof%252Blabelled%252Bdrugs%252Band%252BPET%252Btracers%25253A%252Bsynthesis%252Bof%252Ba%252Bfocused%252Blibrary%252Bof%252B11%252BC-%252Bcarbonyl%252B-labelled%252Bacrylamides%252Bas%252Bpotential%252Bbiomarkers%252Bof%252BEGFR%252Bexpression%26aulast%3D%25C3%2585berg%26aufirst%3DOla%26date%3D2012%26date%3D2012%26volume%3D55%26issue%3D14%26spage%3D477%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Klajnert</span>, <span class="hlFld-ContribAuthor ">Tomasz  Wasiak</span>, <span class="hlFld-ContribAuthor ">Maksim  Ionov</span>, <span class="hlFld-ContribAuthor ">Marcos  Fernandez-Villamarin</span>, <span class="hlFld-ContribAuthor ">Ana  Sousa-Herves</span>, <span class="hlFld-ContribAuthor ">Juan  Correa</span>, <span class="hlFld-ContribAuthor ">Ricardo  Riguera</span>, <span class="hlFld-ContribAuthor ">Eduardo  Fernandez-Megia</span>. </span><span class="cited-content_cbyCitation_article-title">Dendrimers reduce toxicity of Aβ 1-28 peptide during aggregation and accelerate fibril formation. </span><span class="cited-content_cbyCitation_journal-name">Nanomedicine: Nanotechnology, Biology and Medicine</span><span> <strong>2012,</strong> <em>8 </em>
                                    (8)
                                     , 1372-1378. <a href="https://doi.org/10.1016/j.nano.2012.03.005" title="DOI URL">https://doi.org/10.1016/j.nano.2012.03.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nano.2012.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nano.2012.03.005%26sid%3Dliteratum%253Aachs%26jtitle%3DNanomedicine%253A%2520Nanotechnology%252C%2520Biology%2520and%2520Medicine%26atitle%3DDendrimers%252Breduce%252Btoxicity%252Bof%252BA%2525CE%2525B2%252B1-28%252Bpeptide%252Bduring%252Baggregation%252Band%252Baccelerate%252Bfibril%252Bformation%26aulast%3DKlajnert%26aufirst%3DBarbara%26date%3D2012%26volume%3D8%26issue%3D8%26spage%3D1372%26epage%3D1378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm990482t&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2000.43.issue-7%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm990482t&amp;citedByCount=204&amp;pagesCount=3&amp;pageNumber=2" title="Load more citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load more citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/medium/jm990482tn00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482tn00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm990482t&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm990482tf1" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/medium/jm990482tf1.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482tf1.jpeg" id="rightTab-_i5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482tf1.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm990482t&amp;id=jm990482tf1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm990482th00001" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/medium/jm990482th00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482th00001.jpeg" id="rightTab-_i8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 1 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) MeOH/Me<sub>2</sub>NH/20 °C/1 h; (ii) Cl(CH<sub>2</sub>)<sub>2</sub>NMe·HCl/K<sub>2</sub>CO<sub>3</sub>/DMF/100 °C/4 h; (iii) Fe/AcOH/EtOH/H<sub>2</sub>O/reflux/20 min or H<sub>2</sub>/Pt-C (for <b>32</b>); (iv) <i>i</i>-PrOH/CH<sub>2</sub>Cl<sub>2</sub>/Et<sub>3</sub>N/reflux/3 h; (v) CH<sub>2</sub><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCO<sub>2</sub>H/EDCI·HCl/pyridine/DMA/20 °C/2 h.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482th00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm990482t&amp;id=jm990482th00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm990482th00002" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/medium/jm990482th00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482th00002.jpeg" id="rightTab-_i10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 2 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) RO<sup>-</sup>Na<sup>+</sup>/THF/reflux/18−24 h or RS<sup>-</sup>Na<sup>+</sup>/DMSO/65 °C (for <b>39</b>−<b>43e</b>) or RO<sup>-</sup>K<sup>+</sup>/DMSO/25 °C (for <b>42</b>−<b>46f</b>); (ii) Fe/AcOH/EtOH/H<sub>2</sub>O/reflux/20 min or H<sub>2</sub>/Pd−C/MeOH:EtOAc (2:1) (for X = 3‘-Me) or H<sub>2</sub>/Raney Ni/THF (for <b>46f</b>); (iii) CH<sub>2</sub><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCO<sub>2</sub>H/EDCI·HCl/pyridine or Et<sub>3</sub>N/DMA or DMF/2 h or (for <b>50f</b>) CH<sub>2</sub><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCO<sub>2</sub>H/<i>i-</i>BuOCOCl/Et<sub>3</sub>N/THF.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482th00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm990482t&amp;id=jm990482th00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm990482th00003" data-index="4" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/medium/jm990482th00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482th00003.jpeg" id="rightTab-_i12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 3 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) NH<sub>4</sub>OH/EtOH/100 °C/20 h (pressure vessel); (ii) Br<sub>2</sub>/AcOH/HOAc/20 °C/90 min; (iii) Fe/AcOH/EtOH/H<sub>2</sub>O/reflux/10 min; (iv) (EtO)<sub>3</sub>CH/reflux/3 h; (v) HBF<sub>4</sub>/NaNO<sub>2</sub>/−20 °C/18 h; (vi) POCl<sub>3</sub>/reflux/110 min, then 3-chloro-4-fluoroaniline/<i>i-</i>PrOH/60 °C/30 min; (vii) AIBN/(Bu)<sub>3</sub>SnH/90 °C/16 h; (viii) (Ph<sub>3</sub>P)<sub>4</sub>Pd/DMF/100 °C/ 75 min; (ix) NH<sub>3</sub>(g)/<i>i-</i>PrOH/100 °C/24 h (pressure vessel); (x) CH<sub>2</sub><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCO<sub>2</sub>H/2,4,6-triClPhCOCl/Et<sub>3</sub>N/THF/0 °C/15 min, then <b>61</b>/DMAP/THF/0 °C/15 min to rt/2 h; (xi) PtO<sub>2</sub>/H<sub>2</sub>/THF/MeOH/20 °C/18 h; (xii) HOBT/Et<sub>3</sub>N/CH<sub>2</sub><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCO<sub>2</sub>H/EDCI·HCl/DMA/THF/20 °C/6 weeks. </p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482th00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm990482t&amp;id=jm990482th00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm990482th00004" data-index="5" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/medium/jm990482th00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482th00004.jpeg" id="rightTab-_i14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 4 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) CuCN/NMP; (ii) 90% H<sub>2</sub>SO<sub>4</sub>; (iii) H<sub>2</sub>/Pd−C; (iv) (EtO)<sub>3</sub>CH/reflux/8 h; (v) Fe/AcOH/EtOH/H<sub>2</sub>O/reflux/20 min; (vi) HCO<sub>2</sub>H/H<sub>2</sub>SO<sub>4</sub>/reflux/16 h; (vii) POCl<sub>3</sub>, then ArNH<sub>2</sub>; (viii) <i>m</i>-CPBA/CH<sub>2</sub>Cl<sub>2</sub>/20 °C/ 1 h; (ix) NH<sub>3</sub>(g)/<i>i-</i>PrOH/100 °C/20 h (pressure vessel); (x) CH<sub>2</sub><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCO<sub>2</sub>H/Et<sub>3</sub>N, then 2,4,6-triClPhCOCl, then <b>72a</b>/DMAP/THF/0 °C/15 min to rt/2 h.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482th00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm990482t&amp;id=jm990482th00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm990482th00005" data-index="6" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/medium/jm990482th00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482th00005.jpeg" id="rightTab-_i16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 5 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) Pyridine·HCl/200−210 °C/8 min; (ii) Br(CH<sub>2</sub>)<sub>3</sub>OH or Br(CH<sub>2</sub>)<sub>2</sub>OMe/K<sub>2</sub>CO<sub>3</sub>/THF/DMF/reflux/1−2 h; (iii) Et<sub>3</sub>N/MsCl/THF/DMF/0 °C/1 h, then morpholine or 4-Me-piperazine/reflux/4−5 days; (v) <i>m</i>-CPBA/CH<sub>2</sub>Cl<sub>2</sub>/rt/1 h or NaIO<sub>4</sub>/1 N HCl/4 °C (for <b>70c</b>,<b>d</b>); (vi) NH<sub>3</sub>(g)/<i>i-</i>PrOH/100 °C/20 h (pressure vessel); (vii) CH<sub>2</sub><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCO<sub>2</sub>H/Et<sub>3</sub>N, then 2,4,6-triClPhCOCl, then <b>72b</b><b>−</b><b>d</b>/DMAP/THF/0 °C/15 min to rt/2 h; (viii) MeNH<sub>2</sub>/water/DMSO/110 °C/18 h (pressure vessel).</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482th00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm990482t&amp;id=jm990482th00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm990482tf00001" data-index="7" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/medium/jm990482tf00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482tf00001.jpeg" id="rightTab-_i20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 Inhibition of the secretory transport of vinblastine in Caco-2 cells by compounds <b>18</b> and <b>25</b>, in comparison to the known inhibitor cyclosporin A (mean ± SD, <i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2000/jmcmar.2000.43.issue-7/jm990482t/production/images/large/jm990482tf00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm990482t&amp;id=jm990482tf00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"></div><p class="rightTab-references-count">
            This article references 35 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-jm990482tb00001"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00001" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00001_1"><span><span class="NLM_string-ref">Kersemaekers, A. M. F.; Fleuren, G. J.; Kenter, E. G.; Van den Broek, L. J. C. M.; Uljee, S. M.; Hermans, J.; Van de Vijver, M. J. Oncogene alterations in carcinomas of the uterine cervix:  Overexpression of the epidermal growth factor receptor is associated with poor prognosis. <i>  Clin. Cancer Res</i>. <b>1999</b>, <i>5</i>, 577−586.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=586&author=A.+M.+F.+Kersemaekers&author=G.+J.+Fleuren&author=E.+G.+Kenter&author=L.+J.+C.+M.+Van+den+Broek&author=S.+M.+Uljee&author=J.+Hermans&author=M.+J+Van+de+Vijver&title=Oncogene+alterations+in+carcinomas+of+the+uterine+cervix%3A%E2%80%89+Overexpression+of+the+epidermal+growth+factor+receptor+is+associated+with+poor+prognosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKersemaekers%26aufirst%3DA.%2BM.%2BF.%26atitle%3DOncogene%2520alterations%2520in%2520carcinomas%2520of%2520the%2520uterine%2520cervix%253A%25E2%2580%2589%2520Overexpression%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520is%2520associated%2520with%2520poor%2520prognosis%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1999%26volume%3D5%26spage%3D586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00002"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00002" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00002_1"><span><span class="NLM_string-ref">Maurizi, M.; Almadori, G.; Ferrandina, G.; Distefano, M.; Romanini, M. E.; Cadoni, G.; Benedetti-Panici, P.; Paludetti, G.; Scambia, G.; Mancuso S. Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. <i>  Br. J. Cancer</i><b>1996</b>, <i>74</i>, 1253−1257.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1996&pages=1257&author=M.+Maurizi&author=G.+Almadori&author=G.+Ferrandina&author=M.+Distefano&author=M.+E.+Romanini&author=G.+Cadoni&author=P.+Benedetti-Panici&author=G.+Paludetti&author=G.+Scambia&author=S+Mancuso&title=Prognostic+significance+of+epidermal+growth+factor+receptor+in+laryngeal+squamous+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaurizi%26aufirst%3DM.%26atitle%3DPrognostic%2520significance%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520in%2520laryngeal%2520squamous%2520cell%2520carcinoma%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1996%26volume%3D74%26spage%3D1257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00003"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00003" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00003_1"><span><span class="NLM_string-ref">Klohs, W. D.; Fry, D. W.; Kraker, A. J. Inhibitors of tyrosine kinase<i>. Curr. Opin. </i><i>Oncol.</i><b>1997</b>, <i>9</i>, 562−568.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1997&pages=568&author=W.+D.+Klohs&author=D.+W.+Fry&author=A.+J+Kraker&title=Inhibitors+of+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKlohs%26aufirst%3DW.%2BD.%26atitle%3DInhibitors%2520of%2520tyrosine%2520kinase%26jtitle%3DCurr.%2520Opin.%2520Oncol.%26date%3D1997%26volume%3D9%26spage%3D568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00004"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00004" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00004_1"><span><span class="NLM_string-ref">Voldborg, B. R.; Damstrup, L.; Spang-Thomsen, M.; Poulsen, H. S. Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials. <i>  Ann. Oncol</i>. <b>1997</b>, <i>8</i>, 1197−1206.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=1206&author=B.+R.+Voldborg&author=L.+Damstrup&author=M.+Spang-Thomsen&author=H.+S+Poulsen&title=Epidermal+growth+factor+receptor+%28EGFR%29+and+EGFR+mutations%2C+function+and+possible+role+in+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVoldborg%26aufirst%3DB.%2BR.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%2520and%2520EGFR%2520mutations%252C%2520function%2520and%2520possible%2520role%2520in%2520clinical%2520trials%26jtitle%3DAnn.%2520Oncol.%26date%3D1997%26volume%3D8%26spage%3D1206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00005"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00005" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00005_1"><span><span class="NLM_string-ref">Kelloff, G. J.; Fay, J. R.; Steele, V. E.; Lubet, R. A.; Boone, C. W.; Crowell, J. A.; Sigman, C. C. Epidermal growth factor receptor tyrosine kinase inhibitors as potential cancer chemopreventives. <i>  Cancer Epidemiol. Biomarkers </i><i>Prevention</i><b>1996</b>, <i>5</i>, 657−666.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1996&pages=666&author=G.+J.+Kelloff&author=J.+R.+Fay&author=V.+E.+Steele&author=R.+A.+Lubet&author=C.+W.+Boone&author=J.+A.+Crowell&author=C.+C+Sigman&title=Epidermal+growth+factor+receptor+tyrosine+kinase+inhibitors+as+potential+cancer+chemopreventives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKelloff%26aufirst%3DG.%2BJ.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitors%2520as%2520potential%2520cancer%2520chemopreventives%26jtitle%3DCancer%2520Epidemiol.%2520Biomarkers%2520Prevention%26date%3D1996%26volume%3D5%26spage%3D666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00006"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00006" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00006_1"><span><span class="NLM_string-ref">Thompson, A. M.; Bridges, A. J.; Fry, D. W.; Kraker, A. J.; Denny, W. A. Tyrosine kinase inhibitors. 7. 7-Amino-4-(phenylamino)- and 7-amino-4-[(phenylmethyl)amino]pyrido[4,3-<i>d</i>]pyrimidines; a new class of inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor<i>. J. Med. Chem</i>. <b>1995</b>, <i>38</i>, 3780−3788.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=3788&author=A.+M.+Thompson&author=A.+J.+Bridges&author=D.+W.+Fry&author=A.+J.+Kraker&author=W.+A+Denny&title=Tyrosine+kinase+inhibitors.+7.+7-Amino-4-%28phenylamino%29-+and+7-amino-4-%5B%28phenylmethyl%29amino%5Dpyrido%5B4%2C3-d%5Dpyrimidines%3B+a+new+class+of+inhibitors+of+the+tyrosine+kinase+activity+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BM.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%25207.%25207-Amino-4-%2528phenylamino%2529-%2520and%25207-amino-4-%255B%2528phenylmethyl%2529amino%255Dpyrido%255B4%252C3-d%255Dpyrimidines%253B%2520a%2520new%2520class%2520of%2520inhibitors%2520of%2520the%2520tyrosine%2520kinase%2520activity%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D3788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00007"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00007" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00007_1"><span><span class="NLM_string-ref">Bridges, A. J.; Zhou, H.; Cody, D. R.; Rewcastle, G. W.; McMichael, A.; Showalter, H. D. H.; Fry, D. W.; Kraker, A. J.; Denny, W. A. Tyrosine kinase inhibitors. 8. An unusually steep structure−activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor. <i>  J. Med. Chem</i>. <b>1996</b>, <i>39</i>, 267−276.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=276&author=A.+J.+Bridges&author=H.+Zhou&author=D.+R.+Cody&author=G.+W.+Rewcastle&author=A.+McMichael&author=H.+D.+H.+Showalter&author=D.+W.+Fry&author=A.+J.+Kraker&author=W.+A+Denny&title=Tyrosine+kinase+inhibitors.+8.+An+unusually+steep+structure%E2%88%92activity+relationship+for+analogues+of+4-%283-bromoanilino%29-6%2C7-dimethoxyquinazoline+%28PD+153035%29%2C+a+potent+inhibitor+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%25208.%2520An%2520unusually%2520steep%2520structure%25E2%2588%2592activity%2520relationship%2520for%2520analogues%2520of%25204-%25283-bromoanilino%2529-6%252C7-dimethoxyquinazoline%2520%2528PD%2520153035%2529%252C%2520a%2520potent%2520inhibitor%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00008"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00008" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00008_1"><span><span class="NLM_string-ref">Wakeling, A. E.; Barker, A. J.; Davies, D. H.; Brown, D. S.; Green, L. R.; Cartlidge, S. A.; Woodburn, J. R. Specific inhibition of epidermal growth factor receptor tyrosine kinase by 4-anilinoquinazolines. <i>  Breast Cancer </i><i>Res. Treat</i>. <b>1996</b>, <i>38</i>, 67−73.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1996&pages=73&author=A.+E.+Wakeling&author=A.+J.+Barker&author=D.+H.+Davies&author=D.+S.+Brown&author=L.+R.+Green&author=S.+A.+Cartlidge&author=J.+R+Woodburn&title=Specific+inhibition+of+epidermal+growth+factor+receptor+tyrosine+kinase+by+4-anilinoquinazolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWakeling%26aufirst%3DA.%2BE.%26atitle%3DSpecific%2520inhibition%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520by%25204-anilinoquinazolines%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D1996%26volume%3D38%26spage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00009"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00009" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00009_1"><span><span class="NLM_string-ref">Rewcastle, G. W.; Palmer, B. D.; Thompson, A. M.; Bridges, A. J.; Cody, D. R.; Zhou, H.; Fry, D. W.; McMichael, A.; Denny, W. A. Tyrosine Kinase Inhibitors. 10. Isomeric 4-[(3-bromophenyl)amino]pyrido[<i>d</i>]pyrimidines are potent ATP binding site inhibitors of the tyrosine kinase function of the epidermal growth factor receptor. <i>  J. Med. Chem</i>. <b>1996</b>, <i>39</i>, 1823−1835.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=1835&author=G.+W.+Rewcastle&author=B.+D.+Palmer&author=A.+M.+Thompson&author=A.+J.+Bridges&author=D.+R.+Cody&author=H.+Zhou&author=D.+W.+Fry&author=A.+McMichael&author=W.+A+Denny&title=Tyrosine+Kinase+Inhibitors.+10.+Isomeric+4-%5B%283-bromophenyl%29amino%5Dpyrido%5Bd%5Dpyrimidines+are+potent+ATP+binding+site+inhibitors+of+the+tyrosine+kinase+function+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26atitle%3DTyrosine%2520Kinase%2520Inhibitors.%252010.%2520Isomeric%25204-%255B%25283-bromophenyl%2529amino%255Dpyrido%255Bd%255Dpyrimidines%2520are%2520potent%2520ATP%2520binding%2520site%2520inhibitors%2520of%2520the%2520tyrosine%2520kinase%2520function%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D1835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00010"><div class="reference"><div class="NLM_citation" id="rightTab-jm990482tb00010_1"><span><span class="NLM_string-ref">Fry, D. W.; Nelson, J. M.; Slintak, V.; Keller, P. R.; Rewcastle, G. W.; Denny, W. A.; Zhou, H.; Bridges, A. J. Biochemical and antiproliferative properties of 4-[ar(alkyl)amino]-pyridopyrimidines, a new chemical class of potent and specific epidermal growth factor receptor tyrosine kinase inhibitor. <i>  Biochem. Pharmacol</i>. <b>1997</b>, <i>54</i>, 877−887.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1997&pages=887&author=D.+W.+Fry&author=J.+M.+Nelson&author=V.+Slintak&author=P.+R.+Keller&author=G.+W.+Rewcastle&author=W.+A.+Denny&author=H.+Zhou&author=A.+J+Bridges&title=Biochemical+and+antiproliferative+properties+of+4-%5Bar%28alkyl%29amino%5D-pyridopyrimidines%2C+a+new+chemical+class+of+potent+and+specific+epidermal+growth+factor+receptor+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DBiochemical%2520and%2520antiproliferative%2520properties%2520of%25204-%255Bar%2528alkyl%2529amino%255D-pyridopyrimidines%252C%2520a%2520new%2520chemical%2520class%2520of%2520potent%2520and%2520specific%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1997%26volume%3D54%26spage%3D887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00011"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00011" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00011_1"><span><span class="NLM_string-ref">Woodburn, J. R.; Barker, A. J.; Gibson, K. H.; Ashton, S. E.; Wakeling, A. E.; Curry, B, J.; Scarlett, L.; Henthorn, L. R. ZD 1839, an epidermal growth factor tyrosine kinase inhibitor selected for clinical trial development. <i>  Proc. Am. Assoc. Cancer Res</i>. <b>1997</b>, <i>38</i>, 633 (Abstract 4251).</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1997&pages=633&author=J.+R.+Woodburn&author=A.+J.+Barker&author=K.+H.+Gibson&author=S.+E.+Ashton&author=A.+E.+Wakeling&author=B%2C+J+Curry&author=L.+Scarlett&author=L.+R.+Henthorn&title=an+epidermal+growth+factor+tyrosine+kinase+inhibitor+selected+for+clinical+trial+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoodburn%26aufirst%3DJ.%2BR.%26atitle%3Dan%2520epidermal%2520growth%2520factor%2520tyrosine%2520kinase%2520inhibitor%2520selected%2520for%2520clinical%2520trial%2520development%26jtitle%3DProc.%2520Am.%2520Assoc.%2520Cancer%2520Res.%26date%3D1997%26volume%3D38%26spage%3D633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00012"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00012" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00012_1"><span><span class="NLM_string-ref">Moyer, J. D.; Barbacci, E. G.; Iwata, K. K.; Arnold, L.; Boman, B.; Cunningham, A.; DiOrio, C.; Doti, J.; Morin, M. J.; Moyer, M. P.; Neveu, M.; Pollack, V. A.; Pustilnik, L. R.; Reynolds, M. M.; Sloane, D.; Theleman, A.; Miller, P. Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase. <i>  Cancer Res.</i><b>1997</b>, <i>57</i>, 4838−4848.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=4848&author=J.+D.+Moyer&author=E.+G.+Barbacci&author=K.+K.+Iwata&author=L.+Arnold&author=B.+Boman&author=A.+Cunningham&author=C.+DiOrio&author=J.+Doti&author=M.+J.+Morin&author=M.+P.+Moyer&author=M.+Neveu&author=V.+A.+Pollack&author=L.+R.+Pustilnik&author=M.+M.+Reynolds&author=D.+Sloane&author=A.+Theleman&author=P+Miller&title=Induction+of+apoptosis+and+cell+cycle+arrest+by+CP-358%2C774%2C+an+inhibitor+of+epidermal+growth+factor+receptor+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoyer%26aufirst%3DJ.%2BD.%26atitle%3DInduction%2520of%2520apoptosis%2520and%2520cell%2520cycle%2520arrest%2520by%2520CP-358%252C774%252C%2520an%2520inhibitor%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D4848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00013"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00013" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00013_1"><span><span class="NLM_string-ref">Fry, D. W.; Bridges, A. J.; Denny, W. A.; Doherty. A.; Gries, K. D.; Hicks, J. L.; Hook, K. E.; Keller, P. R.; Leopold, W. R.; Loo, J. A.; McNamara, D, J.; Nelson, J. M.; Sherwood, V.; Smaill, J. B.; Trumpp-Kallmeyer, S.; Dobrusin, E. M. Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor. <i>  Proc. </i><i>Natl. Acad. Sci. U.S.A.</i><b>1998</b>, <i>95</i>, 12022−12027.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=12027&author=D.+W.+Fry&author=A.+J.+Bridges&author=W.+A.+Denny&author=A.+Doherty&author=K.+D.+Gries&author=J.+L.+Hicks&author=K.+E.+Hook&author=P.+R.+Keller&author=W.+R.+Leopold&author=J.+A.+Loo&author=D%2C+J+McNamara&author=J.+M.+Nelson&author=V.+Sherwood&author=J.+B.+Smaill&author=S.+Trumpp-Kallmeyer&author=E.+M+Dobrusin&title=Specific%2C+irreversible+inactivation+of+the+epidermal+growth+factor+receptor+and+erbB2%2C+by+a+new+class+of+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DSpecific%252C%2520irreversible%2520inactivation%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520and%2520erbB2%252C%2520by%2520a%2520new%2520class%2520of%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D12027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00014"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00014" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00014_1"><span><span class="NLM_string-ref">Smaill, J. B.; Palmer, B. D.; Rewcastle, G. W.; Denny, W. A.; McNamara, D. J.; Dobrusin, E. M.; Bridges, A. J.; Zhou, H.; Showalter, H. D. H.; Winters, R. T.; Leopold, W. R.; Fry, D. W.; Nelson, J. M.; Slintak, V.; Elliot, W. L.; Roberts, B. J.; Vincent,  1397  P. W.; Patmore, S. J. Tyrosine kinase inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(phenylamino)pyrido[<i>d</i>]pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptor. <i>  J. Med. Chem</i>. <b>1999</b>, <i>42</i>, 1803−1815.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1815&author=J.+B.+Smaill&author=B.+D.+Palmer&author=G.+W.+Rewcastle&author=W.+A.+Denny&author=D.+J.+McNamara&author=E.+M.+Dobrusin&author=A.+J.+Bridges&author=H.+Zhou&author=H.+D.+H.+Showalter&author=R.+T.+Winters&author=W.+R.+Leopold&author=D.+W.+Fry&author=J.+M.+Nelson&author=V.+Slintak&author=W.+L.+Elliot&author=B.+J.+Roberts&author=P.+W.+Vincent&author=S.+J+Patmore&title=Tyrosine+kinase+inhibitors.+15.+4-%28Phenylamino%29quinazoline+and+4-%28phenylamino%29pyrido%5Bd%5Dpyrimidine+acrylamides+as+irreversible+inhibitors+of+the+ATP+binding+site+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252015.%25204-%2528Phenylamino%2529quinazoline%2520and%25204-%2528phenylamino%2529pyrido%255Bd%255Dpyrimidine%2520acrylamides%2520as%2520irreversible%2520inhibitors%2520of%2520the%2520ATP%2520binding%2520site%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00015"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00015" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00015_1"><span><span class="NLM_string-ref">Sherwood, V.; Bridges, A. J.; Denny, W. A.; Rewcastle, G. W.; Smaill, J. B.; Fry, D. W. Selective inhibition of heregulin-dependent tyrosine phosphorylation and cellular signaling through erbB2, erbB3 and erbB4 by PD 158780 and a new irreversible inhibitor, PD 183805. <i>  Proc. Am. Assoc. </i><i>Cancer Res</i>. <b>1999</b>, <i>40</i>, 723 (Abstract 4778).</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&conference=Proc.+Am.+Assoc.+Cancer+Res.&author=V.+Sherwood&author=A.+J.+Bridges&author=W.+A.+Denny&author=G.+W.+Rewcastle&author=J.+B.+Smaill&author=D.+W.+Fry&title=Selective+inhibition+of+heregulin-dependent+tyrosine+phosphorylation+and+cellular+signaling+through+erbB2%2C+erbB3+and+erbB4+by+PD+158780+and+a+new+irreversible+inhibitor%2C+PD+183805"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dproceeding%26sid%3Dliteratum%253Aachs%26aulast%3DSherwood%26aufirst%3DV.%26atitle%3DSelective%2520inhibition%2520of%2520heregulin-dependent%2520tyrosine%2520phosphorylation%2520and%2520cellular%2520signaling%2520through%2520erbB2%252C%2520erbB3%2520and%2520erbB4%2520by%2520PD%2520158780%2520and%2520a%2520new%2520irreversible%2520inhibitor%252C%2520PD%2520183805%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00016"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00016" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00016_1"><span><span class="NLM_string-ref">Gogolimska, B.; Gruda, I. Synthesis of bromonitrobenzyl bromides. <i>  Acta</i><i>Polon. Pharm</i>. <b>1963</b>, <i>20</i>, 345−346; <i>Chem. Abstr</i>. <b>1963</b>, <i>62</i>, 463.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1963&pages=346&author=B.+Gogolimska&author=I+Gruda&title=Synthesis+of+bromonitrobenzyl+bromides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGogolimska%26aufirst%3DB.%26atitle%3DSynthesis%2520of%2520bromonitrobenzyl%2520bromides%26jtitle%3DActa%2520Polon.%2520Pharm.%26date%3D1963%26volume%3D20%26spage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00017"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00017" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00017_1"><span><span class="NLM_string-ref">Morley, J. S.; Simpson, J. C. E. The chemistry of simple heterocyclic systems. Part 1. Reactions of 6- and 7-nitro-4-hydroxyquinazoline and their derivatives. <i>  J. Chem. Soc.</i><b>1948</b>, 360−366.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=1948&pages=366&author=J.+S.+Morley&author=J.+C.+E+Simpson&title=The+chemistry+of+simple+heterocyclic+systems.+Part+1.+Reactions+of+6-+and+7-nitro-4-hydroxyquinazoline+and+their+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00017_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorley%26aufirst%3DJ.%2BS.%26atitle%3DThe%2520chemistry%2520of%2520simple%2520heterocyclic%2520systems.%2520Part%25201.%2520Reactions%2520of%25206-%2520and%25207-nitro-4-hydroxyquinazoline%2520and%2520their%2520derivatives%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1948%26volume%3D360%26spage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00018"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00018" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00018_1"><span><span class="NLM_string-ref">Barraclough, P.; Black, J. W.; Cambridge, D.; Collard, D.; Firmin, D.; Gerskowitch, V. P.; Glen, R. C.; Giles, H.; Hill, A. P.; Hull, R. A. D.; Iyer, R.; King, W. R.; Kneen, C. O.; Lindon, J. C.; Nobbs, M. S.; Randall, P.; Shah, G. P.; Smith, S.; Vine, S. J.; Whiting, M. V.; Williams, J. M. Inotropic “A” ring substituted sulmazole and isomazole analogues. <i>  J. Med. </i><i>Chem</i>. <b>1990</b>, <i>33</i>, 2231−2239.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=2239&author=P.+Barraclough&author=J.+W.+Black&author=D.+Cambridge&author=D.+Collard&author=D.+Firmin&author=V.+P.+Gerskowitch&author=R.+C.+Glen&author=H.+Giles&author=A.+P.+Hill&author=R.+A.+D.+Hull&author=R.+Iyer&author=W.+R.+King&author=C.+O.+Kneen&author=J.+C.+Lindon&author=M.+S.+Nobbs&author=P.+Randall&author=G.+P.+Shah&author=S.+Smith&author=S.+J.+Vine&author=M.+V.+Whiting&author=J.+M.+Williams&author=+Inotropic&title=%E2%80%9CA%E2%80%9D+ring+substituted+sulmazole+and+isomazole+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00018_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarraclough%26aufirst%3DP.%26atitle%3D%25E2%2580%259CA%25E2%2580%259D%2520ring%2520substituted%2520sulmazole%2520and%2520isomazole%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D2239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00019"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00019" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00019_1"><span><span class="NLM_string-ref">Roth, G. A.; Tai, J. J. A new synthesis of aryl substituted quinazolin-4(1<i>H</i>)-ones. <i>  J. Heterocycl. Chem</i>. <b>1996</b>, <i>33</i>, 2051−2053.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1996&pages=2053&author=G.+A.+Roth&author=J.+J+Tai&title=A+new+synthesis+of+aryl+substituted+quinazolin-4%281H%29-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00019_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DG.%2BA.%26atitle%3DA%2520new%2520synthesis%2520of%2520aryl%2520substituted%2520quinazolin-4%25281H%2529-ones%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1996%26volume%3D33%26spage%3D2053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00020"><div class="reference"><div class="NLM_citation" id="rightTab-jm990482tb00020_1"><span><span class="NLM_string-ref">Palmer, B. D.; Trumpp-Kallmeyer, S.; Fry, D. W.; Nelson, J. M.; Showalter, H. D. H.; Denny, W. A. Tyrosine kinase inhibitors. 11. Soluble analogues of pyrrolo- and pyrazoloquinazolines as epidermal growth factor receptor inhibitors:  synthesis, biological evaluation, and modeling of the mode of binding. <i>  J. Med. Chem</i>. <b>1997</b>, <i>40</i>, 1519−1529.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=1529&author=B.+D.+Palmer&author=S.+Trumpp-Kallmeyer&author=D.+W.+Fry&author=J.+M.+Nelson&author=H.+D.+H.+Showalter&author=W.+A+Denny&title=Tyrosine+kinase+inhibitors.+11.+Soluble+analogues+of+pyrrolo-+and+pyrazoloquinazolines+as+epidermal+growth+factor+receptor+inhibitors%3A%E2%80%89+synthesis%2C+biological+evaluation%2C+and+modeling+of+the+mode+of+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00020_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DB.%2BD.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252011.%2520Soluble%2520analogues%2520of%2520pyrrolo-%2520and%2520pyrazoloquinazolines%2520as%2520epidermal%2520growth%2520factor%2520receptor%2520inhibitors%253A%25E2%2580%2589%2520synthesis%252C%2520biological%2520evaluation%252C%2520and%2520modeling%2520of%2520the%2520mode%2520of%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D1529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00021"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00021" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00021_1"><span><span class="NLM_string-ref">Thompson, A. M.; Murray, D. K.; Elliott, W. L.; Fry, D. W.; Nelson, J. A.; Showalter, H. D. H.; Roberts, B. J.; Vincent, P. W.; Denny, W. A. Tyrosine kinase inhibitors. 13. Structure−activity relationships for soluble 7-substituted 4-[(3-bromophenyl)amino]-pyrido[4,3-<i>d</i>]pyrimidines designed as inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor. <i>  J. Med. Chem</i>. <b>1997</b>, <i>40</i>, 3915−3925.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=3925&author=A.+M.+Thompson&author=D.+K.+Murray&author=W.+L.+Elliott&author=D.+W.+Fry&author=J.+A.+Nelson&author=H.+D.+H.+Showalter&author=B.+J.+Roberts&author=P.+W.+Vincent&author=W.+A+Denny&title=Tyrosine+kinase+inhibitors.+13.+Structure%E2%88%92activity+relationships+for+soluble+7-substituted+4-%5B%283-bromophenyl%29amino%5D-pyrido%5B4%2C3-d%5Dpyrimidines+designed+as+inhibitors+of+the+tyrosine+kinase+activity+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00021_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BM.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252013.%2520Structure%25E2%2588%2592activity%2520relationships%2520for%2520soluble%25207-substituted%25204-%255B%25283-bromophenyl%2529amino%255D-pyrido%255B4%252C3-d%255Dpyrimidines%2520designed%2520as%2520inhibitors%2520of%2520the%2520tyrosine%2520kinase%2520activity%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D3925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00022"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00022" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00022_1"><span><span class="NLM_string-ref">Trinks, U.; Buchdunger, E.; Furet, P.; Kump, W.; Mett, H.; Meyer, T.; Muller, M.; Regenass, U.; Rihs, G.; Lydon, N.; Traxler, P. Dianilinophthalimides:  potent and selective, ATP-competitive inhibitors of the EGF-receptor protein tyrosine kinase. <i>  J. Med. Chem</i>. <b>1994</b>, <i>37</i>, 1015−1027.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=1027&author=U.+Trinks&author=E.+Buchdunger&author=P.+Furet&author=W.+Kump&author=H.+Mett&author=T.+Meyer&author=M.+Muller&author=U.+Regenass&author=G.+Rihs&author=N.+Lydon&author=P.+Traxler&author=+Dianilinophthalimides&title=potent+and+selective%2C+ATP-competitive+inhibitors+of+the+EGF-receptor+protein+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00022_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrinks%26aufirst%3DU.%26atitle%3Dpotent%2520and%2520selective%252C%2520ATP-competitive%2520inhibitors%2520of%2520the%2520EGF-receptor%2520protein%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D1027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00023"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00023" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00023_1"><span><span class="NLM_string-ref">Fenn, J. B.; Mann, M.; Meng, C. K.; Wong, S. F.; Whitehouse, C. M. Electrospray ionization for mass spectrometry of large biomolecules. <i>  Science</i><b>1989</b>, <i>246</i>, 64−71.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=246&publication_year=1989&pages=71&author=J.+B.+Fenn&author=M.+Mann&author=C.+K.+Meng&author=S.+F.+Wong&author=C.+M+Whitehouse&title=Electrospray+ionization+for+mass+spectrometry+of+large+biomolecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00023_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFenn%26aufirst%3DJ.%2BB.%26atitle%3DElectrospray%2520ionization%2520for%2520mass%2520spectrometry%2520of%2520large%2520biomolecules%26jtitle%3DScience%26date%3D1989%26volume%3D246%26spage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00024"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00024" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00024_1"><span><span class="NLM_string-ref">Stewart, B. H.; Chan, O. H.; Lu, R. H.; Reyner, E. L.; Schmid, H. L.; Hamilton, H. W.; Steinbaugh, B. A.; Taylor, M. D. Comparison of intestinal permeabilities determined in multiple in vitro and in situ models:  relationship to absorption in humans. <i>  Pharm. Res.</i><b>1995</b>, <i>12</i>, 693−699.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1995&pages=699&author=B.+H.+Stewart&author=O.+H.+Chan&author=R.+H.+Lu&author=E.+L.+Reyner&author=H.+L.+Schmid&author=H.+W.+Hamilton&author=B.+A.+Steinbaugh&author=M.+D+Taylor&title=Comparison+of+intestinal+permeabilities+determined+in+multiple+in+vitro+and+in+situ+models%3A%E2%80%89+relationship+to+absorption+in+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00024_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStewart%26aufirst%3DB.%2BH.%26atitle%3DComparison%2520of%2520intestinal%2520permeabilities%2520determined%2520in%2520multiple%2520in%2520vitro%2520and%2520in%2520situ%2520models%253A%25E2%2580%2589%2520relationship%2520to%2520absorption%2520in%2520humans%26jtitle%3DPharm.%2520Res.%26date%3D1995%26volume%3D12%26spage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00025"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00025" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00025_1"><span><span class="NLM_string-ref">Scala, S.; Akhmed, N.; Rao, U. S.; Paull, K.; Lan, L. B.; Dickstein, B.; Lee, J. S.; Elgemeie, G. H.; Stein, W. D.; Bates, S. E. P-Glycoprotein substrates and antagonists cluster into two distinct groups. <i>  Mol. Pharmacol</i>. <b>1997</b>, <i>51</i>, 1024−1033.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1997&pages=1033&author=S.+Scala&author=N.+Akhmed&author=U.+S.+Rao&author=K.+Paull&author=L.+B.+Lan&author=B.+Dickstein&author=J.+S.+Lee&author=G.+H.+Elgemeie&author=W.+D.+Stein&author=S.+E+Bates&title=P-Glycoprotein+substrates+and+antagonists+cluster+into+two+distinct+groups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00025_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScala%26aufirst%3DS.%26atitle%3DP-Glycoprotein%2520substrates%2520and%2520antagonists%2520cluster%2520into%2520two%2520distinct%2520groups%26jtitle%3DMol.%2520Pharmacol.%26date%3D1997%26volume%3D51%26spage%3D1033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00026"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00026" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00026_1"><span><span class="NLM_string-ref">Horio, M.; Lovelace, E.; Pastan, I.; Gottesman, M. M. Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesicles. <i>  Biochim. Biophys. Acta</i><b>1991</b>, <i>1061</i>, 106−111.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1061&publication_year=1991&pages=111&author=M.+Horio&author=E.+Lovelace&author=I.+Pastan&author=M.+M+Gottesman&title=Agents+which+reverse+multidrug-resistance+are+inhibitors+of+%5B3H%5Dvinblastine+transport+by+isolated+vesicles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00026_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHorio%26aufirst%3DM.%26atitle%3DAgents%2520which%2520reverse%2520multidrug-resistance%2520are%2520inhibitors%2520of%2520%255B3H%255Dvinblastine%2520transport%2520by%2520isolated%2520vesicles%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1991%26volume%3D1061%26spage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00027"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00027" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00027_1"><span><span class="NLM_string-ref">Zacherl, J.; Hamilton, G.; Thalhammer, T.; Riegler, M.; Cosentini, E. P.; Ellinger, A.; Bischof, G.; Schweitzer, M.; Teleky, B.; Koperna, T.; Wenzl, E. Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH. <i>  Cancer Chemother. </i><i>Pharmacol</i>. <b>1994</b>, <i>34</i>, 125−132.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1994&pages=132&author=J.+Zacherl&author=G.+Hamilton&author=T.+Thalhammer&author=M.+Riegler&author=E.+P.+Cosentini&author=A.+Ellinger&author=G.+Bischof&author=M.+Schweitzer&author=B.+Teleky&author=T.+Koperna&author=E+Wenzl&title=Inhibition+of+P-glycoprotein-mediated+vinblastine+transport+across+HCT-8+intestinal+carcinoma+monolayers+by+verapamil%2C+cyclosporine+A+and+SDZ+PSC+833+in+dependence+on+extracellular+pH"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00027_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZacherl%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520P-glycoprotein-mediated%2520vinblastine%2520transport%2520across%2520HCT-8%2520intestinal%2520carcinoma%2520monolayers%2520by%2520verapamil%252C%2520cyclosporine%2520A%2520and%2520SDZ%2520PSC%2520833%2520in%2520dependence%2520on%2520extracellular%2520pH%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1994%26volume%3D34%26spage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00028"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00028" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00028_1"><span><span class="NLM_string-ref">Ford, J. M.; Hait, W. M. Pharmacology of drugs that alter multidrug resistance in cancer. <i>  Pharmacol. Rev</i>. <b>1990</b>, <i>42</i>, 155−199.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1990&pages=199&author=J.+M.+Ford&author=W.+M+Hait&title=Pharmacology+of+drugs+that+alter+multidrug+resistance+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00028_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFord%26aufirst%3DJ.%2BM.%26atitle%3DPharmacology%2520of%2520drugs%2520that%2520alter%2520multidrug%2520resistance%2520in%2520cancer%26jtitle%3DPharmacol.%2520Rev.%26date%3D1990%26volume%3D42%26spage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00029"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00029" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00029_1"><span><span class="NLM_string-ref">Rewcastle, G. W.; Palmer, B. D.; Bridges, A. J.; Showalter, H. D. H.; Sun, L.; Nelson, J.; McMichael, A.; Kraker, A. J.; Fry, D. W.; Denny, W. A. Tyrosine kinase inhibitors. 9. Synthesis and evaluation of fused tricyclic quinazoline analogues as ATP site inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor. <i>  J. Med. Chem</i>. <b>1996</b>, <i>39</i>, 918−928.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=928&author=G.+W.+Rewcastle&author=B.+D.+Palmer&author=A.+J.+Bridges&author=H.+D.+H.+Showalter&author=L.+Sun&author=J.+Nelson&author=A.+McMichael&author=A.+J.+Kraker&author=D.+W.+Fry&author=W.+A+Denny&title=Tyrosine+kinase+inhibitors.+9.+Synthesis+and+evaluation+of+fused+tricyclic+quinazoline+analogues+as+ATP+site+inhibitors+of+the+tyrosine+kinase+activity+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00029_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%25209.%2520Synthesis%2520and%2520evaluation%2520of%2520fused%2520tricyclic%2520quinazoline%2520analogues%2520as%2520ATP%2520site%2520inhibitors%2520of%2520the%2520tyrosine%2520kinase%2520activity%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00030"><div class="reference"><div class="NLM_citation" id="rightTab-jm990482tb00030_1"><span><span class="NLM_string-ref">Meier, J. Pharmacokinetic comparison of pindolol with other beta-adrenoceptor-blocking agents. <i>  Am. Heart J</i>. <b>1982</b>, <i>104</i>, 364−373.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=1982&pages=373&author=J+Meier&title=Pharmacokinetic+comparison+of+pindolol+with+other+beta-adrenoceptor-blocking+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00030_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeier%26aufirst%3DJ%26atitle%3DPharmacokinetic%2520comparison%2520of%2520pindolol%2520with%2520other%2520beta-adrenoceptor-blocking%2520agents%26jtitle%3DAm.%2520Heart%2520J.%26date%3D1982%26volume%3D104%26spage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00031"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00031" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00031_1"><span><span class="NLM_string-ref">Fagerholm, U.; Johansson, M.; Lennernas, H. Comparison between permeability coefficients in rat and human jejunum. <i>  Pharm. Res</i>. <b>1996</b>, <i>13</i>, 1336−1342.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1996&pages=1342&author=U.+Fagerholm&author=M.+Johansson&author=H+Lennernas&title=Comparison+between+permeability+coefficients+in+rat+and+human+jejunum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00031_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFagerholm%26aufirst%3DU.%26atitle%3DComparison%2520between%2520permeability%2520coefficients%2520in%2520rat%2520and%2520human%2520jejunum%26jtitle%3DPharm.%2520Res.%26date%3D1996%26volume%3D13%26spage%3D1342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00032"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00032" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00032_1"><span><span class="NLM_string-ref">Schabel, F. M., Jr.; Griswold, D. P., Jr.; Laster, W. R., Jr.; Corbett, T. H.; Lloyd, H. H. Quantitative evaluation of anticancer agent activity in experimental animals. <i>  Pharmacol. Ther</i>. <b>1977</b>, <i>1</i>, 411−435.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1977&pages=435&author=F.+M.+Schabel&author=+Jr&author=+Jr&author=+Jr&author=H.+H+Lloyd&title=Quantitative+evaluation+of+anticancer+agent+activity+in+experimental+animals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00032_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchabel%26aufirst%3DF.%2BM.%26atitle%3DQuantitative%2520evaluation%2520of%2520anticancer%2520agent%2520activity%2520in%2520experimental%2520animals%26jtitle%3DPharmacol.%2520Ther.%26date%3D1977%26volume%3D1%26spage%3D435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00033"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00033" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00033_1"><span><span class="NLM_string-ref">Leopold, W. R.; Nelson, J. M.; Plowman, J.; Jackson, R. C. Anthrapyrazoles, a new class of intercalating agents with high-level, broad spectrum activity against murine tumors. <i>  Cancer Res</i>. <b>1985</b>, <i>45</i>, 5532−5539.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1985&pages=5539&author=W.+R.+Leopold&author=J.+M.+Nelson&author=J.+Plowman&author=R.+C+Jackson&title=Anthrapyrazoles%2C+a+new+class+of+intercalating+agents+with+high-level%2C+broad+spectrum+activity+against+murine+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00033_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeopold%26aufirst%3DW.%2BR.%26atitle%3DAnthrapyrazoles%252C%2520a%2520new%2520class%2520of%2520intercalating%2520agents%2520with%2520high-level%252C%2520broad%2520spectrum%2520activity%2520against%2520murine%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D1985%26volume%3D45%26spage%3D5539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00034"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00034" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00034_1"><span><span class="NLM_string-ref">Elliott, W. L.; Howard, C. T.; Dykes, D. J.; Leopold, W. R. Sequence and schedule-dependent synergy of trimetrexate in combination with 5-fluorouracil in vitro and in mice. <i>  Cancer Res</i>. <b>1989</b>, <i>49</i>, 5586−5590.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1989&pages=5590&author=W.+L.+Elliott&author=C.+T.+Howard&author=D.+J.+Dykes&author=W.+R+Leopold&title=Sequence+and+schedule-dependent+synergy+of+trimetrexate+in+combination+with+5-fluorouracil+in+vitro+and+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00034_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DElliott%26aufirst%3DW.%2BL.%26atitle%3DSequence%2520and%2520schedule-dependent%2520synergy%2520of%2520trimetrexate%2520in%2520combination%2520with%25205-fluorouracil%2520in%2520vitro%2520and%2520in%2520mice%26jtitle%3DCancer%2520Res.%26date%3D1989%26volume%3D49%26spage%3D5590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm990482tb00035"><div class="reference"><strong class="refLabel"><a href="#jm990482tb00035" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-jm990482tb00035_1"><span><span class="NLM_string-ref">Elliott, W. L.; Roberts, B. J.; Howard, C. T.; Leopold, W. R. Chemotherapy with [SP-4-3-(<i>R</i>)]-[1,1-cyclobutanedicarboxylato(2-)](2-methyl-1,4-butanediamine-N,N‘)platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo. <i>  Cancer Res</i>. <b>1994</b>, <i>54</i>, 4412−4418.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1994&pages=4418&author=W.+L.+Elliott&author=B.+J.+Roberts&author=C.+T.+Howard&author=W.+R.+Leopold&author=+Chemotherapy&author=+N%E2%80%98&title=in+combination+with+standard+agents+against+murine+tumors+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm990482tb00035_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DElliott%26aufirst%3DW.%2BL.%26atitle%3Din%2520combination%2520with%2520standard%2520agents%2520against%2520murine%2520tumors%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D1994%26volume%3D54%26spage%3D4418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm990482t&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2000.43.issue-7%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm990482t" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm990482t" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                286KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67990c36ac183c8e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
